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This thesis principally examines the kinetics and mechanism of 
hydrolysis of cirazoline hydrochloride in aqueous solution and the 
stabilising effect of sodium dodecylsulphate (SDDS) which results from 
a variety of drug-surfactant interactions.
The introduction outlines the factors affecting hydrolysis kinetics and 
briefly reviews the stability and medicinal and physicochemical 
properties of imidazolines. The properties of surface active agents 
particularly micellization and solubilization are examined and separate 
sections are devoted to interactions between large organic ions of 
opposite charge and the effect of surfactants on reaction kinetics and 
equilibria. Experimental work is divided into seven sections dealing 
with materials and general methods; HPLC and UV analysis techniques; 
pKa determination; NMR studies into imidazoline acidity; ion-pair and 
complex formation; micellization and solubilization; and kinetics of 
hydrolysis.
The poor stability of cirazoline relative to a series of other 
medicinal Imidazolines was established. Examination of experimental 
data indicates that degradation of cirazoline is mediated through 
uncatalysed and specific base catalysed hydrolysis of the protonated 
species and that the relative instability of cirazoline is due to the 
presence of an ether linkage in the 2-substituent.
(iv)
The interactions between cirazoline and dodecylsulphate ions in aqueous 
solution were studied in terms of ion-pair formation, complexation, 
micellization and solubilization. Aqueous, crystalline complex, liquid 
complex (coacervate) and micellar (pseudo)phases were identified. An 
automated conductimetric titration technique is described for the 
determination of ion-pair association constants, solid and liquid 
complex apparant solubility products (Ks'), CMC values, concentration 
of SDDS required to totally solubilize cirazoline (SOLf) and 
cirazoline-SDDS micelle association constants (K^). The effect of 
temperature, ionic strength and initial cirazoline hydrochloride 
concentration on K s*, CMC, SOL^ and values were evaluated. NMR, DSC 
and solubility techniques were also employed in evaluating the 
interactions.
Experiments to investigate the effect of SDDS on the specific base 
catalysed hydrolysis were performed in the absence of buffer salts at 
pH 7.0 and at temperatures of 30°C and 50°C using 0.2 and 2 x 10“^ M 
initial concentrations of cirazoline hydrochloride. Complexation and 
micellar stabilization mechanisms were Identified and a model is 
proposed for the prediction of rate modifying effects due to both these 
mechanisms.
The physicochemical nature and solubility of a series of imidazoline 
dodecylsulphate and cirazoline alkylsulphate complexes have also been 
studied and the results discussed in the light of their chemical 
structures.
ORIGIN AND SCOPE
Interactions occuring between large organic ions of opposite electrical 
charge are of importance in many areas of pharmacy, e.g. chemical, 
microbiological and physical stability of formulations, compatibility, 
analysis, drug design and drug absorption and d i s t r i b u t i o n ^ ^ .
Tomlinson et al^®0 have suggested that surfactants can protect 
oppositely charged drugs from hydrolysis by ion-pair or complex 
formation and micellar stabilization of labile drugs is a well 
documented phenomenon^1.
Cirazoline is a potent a-adrenergic agonist*^ but is rapidly hydrolysed 
in aqueous solution^. Davies et al^*16 have shown that cirazoline 
may be stabilized by the addition of SDDS although poor tolerance of 
SDDS solutions have prevented its commercial use. This present work 
was initiated in an attempt to characterise much more definitively the 
hydrolysis of cirazoline and to study the interactions between 
cirazoline and dodecylsulphate ions in a fundamental manner in order to 
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1. INTRODUCTION
1.1 DRUG STABILITY AND REACTION KINETICS
Drugs may be formulated into solid, semi-solid or liquid dosage forms. 
As such they are subject to chemical degradation due to the presence 
of, or exposure to water, oxygen, light and ionising radiation. The 
rates of such degradation processes are subject to modification by 
factors such as pH, temperature and the presence of excipients 
including electrolytes, buffers, cosolvents, surfactants, polymers and 
antioxidants. Additionally trace impurities such as metal ions and 
peroxides present in the drug sample, excipients or solvents may 
influence drug stability. Examples illustrating the effect of 
formulation on drug stability are widespread throughout the scientific 
literature and have been the subject of comprehensive reviews and
textsl-^ b
1.1.1 General Hydrolysis Reaction Kinetics
The detailed theoretical treatment of kinetics associated with chemical 
hydrolysis reactions is the subject of many texts^-lO. Consequently 
this section is confined to the expressions which have been used to 
interpret the experimental kinetic data described in section 8 and 
discussed in section 9.
The law of mass action states that the rate of a reaction, at 
constant temperature, is proportional to the product of the molar 
concentration of each reactant raised to a power equal to the number of 
molecules of the substance undergoing the reaction. Hydrolysis 
reactions are generally bimolecular processes involving an attacking
-2-
species and the substrate (S):
aS 4 b (attacking species) — > reaction products
The rate equation may therefore be described by equation 1.1.
Rate ® -d tS] = k# [S]a. [attacking species]^ (1.1) 
dt
Where [] indicates concentration and k is the reaction rate constant. 
The order of reaction, n, is an empirical observation and is defined as 
the sum of the exponents of the concentration terms that occur in the 
observed rate expression, i.e. n * (a+b). If the concentration of 
attacking species is kept constant throughout the hydrolysis process, 
then equation 1.1 may be reduced to:
Rate *= -d tS] * kobg# [S ]n (1#2)
dt
Where kQ^s is the observed rate constant and is equivalent to the 
product of the true bimolecular rate constant, k, and the concentration 
of attacking species raised to the power b. Hence in a controlled 
system whereby the attacking species concentration is maintained 
constant, many hydrolysis reactions are observed to follow first order 
kinetics (i.e. n * 1). For simple unit orders the observed reaction 
rate constant, k0^s, is readily obtained from the integrated form of 
the rate equation 1.2:
for, zero order reactions n=0 and [St] - [SQ ] ■ -k.t (1.3)
first order reactions n=l and loge[St]/[SQ ] * -k.t (1.4)
second order reactions n=2 and l/[St]-l/[S0 ] ■ k.t (1.5)
Where [S0 ] is the initial substrate concentration and [St] is the 
substrate concentration at time t. An alternative method of
-3-
determining first order rate constants is the Guggenheim method. This 
technique involves determining the change in substrate concentration, 
A [S], over a fixed time interval, At, for different initial 
concentration of substrate (equation 1.6):
-k. t
log 10 A [S] - ----  ♦ C (1.6)
2.303
Where C is a constant and t is time. Fractional order reactions often 
show a good fit to unit order equations (e.g. equations 1.3 to 1.5). 
These orders can be determined by studying the reaction at various 
initial substrate concentrations.
1.1.2 Factors Affecting Hydrolysis Reaction Kinetics
(a) Effect of pH and Substrate Species
The hydronium (H30+ ) and hydroxide (OH- ) ions are often very effective 
catalysts for hydrolysis reactions and pH therefore has a marked effect 
on the rate of such reactions. This phenomenon is known as specific 
acid-base catalysis. For a substrate, S, undergoing simultaneous 
uncatalysed and specific acid and base catalysed hydrolysis reactions 
under pH controlled conditions, the observed first order rate of 
reaction may be given by:
-dISl = kobs [S] = kw [S][H20] ♦ k x [S][H30*] ♦ k2[S][OH” ] (1.7)
dt
thus, kobs = ko ♦ ki [H30+ ] ♦ k£ [0H“ ] (1.8)
Where kobs, kw , kj and k£ are the observed, uncatalysed, specific acid 
and specific base catalysed reaction rate constants respectively;
[H£0], [H30+ ] and [OH- ] are the concentrations of water, hydronium and 
hydroxide ions respectively and [S] is the substrate concentration. In
-4-
dilute aqueous solution, [H2O] is large and constant and the water term 
may be written as kQ (= kw [H2O]).
Many drug molecules are capable of existing in different ionic forms 
e.g. imidazolines may exist as the neutral(S) or protonated (SH4 ) 
6pecies. The fraction of each species present is dependent upon the 
pKa of the substrate and the pH of the solution which may be calculated 
from equation 1.9s
pH * pKa 4 login ~ logio ^SH4 t1*9 )
TsFT
Where Vgjj4 is the activity coefficient of the protonated species. Each 
species will be susceptible to hydrolysis at different rates. Under 
these circumstances equation 1.8 must be modified to account for the 
fraction of protonated (fsH4  ^ an(* neutral (fg) species:
*obs = (k0 * *1 [H3O+] + k2 [0H-])fSH4 4 (k3 4 k4 [H30*] 4
k5 [0H“ ])fs (1.10)
Where kQ, k^ and k2 are the rate constants for the uncatalysed, 
specific acid and specific base catalysed reactions respectively for 
species SH4 ; and k3 , k4 and k5 are the equivalent rate constants for 
species S.
(b) General Acid-Base Catalysis
General acid-base catalysis is the rate modifying effect of Lowry- 
Bronsted acids and bases. Buffer salts in reactant solutions are 
known to act as Lowry-Bronsted acids and/or bases and can therefore 
contribute to the observed hydrolysis reaction rate. Thus the observed 
rate constant for a protonated base (such as the imidazolinium ion),
-5-
SH+ , in a buffer salt solution containing both a Lowry-Bronsted acid 
and base is given by:
kobs " (ko k llH30'*'] ♦ [0H“ ] + kg[HA] ♦ ky[A“ ] ♦ kg[B]
4 k9[BH+ ]).fSH* (1.11)
Where kg, ky, kg and k9 are the rate constants due to attack of 
unionized acid, HA, its conjugate base, A*, unionized base, B, and its 
conjugate acid, BH+ , respectively.
(c) Effect of Ionic Strength (i)
The ionic strength of a solution will have a direct influence on the 
rate of a reaction by its effect on the thermodynamic activities of 
reacting species and transition complex. This Is known as the primary 
salt effect. Ionic strength, I, is defined by:
I - 1 y y  Mi Zi2 (1.12)
2 1
Where the summation relates to the number of different ionic species in 
solution, i; M is the molar concentration and z is the charge of each 
ionic species. The relationship between the rate constant and 1 is given 
by the Bronsted-Bjerrum equation:
logiok1 “ log10 k * 2 (-log102±) (1.13)
and -logio?i. = ^z^zgll/2 (1.14)
Where k 1 is the rate constant at ionic strength I and k Is the rate
constant for any specific process i.e. k = ki or k2*..» ki; z^ and zg
are the charges on the interacting ions and A is the Debye-Huckel 
constant which may be calculated from the relative permittivity and
-6-
temperature of the solution:
A = J  2 7TN ~  ”  1.8246xl06 , ,
V —    =  _ mol"1/2 l1/2 K3/2 (1.15)
1000. 2.303 Kb3/2 (£T)3/2 ( E T )3/2
Where N = Avogadro's number 
e = Charge on electron 
KB s Boltzmann's constant 
T = Absolute Temperature (K)
6 = Relative permittivity
Equation 1.14 is usually valid at ionic strengths < 0.01M. For 
solutions of higher concentration (I < 0.1M) a modified form of the 
equation is used:
j  I1/2
- l o g i c a l *  A zAzB ______________  (1.16)
14Bai I1/^
Where B is a second Debye-Hiickel constant, also dependent upon the 
relative permittivity of the solvent and temperature (equation 1.17):
(
8 7T N e 2V -/2 1 50.29 x 10 ® cm"^mol“^/2l^ -/2K"^/2 (1.17)
iooo kb / (et)1/2 TetTTT?
and a^ is the mean diameter of the reacting ions. For most aqueous 
electrolytes at 25°C the product B.a^ is approximately unity and 
equation 1.16 reduces to:
ll/2 (1.18)
-logiofi = A zAzB _____
1 4 11/2
At moderately high ionic strengths, (0.1 - 1.0M), equation 1.16 must be 
further modified to account for the observed increase in Y 4 with
-7-
increasing ionic strength (equation 1.19):
-log10/ l  ■ A z^zgl1/2 - Cl
(1.19)
1 ♦ B a ^ I 1/2
Where C is an empirical constant.
Values of A and B for aqueous systems at different temperatures may be 
obtained from Robinson and Stokes^.
If one or both of the interacting species are uncharged the product 
ZAZB = 0 anc* equation 1.13 predicts an absence of ionic strength 
effects. An effect may be observed at higher ionic concentrations, 
(>0 .1M), however, where activity effects for neutral species may become 
significant. Under these circumstances the effect is best described
Where b is an empirical constant.
A secondary salt effect also exists which is due to the influence of 
ionic strength on the ionization constant, Ka (see equation 1.9). For 
a weak base:
respectively. Since ionic strength influences activity coefficients 
according to Debye-Huckel Law (equations 1.14, 1.16, 1.18 and 1.19), 
it also affects the relative concentrations of the unprotonated, [S], 
and protonated, [SH4 ], species and thus directly influences the rate of 
reaction (equation 1.10). Salt effects of this nature are produced by
by:
log k' = log k + bl (1.20)
[SH+ ] 2fSH+
(1.21)
Where ^S» 0H+ and *SH4 are the activity coefficients of S, H4 and SH4
-8-
both foreign salts and ionizable substrates. With strong acids and 
bases the secondary salt effect is small since the species are almost 
completely dissociated under all conditions.
(d) Effect of Relative Permittivity ( C )
The reaction rate of ionic species is influenced by a change in the 
relative permittivity of the medium due to modification of 
electrostatic interactions between the ions. For an interaction 
between two ions, the effect of relative permittivity, i, , on the 
reaction rate, is given by:
2AZB (1.22)
lQglO K * loSlO k £=0-------
KBTr£
Where kfc=0 is the rate constant at infinite relative permittivity and
r is the radius of the complex obtained from the reactants
A and B and * 4 rB
Hence an increase in £ will result in a decrease in the reaction rate
of oppositely charged reactants and an increase in the reaction rate of 
similarly charged reactants.
(e) Effect of Temperature
The rate of most hydrolytic reactions increases two-to-threefold with 
each 10°C rise in temperature. Two similar expressions based on 
classical collision theory (the Arrhenius equation, equation 1.23) and 
transition state theory (equation 1.24) have been derived to explain 
the relationship between temperature and rate constant, k:
k = A.e"Ea/RT (1.23)
k = RT . e A S */R #e ~AH*/RT (1.24)
Nh
-9-
Where A s Frequency factor
Ea = Activation energy
x
A S  = Standard entropy of transition complex formation 
x
A H  = Standard enthalpy of transition complex formation
h = Planck's constant
R = Gas constant
Equations 1.23 and 1.24 are useful in that the rate constant at any 
temperature may be extrapolated from a series of measurements at 
convenient temperatures.
1.2 2-IMIDAZOLINES
Imidazolines are five membered nitrogen heterocyclic compounds 
possessing a cyclic amidine arrangement of two nitrogen atoms. 
2-substituted-2-imidazolines are partially reduced 4,5-dihydro- 
imidazoles which are substituted in the 2-position. The structure of 
cirazoline and other medicinal imidazolines is shown in figure 1.1.
1.2.1 Medicinal Uses
The pharmacological action of the 2-substituted-2-imidazolines is 
dependent upon the substituent structure and may be classified into 
three main groups^* 13.
(i) a-Adrenergic Antagonist
Tolazoline and phentolamine are a-adrenergic antagonists with direct 
dilator action on the peripheral blood vessels, especially the 
arterioles and capillaries and therefore increase peripheral blood 
flow. They are mainly used in the treatment of peripheral vascular 
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Naphazoline, tramazoline, oxymetazoline, tymazoline, fenoxazollne and 
cirazoline are sympathomimetic agents with marked a-adrenergic 
activity. Naphazoline is a potent vasoconstrictor with rapid and 
prolonged action in reducing swelling and congestion when applied to 
mucous membranes. Cirazoline has been reported to have potent 
a-adrenergic agonist properties but its poor stability has prevented 
its widespread use^"!^. This group of imidazolines is used in the 
form of nasal drops for the relief of nasal congestion and chronic and 
acute rhinitis.
(iii) Hj-antagonists
Antazoline is an H^-antagonist and has the properties and uses of other 
non-imidazoline antihistamine agents such as promethazine. It is one 
of the least active and has a short duration of action. Local 
anaesthetic and anticholinergic properties have also been reported. 
Tymazoline has been reported to possess antihistamine properties but 
its a-adrenergic effects predominate.
In addition, Cifenline has recently been reported to have anti- 
arrhythmic properties^®.
1.2.2 Physlochemical Properties
Physiochemical properties of medicinal 2-substituted-2-imidazolines are 
summarised in table 1.1. These Imidazolines are monoacldic bases and 


































































































R — C —IJJ—C H ^ - C H j - N H ,  
H
I H;
Carboxylic acid R _JJ;_0 H  +  fJH-CH,,—  C H 2~NH,, Ethylenediamine
derivative
Figure 1.2 - General scheme for the protonation and hydrolysis of the 
2-imidazoline ring showing hydrolysis of its primary 
degradation product.
R — C





+  H D O
Figure 1.3 - Acidity of the imidazoline exocyclic methylene protons 
demonstrated by exchange with deuterium from deuterium 
oxide (D2O).
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The Increase in acidity of the conjugate acid from 2-methyl-2- 
imidazoline (pKa = 11.09)19 to phentolamine (pKa * 9.29)^1 follows the 
increase of electron withdrawing ability of the 2-substituent.
Kounterellis has obtained evidence for the acidity of the exocyclic 
methylene protons in nine 2-substituted-2-imidazolines^^. Samples were 
analysed using proton magnetic resonance (PMR) and carbon magnetic 
resonance (CMR) spectroscopy using DMSO and D£0 as solvent. The 
relative acidity of the groups was assessed by determining the time 
required for complete exchange of the exocyclic methylene protons with 
the deuterium from D2O, (figure 1.3). Acidity of the exocyclic 
methylene group was found to be dependent upon 2- substituent structure; 
table 1.1 shows the times given for complete exchange of the protonated 
species.
The differences in imidazoline acidity were explained by the relative 
electron withdrawing nature of the substituent and the presence of 
bulky ortho groups on the aromatic ring (figure 1.1) which restrict 
exchange due to steric hinderance. 2-methy1-2-imidazoline has an 
electron donating (methyl) group and consequently does not exchange.
The acidity enhancement by electron withdrawing substituents results 
from stabilization of the intermediate carbanion through charge 
delocalization. The relatively low acidity of the exocyclic methylene 
groups in cirazoline and tymazoline was explained by the presence of 
bulky ortho groups. However, steric hinderance does not fully explain 
the weak acidity of cirazoline and tymazoline since xylometazoline has 
two methyl substituents which are closer to the exocyclic methylene 
group than the substituents in cirazoline and tymazoline and yet 
xylometazoline exchanges completely in 100 hours (table 1.1).
Comparison of exchange rates obtained by Kounterellis^O is complicated 
by the use of different solvent systems; the ratio of imidazoline, DMSO 
and D2O was varied to enable resolution of PMR peaks. Bimolecular 
reactions usually follow first or second order kinetics and reaction 
rates are therefore dependent upon the concentration of reactants (i.e. 
imidazoline, D2O and OD"). Changes in imidazoline and D2O 
concentrations will therefore affect the exocyclic exchange rate. In 
addition, the pH (or pD) of the system was not controlled and the 
concentration of OH" (OD") would therefore also have been different for 
each system, (imidazolines have pKa values in the range 9.3-11.1 at 
25°C, see table 1.1).
1.2.3 Stability of 2-Imldazolines
A highly characteristic property of the 2-substituted-2-imidazolines is 
their tendency to undergo hydrolysis with the formation of N-acylated 
ethylenediamines on treatment with acids and bases (figure 1.2)23,24# 
Further hydrolysis of these amide derivatives leads to formation of 
ethylene diamine and the carboxylic acid derivative. The rate of 
imidazoline hydrolysis is dependent upon substituent structure and 
species type (protonated or unprotonated). 2-ary1-2-imidazolines are 
generally more resistant to hydrolysis than 2-alky1-2- imidazolines and 
early work indicated the protonated form to be more stable than the 
corresponding free base23. Hoffmann associated this with the highly 
symmetrical 2-imidazolinium ion structure relative to that of the 
uncharged molecule23 (figure 1.2).
The effects of 2-alkyl substituents on the rate of hydrolysis of 1- 
hydroxyethyl-2-imidazoline in 95% ethanol, containing 3.75 x 10"2 M 
NaOH has been studied by Harnsberger and Riebsomer^S. Half-life 
(minutes) for each substituent at 48.9°C, given in the rank order of
-17-
decreasing electron donating ability, was determined as: -0(0113)3 =
612, -CH(CH3)2 = 187, -C17 H35 = 115, -C5 H n  = 118, -C2 H5 = 80, -CH3
= 150 and -H = 14. The ability of the 2-substituent to stabilize 2- 
imidazolines therefore follows the order of electron donating ability 
with the exception of the methyl substituent. The authors proposed 
that the reaction is due to specific base catalysis of the unprotonated 
species through hydrolytic attack on the € +  2-carbon. 2-substituents 
with the ability to reduce the small positive charge through electron 
donation should therefore reduce the probability of attack by 
hydroxide ions. No explanation for the anomolous stability of the 2- 
methyl imidazoline was given however.
In a further study^^, the effect of pH on the hydrolysis of
l-hydroxyethyl-2-penty1-2-imidazoline was reported. The rate of
reaction in buffered one molar sodium perchlorate increased 
proportionally with pH up to pH 11.5 and then tailed off becoming 
independent of pH above pH 12.5. Harnsberger and Riebsomer explained 
the variation in rate of hydrolysis with pH by the formation of a 
complex between the imidazoline base and hydroxide ion. The initial 
reaction is fast and reversible while the reaction of the complex with 
water to form the observed hydrolysis products is rate controlling and 
irreversible. This mechanism has recently been supported in a study by 
Fernandez and Lamden^on the hydrolysis of l-aryl-2-pheny 1-2- 
imidazoline in boiling (80.7°C) 95% ethanolic solutions of potassium 
hydroxide.
This view that the imidazolinium ion is stable relative to the free 
base was contradicted by Martin and Parcell^® who investigated the 
hydrolysis of 2-substituted 2-thiazolines and 2-methy1-2-imidazoline.
Hydrolysis was studied across the ionization region of 2-methyl-2-
-18-
imidazoline and a value of 2.6 (40.1) min"* was obtained for the 
specific base catalysed hydrolysis rate constant for the protonated 
species (k£) at 25°C. These authors claimed that 'statements in the 
literature to the effect that the cationic form of imidazolines is more 
stable than the free base are kinetically incorrect'. A very low rate 
constant for the specific acid catalysed hydrolysis of the protonated 
species was predicted (kj = 2.6 x 10” ^ min” l M”*).
The base catalysed hydrolysis of 2-nonyl-2-imidazoline has been studied 
by Savignac et al^^. The effect of pH in the alkaline region on the 
degradation at 50°C was investigated using carbonate buffer (pH 9.7 - 
10.4) and sodium hydroxide solution (pH 10.3 - 13.0). At pH 9.7 the 
observed rate constant was 2.5 x 10”-> s”  ^ which rose to 34.6 x 10“-> s”l 
at pH 11.6, but became independent of pH above this value.
At high pH there is a very small proportion of the substrate present as 
the protonated species and the authors offer two possible explanations 
for the plateau in the stability-pH profile:
(i) due to attack of water on the neutral form of the substrate;
(ii) reaction of hydroxyl ion on the protonated species.
The second explanation was preferred and a correlation between the 
fraction of protonated substrate and k0^s was attempted. Difficulty in 
determining the pKa of nony1-2-imidazoline due to poor substrate 
solubility and stability and electrode response problems prevented 
production of definitive evidence for the theory. The conclusions 
reached in this work also contradict the mechanism suggested by 
Harnsberger and Riebsomer 25,26#
Savignac et al^9 point out that these reactions should be accompanied 
by a positive or zero entropy change which contradicts their
-19-
experlmental value of -20 cal mol"* K"! for nony1-2-imidazoline. Such 
a mechanism also supposes the accumulation of intermediate which was 
not indicated by their experimental data.
Reported data on the stability of medicinal 2-substituted imidazolines 
is limited. Stern et al^O evaluated the hydrolysis of naphazoline and 
derived an equation relating the observed rate constant for the first 
order hydrolysis reaction (k0^s) to the specific base catalysed rate 
constants for the salt (k£) and base (k5) species and dissociation
constant, K a (equation 1.25)j
/ k2 [H30+] 4 k5.Ka \
log kobs “ "P011 * log | ------------ :  ) (1.25)
\ Ka 4 [H30+ ] /
The effect of pH was investigated in the region pOH 0-8 at 25°C using 
various buffer systems to maintain pH. Experimental data in the range 
pOH = 4-7 showed a linear relationship between log k0^s and pOH with a 
slope of -1.00 indicating exclusive specific base catalysis of the 
protonated species in this pOH region (figure 1.4). A k£ value of 182 
hours"! M“! at 25°C was obtained from the intercept. A plateau in the 
pOH-stability profile was observed in the pOH region 0.5-3 and the 
observed rate constant became independent of pOH. The nature of the
profile indicated that hydolysis of free base does not contribute
significantly to the overall rate constant under the experimental 
conditions, i.e. k£ >>> k5 , although the authors calculated a value of 
k5 = 0.187 hours"! M“! at pH 13 using equation 1.24. Their treatment 
is suspect, however, since deviation between the experimental and 
theoretical stability-pOH profile (calculated using equation 1.25 and 
derived k£ and k5 values) occurs (figure 1.4). An activation energy 
of 16.4 kCal mol”! and frequency factor of 1.91 x lo!^ hours"! was 
determined from the variation of k£ with temperature. Similar
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pOH
Figure 1.4 - Plot of logjQ ^obs versus pOH for the hydrolysis of 
naphazollne at 25°C. Curves were calculated using








Figure 1.5 - Plots of k0bs (log^Q scale) versus pH for the 
hydrolysis of cifenline at the temperatures 
indicated. Curves were calculated using equation 1.26 
(from Ross et al18).
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observations were obtained by Yamana et al^l for the hydrolysis of 
oxymetazoline at 65° and 90°C, pOH 0.5-6.
The kinetics of hydrolysis of tymazoline^ f xylometazoline^ and 
tolazoline^ in the pH range 0.1-7.1 has been studied at various 
temperatures by Grabowska and co-workers. Results show the stability 
of these 2-imidazolines to be heavily dependent upon the nature of the
2-substituent. In phosphate buffer, pH 7.1 (25°C) and 70°C k0bs for 
xylometazoline, tolazoline and tymazoline were calculated as 4.48, 59.7 
and 335 x 10”^ hours”  ^ respectively. The reaction rate was pH 
dependent and the log k0^s - pH profile for xylometazoline and 
tolazoline showed evidence of specific acid catalysis which was absent 
in the tymazoline profile. A rapid rise in rate constants above pH 
about 3.5 occurred for all imidazolines indicating specific base 
catalysed hydrolysis.
Ross et al^® have recently studied the hydrolysis of cifenline at 
pH 7.2 - 12.8, 25 - 80°C. First order rate constants at constant ionic 
strength (1.0 M KC1) were determined from data plotted according to the 
first order rate equation (equation 1.4) or by the Guggenheim method 
(equation 1.6). The log^Q ^obs"PH profile is shown in figure 1.5; 
lines were drawn using equation 1.26.
k0bs ~ ^0 * ^2 [OH ]
K a [0H” ]/Kw + 1 (1.26)
Where Kw is the ionization constant for water.
The data are consistant with a mechanism involving reaction of the 
protonated species with water (at low pH and high temperature only) and 
hydroxide ion (equation 1.26). The authors were unable to fit these 
data to the mechanism proposed by Harnsberger and R i e b s o m e r ^ a n d
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concluded that the data support the simple ionization mechanism 
proposed by Martin and Parcell^S.
The hydrolysis of cirazoline hydrochloride has also been studied by 
Davies et al^-*, Stroud et a l ^  and Fedynec et al^ .  Davies et al 
determined the effect of pH on the observed first order rate constants 
in Macllvaine's citrate-phosphate buffer (ionic strength 0.5 M) at 
80°C^. The log k0t,s ~pH profile in the acid region (pH 2.9 - 7.0) 
showed potent specific base catalysis and the absence of specific acid 
catalysis. The slope of the profile in the region pH 5.0 - 7.0 was 
determined as 0.84 and the authors suggested a buffer catalysis effect. 
An activation energy and frequency factor of 99.3 kJmol"! and 4.86 x 
10^ s’ 1 were calculated at pH 4.6. At pH 7.0, 80°C the first order 
rate constant was 6.72 x 10“^ s”l. Grabowska et found first
order rate constants under approximately the same conditions (pH 7.1, 
80°C) as: tolazoline = 4.45 x 10”^ s”*, and xylometazoline = 3.89 x
KT^s"!, thus highlighting the relatively poor stability of cirazoline. 
Davies et al postulated that the instability of cirazoline is due to 
the presence of the ether linkage which donates electrons to the 
benzene ring and makes the imidazoline ring more susceptable to 
hydrolytic attack^.
1.3 SURFACE ACTIVE AGENTS
A surface active agent, is a compound which adsorbs strongly at an 
interface, for example between air-liquid, liquid-liquid and solid- 
liquid phases, and has the ability to lower the interfacial (surface) 
energy. Surface active materials include polymers such as proteins and 
smaller molecules such as soaps and detergents. The latter are known 
as association colloids due to their ability to aggregate in solution, 
forming particles of colloidal dimensions. The term "surfactant" is
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often taken to mean this type of surface active agent which are 
characterised by the possession of both polar (hydrophilic) and non­
polar (hydrophobic) regions on the same molecule.
The hydrophobic portion of the molecule is most commonly a flexible 
hydrocarbon chain although many compounds contain aromatic hydrophobic 
groups. Typically 8-20 carbon atoms are contained within this moiety. 
The hydrophilic portion may be ionized or consist of a non-ionic polar 
moiety and it is this feature which provides the most commonly used 
classification of surfactant structure; i.e. anionic, cationic, 
zwitterionic and non-ionic surfactants. This dual nature is 
responsible for the amphipathic nature of surfactants and it is the 
balance between the hydrophobic and hydrophilic parts of the molecule 
(ion) which gives the special properties associated with surface active 
agents.
In aqueous solution the hydrocarbon portion interacts only weakly with 
the water molecule and the strong self interaction between the water 
molecules arising from dispersion forces and hydrogen bonding act 
cooperately to "squeeze" the hydrocarbon out of the water. This 
phenomenon is termed the hydrophobic effect. However, the polar or 
ionic portion of the molecule, usually termed the head group, interacts 
strongly with the water via dipole-dipole or ion-dipole interactions 
and is solvated. An amphiphile will therefore, tend to 
accumulate at an interface in such an orientation that its hydrophilic 
head group is anchored in the aqueous phase with its hydrophobic 
portion in minimal contact with the water. These forces are also 
responsible for aggregation or micelle formation in surfactant systems; 
figure 1.6 illustrates some of the structures which may form in 
solutions of amphiphile molecules in water^.
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1.3.1 Mlcelllzatlon
Micelles may be defined as 'aggregates of colloidal dimensions existing 
in equilibrium with the molecules or ions from which they are formed'. 
Micelles may be small aggregates of nearly spherical shape but at 
higher concentration larger micelles which may be lamellar or 
rod-shaped may form. Such micellar aggregates together with the 
monomers from which they are formed constitute a single isotropic 
solution phase. Distinct liquid crystalline phases may exist and 
separation of surfactant-rich phases (coacervation) and solid crystals 
may occur (figure 1.6).
Micellization can be envisaged as the stepwise aggregation of monomers, 
S f using a multiple equilibrium model36“39j
*2
Si 4 S i 5 = ± S 2  
*3
S1 4 s2 s = = ±  s3 
K4
Sj 4 S3 *----: S4
k mSi 4 sN_l5=a*sN
Where Kjj is the micelle equilibrium constant and N is the aggregation 
number. In theory the multiple equilibrium model could result in a 
wide range of micellar sizes from dimers (S2) to extremely large 
micelles (Sjj). However, for typical surfactants the size distribution 
curve is bimodal, the peaks of which represent monomers (and possibly 
dimers and trimers) and monodisperse spherical micellar aggregates.
This self association pattern may be rationalized in terms of the 
factors which promote and inhibit micellar growth. The impetus in 
micelle formation or cooperativity derives mainly from the entropic 
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Figure 1.6 - Possible states of an amphiphile in water, (from Couper^).
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environment to the micelle interior. The efficiency of shielding the 
hydrophobic group from the water increases with increase in aggregate 
size. Factors which limit micelle size (anti-cooperativity) for ionic 
surfactants arise from the progressive increase in charge repulsion 
between the headgroups at the micellar surface as the micellar size 
increases.
Two main approaches to the thermodynamic analysis of micellization have 
been widely used, viz the phase separation and mass action models. In 
the phase separation model the micelles (and counterions for ionic 
micelles) are considered to form a separate phase at the critical 
micelle concentration, CMC, whereas the basic mass action model assumes 
surfactant monomers, (counterions), and micelles are in association- 
dissociation equilibrium. When the aggregation number is large and 
concentrations close to the CMC are considered, both treatments result 
in equation 1.27 for the free energy change of micellization of one 
mole of surfactant ( A G ° jj):
A G° m - RT logg xCMC 4 RT (1 - a) loge xz (1.27)
Where xqjjc and xz are the mole fractions of monomer and counterion 
respectively, R is the gas constant, T is the absolute temperature and 
a is the degree of counterion dissociation.
In the absence of added electrolyte, equation 1.27 reduces to equation 
1.28.
AG°jf = (2 - a) RT loge x ^ C  (1.28)
or expressed in molal concentration terms,
A G ° m - (2 - a) RT logg CMC - (2 - a) RT loge 55.5 (1.29)
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The mass action approach is generally thought to be a more realistic 
treatment than the phase separation model. Assumptions and limitations 
to both methods have been discussed by Franks^ and Attwood and 
Florence^1. Thermodynamic models based on a modified mass action 
model^, a multiple equilibrium model43t44 and the Poisson-Boltzmann 
e q u a t i o n ^ »46 have recently been proposed.
The large negative free energy of micellization results from a small, 
usually positive, enthalpy change, AH° h , and a large positive entropy 
change, AS°fj. In general values of A H ° m decrease with increasing 
temperature and may become negative at high temperatures.AH°m  has been 
measured directly by calorimetry although more usually, it is estimated 
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d (1/T) / K
The standard entropy of micellization is then obtained from equation 
1.31.
A G ° m  - A H ° m - T A S ° m (1.31)
Franks^O has summarised changes in thermodynamic quantities for 
micellization of many surfactants under a variety of experimental 
conditions. Values for SDDS at 25°C have been reported as AH° jj = -1.3 
to 4 2.2 kJ mol"1; AS°^ = 68.6 to 79.9 J mol K"1, giving values of 
AG° m = -22 k J mol"1.
Micellar aggregation is a highly dynamic and reversible process. Fast 
kinetic investigations of micellar solutions show two relaxation times 
with widely different time scales47»48# The slow process has been 




temperature jump, pressure jump and stopped flow techniques enabled an 
estimate of the micelle life-time in the region of AO - 70 x 10"^ 
seconds to be obtained^®. The fast process which has been detected 
using ultrasonic absorption, NMR and ESR techniques has a relaxation 
time of about 6 x 10”^ seconds^® and has been identified with the 
exchange of monomers between the micellar species and the bulk 
solution. Experimental studies into the kinetics of micellization 
have been reviewed by Muller^ and the topic has recently been 
discussed by Aniansson^O.
Evidence for the existence of micelles is based on the fact that 
physical properties of surfactant solutions exhibit an abrupt 
discontinuity which takes place over a narrow concentration range - the 
critical micelle concentration (CMC). The literature from 1926 up to 
1966 has been critically surveyed by Mukerjee and Mysels who have 
published a collection of CMC values for over 700 compounds based on 
333 references and shows some 70 methods have been used for CMC 
determinations^*. Examples of physical properties used in the 
determination of CMC values include osmotic pressure, turbidity, 
solubilization, magnetic resonance, surface tension, conductivity and 
self diffusion; methods which have been employed more recently include 
positron anhilation techniques^ t electron paramagnetic resonance^, 
and keto-enol tautomerism^. The sharpness of the inflexion point at 
the CMC depends upon the aggregation number, N, micellar equilibrium 
constant, K^, and degree of dissociation a. Low N and values 
result in a gradual change in physical property at the CMC.
Micellar aggregation has been the topic of much recent work and many 
reviews and proceedings of international symposia have appeared in the
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literature (e.g. Surfactant Systems^*; Micellization, Solubilization 
and Microemulsions®®, Solution Chemistry of Surfactants®®; Solution 
Behaviour of Surfactants®?; Surfactants in Solution®®; Anionic 
Surfactants^lO»211. an(j Surfactants®®). in this thesis anionic 
surfactants, and in particular SDDS, will be considered in detail but, 
where applicable, reference to other types of surfactant systems will 
be made.
1.3.1.1 STRUCTURE OF IONIC MICELLES
Pioneering work by McBain and Salmon®^ in 1920 suggested the formation 
of two types of micelle, spherical ionic micelles and lamellar neutral 
micelles. G.S. Hartley®* later proposed that the association unit for 
ionic surfactants was spherical with a radius approximately equal to 
the length of a hydrocarbon chain. Many of the counterions were bound 
to the charged headgroups composing the micelle surface and the 
interior of the micelle had the properties of liquid hydrocarbon. The 
internal structure of micelles particularly the extent of water 
penetration and the conformation of alkylchains within the micelle core 
is the subject of considerable controversy. Currently five models are 
proposed:
(i) Hartley's 'Oil' Droplet Model®*
(ii) Menger's 'Pincushion' Model®^
(iii) Fromherz's 'Surfactant-block' Model®®
(iv) Dill and Florey's 'Interphase (Lattice)' Model®^*®®
(v) Gruen's 'Standard Picture' Model®®*®?
The Hartley and Gruen models predict a smooth micelle surface, little 
water penetration into the core and minimal hydrocarbon-water contact 
at the micelle surface. Conversely a rough micellar surface with
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extensive hydrocarbon-water contact is proposed by the Menger, Fromherz 
and Dill and Florey models. The Menger 'pincushion1 model also 
predicts extensive penetration of water into the hydrocarbon core.
Much of the recent literature has re-supported the classical Hartley 
micelle concept as illustrated by the Gruen 'Standard Picture' model^G 
(figure 1.7). The Gruen model predicts symmetrical aggregates in 
which, on average, each amphiphile has almost all of its hydrocarbon 
chain in the micelle core; the ionic headgroups, ions and water are 
almost totally excluded from the core; the chains are conformationally 
disordered (liquid like) and fill the core at approximately liquid 
n-alkane density throughout; the spatial freedom of movement is 
smallest for groups near the headgroup and Increases along the chain; 
the chain may also, to a limited extent, exist outside the core and 
small voids may exist in the core as a consequence.
The layer surrounding the core is termed the Stern layer which 
contains, in addition to the hydrated polar head groups, a number of 
counterions given by (1 - a)N. The Stern layer constitutes the inner 
part of the electrical double layer surrounding the micelle. The 
outer, more diffuse Gouy Chapman layer, contains the remaining aN 
counterions. The thin section of the diffuse layer up to the shear 
plane in addition to the core and the Stern layer are considered to 
form the kinetic micelle, which will migrate under an applied EMF.
In contrast to the micellar core, there is little doubt that the Stern 
layer of ionic micelles is heavily hydrated. Studies into pH- 
independent hydrolysis reactions and the extent of hydration of 











Figure 1.7 - Idealised structure of a SDDS micelle according to the
Gruen 'Standard Picture Model'66. Hydrocarbon core, Stern 
layer, shear plane, and Gouy-Chapman diffuse layer are 
shown, ( = Na4 counterions).
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micelles is little different to bulk water^-®. There is general 
agreement that the relative permittivity, £, of the Stern layer is 
intermediate between the value of 79 for water and two for 
h y d r o c a r b o n s ^ M u k e r j e e  and Rayll^ found the effective £ was 36 near 
the headgroups of dodecylpyridimium iodide micelles and Beunen and 
Ruckenstein^O predict a value of 65 - 70 at the outer compact layer and 
less than 7 at the inner layer of SDDS micelles. The low value of £. 
may be attributed to the large ionic concentration in the Stern layer 
and inner part of the diffuse layer. Cordes calculated that the 
concentration of charged groups at the micellar surface is about 
3 - 5 M; 80% of these charges being neutralized directly through the 
incorporation of counterions^®.
The outer region of the ionic micelle is the Gouy-Chapman diffuse 
layer which contains the excess counterions necessary to neutralize the 
charge of the kinetic micelle. The distribution of ions in this layer 
follows the Boltzmann Law (equation 1.32).
n*_ = n0 exp^ze^^B ^  (1.32)
Where n+^  are the concentration of anions and cation of valency at 
the part of the diffuse layer where the potential is J^and nG is the 
relevant concentration in the bulk, e is the electron charge, Kg is the 
Boltzmann constant and T in the absolute temperature.
The binding of counterions to a micelle may be viewed in chemical terms 
as a mass action type of ion-pairing or as a distribution in a 
Gouy-Chapman type of double layer. The mass action approach may be 
represented for an anionic micelle by equation 1.33.
KM
NS~ ♦ pZ* 5 = *  [SflZp] (N-p)- (1.33)
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Where S“ , Z+ and [SjjZp] correspond to the concentrations of the 
monomer, counterion and micelle respectively; N is the micelle 
aggregation number and is the equilibrium constant for the 
association. The quantity (N-p) is the residual charge on the micelle 
and the degree of counterion dissociation, a, is given by equation 
1.34, where 0 is the degree of counterion binding;
a = 1 - 0 - (N - p) (1.34)
N
Instead of characterising counterion binding by a chemical equilibrium 
description involving specific complex formation (mass action model), 
Gouy-Chapman theory considers a continuous non-specific counterion 
distribution. The difficulty in unamibiguously dividing counterions 
into bound and free ions hence accounts for the different results 
obtained for 0 by different experimental techniques. Lindman and 
Wennerstrom^® recognise the continuous counterion distribution 
principle but point out the usefulness of the degree of counterion 
association. The same authors list some general features of counterion 
binding for simple hydrophilic counterions as;
(i) 0 usually lies in the range 0.5 to 0.8,
(ii) different experimental approaches give the same general picture 
of counterion binding,
(iii) ion specificity is small among monovalent ions but may be 
important for size and shape and for phase equilibria,
(iv) ion competition effects may be marked (e.g. divalent ions 
replace monovalent ions),
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(v) 3 is approximately independent of surfactant concentration,
temperature and alkyl chain length,
(vi) 3 increases slightly with aggregate shape from spheres over rods 
to lamellae,
(vii) 3 is only slightly affected by added electrolyte.
However, the mass action model predicts a change in 3 with temperature, 
added electrolyte and dilution of the system and Lindman^® cites these 
observations as failings of this approach. Gunnarsson et al^9, Jonsson 
and Wennerstrom^^, Beunen and Ruckenstein^, and Frahm and Diekmann^^ 
have recently proposed models for counterion binding based on the 
Poisson-Boltzmann equation.
Franks^® and Anacker^® have summarised values of 3 for various 
surfactants determined using different experimental conditions and 
techniques; values for SDDS solutions at 25°C have been reported as 
between 3 “ 0.62 and 0.86. Recent literature reports give 3 values for 
SDDS as 0.66 ^2 and 0.74 ^3 (EMF measurements) and 0.51 ^4 (metal 
complex formation).
1.3.1.2 THE SIZE AND SHAPE OF MICELLES
A variety of evidence in support of an idealized spherical shape in 
the vicinity of the CMC has been reported for cationic, anionic and 
non-ionic s u f a c t a n t s ^ .  However, several authors have shown from 
geometrical consideration that most of the common surfactants with a 
single hydrocarbon chain cannot form truely spherical micelles^
As the micellar radius is always limited by the maximum possible 
extension of the hydrocarbon chain, it is possible to establish the
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greatest possible aggregation number, Nmax, for spherical micelles of a 
given chain length. Schott calculated Nmax as 39.2, 54.3, 72.0 and
92.2 for C^Q* ®12» ^14 anc* ^16 surfactants, respectively^. These 
values are slightly lower than experimentally determined aggregation 
numbers of 41, 64, 80 and 100 respectively for sodium alkyl sulphates 
at 25°C^^, indicating some lack of micellar sphericity.
Tanford has proposed the formation of oblate and prolate ellipsoids to 
account for larger aggregation numbers, and from theoretical 
considerations, indicates that, except when head group repulsion is 
very strong, oblate ellipsoids are thermodynamically favoured over 
prolate e l l i p s o i d s ^ . Israelachivili et al rejected the oblate 
spheroid because of excessive curvature and proposed a disturbed oblate 
spheroid structure similar in shape to a red blood cell^. Further 
micellar growth was thought to lead to a cylindrical micelle with 
hemispherical ends.
Anacker^® has reviewed the literature regarding micellar shape and 
discussed possible shapes in terms of core surface area per monomer. 
Figure 1.6 shows some suggested shapes of ionic m i c e l l e s ^ .
In contrast to many cationic micelles whose shape is often sensitive to 
concentration, SDDS micelles remain approximately spherical unless 
exposed to high electrolyte concentration^*. The most obvious 
evidence of micellar growth and asymmetry is probably the dramatic 
increase in viscosity of the solution. Other methods used to determine 
micelle shape and molecular weight include light scattering, 
ultracentrifugation, membrane osmometry, magnetic resonance techniques, 




Typical values of aggregation number (N) range from about 20 for very 
small micelles to many hundred for large ones. For SDDS, N has been 
reported to be about 70 (25°C)®^ whilst fluorescent quenching 
techniques give the micelle radius (r) as 1.79 nm8 l.
1.3.1.3 FACTORS AFFECTING CMC AND MICELLAR STRUCTURE
(a) Surfactant Structure
An increase in alkyl chain length results in an exponential decrease in 
CMC and a slight increase in aggregation number, N, and degree of 
counterion binding, p, due to the decreased charge density. Birdi has 
discussed the effect of alkyl chain length on the CMC, N and free 
energy of solubilization in alkylsulphate surfactant systems82. The 
structure, number and position of ionic head groups and the nature of 
the counterion also influence CMC and micellar size. For 
dodecylsulphates, inorganic counterion effects are more dependent upon 
valency than structure within a valency series; (CMC range 6.09 - 8.92 
x 10"3 M, Li4 > Na4 > K4 > Cs4 ; 1.66 - 2.2 x 10"3 M Mn24 > Cu24 > Mg24 
> Co24)83.
The hydrophobicity of organic counterions also has a pronounced effect. 
For a series of alkyItrimethylammonium dodecylsulphates increasing 
alkylchain length from methyl to hexyl reduced the CMC at 25°C from 
5.52 to 1.25 x 10"3 M 83. A similar effect with increasing organic 
counterion hydrophobicity has been noted for cationic pyridinium 
surfactants8^. Berr et al compared the micellar properties of SDDS and 
trimethyl ammonium dodecylsulphate (TMADDS) at 30°C; TMADDS micelles 
were found to be smaller and have a higher charge, smaller degree of 
aggregation and less but more deeply penetrating water than SDDS 
micelles83. These results were associated with the smaller size of the
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sodium Ion which allows a greater number of ions to fit in the 
available spaces around the sulphate head groups causing SDDS to have a 
smaller overall charge than TMADDS.
Counterions may induce striking viscoelastic behaviour in aqueous 
surfactant solutions. Gravesholt®® compared the effect of substituted 
benzoate counterions with that of the conventional bromide counterion 
on the CMC and viscoelasticity of cetyltrimethylammonium (CTA) systems 
at 25° and 40°C. All organic salts studied had low CMC values 
compared to CTAB but theological character was dependent upon 
molecular structure of the counterion; 2-hydroxybenzoate,
3-chlorobenzoate and 4-chlorobenzoate gave rise to viscoelasticity 
whereas 2-chlorobenzoate, 3-hydroxybenzoate and 4-hydroxybenzoate did 
not change the viscosity. The viscoelastic properties of CTA- 
salicylate were further investigated by Ulmius et al using PMR and 
linear dichroism techniques who attributed this behaviour to the 
presence of moderately large rod-shaped micelles which form long range 
periodic structures®^. However, the secondary structure in 
viscoelastic amphiphile solutions must differ fundamentally from the 
ordinary spherical or rod-like micelles since such aggregates do not 
show any viscoelastic effect in pure CTAB solution even at high 
concentration.
Hoffmann et al have recently reported further studies into the 
viscoelastic nature of cetylpyridinium salicylate systems using small 
angle neutron scattering, SANS, static and dynamic light scattering, 
electric birefringence and rheological techniques®®. At 25°C globular 
micelles form above the CMC of the system (1.5 x 10"^ M) but at a 
total concentration of 5 x 10"^ M transition to rod-like micelles
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occurs. At a further characteristic concentration the rheological 
properties change and viscoelastic behaviour is observed.
High viscosities in CTA-tosylate surfactant systems have also been 
reported by Gamboa and Sepulveda®^; a 7000 fold Increase in relative 
viscosity at 25°C occurred as surfactant concentration was increased to 
5 x 10“2 m . Sepulveda and Perez-Cotopoz^O prepared a series of 
cetyltrimethylammonium alkylxanthate salts; methyl, ethyl, n-butyl and 
hexyl xanthate salts had very low solubility and precipitated from 
solution whereas propyl and amyl xanthate salts were extremely soluble 
and formed highly viscous solutions.
(b) Addition of Inorganic Electrolyte
Addition of electrolyte causes a reduction in the thickness of the 
ionic atmosphere surrounding the ionic head groups and a consequent 
decreased repulsion between them. This screening action is attributed 
to counterion binding which reduces the electrical work required for 
micelle formation. Electrolyte effects are primarily governed by the 
concentration and valency of the ions; an Increase of either results in 
a decrease in CMC and Increase in aggregation number.
The CMC of univalent ionic surfactants in the presence of added 
univalent salt, (CMCj), was shown experimentally to be related to the 
total molar concentration of ions (equivalent to the concentration of 
added salt, Cz , plus the concentration of surfactant at the CMC)^1, 
(equation 1.35). Subsequently Tartar derived a similar relationship 
based on Debye-Huckel theory^,
log10 CMCj - a log10 (Cz 4 CMC) 4 b (1.35)
Where a and b are constants for a particular ionic group. Lange
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calculated a as -0.503 for SDDS ^3# Backlund et al^® found CMC 
values of SDDS varied from 8.1 - 1.5 x 10”® M at 25°C as added NaCl 
increased from zero to 0.1 M giving values of a = -0.675 and b = -3.49.
The effect of electrolyte on the size and shape of SDDS micelles and 
in particular the sphere-to-rod transition has been the subject of many 
recent publications^*®® *73 ,94-104. jn 1980 Kratohvil^? critically 
examined the literature values for aggregation number of SDDS in the 
presence of added sodium chloride. Mazer and co-workers used 
quasielastic light scattering to investigate the effects of temperature 
and sodium chloride c o n c e n t r a t i o n ^ - ^ ® . ^ dramatic increase in
micellar weight and a change in shape from roughly spheroidal 
aggregates to a polydisperse distribution of spherocylindrical 
aggregates was observed at 0.45 M NaCl and 25°C (figure 1.8). 
Aggregation numbers of approximately 80 and 1000 were calculated for 
SDDS micelles at 25°C in the presence of 0.15 and 0.6 M NaCl 
respectively. At 18°C and in 0.6 M NaCl an aggregation number of about 
1600 was found and the authors proposed a micellar shape corresponding 
to a prolate elipsoid with a semi-minor axis of 2.5 nm (equivalent to 
two elongated hydrocarbon chains) and semi major axis of 67.5 nm^S.
This work was subsequently critizised by Hayashi and Ikeda who found 
aggregation numbers of 97, 528 and 1630 in 0.1, 0.6 and 0.8 M NaCl 
respectively at 25°C^^-. Recent studies using quasielastic light 
scattering and flourescence quenching have been reported by Chang and 
Kaler^O® and Chen and co-workers^^ respectively.
The extent of counterion binding in micellar SDDS-NaCl systems has been 
studied by Backlund et al using Na+ specific electrodes^®. The degree 
of counterion association, |3, was found to decrease slightly from 0.735 
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Figure 1.9 - Effect of temperature on the CMC of
(a) SDDS , and (b) CH3 (CH2 >9 (OCH2CH2 ^ O H  , 
(from Goddard and Benson-*-^).
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Further increase in NaCl concentration to 0.3 M had no effect on |3.
(c) Addition of Non-electrolyte
The addition of low molecular weight organic additives in aqueous 
solutions of surfactants is known to alter the CMC^l*105,106# -phe m0st 
commonly studied additives have been urea and its derivitives, 
alcohols, sugars and hydrocarbons. Substances that affect the CMC of 
surfactants may be classified as penetrating (a solubilization 
phenomenon) and non-penetrating (a solvent phenomenon).
The interaction between unionised benzoic acid derivatives and 
dodecyl, tetradecyl and cetyltrimethylammonium bromide was investigated 
by WanlO?. 2-hydroxybenzoic acid interacted with the surfactants 
leading to increased viscosity which reached a maximum at 
approximately the concentration where the surfactant solution became 
saturated with acid. Increasing concentrations of 2-hydroxybenzoic 
acid also changed the rheological behaviour from Newtonian to non- 
Newtonian. The interaction was found to be specific to 2-hydroxy 
substitution of benzoic acid as no viscosity effect was observed with 
benzoic acid, 3- and 4-hydroxybenzoic acid, acetylsalicylic acid, or 2, 
3 and 4 substituted isomers of amino, chloro and nitro substituted 
benzoic acid. However, high viscosities have been reported in CTAB- 
benzoic acid systems in the presence of 0.1 M NaBr (relative viscosity 
= 585 in 0.1 M CTAB - 0.025 M benzoic acidic®). These findings are 
somewhat different to those obtained with pure CTA salts by 
Gravesholt®^ (see section (a) ). In this study CTA-3-chlorobenzoate 







The effect of temperature changes on the CMC of ionic surfactants is 
small in comparison with effects of added electrolyte and chemical 
structure of the amphiphile ion. A minimum in the CMC temperature 
curve, Tmin , for ionic surfactants occurs typically between 20° and 
30°C and has been reported as 26°C for SDDSl09,110# Figure 1.9 shows 
the effect of temperature on the CMC of SDDS and the non-ionic 
surfactant, CH3(CH2)9(0CH2CH2)50H m .  The effect of temperature 
increase on CMC is governed by two opposing factors; (a) dehydration of 
the monomers and (b) thermal agitation causing disruption of the 
structured water and reduction in the adhesion forces between monomers. 
Below Tm£n the effect of dehydration is dominant whereas above this 
temperature thermal agitation serves to increase the CMC.
The reduction in adhesive forces between monomers generally causes a 
reduction in micellar size of ionic surfactants with increase in 
temperature. Mazer et al^»95 has studied the effect of temperature 
(10 - 90°C) on the size of SDDS micelles in sodium chloride solutions, 
(figure 1.8). A minimum micellar size corresponding to a sphere with a 
hydrated radius of about 2.5 nm is approached at high temperature in 
all NaCl concentrations.
1.3.2 Solubilization
The literature on solubilization by micelle forming surfactants is 
extensive and has been recently reviewed by Attwood and Florence^1 and 
Mukerjee^O^,106. Solubilization by colloidal surfactants is dependent 
upon the presence of a micellar phase and a characteristic feature is 
the existance of a critical, small range of concentrations below which 
there is no appreciable solubilization and above which the solubility
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increases approximately linearly with the surfactant concentration.
This CMC will generally be lower than the CMC of the system in the 
absence of solubilized species^^.
1.3.2.1 SOLUBILIZATION CAPACITY
The solubilization capacity may be defined as the saturation 
concentration of solubilizate for a given concentration of surfactant 
whilst maintaining a simple isotropic solution^1. The saturated 
solubility of the solute may conveniently be expressed as the ratio of 
the number of moles of solubilizate to the number of moles of 
micellized surfactant, although other notations are used. For a 
particular surfactant this molar ratio is often found to remain 
constant above the CMC over a wide range of surfactant concentrations. 
However, this is not always so and care must be exercised in 
extrapolating data from one surfactant concentration to another^1.
1.3.2.2 MICELLE-WATER DISTRIBUTION CONSTANT
The distribution equilibrium of a solubilizate between micelles and the 
intermicellar solution may be determined under varying degrees of 
saturation.
The distribution of a solute, X, may be rationalized using the phase 
separation model for micellization and defined by the partition 
constant, Kp, (equation 1.36):
K p - [X(M)]
  (1.36)
Ix (aq)J
Where [X(jj)] and [X(aq)] are the concentrations in the micellar and 
aqueous phases respectively. For a saturated system, Kp may be
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obtained from the slope of a plot of saturated solubility of 
solubilizate in the surfactant system Cs, against micellized 
surfactant monomer concentration, [S(m )], (equation 1.37);
Cs = (Kp-l).7.[X(aq)].[S(M )] 4 [X(aq)] (1.37)
Where v is the partial molar volume of surfactant micelles.
Solubility data may also be treated by a mass action approach which
leads to classical Langmuir (equation 1.38) and Scatchard 
(equation 1.39) binding equations*.
r - riKd [X(aq)]
-------------  (1.38)
1 * K d [X(aq)l
r = nKd - rKd (1.39)
[^(aq)J
Where r is the mole ratio of bound solute to total solute, n is the 
maximum number of independent binding sites on the surfactant micelle 
and K d is the intrinsic dissociation constant for the binding of solute
molecules to one of the sites.
The micelle-water distribution equilibrium under unsaturated conditions 
has been determined by^l dialysis, potentiometric titration, gel 
filtration, fluorescent quenching, NMRH2,113 and Raman 
spectroscopy^-^.
1.3.2.3 LOCATION OF SOLUBILIZATE
Surfactant micelles are fluid-like in nature and solute molecules are 
distributed throughout the micelles with a rapid exchange between 
several states of different location, orientation and energy. Some 
locations and orientations may be greatly preferred, however, and it is
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generally accepted that non-polar solubilizates such as aliphatic 
hydrocarbons are essentially dissolved in the hydrocarbon core of the 
micelles whereas semi-polar and polar solubilizates, e.g. fatty acids 
and alkanols, may be orientated radially in the micelle with the polar 
group either buried (deep penetration) or near the micellar surface 
(short penetration).
MukerjeelO^ has described a two state model for slightly polar 
solubilizates (e.g. benzene) involving a distribution between a 
* dissolved state1, associated with the core, and an 'adsorbed state' 
associated with the micelle/water interface. The mild surface activity 
of benzene in heptane/water systems and the extremely high surface-to- 
volume ratio in micelles allowed Mukerjee to predict a 7 to 1 ratio 
of 'adsorbed' to 'dissolved' benzene molecules in SDDS micelles. The 
distribution between the 'adsorbed state' and 'dissolved state' is 
expected to differ for solubilizates of different structures because of 
variations in surface activity and also with micellar size and shape.
Techniques described for determining the location of solubilizate in 
surfactant micelles include X-ray diffraction, adsorption spectrometry, 
NMR, fluoresence depolarization and electron resonance^*.
1.3.2.4 FACTORS AFFECTING SOLUBILIZATION
(a) Solubilizate and Surfactant Structure
The effect of surfactant structure on the solubilizing capacities is 
dependent upon the solubilization site within the micelle. In general, 
for solubilizates located in the micelle core, the solubilizing 
capacity shows a pronounced increase with increase in the alkyl chain 
length of the surfactant.
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Ionic hydrophobic solutes may be solubilized within oppositely charged 
micelles by an ion-binding mechanism in addition to hydrophobic 
attraction forces (see section 1.4.3 ).
Solute polarity, polarizability, chain length, chain branching, 
molecular size, shape and structure have all been 6hown to affect 
solubility in surfactant micelles. No simple relationship exists 
between any single property of a solubilizate and its maximum additive 
concentration in a given surfactant solution. The solubility parameter 
of the solute and the surfactant determine the solubilization site of a 
particular solute and correct matching of these solubility parameters 
enables selection of the optimum surfactant to obtain maximum 
solubilization.
Solubilization of a series of n-alkanols in anionic and cationic 
micelles was investigated by Holland et al^-^. Kp values were 
calculated by a form of equation 1.36 and the standard free energy, 
AG°p, enthalpy, AH°p, and entropy AS°p, for the process:
solubilizate (aq) solubilizate (h )
were calculated from equations 1.40 - 1.42
A G ° p * -RT loge K p (1.40)
d(1/T) (1.41)
AS°p - AH<>p - AG°p (1.42)
T
The energetics of solubilization of n-hexanol in SDDS were determined 
asAG°p *-16.5 kJ mol-*, AH°p = 4.1 kJ mol"l and AS°p * 69 J mol-  ^K~l,
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thus indicating an endothermic reaction and an entropically driven 
solubilization process11^. ^he mean molar standard free energy for the 
transfer of the alcohol from the aqueous to the micellar phase was 
approximately independent of surfactant type and was determined as 
-2.78 kJ mol"1 per methylene group at 298.2 K. This value is somewhat 
smaller than the reported standard free energy change for the transfer 
of alcohol from the aqueous to the pure state of A G °  * -3.31 kJ mol”! 
per methylene groupie.
The thermodynamics of solubilization of phenothiazine and its n-alkyl 
derivatives by sodium, manganese and zinc dodecyl sulphates has been 
studied by Moroi et si11**. Thermodynamic parameters for the 
interaction between monomeric solubilizate molecules and vacant 
micelles were evaluated using the stepwise association model which also 
gives an association constant for the solubilization process.
Maximum additive concentrations of N-ethyl, N-methyl and phenothiazine 
became smaller as the hydrophobicity of the attached alkylchain 
increased. However, the rank order for values is reversed 
reflecting the dependence of aqueous and micellar solubilities on alkyl 
chain length. Evaluation of thermodynamic parameters using equations 
1.40 - 1.42 gave A G °  = -29.0 kJ mol”1, A H 0 - -21.9 kJ mol”1 and 
AS °  * 24 J mol"1 K”1 and the authors therefore proposed that the sites 




Temperature affects micellar solubilization by the following 
mechanisms:
(i) changes in solubilizate aqueous solubility,
(ii) changes in solubilizate micellar solubility,
(iii) changes in the properties of micelles.
Temperature effects are thus heavily dependent upon the nature of the 
solubilizate and surfactant and prediction of temperature effects is 
therefore difficult. In general, however, an increase in temperature 
results in an increase in the amount of solubilization.
(c) Additives
Electrolyte effects on solubilization by ionic surfactants close to the 
CMC are dominated by the increase in available micellar volume brought 
about by the reduction in CMC of the system. At higher surfactant 
concentrations well in excess of the CMC the situation is more complex. 
The effect of closer packing of surfactant within the micelle due to 
reduced repulsion of headgroups may lead to a reduction in the 
solubilizing capacity.
Non-electrolyte additives may have a synergistic or antigistic effect 
on solubilization. Additives which inhibit micellization naturally 
decrease the solubilizing capacity of surfactants.
1.4 INTERACTIONS BETWEEN IONIC SURFACE ACTIVE AGENTS AND OPPOSITELY 
CHARGED ORGANIC IONS
For ionic surfactants, aggregation of surfactant ions in dilute 
solutions below the critical micelle concentration, CMC, is minimal due
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to electrostatic repulsion of the head groups. However, many 
examples of large organic ion-pairs and ion-triplets formed between 
surfactant ions and large organic ions of opposite charge have been 
described. These interactions are driven by electrostatic 
attraction reinforced by a strong hydrophobic effect; the relative 
contribution of each being dependent upon the structures of both ions 
and their immediate environment. The solubility of these ion- 
pairs/triplets is usually low in aqueous systems and phase separation 
due to complex formation occurs when the solubility has been exceeded. 
Solubilization occurs above the CMC of the system due to strong 
micellar binding of the oppositely charged organic ion.
Tomlinson et al have reviewed the literature (1965-80) on ion-pair and 
complex formation between large organic ions of opposite charge and 
have proposed a series of possible physicochemical equilibria 
between two large organic ions when one ion (B) is surface active and 












Such interactions are important in many areas of pharmacy and may 
affect chemical, microbiological and physical stability of 
formulations, and drug absorption and distribution^^,124,133,135,180, 
185-191,207-209
Tomlinson et al have listed twenty methods reported in the literature 
for the study of large organic ion interactions^-^. For this work the
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primary method used for investigating aggregation and ion-pair and 
complex formation was an automated conductimetric titration technique 
based on the method described by Mukhayer and C o - W o r k e r s l 2 0 - 1 2 2 #
1.4.1 Conductance
Ionic compounds such as salts of weak acids and bases dissociate in 
aqueous solution into ions which are free to carry (or conduct) 
current across the solution. Conductance is the reciprocal of 
resistance and is measured in units of Siemens (S). For a given 
electrolyte solution, conductance decreases proportionally with 
Increasing distance between the electrodes, L, and Increases 
proportionally with the cross-sectional area of the electrodes, A. 
Specific conductance,K, is the conductance of an electrolyte measured 
using a standard cell comprising of electrodes of area 1 cm^ spaced 
1 cm apart. The ratio L/A is constant for any given conductivity cell 
and is referred to as the cell constant, KcELL* The relationship 
between specific conductivity and conductivity, G, is shown in 
equation 1.43.
K  s L .G - K c e l l G (Son-1) (1.43)
A
\Cmay be obtained by using the cell to measure the conductivity of an 
electrolyte solution of known specific conductivity at a given 
temperature.
Conductance will depend upon the concentration of ions present in the 
electrolyte solution. The comparative conductance behaviour of 
different electrolytes is therefore assessed by determining the ratio 
of specific conductance to ion concentration. Since electrolyte 
solutions of the same normality have the same charge concentration it is
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more useful to utilise this form of expressing concentration rather 
than molarity. The equivalent conductivity,A , is defined by 
equation 1.44.
A  = 1000 (1.44)
C
Where C is the concentration of ions in equivalents per litre. The 
equivalent conductivity of strong electrolytes at low concentration is 
found to be experimentally a linear function of the square root of 
concentration, decreasing as the concentration increases.
Extrapolation to zero concentration yields the limiting equivalent 
conductivity A ° ,  and the equivalent conductivity at very low 
concentrations can therefore be represented by equation 1.45.
A  - A o  - A cl/2 (1.45)
Where A is a constant for a given system and temperature. At infinite 
dilution, the motion of an ion is limited solely by its interaction 
with the surrounding solvent molecules, there being no other ions 
within a finite distance. Kohlrausch's law of the independent 
migration of ions states that the limiting equivalent conductance for 
an electrolyte is the sum of the limiting equivalent conductances for 
each of its constituent ions, X°+. (equation 1.46).
A °  “ X°4 4 X°_ (1.46)
Limiting ionic conductivities are very sensitive to change in 
temperature. Host aqueous electrolyte solutions have a temperature 
coefficient for conductivity close to 2% per degree at 25°C;
temperature control of 0.05°C is therefore required for an
experimental precision of 0.1%. At any given temperature, the
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product of limiting ionic conductivity and viscosity of water, (A°*)°), 
for many ions is nearly constant suggesting that viscous forces account 
for most of the resistance to the motion of these ions in water.
For ideal solutions equivalent conductance should be independent of 
concentration. However, due to ion-ion interactions the effective ion 
concentration will not increase proportionally with chemical 
concentration and will therefore decrease with increasing concentration 
as activity corrections become more significant. Ion-ion interaction 
effects on conductance arise from electrophoretic and relaxation 
phenomenona.
(a) The electrophoretic effect arises when the solvated ion moves 
through a viscous medium and drags with it the solution in its 
immediate vicinity. Neighbouring ions therefore have to move, not 
in a stationary medium, but with or against the stream according 
to their charge relative to the first ion.
(b) The relaxation effect is due to the disturbance of the symmetrical 
distribution of the ion cloud around any given ion and will tend 
to decrease the velocity of ions. At equilibrum the ionic 
atmosphere is time average distributed with spherical symmetry and 
therefore exerts no net resultant force on a central ion. As the 
central ion moves to an off centre position it experiences a 
restoring force which rapidly dies away as the atmosphere is 
rearranged by the thermal motion of the constituent ions. The 
average restoring force experienced by the ion is called the 
relaxation effect.
These effects are concentration dependent, falling to zero at infinite 
dilution. The Onsager limiting law for conductivity relates the
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limit ing equivalent conductance at infinite dilution,.A0, to the 
equivalent conductance, A ,  at ionic strength, I, (equation 1.47).
A  = A ° H 2 . 8 0 1  x 106|zAzB|qA° 4 41.25 (|zA| 4 |zB|)
t
£1)3/2 (1 4 q 1/2) tj ( £.T )1/2
I1/2 (1.47)
Where zA and zB are the charges on the respective ions, q is the 
mobility function, £  is the relative permittivity, T is the temperature 
(K) and is the viscosity of the solution. A simplified form is 
given by equation 1.48;
A  = A° - (B 1 ~A .° 4 B2 ) 11/2 (1.48)
Where B^ and B2 are coefficients related to the relaxation and 
electrophoretic effects respectively and are available from standard 
tablesll. For a solution 1:1 of electrolyte containing a single 
species of concentration, C, equation 1.48 becomes equation 1.49;
A  = A° - (Bi-Zl0 4 B2 ) C1/2 (1.49)
For weak electrolytes, the degree of dissociation, a, decreases with 
increasing concentration (equation 1.50) which results in a marked 
reduction of A values as the overall concentration rises.
K eq = o2c (1.50)
1-a
Where K e9 is the ionization constant (equivalent to K a for an uncharged 
weak acid and for an uncharged weak base). The degree of 
dissociation can be obtained from the conductance ratio, equation 
1.51.
a - A  (1.51)
A0
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The Onsager limiting law (equation 1.48) is therefore, modified for 1:1 
weak electrolytes to correct for a, equation 1.52.
-A. - [JL° - (BjJl0 ♦ B2)(*C)1/2 ]a (1.52)
1.4.2 Ion Association and Complex Formation
The generalised form for the interaction between an anion, e.g. an 
anionic surfactant monomer, Sn"(aq), and a cation, XP4(aq), in aqueous 
solution to form a sparingly soluble associated species, SpX n (aq)» and 
a complex, SpXn(c), may be expressed by the following equilibria:
K as s
pSn (aq) 4 nKp4(aq) 3=-"— * SpXn (aq) — SpXn(c)
Kdiss
Where Kass and K^iss are the association and dissociation constants for 
S p ^ n ( a q ) •
1.4.2.1 ION-ASSOCIATION
K aSs defined by equation 1.53:
a spXn(aq)
Kass * --------  “----- <1-53)
(aSn“ (aq))p-<ax p4(a q))naq.
For 1 : 1  electrolytes, such as cirazoline hydrochloride and sodium 
dodecylsulphate, the association may be defined by the ion-pair 
association constant, K^p, (equations 1.54 - 1.56):
3 SX(aq)
K lp -     (1.54)
3 ® (aq) • 3 ^+(aq)
and at low Ionic strengths (<1x10“^ M), where activity can be replaced
-55-
by molar concentration, [ ]:
[SX(aq)]
K ip -   (1.55)
[S ( a q ) H X ^ ( a q)]
[sx( a q ) ]
or, K ip - —    ■■ ■    (1.56)
<[NaS(aq)]T - [SX(aq)])([XCl(aq)]T-[SX(aq)])
tfhere [NaS(aq)]^ and [XCl(aq)]^ represent the total concentrations of 
the two interacting electrolytes (with sodium and chloride 
counterions).
Mukhayer and D a v i s ^ l  have described an automated conductimetrie 
titration method whereby K^p may be determined from observed deviation 
from theoretical conductivity values when the following assumptions are 
made:
(i) the degree of dimerisation (if any) of the surfactant and/or 
organic salt does not change appreciably during the titration,
(ii) the type of ion-pair association does not change appreciably 
during the titration,
(iii) activity effects with respect to the various ionic species can 
be ignored.
The technique involves titrating a moderately concentrated solution of 
surfactant into distilled water (titration I) and a dilute aqueous 
solution of the organic salt (titration II). The calculation of K^p 
for a 1:1 ion-ion interaction (with sodium and chloride counterions) 
may then be described as follows:
the specific conductivity of the surfactant (^jas) at any point during 
titration I is given by equation 1.57:
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J<NaS * 1000 = JL° NaS [NaS(aq)]T (1.57)
If no ion-pair formation occurs during titration II the theoretical 
specific conductance of the mixture k mix at any point in the titration 
would be given by equation 1.58s
K mlx x 1000 = _/L° NaS [NaS(aq)]T ♦jl°XCl [XCl(aq)]T (1.58)
However, since the formed ion-pairs are neutral and non-conducting, the 
experimentally, observed specific conductivity (lC'mix) at any P°*nt 
during titration II is described by equation 1.59.
K.'mix x 1000 “ .A? NaS (tNaS(aq)]^ " [^X(aq)]) 4 (1.59)
_/L°XCl ([XCl(aq)]T - [SX(aq)]) ♦ [SX(aq)] a ° Na+ ♦X°Cl->
Subtraction of equation 1.59 from 1.58 yields:
& K m l x  x 1000 = (j^nix ” mix^ x 1000 = (1.60)
J.O NaS tS^Caq )] ♦ J[P XCl tsx(aq)i “ tSX(aq)]. (^°Na4 4 A°C1"^
A k m i x  x 1000 
<-^ -°NaS 4 ^vXCl* “ (^ °Na4 4 X°ci“ )
and [SX(aq) ] = “ ---------        (1.61)
A k m i x  at any glven concentration of NaS may be calculated as follows;
the theoretical specific conductivity of the mixture, Kmix> w^en no 
ion-pairing takes place is given by equation 1.62:
\Cmix = t^NaS ^(aq)J 4 ^ X C l  ^(aq)J (1.62)
Where^C(aq) is the specific conductance of the conductivity water, 
k'mix should also be corrected for the specific conductivity of the
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solvent. Thus combining equations 1.60 and 1.62 givesAKju^ at any 
surfactant concentration:
^ K m i x  " ^NaS " ^(aqP 4 ^^XCl " ^(aq)^ ~ mix ~ ^(aq)^ “
^Na S  " K(aq)^ “ ^'mix “ ^ XC1> (1.63)
Experimental data from titrations I and II allow the solution of 
equation 1.63 forA)^mix and also provides -^°NaS and -^"°xci*^°Na4 
and A°ci" are obtained from standard tables, hence equation 1.61 can be 
solved for [SX(aq)] at any point in titration II. Since [NaS(aq)]T and 
[XCl(aq)]T in titration II are also known, K^p is thence calculated from 
equation 1.56.
M u k h a y e r ^ 2  and Tomlinson et a l ^ ^  have collated the reported ion-pair 
association constants for various organic anions and cations at 25°C 
and have found a relationship between the total number of carbon atoms 
in the ion-pair and their association constants. K^p values where the 
surfactant is SDDS were reported as 13 M"* (-Me^N4), 19 M“  ^ (-Et4N4),
21 (-Pr^N4 ), 156 (benzyltriphenyl phosphonium) and 7280 M-^
(“CioH2lMe3N4)H^ •
1.4.2.2 COMPLEX FORMATION
Phase separation to form an insoluble hydrophobic complex occurs when 
the solubility of the associated species is exceeded. Hoyer and 
Doerr^^ have investigated the interaction of sodium and hydrogen 
dodecylsulphate with decyltrimethylammonium iodide and hydroxide. 
Decyltrimethylammonium-dodecylsulphate complex was prepared by two 
methods, (a) by mixing equimolar concentrations of aqueous 
decyltrimethylammonium hydroxide and hydrogendodecylsulphate solutions, 
and (b) by mixing equimolar concentrations of aqueous solutions of the 
corresponding salt forms and storage in an ice bath. Method (a)
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produced a turbid microemulsion system which was stable for more than 
three years (diuturnal system) whereas method (b) resulted in 
precipitation and the formation of a crystalline solid. Dissolution of 
these crystals by heating resulted in a microemulsion system with 
similar properties to that obtained by method (a), except that of
stability; within 3-4 hours gross phase separation occurred (caducous
system).
Barry and Russell have investigated the interaction of commercial 
alkyItrimethylammonium bromides with amaranth (anionic dye) using 
surface tension, viscosity, light scattering, microscopy, 
microelectrophoresis, spectroscopy and phase studies^^. Liquid 
droplets of complex were formed when dilute aqueous solutions of 
surfactant and dye were mixed, but floccules formed at high 
concentrations and at very high concentrations some viscoelastic systems 
were observed. The interaction product was termed a 'complex 
coacervate* and exhibited typical behaviour of coacervates in an 
electric field e.g. electrophoresis, disintegration and deformation. 
Coacervation describes the separation of a colloidal solution into two 
liquid layers, one of which is rich in colloidal component and the other
poor. Barry and Gray studied complex coacervation of
alkyltrimethylammonium bromides (Cj2 " ^*16^  with aqueous solutions of 
the anionic dyes tartrazine, amaranth, carmoisine and erythrosine and 
suggested the phenomenon was the result of rapid micellar growth^^.
For all these systems phase separation only occurred at certain mixing 
proportions and temperatures; an excess of dye or surfactant, presence 
of inorganic salt and Increase in temperature all supressed 
coacervation. Their proposed theory of complex coacervation suggested 
the dye induces formation of surfactant micelles at concentrations that 
are well below the CMC of the pure surfactants in water; e.g. a forty
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fold reduction in the CMC of tetradecylmethylammonium bromide at 40°C 
was predicted upon addition of 1.5 x 10"^ M amaranth.
Complex coacervation has also been reported in systems containing 
alkyltrimethylammonium bromide - di and trihydroxy bile salts^^, sodium 
dodecylsulphate - benzyltriphenylphosphonium c h l o r i d e ^ 7 f 
alkylbenzyldimethylammonium chloride - sodium c r o m o g l y c a t e ^ ^ 8 , 129f 
alkylbenzyldimethylammonium chloride - indigo c a r m i n e ^ ^ 8  an(j sodium 
dodecylsulphate - tris (1,10-phenanthroline) iron (II)130,
Lemordant and Gaboriaud^O reported a turbid coacervate phase in the 
latter system which cleared with the formation of a crystalline 
precipitate upon standing. These crystals were isolated by filtration 
and were readily soluble in organic solvents. At high detergent to 
metal chelate ratios, red crystalline needles were formed 
instantaneously and simultaneously with the coacervate phase. Formation 
of crystalline complexes of methylviologen-didodecylsulphate, 
methylviologen-dialkyl sulphonates (C^q - Ciq)131»132 and 
cetyltrimethylammonium-alkylxanthates^O have also been reported.
Sepulveda and Perez-Cotopoz^ prepared cetyltrimethylammonium-alkyl 
xanthates by mixing aqueous solutions of the surfactant bromide and 
xanthate potassium salts at 5°C. CTA-methyl-, ethyl-, butyl- and 
hexylxanthate salts formed solid complexes which were poorly soluble in 
water. CTA-propyl and amylxanthate complexes were also prepared but 
these salts had a high solubility in water giving viscous solutions.
This unexpected behaviour was rationalized in terms of the odd/even 
alteration rule that is usually found in homologous alkyl series when a 




Complexation between oppositely charged ions may be characterised by the 
stoichiometric solubility product, K s. The dissociation constant for 
interaction in aqueous solution, K^^g, is defined by equation 1.64:
(aSn-(aq))P-(aXP+(aq))n
Kdiss ’ ------------------------  (1-64)
aSpXn(aq)
At equilibrium, and in the presence of a separate complex phase 
aSpXn(aq) will be constant and equal to unity (saturated solution). The 
product of the ion activities is then constant and is known as the 
intrinsic solubility product which is defined by equation 1.65:
K s = (aSn-(aq))P-<aXP+(aq))n (1.65)
Writing activities as the product of concentration, [], and activity 
coefficient, (equation 1.66):
K s “ [Sn-(aq)]p -[XP+(aq))n-( ^ S n-(aq))P.( flXP+(aq))n (1.66)
The apparent solubility product, K s', is defined by equation 1.67 and is 
related to the intrinsic solubility product, K s , by equation 1.68.
Kg' “ [Sn‘ (aq)]p -[Xp*(aq)ln (1-67)
Ks = Ks\( 0 Sn-(aq))P.(2fxP*(aq))n (1.68)
For uni-univalent systems such as cirazoline hydrochloride and SDDS, K s 
and Kg* may be expressed by equations 1.69 and 1.70 respectively.
Kg - (ag (aq)^•(aX+(aq)^ ~ ^  (aq)1•t^+(aq)1• (^i)^ (1.69)
Kg' “ [S-(aq)][X+ (aq)] “ K s .(3\)-2 (1.70)
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W h e r e ^ ^  is the mean activity coefficient of the ions which at low ionic 
strengths (<1 x 10“^ M) approaches unity and K s* * K s. In the presence 
of complex, and when SX(aq) ->0, K s' may be expressed by equation 
1.71.
K s* " (IS]T - [SX(C)]) ([X]T - [SX(C)]) (1.71)
Where [S]^ and [X]T are the total concentrations of anion and cation 
mixed in the system and [SX(C)] is the concentration of precipitated 
complex. Hence, assuming K s' is constant above the complexation 
point, [SX(C)], (and therefore [S"(aq)] and [X*(aq)]), may be solved 
using the quadratic form of equation 1.71.
The solubility product for the interacting ions may be related to the 




Which for a 1:1 salt becomes:
Cs * K s,1/2 (1.73)
Equation 1.73 has been used by Sepulveda and Perez-Cotopoz in the 
determination of cetyltrimethylammonium-alkylxanthate solubility 
products^0 . A more accurate method for determination of K s* which 
enables the exact stoichiometry of the interaction to be calculated is 
the automated conductimetric titration technique described by 
Hukhayer^-2^, Mukhayer et al^O^ Mukhayer and Davis^l and reviewed by 
Tomlinson et al^-^. For surfactant organic ion interactions, the 
technique involves titrating a concentrated solution of the surfactant 
against a dilute solution of the organic salt. In this way problems 
with micellization of the surfactant in the reaction vessel are usually
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avoided. The end-point of the titration for the formation of insoluble 
complex is given by a marked change in gradient of the conductimetrie 
titration trace (figure 1.10a) and the solution usually goes turbid at 
this point. The apparant stoichiometric solubility product may then be 
obtained from a knowledge of the concentrations of organic ion and 
surfactant at the end-point (equation 1.67) and the stoichiometry of the 
interaction.
An interesting phenomena was observed by Tomlinson and Davies^® in the 
study of complexation between alkylbenzyldimethylammonium chlorides 
(ABDAC) and bischromones and ABDAC and indigo carmine. 'Typical* 
conductimetric titration traces (figure 1.10a) were obtained for the 
former systems but all ABDAC-indigo carmine systems produced the 
unusual and characteristic profiles shown in figure 1.10b where 
conductance rose to a maximum followed by a fall to a minimum and then a 
further rise. These 'atypical' conductimetric titration traces were 
explained by flocculation of indigo carmine in the presence of added 
surfactant. The end-point for the titrations in these systems was taken 
as the point where the initial fall off in conductivity occurs (point A 
in figure 1.10b) rather than where the sharp breakpoint occurs.
1.4.2.3 FACTORS AFFECTING IONIC INTERACTIONS
Tomlinson et a l ^ ^  have reviewed the literature on factors affecting 
ionic interaction and phase stability up to 1980; a brief summary of the 
literature is given here.
(a) Temperature
The onset and character of complex coacervation in ATAB-dye mixtures 
have been shown by Barry and Gray to be heavily dependent upon 































Volume (mis) Indigocarmine (1 x 10”3M) added
Figure 1. 10 - Automated conductimetric titration trace for, (a) sodium cromoglycate (SCG) versus 2.6 x lCT^M 
terdecylbenzyldimethylammonium chloride and (b) indigocarmine versus 1 x 10"3M quindecylbenzyl- 
dimethylammonium chloride, at 25°C, (from Tomlinson and Davis^-23)
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below 40°C although at higher temperatures a dispersed phase consisting 
of isotropic oily droplets was produced333. For tartrazine-, 
erythrosine- and amaranth- surfactant systems, viscous mesomorphic 
phases were often produced which changed into isotropic oil droplets as 
the temperature rose.
Tomlinson et al observed that for six different interacting systems, 
changes in K s' with temperature over the range 5° -60°C exhibit minima 
(Tm in) between 14° and 20°C339. The relationship between K s* and 
temperature was described by the polynomial expression,
(equation 1.74) 119,129,134,135.
log K s* - A-BT*CT2-DT3 (1.74)
The standard free energy change,AG°f, standard enthalpy change,AH°f, 
and standard entropy change,AS°f, of complex formation was calculated 
using equations 1.75 to 1.77 since the activity of the saturated 
solution of the complex is taken as unity (see equation 1.64)33^:
A G ° f = RT logg K s (1.75)
loge K s « A Hff - AS^f (1.76)
RT R
A G ° f = AH°f - T A S ° f (1.77)
Tomlinson et al have observed that for most reported systems, AH°f and 
AS°f are both positive and relatively high at low temperatures, but as 
the temperature is increased above the minimum, AG°f becomes more 
negative and the process becomes primarily enthalpically controlled with 
large negativeAH°f values and smaller positive AS°f values33^.
Mukhayer and Davies explained these temperature effects on coacervate 
formation by coulombic and hydrophobic interactions32^ . At lower
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temperatures the interaction process is controlled by entropic factors 
(hydrophobic interactions) and the stability of the coacervate 
increases (i.e. K s decreases) with temperature. At higher temperatures 
the interaction process is controlled by enthalpic factors (coulombic 
interactions) and the stability of the coacervate decreases (i.e. K s 
increases) with temperature. Although at higher temperatures ion-pair 
formation and complex coacervation between the hydrophobic ions may be 
reduced due to the melting of water structure, the temperature Increase 
also lowers the relative permittivity which should result in an increase 
in ion-pair formation; and the resultant of these opposing effects is a 
large negative enthalpy and a small positive entropy of complex 
formation. However, positive AH°f and AS°f values have been obtained 
for alkylsulphate-alkylpyridinium and alkyltrimethylammonium ion 
s y s t e m s l l ^ ,  alkylbenzyldimethylammonium chloride - SGC s y s t e m s ^ 9 f an<j 
phenothiazine -SDDS systems^^. Table 1.2 shows selected thermodynamic 
parameters for complex formation in (a) BTPC -SDDS^^,
(b) dodecylbenzyldimethylammonium chloride - S C G ^ 9 f an(j
(c) chlorpromazine - SDDS systems^^.
However, the free energy of complex formation should be calculated with 
respect to mole fractions, or in molal terms using equation 1.78s
A G ° f - RT loge K s - RT loge 55.5 (1.78)
HenceAG°f values calculated using equation 1.75, (and therefore, 
derivedAS°f values calculated from equation 1.77), are not valid. AG°f 
and AS°f values for the systems in table 1.2 were recalculated using 









<°C) (kJmol-1) (kJmol-!) (Jmol-k"1)!
1
I
|(a) BTPC-SDDS 5 -6.95 -37.0 12.8
1
179 |
1 (-46.3) (212) |
1 10 -6.98 -37.8 8.0 162 j
1 (-47.3) (195) |
1 30 -6.97 -40.4 10.7 98 j
1 (-50.5) (131) j
50 -6.76 -41.8 28.3 42 j
1 (-52.6) (75) | 
11
| (b) DDBDAC-SCG 5 _ -51.9 12.2
1
231 j
l (-61.2) (264) |
I 35 - -57.1 -24.2 107 j
l (-67.4) (140) j
l 50 - -58.5 -38.2 62 j
I1
(-69.3) (96) | 
11
| (c) CP-SDDS 10 -8.38 -45.4 -24.5
1
74 j
l (-54.9) (107) |
I 30 -8.03 -46.6 -34.0 22.5 j
I (-56.7) (75) j
I 50 -7.52 -46.6 -46.6 1.5 j
l
i
(-57.4) (33) | 
1
Table 1.2 - Selected thermodynamic parameters for complex formation in 
(a) benzyltriphenylphophonium chloride - SDDS (BTPC- 
SDDS)^^, (b) dodecylbenzyldimethylammonium chloride - 
sodium cromoglycate (DDBDAC-SCG)^9t and chlorpromazine - 
SDDS (CP-SDDS)135 systems at the temperature indicated.
(Figures in parentheses areAG°f andAS°f values calculated 
using equations 1.78 and 1.77).
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(b) Structure
The effect of alkylchain length on K s' has been studied in 
benzyltriphenylphosphonium chloride (BTPC) - sodium alkylsulphate 
systems!-^»137, alkylbenzyldimethylammonium chloride (ABDAC) - sodium 
cromoglycate (SCG) systemsl29,128  ^ ABDAC - indigo carmine systems^®»129 
and more recently in cetyltrimethylammonium bromide (CTAB) - alkyl 
xanthate^O and alkyltrimethylammonium bromide (ATAB) - sodium saccharin 
(SS) systems^^. An increase in hydrophobicity (alkylchain length) in 
all systems resulted in an enhanced interaction and a reduction in the 
solubility of the complex. The logarithm, of K s', (or K s), is linearly 
related to the number of methylene groups in the alkylchain, n, 
according to equation 1.79:
log K s ' = a - bn (1.79)
where a and b are constants. Each additional methylene group in the 
alkylchain, n, has been found to provide a constant increment to the 
free energy of complexation of d(AG°f)/dn * "3.5 kJmol” -^ (ATAB-SS)^^, 
-3.20 kJmol” ! (BTPC -sodium alkylsulphate)136 .137, an(j -3.17 kJmol"! 
(ABDAC-SCG)128,129# ^ similar value (-3.5 kJmol"!) was obtained by
Sepulveda and Perez-Cotopoz^O for the transfer of the methylene group 
attached to the xanthate moiety in CTAB-alkylxanthate systems at 25°C 
although Mukhayer and Davies reported a smaller value of -1.01 kJmol"! 
for transfer in substituted phosphonium chloride - SDDS systems^®. The 
latter workers compared the thermodynamics of transfer of the methylene 
group from aqueous phase to complex phase in BTPC - sodium alkylsulphate 
systems to that for the transfer to various other non-aqueous phases at 
25°c 136. Thermodynamic parameters for the complexation process show the
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complex phase is consistant with a liquid-like or coacervate phase with 
some solid-like structure!®8 .
Values of the enthalpy, d(AH°f)/(jn» and entropy, d(AS°f)/(jn , of transfer 
of the methylene group from the aqueous environment to the BTP- 
alkylsulphate complex at 25°C have been estimated from plots of AH°f and 
AS°f versus alkylchain length, linear plots were obtained and d(AH°f)/<jn 
and d(AS°f)/dn were calculated as approximately -2.0 kJmol”1 and 5 J mol” 
1 K"1 respectively1®8 . Similar values of d( AH°f)/dn = -1.50 kJmol"1 and 
d(AS°f)/dn “ 11«2 J mol"1 K"1 were obtained for ABDAC-SCG systems at 
25 ©c 128,129.
The effect of substituents on the solubility of complexes has been 
examined by Mukhayer and Davies (substituted BTPC - SDDS systems)138, 
Tomlinson and Davies (substituted ABDAC - SCG systems)12®, and Tomlinson 
et al (substituted phenothazines - SDDS systems)1®®. For the former 
system, the size of the cation (given by the molecular weight) was found 
to be a determining factor in the interaction1®®. A simple relationship 
did not, however, exist in the substituted ABDAC - SCG system; the 
presence of both methylene and chloro groups in the cation reduced K s* 
but position of the chloro group and proximity to other chloro groups 
also influenced the interaction's. An excellent correlation between 
K s* and the surface activity of the cations involved in the interaction, 
as measured by the CMC, was obtained, however. For five different 
systems, a linear relationship as expressed by equation 1.80 was found.
log Kg' * A. log CMC - B (1.80)
Where A and B are constants which have been determined as A = 3.16, B = 
3.70 for ABDAC - SCG systems128, A = 1.91, B = 3.06 for BTPC - SDDS 
systems11^, and A = 3.23, B = 6.26 for ABDAC - indigo carmine systems11^.
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(c) Ionic Strength
Added electrolyte can greatly affect the stability of the complex 
coacervate phase^-^,125,127,134# jn general, inorganic salts suppress 
coacervation and their effect increases with an increase in the valency 
of the inorganic i o n s ^ 5 e Barry and Gray have shown that for 
tartrazine, amaranth and erythrosine - ATAB systems the extent of 
coacervation is decreased by the addition of s a l t ^ 3 # However, 
coacervation in carmoisine-ATAB systems was increased upon addition of 
inorganic salts and a secondary coacervation area was observed in 
systems containing sodium citrate. Mukhayer and Davies^7 have 
investigated the effect of SDDS concentration on the solubility of BTPC- 
SDDS systems in the presence of added sodium chloride and found that the 
greater the concentration of SDDS in excess of the stoichiometric 
requirement, the less salt was required to supress coacervation.
Complete supression of coacervation was obtained if sufficient salt was 
added; this was explained by charge screening of the Interacting species 
causing a reduction in mutual attraction coupled with a lowering of the 
CMC of the system.
The effect of ionic strength on complex formation in the BTPC-SDDS 
system has been studied in terms of the solubility product of the 
systemic. For uni-univalent ions such as in the BTPC-SDDS and 
cirazollne hydrochloride-SDDS systems, the intrinsic solubility product, 
K s , may be expressed by equation 1.81 and 1.82.
Ks - (CB 2^40)2 = (Cg'&i)2 (1.81)
log cs' - log cB2f i0 - log Kii - log cs + AI1/2 (1.82)
{
Where Cs and C s' are the concentrations of the large complexing ions at 
zero and at i concentrations of added electrolyte, and )f and are
i
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the mean ion activity coefficients at zero and i concentrations of added 
electrolyte. For the BTPC-SDDS system at 25°C and low ionic strength, 
(l<0.1 M), Mukhayer and Davis^^ found an approximately linear 
relationship between log C s' and I1/2 as predicted from equation 1.82. 
Above I ■ 0.1 M, however, solubility increased markedly more than 
predicted by equation 1.82 and this deviation was discussed in terms of:
(i) the large size of the ions and the high degree of hydration,
(ii) increased formation of BTP*-DDS“ , BTP*-C1“ and DDS"-DDS“ ion- 
pairs at high ionic strength, and
(iii) micelle formation.
The authors summarised the effects of ionic strength on coacervate 
solubility by two separate processes; at low ionic strength, (l=<0.1 M), 
the activity coefficient decreases with increased electrolyte 
concentrations as predicted from the Debye-Huckel limiting law,
(equation 1.14), and the complex is salted in; above I * 0.1 M 
aggregation of DDS" monomers (micellization) occurs and the activity of 
the ions decreases markedly and the solubility of the complex shows a 
corresponding increase.
Strictly, the Debye-Huckel limiting law (equation 1.14) used in equation 
1.82 is only valid at I < 0.01 M. However, this invalid approximation 
can not account for the observed increase in C s* as at high ionic 
strengths (I * 0.1 - 1.0 M) increases and may even become larger 
than unity (equation 1.19).
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1.4.3 Hlcellar Binding of Oppositely Charged Organic Ions
1.4.3.1 ASSOCIATION CONSTANT
The association of an organic ion with an oppositely1charged surfactant 
micelle may be defined by the equilibrium^»139-142s
KA
x4(aq) 4 S" ( M ) 5 = *  SX(M) 
and characterised by the association constant, KA :
Ka  = [SX(M)] (1.83)
tx + ( a q ) H S  (M) ]
Where [SX(j^)] is the concentration of organic ion incorporated into 
micelles, [X4(aq)] is the molar concentration of organic ion in water, 
and.[ S “ ( a qjJ is the concentration of micellized monomers of surfactant 
which are not bound to the organic ion, all expressed with respect to 
the total volume of the system.
The thermodynamics of the association process may be calculated using 
equations 1.84 - 1.86, where AG°A , AH°A and AS°A are the standard free 
energy, enthalpy and entropy change for the association process.
AG°a = -RT loge kA “ RT lo8e 55«5 (1.84)
a h °a a s °a (1.85)
= - —  + ------loge 55.5
RT R
= AH° a - T AS° a (1.86)
The interaction between CTAB micelles and sodium p-toluenesulphate, 
sodium toluate, sodium benzenesulphonate and sodium phenylphosphate was 
investigated by Sepulveda using an UV absorption method which 
distinguished between free (or aqueous) and micellar bound anions-^^.
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Data were examined assuming that the micelles were composed of a certain 
number of sites each of which was accessible to one molecule of the 
corresponding anion. Results showed values in the range 1.3 - 2.2 x 
10^ and the number of CTAB molecules per anion in the range 1.3 - 
2.5.
In later studies transfer free energies for a variety of unionised, 
anionic and cationic benzene derivatives from water to CTAB^^»^^- 
and SDDS^l micelles were determined from values. For a series of 
substituted phenols and phenoxide ions values ranged from 0.026 -
0.43 x 10^ for phenol to p-t-amylphenol and from 0.2 - 2.7 x 10^ M“l 
for their corresponding ions. The contribution of each methylene (or 
methyl) group to the free energy of transfer to CTAB micelles was 
calculated as -1.3 kJ mol"* for both unionised and ionised species; the 
negative charge of the phenoxide ion was found to contribute -4.8 kJ 
mol"l to the process. However, a recent comparison of binding 
constants for heterobi-, tri-and tetracyclic cations to SDDS micelles 
with those of the corresponding uncharged carbocyclic solubilzates 
showed that the difference between the neutral and charged compounds was 
small^2# it was proposed that the opposing dual electrostatic effects 
of the positive charge which increases both water solubility and 
micellar interaction approximately cancelled, which resulted in no 
significant change in the value of the association constant!^.
The binding of alkylxanthates to CTAB micelles has been investigated in 
a comprehensive study by Sepulveda and Perez-Cotopoz^O. The interaction 
was described by the solubility product, K s, CMC and K^. In the 
presence of precipitated CTAB-xanthate complex (SX(C)) it was shown that 
the fraction (f) of total xanthate [X]T associated with micelles (SX(^j))
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is given by equation 1.87.
f * [SX(M)] = KA .KS #[s]T 4 ( Ka.Ks W ^s " CMC - [X]t\ (1.87)
“W  CMC. [X]^ V CMC. [X]y^CMC /
Where [S]^ is the total concentration of surfactant .KA can therefore be 
calculated from the slope of a plot of f against [S]^, providing
[SX(m )]» K s and the CMC of the system are known.
Calculated K s, CMC, and KA values for CTAB - 1 x 10"^ M xanthate
systems at 25°C are reproduced in table 1.390. Free energies of
transfer of xanthates from water to complex, ( AG°f), and to CTAB 
micelles ( A G ° a ), are also shown for each xanthate system. Increasing 
hydrophobicity of the alkyl xanthate ion results in a decrease in the 
CMC of the system and an increase in association constant (with the 
exception of methyl xanthate). The similarity in KA (and A G ° A ) values 
for the lowest members of the series (methyl-propyl) was rationalized by 
considering the association of methyl and ethyl xanthates to be 
essentially electrostatic in nature and the hydrophobic contribution of 
the methyl and ethyl moieties is therefore minimal.
1.4.3.2 PHYSICOCHEMICAL NATURE OF IONIC SURFACTANT-ORGANIC ION 
AGGREGATES
Large organic ions of opposite charge often have a profound effect on 
the structure of ionic surfactant micelles. These interactions have 
been investigated by spectrophotometric, fluoresence, conductimetric, 
polarographic and stop-flow methods^®"148# Abe et a l ^ ®  studied the 
binding of 4-phenylazo-l-naphthylamine with six sodium n-alkylsulphates 
and found the presence of 1.6 x 10"^ M dye reduced the CMC for each 
surfactant; e.g. the CMC of SDDS in the absence and presence of dye was 
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Table 1.3 - Critical micelle concentration (CMC), solubility products
(Ks), association constants (KA ), and transfer free energies 
of xanthates from water to solid CTAX ( AG°f ) and from 
water to CTAB micelles ( AG° a ) for each 1 x 10"^ M 
alkylxanthate - CTAB system at 25°C. (From Sepulveda and 
Perez-Cotopoz^O).
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processes were identified dependent upon SDDS concentration;
(a) monomer complexation below the CMC of the dye-surfactant 
aggregate, (b) aggregation at surfactant concentrations between the 
dye-surfactant CMC and the CMC of the pure surfactant and, (c) 
aggregation at surfactant concentrations in excess of the pure 
surfactant CMC. Similar findings were reported by Sato et all*4 who 
investigated the interaction of 3,3'-diethylthiacarbocyanine iodide 
with SDDS; 1:1 aggregates and precipitate were formed at low SDDS 
concentrations or 'lower premicellar region'; an increase in SDDS 
concentration resulted in the formation of dye-rich induced micelles in 
the 'higher premicellar region'; further increases caused deaggregation 
of the dye due to dilution by SDDS and formation of ordinary micelles 
above the CMC. However, the CMC was not measured in the presence of 
the dye as this was assumed to have only a small effect on the CMC 
value. Similar conclusions were reached by Park and co-workers^-*»14 6 
in a study involving the interaction of methyl viologen and SDDS.
The rates of adsorption and absorption of positively charged dyes into 
anionic micelles of sodium alkylsulphates were investigated by Robinson 
et al^7,148 W^Q proposed a two step mechanism; a very rapid diffusion 
controlled adsorption onto the micelle surface followed by slow 
intercalation or absorption into a more strongly bound site in the 
hydrocarbon interior of the micelle. A more recent study, however, 
concluded that the micellized site of dyes is close to the surface of 
SDDS micelles206.
The effect of cationic surfactants on the size of SDDS micelles is 
varied. Almgren and Swarup 149,81 an(j Malliaris et al^ 0 found 
alkyItrimethylammonium bromide surfactants induced micelle growth the 
degree of which was dependent upon mole fraction of SDDS^ 0 whereas
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symmetrical ions such as tetraalkylammonium and tetraphenylphosphonium 
ions have been reported to shrink micelles and act as spacers between 
the SDDS headgroups®l>1^9,151# This latter effect is most marked with 
the most hydrophobic ion studied-tetraphenylphosphonium chloride - 
where 4.5 x 10"^ M and 16.6 x 10”^ M ion reduced the mean aggregation 
number of 5 x 10“^ M SDDS to 64.5 and 40.6 respectively at 20°C.
The effect of sodium tosylate (NaTOS) and sodium benzenesulphonate 
(NaBS) on the viscosity of CTAB micelles at 25°C was investigated by 
Gamboa and Sepulvedal52# ^11 systems exhibited non-Newtonian flow and 
relative viscosities were therefore calculated for zero flow rate. 
Relative viscosities increased with increasing CTAB concentration for 
both systems, e.g. for 5 x 10”^ m NaTOS, CTAB range 0.2 - 7 x 10"^ m, 
relative viscosities rose from 1.7 to 1 x 10^. NaBS had a similar 
viscosity raising effect but to a lesser degree. The authors also 
demonstrated that if sufficient organic counterions were added to a 
micellar solution initially containing inorganic counterions, the 
micelle would finish up with only bound organic counterions and the 
system corresponded to a solution having the new micellar species,
i.e. complete ion exchange. The viscosity raising effect of added 
sodium bromide was demonstrated by the addition of 5 x 10”^ M NaBr to 
5 x 10"2 M CTA-T0S which increased the relative viscosity from 7 x 10^ 
to 1.6 x 10^ 152.
The high viscosities observed in these systems were interpreted in 
terms of micellar sphere-to-rod transition which occurs over a certain 
range of concentration of either surfactant or added salt. Axial 
ratios were calculated as 80, giving a rod length of 418 nm, for both 
CTAB-NaTOS and CTAB-NaBS systems. The transition was considered as 
coalesence of spherical micelles for which two negative and two
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positive factors contributing to the free energy were identified. 
Negative contributions favouring coalesence arose from a decrease in 
the interfacial tension due to a decrease in micelle surface area and 
attractive van der Waals forces. Positive contributions inhibiting 
coalesence were due to the decrease in the number of kinetic particles 
which involved a decrease in the entropy of the system and repulsion of 
the head groups derived from their closer approximation in a 
cylindrical micelle. The second positive contribution could be 
diminished by increasing the ionic strength of the solution and/or by 
adding counterions that are strongly bound to micelles.
High viscosities and large micelle molecular weights in 
tetradecyltrimethylammonium bromide (TTAB) - sodium deoxycholates 
systems has been reported which is dependent upon mole percent of 
TTABl26# Such effects were not observed with TTAB - sodium cholate 
systems and it was concluded that the differences in micellar structure 
were due to the distribution of the hydroxyl groups on the steroid 
nucleus.
Davis et a l ^ 5  have recently reported the formation of viscoelastic 
gels in sodium saccharin - alkyltrimethylammonium bromide (SS-ATAB) 
mixtures. A rapid rise in viscosity occured at concentrations well 
above that necessary for the formation of a ljl complex which was 
explained by the formation of large rod-like micelles above the CMC of 
the system. The concentration of SS-ATAB at the critical viscosity 
point, CMC and onset of complex formation (=(Ks)1/2) were all related 
to alkylchain length of surfactant, n, by equation 1.88.
log C = a-bn (1.88)
Where C is concentration and a and b are constants for a given
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concentration parameter. The contribution of the methylene group to 
micelle formation and complexation (obtained from b, equation 1.88) are 
identical indicating the similarity between the two processes.
1.5 SURFACTANT EFFECTS ON REACTION RATES AND EQUILIBRIA
The extensive literature regarding surfactant effects on reaction 
kinetics and chemical equilibria has been the subject of numerous 
reviews^®»153-160  ^ recent examples are Attwood and Florence^!, 
Sudholter et al!®!, Chaimovich et al!®2 and Bunton!®®. Surfactant 
micelles are known to affect a diverse range of chemical reaction rates 
and may catalyse or inhibit reactions involving hydrolysis, oxidation, 
reduction, nucleophilic substitution, elimination, polymerisation, 
photochemical and electron transfer processes. The reaction pathway 
may also be influenced by the presence of surfactants and there are a 
number of examples of micellar control of reaction products and 
stereoselective synthesis®®®»^!»!®®. In addition to producing kinetic 
effects, micelles may affect the equilibrium of chemical reactions and 
the term Micellar catalysis' may therefore be regarded as somewhat 
incorrect as a 'true' catalyst must not shift the equilibrium to a 
considerable degree!®®. However, this term is much used in the 
literature and is useful because the surfactant is not utilized in the 
reaction and produces a marked effect on the reaction rate when added 
in low concentrations.
Reactivity in surfactant systems is of considerable pharmaceutical 
Interest as optimization of surfactant type and concentration may 
enable stabilization of labile drugs and excipients and prevent 
unwanted interactions leading to destabilization of pharmaceutical 
products. The literature up to 1983 has been reviewed by Attwood and 
Florence and includes examples of micellar inhibited hydrolyses of
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aspirin, indomethacin, chloramphenicol, procaine, p-aminobenzoate, 
p-aminophenylacetate, nicotinic acid esters, benzocaine and 
derivatives, homatropine, penicillin and cephalosporins^. Other 
recent examples include a five fold reduction in the rate of hydrolysis 
of indomethacin and related compounds by SDDS, (C^gTAB catalysed the 
reaction)!®^. inhibition of the acid catalysed hydrolysis of p-lactam 
antibiotics by polyoxyethylene-23 lauryl ether and CTAB, (SDDS 
catalysed the reaction^®®), pH dependent inhibition and catalysis of 
aspirin by CTAB and cetylpyridinium chloride^-®^, a mechanistic change 
in the acidic hydrolysis of diazepam by SDDS^®®, and the inhibition of 
the base catalysed hydrolysis of cirazoline by sodium 
alkylsulphates^®*1®, sodium dodecylethoxysulphates^® and sodium 
polyoxyethylene sulphate^.
Davies et a l ^  investigated the rate modifying effect of SDDS on a 
4 x 10”® M solution of cirazoline hydrochloride at pH 7.0 and 40°C in 
the presence of Mcllvaine's citrate-phosphate buffer (ionic strength * 
0.5 M). Equimolar concentrations of cirazoline hydrochloride and SDDS 
resulted in the formation of an insoluble complex. Solubilization of 
this in excess SDDS above its CMC yielded marked stabilization; shelf 
lives, calculated for pH A .6 , Increased from 18 weeks in the absence of 
surfactant to 8.7 and 1A years at concentrations of 3.0 and 
6.0 x 10“2 M SDDS respectively.
In a later study, performed under similar experimental conditions, 
these workers investigated the effect of solubilization of cirazoline 
dodecylsulphate complexes in 10% PEG A00, 5% Tween 80, sodium 
alkylsulphates (C^q “ Cl2^ an<* s°dium dodecylethoxysulphates (E2 - E4) 
on the stability of cirazoline^-®. Solubilization by 10% PEG and within 
the non-ionic micelles of Tween 80 had no effect on the rate of
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hydrolysis of cirazoline. The degree of stabilization afforded by 
solubilization in excess SDDS was found to be a function of both 
cirazoline and SDDS concentration. For 5 x 10”^ M cirazoline 
hydrochloride, no effect was observed at SDDS concentration at or below 
1 x 10-3 M, indicating the absence of premicellar stabilization of the 
drug-surfactant complex (CMC = 4.5 x 10“^ M ) ^ .  At SDDS concentrations 
between 5.0 - 7.5 x 10“^ M, marked stabilization occurred, the 
magnitude increasing with surfactant concentration (figure 1.11a). At 
higher concentrations of cirazoline hydrochloride (4 x 10"^ M) a 
similar stability-SDDS cocentration profile was produced except that 
the curve was shifted to higher SDDS concentrations due to an increase 
in the CMC of the system (figure 1.11a).
The effect of alkylsulphate chain length on cirazoline stabilization is 
shown in figure l.llb^. For a given surfactant concentration the 
stabilizing effect was found to increase with increasing chain length 
which was explained in terms of changes in the CMC, micellar 
partitioning, aggregation number and complex association constants. A 
linear relationship was observed between the stabilizing factor and 
alkylchain length for a given concentration of surfactant^.
The hydrophilic nature of sodium dodecylethoxysulphate surfactants 
(Empicols and Texapon ASV) was also investigated. A linear 
relationship with negative slope was obtained between the stabilization 
factor and number of ethylene oxide groups, reflecting the increase in 
CMC together with a decrease in micellar partition and complex 
association constants with increasing hydrophilic properties of the 
surfactants^.
The stability of cirazoline hydrochloride (4 x 10"^ M) in the presence 
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Effect of sodium alkylsulphate concentration on the stabilization factor (k(aq)/kSDDS) for the 
hydrolysis of cirazoline hydrochloride at 40°C, pH 7.0,Macllvaines buffer, ionic strength = 0.5M ,
(a) 5 x 10“4 and 4 x 10"3 M cirazoline hydrochloride in the presence of SDDS, and (b) 5 x 10”4 M 
cirazoline hydrochloride in the presence of sodium alkylsulphates (C10 - C^), (from Stroud et al16)
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also studied by Fedynec et al^; a mean stability factor of 4.0 was 
reported which was independent of temperature (22 - 50°C).
1.5.1 Mechanism of Micellar Effects on Reaction Rates
The interface formed at the ionic headgroups of micelles in the 
presence of a surrounding aqueous environment provides an unusual 
microenvironment in which chemical reactions may occur^-®. The 
mechanism of micellar effects on chemical reaction rates may be 
rationalised in terms of medium (or polarity) effects and proximity
effects*^.
1.5.1.1 MEDIUM EFFECTS
Micelles have solvent properties different from those of water (section
1.3.1.1), e.g. they are less polar and therefore rate constants in the 
micellar environment could be different in accordance with dielectric 
constant changes^^, (section 1.1.2(d)). In addition the mutual 
orientation of the reactants in the micelle may influence the rate of 
reaction. These effects are difficult to quantify for bimolecular 
processes such as hydrolysis reactions, however, spontaneous 
unimolecular reactions provide a means of investigating reaction rates 
in micelles; e.g. anionic decarboxylations, arylsulphate anion 
decompositions and arylphosphate dianion decomposition reactions are 
slower in water than in less polar solvents and micellar catalysis at 
the surface of both cationic and nonionic micelles is observedl^»164. 
(Anionic micelles have no effect on these reactions probably because 
the negatively charged substrates remain in the aqueous phase). In 
contrast S^i reactions are much faster in water than in less polar 
solvents and micellar inhibition is observed*^.
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Comparison of aqueous k^(aq), and micellar, bimolecular (2nd
order) reaction rate constants is complicated by the need to assess a 
volume element for reactions within the micellar pseudophase; this is 
usually taken as the Stern layer because the micelle surface is the 
assumed reaction site for most micelle catalysed reactions.
Reported results indicate that micelles may have a catalytic effect, 
(i.e. k^(H) > k^(aq), e.g. the reaction of azide ion with 
2 ,4-dinitrochloronaphthalene, k^(jj)/k^(aq) « 400); an inhibitory 
effect, (i.e. k^jj) < k^(aq), e.g. acid catalysed benzidine
rearrangment); or no significant effect, (i.e. k ^ ^ )  ®^k^(aq), e.g. the 
alkaline hydrolylsis of carboxylate or phosphate esters), on 
bimolecular reaction rates^^. Published results for micellar effects 
on bimolecular reactions have recently been summarised by Romsted^^.
1.5.1.2 PROXIMITY EFFECTS
Proximity effects result from micelles bringing reactants together or 
by keeping them apart. The contribution of these effects is largely 
determined by the extent of the ionic (coulombic) and hydrophobic 
interactions between the reactants and the micelles.
In 1934 Hartley proposed a set of rules to predict the expected 
direction of micellar effects on the apparant pKa (pKa') shifts of 
acid-base Indicators!^• Anionic micelles should attract hydrogen ions 
from bulk solution and therefore increase the extent of protonation of 
solubilized weak bases and decrease the dissociation of solubilized 
weak acids. Conversely, cationic micelles should repel hydrogen ions 
and therefore have opposite effects to anionic micelles. The 
Importance of these coulombic effects on the interaction between ionic 
micelles and reactive ions was recognised many years ago; for example
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the rate of reaction of a variety of hydrophobic substrates with 
nucleophiles was increased by cationic surfactants because the micelles 
could incorporate both substrate and the reactive nucleophile^^.
These reactions were inhibited by anionic surfactants because the 
micelles incorporated the substrate but repelled the reactive 
nucleophile.
1.5.2 Factors Affecting Micellar Catalysis and Inhibition
For most systems the presence of surfactant micelles is necessary 
before substantial rate effects are observed. Hence factors which 
govern the amount and nature of the micellar pseudophase and the 
association of substrate(s) to the micelles also affect the extent of 
stabilization or catalysis (see sections 1.3.1.3, 1.3.2.4 and 1.4.3). 
However, surfactant and substrate structure, charge and the presence of 
additives, (particularly electrolytes), are also of fundamental 
importance.
1.5.2.1 SURFACTANT AND SUBSTRATE STRUCTURE
The nature and degree of the rate modifying effects due to the presence 
of surfactant micelles are difficult to predict. The coulombic and 
hydrophobic interactions which control micellar catalysis and 
inhibition are illustrated by the data in table 1.4, (from Bunton^^). 
Coulombic interactions are evident but hydrophobic interactions are 
also important as shown by the effect on some reactions by non-ionic 
micelles. In general, for bimolecular reactions involving at least one 
charged species coulombic factors are of prime importance and the most 
potent effects are observed using ionic surfactants, (e.g. the base 
catalysed hydrolysis (saponification) of carboxylic esters, table 1.4.
- 8 5 -
Surfactant
Substrate Reagent Cationic Anionic Nonionic
Carboxylic  es te i^ O H - Catalysis Inhibition No effect
RCO. O -^ ^ N Q s  
n
/*= v
RN N Catalysis Catalysis
O H" Catalysis Inhibition No effect
r
N Oq
( PhO)2 PO. O - ^ - N Q s F~ C atalysis Inhibition Inhibition
X  N02 
¥
P h N H 2 Catalysis C atalysis Catalysis
T
N02
XCHe-CO. O -^ ^ -K Q s  b O H” Catalysis
A rC (O M e)3 H +, H ?0 Inhibition Catalysis
aSaponification by the Ba c 2 m echanism .
^Reaction by E lc B  mechanism with form ation of a ketene interm ediate when X  is strongly electron w ith­
draw ing.
Table 1.4 - Micellar catalysis and inhibition of some bimolecular 
reactions, (from B u n t o n ^ ? ) .
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Red dy and Katiyar^l» investigated the effect of hydrophobic and 
coulombic interactions by studying the influence of a non-ionic 
surfactant, (Brij 35), and a series of cationic, (C9TAB - CjgTAB), and 
anionic, (SOS-STDS), surfactants of increasing n-alkylchain length on 
the reaction of ethylviolet (EV*, 9 x 10"^ M) with hydroxide ion.
CgTAB and C^qTAB exhibited negligible effects whereas C12TAB - C^gTAB 
catalysed the reaction with 2 x 10"3 M OH", the extent of which 
increased with increasing alkylchain length. Anionic micelles strongly 
inhibited the reaction with 0.2 M OH" and all alkylsulphate surfactants 
studied produced a similar maximal degree of rate retardation , 
associated with complete incorporation of EV4 within the anionic 
micelles. The concentration of surfactant required to inhibit the 
reaction decreased with increasing alkyl chain length, however,
(figure 1.12). Brij 35 micelles catalysed the reaction the degree of 
which increased with increasing concentration of hydroxide ion,
(2 - 7 x 10"3 M).
The extent of catalysis by C^gTAB was correlated to the structure of 
the substrate; the more hydrophobic the substrate the greater the 
degree of catalysis. These results were discussed in terms of 
hydrophobic forces overcoming the unfavourable electrostatic force.
1.5.2.2 ELECTROLYTE
Added salts with non-reacting ions generally reduce the degree of 
micellar catalysis or inhibition of bimolecular reactions involving 
ionic reactants due to competition for micelle binding sites between 
the reactive ions and the added unreactive ions. Peturbation of 
micellar structure especially with hydrophobic counterions may also be 
important.
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Added counterions significantly inhibited the C ^ T A B  catalytic effect 
on reactions of EV+ with OH" at 3 x 10"^ M surfactant^ the
effectiveness being a function of the charge density:
NO3" > Br" > Cl" > SO42" > CH3C02“ > F"
Similar effects were observed for the acid hydrolysis of 
trimethylorthobenzoate in anionic micelles where the degree of 
inhibition followed the order^3.
R4N+ > CS+ > Rb+ > K+ > Na+ > Li+ > no salt
Incorporated ions and buffers complicate the analysis of micelle 
catalysed reactions since they may act as general acid-base catalysts 
and also produce changes In the properties of micelles^2 . The effect 
of sodium hydroxide and borate, carbonate/bicarbonate and 
triethylamine/triethylammonium chloride buffers on the hydrolysis of 
N-methyl-N-(4,-nitrophenyl)-2-phenoxyacetamide at 65.5°C in the absence 
and presence of micelles of cetytrimethylammonium bromide (CTAB) was 
studied by Broxton^-^^. The magnitude of catalysis was shown to be 
dependent on the buffer system used, the concentration of detergent, 
the concentration of buffer, the pH and the presence of added salts.
The effect of the nature and concentration of buffers on the base 
hydrolysis of p-nitrophenylcarboxylates catalysed by CTAB at 25°C was 
measured by Funasaki-^2 . The rate constant-buffer concentration 
profile depended markedly upon the type of buffer and the following 
effects were noted:
(i) an increase In micellar concentration resulting from a decrease
in CMC.
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(ii) an incorporation of the base components of the buffers,
(e.g. carbonate ion) into the micelles which act as catalysts.
(iii) an increase in bulk rate constant.
(iv) a decrease in surface hydroxide ion concentration with 
increasing ionic strength.
(v) a decrease in surface hydroxide ion concentration resulting from 
a decrease in the surface charge density which is brought about 
by penetration of the base components of buffers into micelles.
1.5.3 Quantitative Treatment Of Micellar Rate Effects - The 
Pseudophase Model
Micellization and micellar structure have been discussed in terms of 
various models (see section 1.3.1) but for kinetic studies it is most 
convenient to use the pseudophase model, i.e. a micelle is regarded as 
a submicroscopic aggregate which behaves as if it were a separate 
reaction medium with its own properties. Reactions may then be 
regarded as occurring in either the aqueous or the micellar pseudophase 
with reactants being rapidly equilibrated between the two. The 
quantitative estimation of micellar catalysis and inhibition is 
therefore dependent upon a knowledge of the distribution of reactants 
between aqueous and micellar pseudophases and calculation of the rate 
constants of reaction in each pseudophase.
1.5.3.1 MENGER AND PORTNOY ENZMYE MODEL174
Early work was pursued in the hope that micelles might function as 
simple models for enzymes17^. The first real proposal of a general 
model for the quantitative analysis of micellar effects on reaction 
kinetics was the Menger and Portnoy Enzyme Model174. This model
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assumes simple pseudophase partitioning of a single substrate, 
independent reactivity in the two pseudophases, a constant surfactant 
monomer concentration (equal to the CMC), absence of complexation 
between the substrate and surfactant monomer, and non-perturbation of 
micellization by the substrate.
The equilibrium distribution of a substrate, X, between the micellar 
and aqueous pseudophases can be described bys
Ka
Where X(aq) and X(m ) represent the substrate in the aqueous and 
micellar pseudophases respectively, S(^) is surfactant monomer in the 
micellar pseudophase, KA is the substrate association constant, 
(defined by equation 1.83 or, alternatively written in terms of the 
concentration of micelles = [S(m )]/n » where N is the aggregation
number), P is the reaction product and k(aq) and k(j^ ) are the first
order rate constants in the aqueous and micellar pseudophases 
respectively. The rate equation is given by equation 1.89s
-4121,- 88 k(aq)IX(aq)) + k(M)[X(M)] (1.89)
dt
The overall observed first order rate constant, k0j>s , is then given by 
equations 1.90 and 1.91 which have the same general form as the 
Michaelis-Menton and Lineweaver-Burke equations of enzyme kinetics 
respectively;
k0bs = k(aq) 4 k(M ) KA ([S]T - CMC)
-------------------------------- (1.90)
1 4 Ka  ([S]t - CMC)
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1 = 1 + 1
-------------      (1.91)
k(aq) “ ^obs ^(aq) " ^(M) ^(aq) ” ^(m )) - CMC)
Where [S]T is the total concentration of surfactant. values 
determined kinetically for some micellar inhibited reactions agree 
reasonably well with those determined directly and for hydrophobic 
substrates are similar in magnitude to enzyme-substrate binding
constants^?.
This model was originally applied to describe the micelle inhibited 
saponifation of 4-nitrophenylalkanoates in the presence of sodium 
laurate*^. Menger and Portnoy concluded that k(jj) for this reaction 
was within experimental error of zero. However, Quina and co-workers 
recently measured the extent of micellar inhibition of the alkaline 
hydrolysis of both long chain N-alkyl-4-cyanopyridinium ions and p- 
n i t r o p h e n y l a l k a n o a t e s ^ 6  and concluded that the hydroxide ion reacts 
with the substrate within the micellar pseudophase and not just with 
unbound substrate in the aqueous phase.
This simple model has been applied successfully to micellar catalysed 
unimolecular reactions and to many micellar inhibited reactions when 
k(aq)>>k(j^). However, it fails to predict;
(a) the observed maximum in rate constants with increasing surfactant 
concentration for many micelle catalysed reactions;
(b) the effect of increasing unreactive hydrophilic electrolyte on 
reactions between charged substrates within ionic micelles^**.




The limitations of the enzyme model led Berezin and co-workers to 
develop a much more general model which, in addition to the basic 
assumptions of the enzyme model174, assumed that all substrates undergo 
independent pseudophase partitioning. Their model Is valid for 
reactions involving only uncharged substrates in the presence of ionic 
surfactants and for most reactions carried out in the presence of non­
ionic detergents16^ . However, for reactions involving ionic substrates 
in the presence of ionic detergents the assumption of simple 
pseudophase partitioning proves to be inadequate. Whilst the binding 
of organic substrates can be described by a simple partition (or 
association) constant, this approach cannot be used for the binding of 
hydrophilic ions to the surface of the micelle16^.
1.5.3.3 PSEUDOPHASE ION EXCHANGE MODEL175»164
Romsted extended the pseudophase model, retaining the fundamental 
assumptions of the Berezin model but treating the partitioning of 
hydrophilic ions in an entirely different fashion. The Stern layer of 
the micelle was considered to be saturated with respect to counterions, 
comprising a mixture of attacking ions, (Y), and inert ions (Z). These 
separate species were assumed to partition between the micellar Stern 
layer and the aqueous phase in accordance with an ion exchange 
equilibrium, (equation 1.92)175»164»16Z;
Y (aq) * z( M ) t = ± y (M) 4 z (aq)
t Y ( M ) 1t z ( aq)  1 
Ky/2 - _____________________  (1.92)
t Y ( a q ) 1t z ( M ) 1
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Where the subscripts (aq) and (M) refer to the aqueous and micellar 
pseudophases respectively and Ky/2 Is the ion exchange selectivity 
constant.
Using these assumptions, Romsted derived expressions that permit 
analysis and prediction of kinetic behaviour for several reaction types 
in micellar solution, including the effect of added inert salt on 
reaction rates^5# The observed overall second order rate constant, 
k^obs was shown to be given by equation 1.93 1^5.
k(„) p K p <[S]T - CMC) D + k(aq)
k2obs - ____________________________________      (1.93)
(Kp ([s P-'-c m cM D U y I'M z ]'1' k y /z > k p ([s F - cmc+ D
Where p is the degree of counterion association (= constant) and D is 
the molar density of the micellar pseudophase in moles litre"
The distribution of an uncharged organic substrate is described by a 
partition constant, Kp, (see section 1,3.2), If the substrate is a 
hydrophobic ion of opposite charge to the micelle then it should in 
theory be treated as an exchangeable ion. However, these ions bind 
strongly and their Interactions with the micellar pseudophase may be 
described by a simple association constant^^, K^, (see section
1.4.3.1), similar to that for neutral substrates. Association 
constants may be determined by a variety of techniques (e.g. 
solubility) or by selecting the value which gives the best fit to the 
kinetic d a t a ^ 4 #
Modifications to the pseudophase ion exchange model have been put 
forward by Chaimovich and c o - w o r k e r s ^ ^ , 177-179 an(j Berezin^^. Quina 
et al have recently investigated the binding of OH" to SDDS micelles 
and the effect of addert inert electrolyte (NaCl) on the rate of base
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catalysed hydrolysis of N-aryl-4cyanopyridinium ion and
p - n i t r o p h e n y l a l k a n o a t e l ? * ) .  por totally bound substrate in a pH
controlled system, a modified ion exchange formalism predicted the 
experimentally determined linear dependence of the observed first order 
rate constant, k0t>s, on the concentration of added inert salt (NaCl), 
i.e. k0bs cc Cz 1^.
1.5.3.4 LIMITATIONS OF THE PSEUDOPHASE MODELS
The pseudophase models assume that the substrate does not complex with 
surfactant monomer and that the substrate does not perturb
micellization. These assumptions are not normally valid at low
surfactant concentrations, particularly when the reactants and/or 
counterions are hydrophobic, and the simple pseudophase and ion 
exchange pseudophase models usually fail to predict observed behaviour 
in the CMC region*^. Changes in the structure of micelles at higher
surfactant concentrations may also result in the failure of pseudophase
modelsl®^. Although the ion exchange model has been shown to correctly 
interpret the effect of substrate charge and chain length, buffers, pH 
and specific salt effects, it fails to describe the catalytic 
properties of cationic surfactants with reactive hydrophilic 
counterions such as OH" or 163,164. ^he reason for this failure is 
not known although Romsted has postulated that one or more of the 
pseudophase assumptions is not valid, e.g. cooperative micelle 
formation and/or constant counterion b i n d i n g l ^ .
1.5.4 Non-Micellar Surfactant Effects
With hydrophobic reactants, rate effects are often observed at 
surfactant concentrations below the CMC in water which could be caused 
by reactant-induced micellization or to reaction in sub-micellar
-94-
aggregates^®®. One example where monomeric surfactant may have been 
able to affect the rate of a chemical reaction is given by the reaction 
of triphenylmethane dyes with hydroxide ion (figure 1.12). Reddy and 
Katiyar^l have reported a marked inhibition of the reaction in the 
presence of very low concentrations of alkylsulphate surfactants which 
they ascribed to the formation of sub-micellar aggregates (see section 
1.3.1). However, an ion-pairing mechanism whereby alkylsulphate ions 
compete with hydroxide ions for the carbonium ion reactive site is a 
more probable explanation of the inhibition. Ion-pairing would also 
account for the effect of surfactant chain length on the reaction; the 
ion-pair association constant, K^p, is a function of the hydrophobicity 
of the interacting ions (see section 1.4.2) and the higher 
alkylsulphate homologues would therefore be expected to interact more 
strongly with the cationic carbonium ion. At higher surfactant 
concentrations, solubilization by alkylsulphate micelles is probably 
the primary mechanism of inhibition.
Tomlinson et al^-®® have suggested that for systems whereby the 
degrading species is ionised and the surfactant is of opposite 
electrical charge, then complexation between the two ions may be the 
prime stabilization mechanism. These workers presented theoretical and 
experimental treatments for the interaction between the cholinesters, 
acetylcholine chloride, and propionyl, butyl, myristyl and succincyl 
choline iodide with a series of alkylsulphates and demonstrated a 
relationship between ester hydrolysis half-life and the solubility 
product of the complex. The treatment presented predicted;
(i) the stability of the charged solute should Increase linearly 
with an increase in alkylchain length of either ion;
0 5
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Sodium Alkylsulphate Concentration (M x 10^)
Figure 1.12 - Variation of the observed first order rate constant, kQbs, with concentration of sodium 
alkylsulphates for the reaction of ethylviolet (9 x 10”  ^ M) with 0H“ (0.2 M), (a) sodium 
tetradecyl-, dodecyl-, and decylsulphates and (b) sodium decyl- and octylsulphates, (from 
Reddy and Katiyar^l).
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(ii) the stability should increase with increased concentration of 
surfactant;
(iii) an alteration in K s should be reflected in a change in solute 
stability.
The stabilizing effect due to (i) and (ii) was demonstrated using data 
reported by Nogami for acylcholinester-SDDS and acetylcholine sulphate- 
SDDS systems^-® 1. In addition the decrease in stabilizing effect 
reported by Nogami^®^ for methylene bromide-SDDS systems at 70°C upon 
increase in ionic strength was cited as an example of the effect of 
environmental changes on K s ((ii), above). The authors argued that the 
increase in ionic strength should depress the CMC of the system thereby 
resulting in greater protection if micellar stabilization was the 
mechanism of protection against degradation. The K s' of alkylsulphate- 
acetylcholine ester systems was shown to increase with increase in ionic 
strength and the complexation theory presented was used to explain the 
above results. However, the effect of electrolyte on the ability of 
ionic micelles to modify reactions between interacting ions (see section
1.5.2.2) was not taken into account in this treatment and it is this 
mechanism which is most likely to determine the observed reaction rate. 
Also, as these systems represent solubilized acylcholinesters in the 
absence of complex, it is more valid to consider micelle association 
constants rather than the solubility product which effectively describes 
the equilibrium between complex and aqueous phases.
-97-




Grade A or B analytical glassware was used according to availability.
2.1.1.2 BALANCES
(i) Oertling R20 single pan
Maximum weight capacity : 200 g 
Minimum division : 1 mg
(ii) Oertling TP31 single top pan
Maximum weight capacity : 220 g 
Minimum division : 10 mg
2.1.1.3 ANALYTICAL EQUIPMENT
(i) Perkin Elmer 550S UV-VIS double beam spectrophotometer in 
conjunction with Perkin Elmer 561 recorder.
(Bodenseewerk Perkin Elmer & Co. GMBH, Uberhagen, W.G.)
Range s 195 - 750 nm 
Wavelength accuracy: 0.5 nm
Wavelength reproducibility: *_ 0.2 nm 
Photomeric accuracy: 0.005k at 1A
Photomeric reproducibility: +_ 0.002A at 1A
(ii) Jeol JNM GX 270 NMR spectrometer.
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(iii) DuPont 910 differential scanning calorimeter with DuPont 9900 
computer/thermal analyser.
(DuPont Company, Quilen Building, Wilmington, Delaware, U.S.A.)
Sample size : 0.5 - 100 mg
Temperature range: 170 to 600°C
Temperature reproducibility: 4 0.1°C
Calorimetric sensitivity : 6 /*Wcm“ l (RMS)
Calorimetric precision : 1%
Baseline stability : 20 fjtW
Thermocouples - differential chromel -constantan
sample chromel - alumel
control Plantinel II
(iv) HPLC
(a) Haskel pneumatic column packer
(Haskel Ltd., North Hylton Rd., Sunderland)
(b) SP1800 Liquid Chromatograph
(Spectraphysics Ltd., 17 Brick Knoll Park, St. Albans, Herts.) 
Fitted with:
SP8110 Autosampler
SP9500 Communication interface device
SP8440 Variable wavelength detector (190 - 600 nm)
SPA 100 Computing integrator
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2.1.1.4 pH EQUIPMENT
Phillips digital pH meters
PW9410 PW9421
Display 3* LED 4* LED
Range : 0 - 14.0 pH units 19.999 pH units
Resolution ; 0.01 pH units 0*001 pH units
Instrument accuracy : < 0.02 pH units 0.001 pH units
Temperature stability : 0.002 pH/K 0.001 pH/K







Phillips CAH 11 high temperature combined glass-silver/silver 
chloride electrode. 
pH range : 0 - 14 pH units
Temperature range s 0 - 130°C.
Phillips CE 1 combined glass-silver/silver chloride electrode. 
pH range : 0 - 12 pH units
Temperature range : 0 - 70°C
Radiometer 405-60 high temperature combined glass-silver/silver 
chloride electrode. 
pH range s 0 - 12 pH units 
Temperature range i 10 - 100°C
Radiometer pH stat assembly
(Electronic measuring Instruments, Copenhagen, Denmark). 
Accuracy of assembly : 0.05 pH
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(a) TTT60 titrator
Accuracy x 0.02 pH (4^  2 mv)
Stability x 4_ 0.1% (within 4^ 10°C temperature variations and 
10% line voltage variation)
(b) ABU12 autoburette
Burette assembly type B220 (2.5 ml volume)
Accuracy x 4_ 2.5 pi £  0.5%
Titrant flowrate x adjustable during titration from 1.25 to 160% 
of total burette volume min“l.
(c) PHM61 pH meter
Range : 0 to 14 pH units (division 0.1 pH units)
0 to £  1400 mv (division 10 mv)
Repeatability x 0.01 pH (1 mv)
Accuracy (25°C) : 0.03 pH
2.1.1.5 C0NDUCTIMETRY
(i) Wayne Kerr B642 autobalance universal bridge 
(Wayne Kerr Company Ltd., New Malden, Surrey).
Frequency : internal source/detection 1591.5 j4 0.5 Hz (l j = 10^)
Range : Conductivity 1 x 10“ ^  - 1 x 10^ S
Resistance 1 x 10"^ - 1 x 1 0 ^  ohm 
Capacitance 1 x 10“^  - 10 F 
Inductance 1 x 10"^ - 1 x 10^ H 
Accuracy : 0.1% at 1591.5 Hz
Output : 0 - 100 mV from conductivity and capacitance meter circuits 
Ambient temperature range : 0 - 40°C
'ii) Mullard E7591B dip-type conductivity cell
Nominal cell constant x 1.44
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(iil) Servagor 120 Y-time recorder 
(Gorez Metrawatt)
Recording width s 250 mm
Scale : 0 - 100 linear, 20 division
Chart speeds : 6 chart speeds - 3, 12, 60 cm min'^-or hr“  ^
Range s 2, 5, 10, 20, 50, 200, 500 mV F.S.D.
(iv) Model 34/A syringe pump
(Sage Instruments, 540 Memorial Drive, Cambridge, U.S.A.) 
Nominal flow rate range (5 ml syringe) j 1.2 x 10“3 - 
2.7 mis min“l
(v) Hamilton precision 5 ml gas tight syringe
(Bonaduz AG, P.O. Box 26 CH7402 Bonaduz, Switzerland).
2.1.1.6 PARTICLE SIZE ANALYSER
Coulter N4 MD sub-micron particle analyser with size distribution, 
processor analysis and multiple scattering angle detection.
(Counter Electronics Ltd., Northwell Drive, Luton, Beds, LU3 3RH).
Sample particle size range : 3 to 300 nm
Sample molecular weight range : 10^ - 10^  Daltons
Unimodal analysis reproducibility : 3% cv
Laser : 4 mW helium - neon (632.8nm)
Optics : fibre optics located at 15.2,
21.1, 13.2, 41.9, 51.8 and 90°. 
Temperature range s 0 to 90°C 4^  0.2°C.
2.1.1.7 MIS CELLANE0US
(i) Water baths











Grant shaking water bath.
Shaking rate range i 20 - 200 min"*
Temperature range : 0 - 80°C
Grant heater stirrer type SU6 (in conjunction with Grant water 
bath).
Adjustable control thermostat range 0 to 80°C.
Magnetic stirrer/heater
(Rodwell Scientific Instruments, Brentwood)
Travelling vernier microscope
(Precision Tool and Instruments Co., Thornton Heath, Surrey).
Agla micrometer syringe outfit 
(Wellcome Reagents Ltd., Beckenham, Kent).
Micrometer and Syringe (0.5 ml luer fitting) fitted with 
straight glass needle.
Accuracy s 5 x 10”^ at 0.01 ml increment.
Buchi Rotavapor R110
Bath cooler (U-cool)
(Meslab Instruments Inc., Portsmouth N.H., U.S.A.)
Vacuum Oven 
Filtration Units
Swinnex 25 mm filter holder in conjunction with Whatman 




All chemicals other than Imidazoline drugs used in this study were of 
AnalaR Grade (BDH Chemicals Ltd., Poole, England), or AR Grade 
(Fisons, Loughborough, England); with the exception of the followings
Apovincamine
N-(cyclopropyl-2-phenoxy-acetyl) ethylene
) Gifts from Synthelabo, 
)
) 58 rue de la Glaciere, 
)
diamine (II) hydrochloride (CPAE hydrochloride ) Paris, France.















HPLC Grade - Fisons, 
Loughborough, England.
Burroughs
Technical Grade - Fisons, Loughborough,
England
Sodium dichromate Technical Grade - Fisons, Loughborough,
England
Soda Lime (4 - 10 mesh) Lab. Reagent BDH Ltd., Poole, 
England
Silica gel (1-3 mm) Lab Reagent Fisons, Loughborough, 
England
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Glass wool 'Low in lead' BDH Ltd., Poole
England
1.0 M HC1 solution Convol BDH Ltd., Poole
England
1.0 M NaOH solution Convol BDH Ltd., Poole
England
2.1.2.1 IMIDAZOLINES
Cirazoline hydrochloride and fenoxazoline hydrochloride were gifts from 
Synthelabo (58 rue de la Glaciere, Paris, France). Tolazoline 
hydrochloride, naphazoline nitrate, xylometazoline hydrochloride, and 
antazoline sulphate, were gifts from CIBA Laboratories, Horsham, West 
Sussex, England. 2-methy1-2-imidazoline was obtained as 'Genlab 
Grade' from Koch Light Ltd., Haverhill, Suffolk. All samples except 
cirazoline hydrochloride were used as received. 2-methy1-2-imidazoline 
was observed to contain high levels of moisture (estimated at 10%, see 
section 3.2); attempts to dry samples proved difficult and the material 
was therefore, used as received.
Purification of Cirazoline Hydrochloride
Samples of cirazoline hydrochloride were recrystallised twice from 
ethyl acetate s ethanol (3si). Anhydrous cirazoline hydrochloride was 
used throughout the study and was prepared by drying purified samples 
to constant weight at 50°C, 900 mBar reduced pressure with silica gel 
desiccant. Samples were stored at ambient temperature over silica gel 
in a desiccator to prevent moisture uptake.
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Characterisation
Samples of all imidazolines were characterised by HPLC and ultra-violet 
(UV) and nuclear magnetic resonance (NMR) spectroscopy. Purified, 
anhydrous cirazoline hydrochloride samples were also examined by 
differential scanning calorimetry (DSC) and infra-red spectoscopy (IR). 
UV spectroscopy gave the following absorption maxima (nm):
Cirazoline hydrochloride 275
2-methyl imidazoline 218
Tolazoline hydrochloride 256, 262
Naphazoline nitrate 270, 281, 288, 291
Xylometazoline hydrochloride 264
Antazoline hydrochloride 241, 292
Fenoxazoline hydrochloride 268, 274
These values are in good agreement with literature values (table 1.1). 
NMR spectra are shown in figures 5.1a to 5.7a and were consistent 
with structure. HPLC and NMR Chromatograms showed no evidence of 
impurities for all samples except fenoxazoline hydrochloride. HPLC 
chromatograms and NMR spectra of fenoxazoline hydrochloride showed an 
additional peak(s) corresponding to its primary hydrolysis degradation 
product (figure 3.9 and 5.2 respectively). The extent of degradation 
was estimated as 20% by NMR (see section 5.4). Fenoxazoline 
hydrochloride was therefore only used for degradation studies. The 
cirazoline hydrochloride IR spectum was consistent with structure and 
the DSC spectum (figure 2.1) showed a sharp melting point peak at 
188.2°C. No peak associated with loss of water of hydration was
- 0.2  -
-0.4-
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4Q 80 100 120 
TempQrcturG (°C)
140 160 160
Figure 2.1 - Differential scanning calorimetry spectrum of anhydrous cirazoline hydrochloride.
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observed, confirming the sample was anhydrous. The small peak at about 
140°C is thought to be a crystalline transition.
2.1.2.2 SURFACTANTS
Purification of Sodium Dodecyl Sulphate (SDDS)
Commercial samples of surfactants often contain impurities including 
homologues and unreacted reagents. Although the SDDS sample used in 
this study was of Primar Grade, (>99% SDDS), hydrolysis to dodecan-l-ol 
may occur upon storage. SDDS was therefore subjected to the 
purification process described by Mukhayer and Davis^l.
The sample was Soxhlet extracted with petroleum ether, (40 - 60°), for 
48 hours, dried and recrystallised twice from absolute ethanol. The 
resulting crystals were dried to constant weight at 40°C, 900 mBar 
reduced pressure. The purity of the sample was checked by surface 
tension and NMR Spectroscopy.
(a) Surface Tension
Impurities in a sample of surfactant may be detected by a 
characteristic minimum in surface tension - concentration curves.
The technique used was the Wilhelmey Plate method; the equipment used 
in this laboratory has been described in detail by S h e t e w i ^ ^
The surface tension of a l i q u i d , i s  given by equation 2.1, where g 
is the acceleration of gravity and W is the weight in grams necessary 
to detach a thin glass microscope coverslip of thickness, t, and 
length, 1, from the surface of the liquid.
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The dimensions of the coverslip were determined using a travelling 
microscope.
The accuracy of determination was checked by measuring the surface 
tension of toluene, acetonitrile (both HPLC grade) and double distilled 
water; the latter has a very high surface energy and is therefore 
easily contaminated. To minimise this risk, the surface tension data 
was obtained from freshly distilled water collected from a receiving 
vessel which had been left to overflow for at least 30 minutes.
Results obtained from single samples of each liquid are shown in table
2.1 together with known values obtained from the literature. Observed 
data are well in agreement with reported values and thus confirms the 
validity of the method.
Surface tension measurements were taken for 2-20 x 1 0 " %  concentration 
of purified SDDS; results are shown in table 2.2 and plotted 
graphically in figure 2.2. The absence of a minimum in the curve 
Indicates that the material was pure.
The CMC of SDDS at 25°C was estimated as 8.40 x 1 0 " %  (literature 
value - mean 8.2 x 10"%, range 8.1 - 8.4 x 10"^ M)^l.
(b) NMR Spectroscopy
An NMR spectrum of a sample of purified SDDS was obtained using HD0 
as reference, (4.60 ppm). The spectrum and SDDS structure are shown 
in figure 2.3. The spectrum was consistant with structure and no 
anomalous peaks were detected. Assignments and Integral values are 
shown together with the NMR data for sodium octyl sulphate, (SOS), 
sodium decyl sulphate, (SDS) and sodium tetradecyl sulphate, (STDS), 
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SDDS Concentration (M x 10^)
Figure 2.2 - Effect of concentration on surface tension of sodium
dodecylsulphate solutions in double distilled water at 25°C.
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- Proton NMR spectra for sodium dodecylsulphate
in D20, 20°C.
c h 3 ( c h 2 )  CH2 C H 2 S 0 4 .M a
t t 5 t t
A  B  C D
HDO
II > MJ \
ITo T 7
Chemical Shift (ppm)
Figure 2.A - Proton NMR spectra for sodium octylsulphate in
D20, 20°C.
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- Proton NMR spectra for sodium decylsulphate
in D20, 20°C. 1 = Impurity
HDO
CH „  S O .  . NaCH
10 8 6 4 2 0
Chemical Shift (ppm)
Figure 2.6 - Proton NMR spectra for sodium tetradecylsulphate
in D20, 20°C.
-113-
Synthesis of Sodium Octyl, Decyl and Tetradecyl Sulphates
Sodium octyl sulphate, (SOS), sodium decyl sulphate (SDS) and sodium 
tetradecyl sulphate, (STDS) were synthesized from the corresponding 
alcohol and sulphuric acid. Purification was by extraction with 
butan-l-ol, Sox'hlet extracton and recrystallistion from ethanol.
(a) Sodium Octyl Sulphate
96% H2SO4, (78.5g) was added dropwise over one hour to stirring 
octan-l-ol, (100.Og) in an ice bath. The resulting equimolar mix was
then allowed to react at room temperature for 48 hours.
(b) Sodium Decyl Sulphate
96% H2SO4, (129.2g) was added dropwise over one hour to decan-l-ol 
(201.7g) In an ice bath. The resulting equimolar mix was then 
allowed to react at room temperature for 48 hours.
(c) Sodium Tetradecyl Sulphate
Tetradecan-l-ol is a solid at room temperature and excess sulphuric 
acid (4si) was therefore used as solvent. 96% H2SO4 (191.2g) was added 
dropwise over one hour to tetradecan-l-ol (100.2g) at ambient 
temperature and left to react for five days.
(d) Purification
The following procedure was used for the purification of SOS, SDS and 
STDS;
The crude surfactant mix was diluted with distilled water and 
neutralised by the slow addition of solid sodium carbonate. The sodium 
alkyl sulphate was immediately extracted from the aqueous mix with 
butan-l-ol, (4 x 100 ml). The volume of the upper, butan-l-ol layer 
increased from 100 ml to approximately 250 ml upon shaking, indicating
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the production of a ternary phase, (butan-l-ol s water : sodium alkyl 
sulphate). Evaporation to dryness at 70°C and 600 mm Hg reduced 
pressure, (Rotavapor R110) produced a solid residue of crude sodium 
alkyl sulphate and a distillate composed of two immisible liquids 
(butan-l-ol and water). The residue was Soxhlet extracted with 
petroleum ether (40 - 60°) for five days followed by diethyl ether for 
two days. The solid was dried overnight at ambient temperature and 
reduced pressure to remove traces of organic solvent.
Recrystallisation from ethanol was hampered by the presence of 
inorganic ions due to ternary phase production at the extraction stage. 
These ions were removed by filtering a hot solution of alkyl sulphate 
in ethanol before recrystallising at 4°C. This process was repeated 
and the resulting crystals dried to constant weight at ambient 
temperature and reduced pressure.
(e) Characterisation
SOS, SDS and STDS samples were examined by NMR. Samples were run in 
D2O using HDO as reference, (4.60 ppm). Spectra are shown in figures
2.4 to 2.6 and are consistent with structure. No anomolous peaks 
were detected in the SOS and STDS spectra indicating a high degree of 
purity. A small triplet peak was observed at a chemical shift of 
3.40 ppm in the SDS sample spectrum, however, indicating the presence 
of Impurity (estimated at about 2%). NMR data are summarised in 
table 2.3.
2.1.2.3 DOUBLE DISTILLED WATER
Tap water was distilled through an all glass laboratory still and 
collected In vessels reserved solely for this purpose. This water 
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D 1.90(2) 1.87(2) 1.92(2) 2.04(2) | 
1
Table 2.3 - NMR data for sodium alkyl sulphates in D2O. (See figures 
2.3-2.6 for explanation of assignment).
(SOS " sodium octyl sulphate, SDS * sodium decyl 
sulphate, SDDS ® sodium dodecyl sulphate, STDS e sodium 
tetradecyl sulphate).
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fractionating column containing cut glass, (pyrex), tubing. The 
resultant double distilled water was collected in glass containers 
reserved solely for this purpose. Such water was shown to have a 
surface tension of 72.03 mNM"l and specific conductivity of less than 
1 x 10 ”6 Scm"l at 25°C.
2.2 GENERAL METHODS
2.2.1. Cleaning of Glassware
All glassware was Immersed in chromic acid mixture for at least one 
hour, rinsed six times with tap water followed by three times with 
distilled water. Cleaned glassware was dried in a hot air oven 
before use or storage.
2.2.2 Ageing of Glassware
Glass and silica surfaces can acquire a negative charge when in 
contact with aqueous solution and positively charged species in 
solution can be attracted and adsorbed onto such surfaces. This 
effect is an important factor in studies involving cationic 
surfactants and may be relevant to solutions of protonated drugs such 
as cirazoline hydrochloride or other imidazoline salts. Alkyl 
sulphates and ion-pair/complexes may also be adsorbed on to surfaces 
by an hydrophobic attraction.
An ageing process was therefore applied to all glassware used for 
imidazoline and surfactant solutions. Glassware was presaturated for 
at least 24 hours with the same concentration of solution to be used 
in the study. The containers were washed with distilled water, dried 
and used for the relevant solution throughout the work without 
subjecting them to further chromic acid treatment.
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2.2.3 Temperature Measurements
All temperature measurements at or below 50°C were made with 
reference to a calibrated mercury in glass thermometer range -5 to 
50°C, graduated at intervals of 0.1°C (calibration factor = 1.000)194# 
A mercury in glass thermometer, range -10 to 110°C, graduated at 
intervals of 0.5°C was used for temperature measurements between 50 
and 80°C.
2.2.4 Preparation of Buffers
The following standard buffer solutions were prepared according to
Buffers were stored in stoppered flasks at 4°C and discarded after 
four weeks.
2.2.5 pH-Measurement
2.2.5.1 TECHNIQUE FOR STANDARDISING pH METERS
Both types of pH meters (digital and pH-stat unit) were standardised 
prior to each experimental determination of pH using standard buffers. 
The pH electrode and standard buffers were equilibrated to the 
experiment temperature before use. Equlmolal phosphate buffer was used 
Ln conjunction with either phthalate buffer (for experiment pH < 6.85) 
)r borax buffer (for experiment pH >6.85). The pH of standard buffers 
it the required temperature was taken from Bates*^.
Bates^S.
(a) Equimolal (0.025 m) phosphate
(b) Potassium hydrogen phthalate (0.05 m)
(c) Borax (0.01 m)
pH 4.008 at 25°C
pH 6.865 at 25°C
pH 9.180 at 25°C
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2.2.5.2 CHOICE OF pH ELECTRODE
Thte Phillips CE1 pH electrodes were used for pH measurement below 
70®C and pH 12. For temperatures > 70°C and below pH 12 the Radiometer 
♦05-60 pH electrode was used. The Phillips CAH-11 electrode was used 
:oir pH determinations of pH 12 and above.
^.2.5.3 pH-MEASUREMENT IN CIRAZOLINE - SDDS SYSTEMS
Ihe response time and sensitivity of electrodes were found to 
decrease when used for long periods in mixtures of cirazoline and 
SDDS solutions; this is probably due to adsorption of cirazoline 
dodecyl sulphate onto the glass envelope. The electrode was therefore 
removed from such solution immediately after measurement and the 
electrode response checked using standard buffers. If any drift or 
sluggish response was noted, the electrode was washed in 95% ethanol, 
staked for a few hours in 0.1 M HC1 and recalibrated.
Is practice, the change in electrode response was negligible if used
for less than about 30 minutes.
2.2.5.A EFFECT OF MAGNETIC STIRRER ON pH MEASUREMENT
Tie magnetic stirrers used with the automated pH-stat unit were found
tc significantly affect the pH readings of solutions, causing an 
apparent shift to lower pH values. This effect was investigated by
monitoring the pH of NaOH, (0.1 M), HC1, (0.1 M) and phosphate buffer
solurion using the pH-stat assembly in conjunction with the Phillips
CE1 electrode. A change of pH of - 0.10 pH units occurred when using
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the magnetic stirrer. This change of pH was independent of the pH of 
the solution.
A correction factor of 4 0.10 pH units was therefore applied to all 




High performance liquid chromatography (HPLC) is probably now the 
technique of choice in pharmaceutical analysis and is the subject of 
several comprehensive r e v i e w s ! 9 6 - 1 9 8 # The different modes of 
chromatographic separation available with HPLC are given below:
1. Adsorption
2. Liquid - liquid partition
3. Reversed phase




Detection techniques include UV absorption, refractive index, 
fluorescence, electrochemical, electron capture and mass 
spectrometry. Various parameters are used to characterise the 
efficiency of a chromatographic system.
The retention of a solute is indicated by the column capacity ratio, 
k' (equation 3.1):
k' = t„ - tn (3.1)
co
Where tr is the retention time of the given peak and tQ is the 
retention time of the solvent peak.
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The efficiency of a chromatographic column is measured by the number
of theoretical plates, N, to which the column is equivalent. N is
calculated using equation 3.2:
N = 16 In2 = 5.54 tt* 2 (3.2)
W W 1/2
Where W is the base line width of the peak and W]y2 *-s t*ie Pea^ width 
at half-height. Typical values of N lie in the range 1000 - 20,000 
plates.
The resolution, R s, of two chromatographic peaks is a measure of 
their separation, (equation 3.3):
R s = 2 (to - ti) (3.3)
(Wx ♦ W2 )
Where t^ and t2 are the retention distances and W^ and W2 the peak 
base widths of peaks 1 and 2 respectively. For two Gaussian peaks,
effective base line resolution is obtained for R s * 1.5.
The selectivity , a, is defined as the ratio of the column capacity 
ratio of the two peaks of interest, (equation 3.4):
a = k *2
  (3.4)
k'i
Quantification of sample concentration is achieved by reference to 
standard solutions. Two forms of reference are possible, namely 
internal standard and external standard techniques. The former 
method involves the inclusion of a standard substance of known 
concentration in the sample mixture. Ideally the internal standard 
should have a chemical structure similar to that of the sample but 
sufficiently different to enable resolution of the sample and 
standard peaks. The standard must be stable under the assay
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conditions and other peaks in the chromatogram such as those due to 
degradation product(s)f must not interfere with the standard peak. 
Sample concentration is expressed as peak height ratio, or 
preferably peak area ratio (sample peak area/internal standard peak 
area). Reference to peak area ratio/concentration calibration curves 
allows calculation of sample concentration, (see also section 3.1.6). 
The external standard technique involves the injection of a solution 
of known concentration alongside the unknown samples. Quantification 
of unknown samples is made by direct reference to the external 
standard peak height/area.
The advantages of the external standard method is that it is the 
simpler technique and only involves one chemical entity. The latter 
may be important when strict control of experimental conditions is 
not possible. The internal standard method, although more 
complicated in development, has the advantage that the injection 
volume is not critical for the determination.
3.1.1 Description
A reversed phase ion-pair stability indicating HPLC assay for 
cirazoline was developed from the method described by Davies et al^. 
The assay technique also allowed determination of the primary 
degradation product, CPAE. This ability to assay both reactant and 
product of the hydolysis allowed great versatility in determining the 
extent of cirazoline degradation and reaction rate constants.
A 100 mm x 5 mm Spherisorb ODS Column was used in conjunction with an 
aqueous sodium acetate buffer s acetonitrile (30 : 70) mobile phase 
System with apovincamine solution in acetronitrile as internal 
standard. The assay was modified by increasing the aqueous buffer 
concentration from 0.1 M to 0.2 M and reducing the flow rate
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from 1.2 mis min” l to 1.0 mis min~l. This adjustment improved the 
assay by increasing sensitivity and reducing the total analysis time 
frn-n s p v ^  ro five minutes while retaining base line separation of 
peaks.
The HPLC conditions are summarised below:
Column : 100 x 5 mm Spherisorb S5 0DS
Mobile Phase : (i) Sodium acetate (aq) 0.4 M 150 mis
(ii) Glacial acetic acid 40 mis
(iii) Distilled water 110 mis
(iv) Acetonitrile 700 mis
pH adjusted to 5.2 with (i)/(ii)
Flow Rate : 1.0 ml min“l
Detection : UV at 275 nm
Attenuation : 0.02 - 0.08 AUFS
Load : 10 pi





Apovincamine (5 - 20 |ig ml“^)* 
Minimum two per sample
* Added as 12.5 - 100 pg ml“^ solution in acetonitrile because of 
poor aqueous solubility.
3.1.2 Preparation of Column and Evaluation of Performance
The 100 x 5 mm Spherisorb S5 0DS column used throughout was slurry 
packed In isopropanol and hexane at 7000 psi using a Haskel pneumatic 
column packer.
The reverse phase testing procedure of Bristow and Knox was used to 
evaluate column performance^^. A test solute mix of phenol, anisole
-124-
and phenetole was chromatographed using methanol : water, (60 : 40) 
mobile phase. The number of plates was calculated for the last peak 
(phenetole) using equation 3.2 and was found to be 3033 plates (30330 
plates metre ”1). This value is within the range normally observed in 
HPLC systems.
3.1.3 Specificity of Cirazoline and CPAE Assays
Separate solutions of 2 x 10“^ M cirazoline hydrochloride (aq),
2 x 10"^ M CPAE hydrochloride (aq), 10 pg ml”l apovincamine (in 20% 
acetonitrile) and a mixture of the three solutions (in 20% 
acetonitrile) were chromatographed using the conditions described in 
section 3.1.1. Hydrochloric acid (final concentration of 4 x 10"^ M) 
was included in all solutions to inhibit degradation. A chromatogram 
of the mixture run at a chart speed of 4 cm min"* (8 x normal) is 
given in figure 3.1. CPAE, cirazoline and apovincamine peaks had 
retention times of 2.0, 3.0 and 4.0 minutes respectively.
Satisfactory base line separation resolution and selectivity were 
obtained for both CPAE/cirazoline (Rs = 2.1, a - 2.0) and 
cirazoline/apovincamine (Rs = 1.6, a = 1.5) peaks. Chromatographic 
parameters are shown together with HPLC data for other imidazolines 
in table 3.1.
The cirazoline assay was shown to be stability indicating by 
degrading 2 x 10"^ M cirazoline hydrochloride in equimolal phosphate 
buffer (0.025 m), pH 6.85 at 70°C down to about 60% residual 
concentration. Samples taken during the experiment were assayed and 
the results show a decrease in cirazoline peak size and the 
concomitant appearance of a peak with similar characteristics to the 





0 1 2 3 4 5
Minutes
Figure 3.1 - HPL Chromatogram of a mixture of 2 x 10“* M CPAE (i), 2 x 10“* M cirazoline 
hydrochloride (II) and 10 pg ml“l apovincamine (IS) in 20% acetonitrile,
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Table 3.1 - Chromatographic parameters for the HPLC assay of 
imidazolines and CPAE. I = Degradation peak,
II * Imidazoline or CPAE peak, IS * Internal Standard. 
(CIR *= cirazoline, ANT s antazoline, FEN = fenoxazoline, 
NAP * naphazoline, TOL * tolazoline,
XYL = xylometazoline.)
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HPLC chromatogram of initial and partially degraded, (60% residual 
concentration), samples are given in figure 3.2.
A solution of CPAE hydrochloride was produced in situ by fully 
degrading a 0.01 M solution of cirazoline hydrochloride in sodium 
hydroxide at pH 8.0 and 80°C. After 24 hours the solution was 
neutralised with 0.1 M HC1 and suitably diluted. The resultant 
chromatogram for the CPAE solution is shown in figure 3.3a. The CPAE 
assay was shown to be stability indicating by degrading a 1 x 10“  ^ M
sample of CPAE hydrochloride in 0.1 M NaOH at 70°C. Samples taken
over a 24 hour period were assayed and results showed a decrease in
CPAE peak size and the concomitant appearance of a peak with a
retention time of 1.4 minutes (figure 3.3b). This peak is thought to 
be associated with production of cyclopropyl-2-phenoxy-acetic acid.
The CPAE chromatogram, (figure 3.3a) shows the absence of significant 
peaks at retention times associated with cirazoline and the CPAE 
degradation product, indicating that all cirazoline had been 
converted exclusively to CPAE (figure 3.3a). This solution was used 
throughout the study as a standard solution of CPAE hydrochloride.
3.1.4 Linearity of Cirazoline and CPAE Assays
Calibration curves of peak area ratio against concentration were 
constructed for cirazoline and CPAE over the concentration range 
0 - 36 x 10“5 m. Solutions were prepared containing 20 pg ml“l 
apovincamine (internal standard) in 4 x 10"^ M HC1, 20% acetonitrile. 
Data and linear regression analysis results are given in table 3.2 
m d  calibration curves are shown in figure 3.4. Results show peak 
irea ratio to be proportional to concentration for both cirazoline 
ind CPAE.








0 Minutes 5 0 Minutes 5
Figue 3.2 - HPL Chromatogram of 3.2 x 10”* M cirazoline hydrochloride 
(II), (a) initial sample, (b) after storage in phosphate 
buffer pH 6.85, 70°C for 38 minutes. I = CPAE, IS =
20 pg ml”l apovincamine. (Chart speed 5smm min“l, 











1  j-Minutes  ^ rt Minutes ^
>.3 - HPL chromatogram of 1.6 x 1 0 M CPAE (il), (a) sample
prepared by degrading 0.01 M cirazoline hydrochloride 
at pH 8.0, 80°C for 24 hours, (b) sample after 24 hours 
storage in 0.1 M NaoH, 70°C showing production of 
cyclopropyl-2-phenoxy-acetic acid (i). (Chart speed =
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-0.0142 (0.0047) | 
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Table 3,2 - HPLC calibration data and linear regression analysis data 
for cirazoline and CPAE using apovincamine (20 pg ml"l) 
as internal standard.






Concentration (M x 104)
Figure 3.4 - HPLC calibration plot for cirazoline hydrochloride,
(— • — ), and CPAE, (— ) , using 20 pg ml”l apovincamine 
as internal standard.
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Negative intercepts (> 2 S.D.s from the origin) were obtained for
both cirazoline (intercept - -0,038) and CPAE (-0.014). The 
magnitude of the intercepts is small, however, and the error in first 
order rate constant determination resulting from the assumption that 
the calibration curves pass through the origin is considered to be 
minimal (<2%). The concentration of sample solutions was therefore 
calculated by reference to a single standard solution, which was 
injected at the start of each assay and repeated after every ten 
sample solutions. The molar concentration of sample was calculated 
from equation 3.5.
Sample = Standard x Mean Peak Area Ratio (Sample) (3.5) 
Concentration Concentration Mean Peak Area Ratio (Standard)
The sensitivity of the assay at 0.04 AUFS was determined by assaying 
solutions of 3.0 - 30 x 10"^ M cirazoline hydrochloride and
3.2 - 32 x 10“6 M CPAE hydrochloride. The minimum detectable 
concentration at the normal sensitivity of 0.04 AUFS was found to be 
10 x 10“6 m for cirazoline and 6.4 x 10"^ M for CPAE.
Samples taken from surfactant experiments contain SDDS which may 
affect the assays. This was tested by constructing calibration 
curves for cirazoline and CPAE in the absence and presence of 0.016 M 
SDDS. Calibration solutions were prepared containing cirazoline 
hydrochloride (0.8 - 4.8 x 10“^ M), CPAE hydrochloride (0.4 -2.4 x 
10”^ M), internal standard (10 pg ml"l) and 4 x 10"^ M HC1. The 
stability of cirazoline and CPAE solutions awaiting assay was 
evaluated by analysing the aqueous calibration solutions after 
storage for one and two months at ambient temperature. Linear 
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Table 3,3 - Linear regression analysis data for calibration curves
in the absence and presence of 0.016 M SDDS after one and 
two months storage under ambient condition.
(Internal standard - apovincamine 10 pg/ml).
-134-
t-tests on the one month aqueous and SDDS solution data show the 
plots to be indistinguishable at the P ■ 0.05 level for both 
cirazoline (tcaic ■ 0.016, fctab ■ 2.57) and CPAE (tcaic “ 0.892, ttab 
= 2.78). SDDS has therefore no effect on the cirazoline and CPAE 
assays, t-tests on the aqueous one month and two months storage data 
and one month SDDS solution and aqueous two months storage data 
6how the plots to be indistinguishable at the P * 0.05 level for 
cirazoline (tcaic ■ 0.562, ttafc ■ 2.57 and tcaic * 0.552, ttafc * 
2.45), and CPAE (tcaic ■ 1.030, tta]> - 2.57 and tcaic *= 0.266, ttab 
■ 2.57). Storage over a two month period has therefore no effect on 
the cirazoline and CPAE assays. Solutions were normally 
assayed within one month of sampling.
3.1.5 Reproducibility of Cirazoline and CPAE Assays
The reproducibility of the cirazoline hydrochloride and CPAE assays 
was evaluated by assaying ten consecutive injections of a standard 
solution consisting of 3.2 x 10“* M cirazoline hydrochloride,
2 x 10"* M CPAE hydrochloride and 20 pg ml"l apovincamine in 4 x 10"  ^
M HC1, 20% acetonitrile. Statistical analysis on peak areas and peak 
area ratios is given in table 3.4. Cirazoline, CPAE and apovincamine 
peak areas were found to be reproducable (CV ^ 3 % )  but greater 
precision was obtained from the use of peak area ratios (CV < 1.8%); 

























































Table 3.4 - Reproducibility of cirazoline and CPAE assays.
Statistical analysis on ten consecutive injections 
of a mixture consisting of 3.2 x 10“^ M cirazoline 
hydrochloride (II), 2 x 10”^ M CPAE hydrochloride (I) and 
20 jig ml“l apovincamine (IS).
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3.1.6 Calculation of Percent Residual Cirazoline Concentration
The determination of percent residual concentration is used for 
calculation of reaction rate constants (Chapter 8) and is also a 
useful parameter in monitoring possible degradation during non- 
kinetic studies. The ability to assay both cirazoline and CPAE 
concentration allows three methods of calculations
1. Cirazoline concentration alone.
The percent residual concentration (% RC) can be calculated from 
equation 3.6,
% RC - lCIRlsample x 100 (3.6)
[CIR]j
Where [CIR]samp!e an^ [CIR]j are the molar cirazoline concentration 
of the sample and initial sample respectively. This method is the 
simplest of the three but suffers from the disadvantage of requiring 
an accurate knowledge of the initial sample concentration and may 
also be subject to error due to concentration changes in the 
reaction vessel caused by addition of titrant (from the pH stat) and 
from evaporation during the experiment.
2. CPAE concentration alone.
The percent residual concentration can be calculated using the molar 
CPAE concentration, (equation 3.7).




Where [CPAE]samp2e is the molar CPAE concentration in the sample.
This method is necessary when representative sampling of cirazoline 
cannot be achieved. The calculation relies on representative 
sampling of CPAE, an accurate knowledge of the initial molar 
cirazoline concentration value and of the stability of CPAE under the 
experimental conditions.
3. Cirazoline and CPAE Concentration.
Percent residual concentration can be calculated using both 
cirazoline and CPAE concentrations from equation 3.8.
% RC - [CIR]sample x 100 (3.8)
[CIR]sample 4 [ C P A E ] p
This method relies on representative sampling for both cirazoline and 
CPAE and the latter must be stable under the experimental conditions. 
The method has the advantage of requiring only relative concentrations 
and not absolute values. Errors due to volume changes in the reaction 
flask (e.g. addition of titrant and evaporation) and pipetting are 
negated, thus improving the accuracy and precision of the assay.
Direct sampling at temperatures other than 20°C is thus possible as 
the volume of the sample is not critical to the assay. The amount of 
degradation can be determined from one sample and does not rely on 
initial or other values. This is especially useful as a 'quality 
control' assay In the calculation of possible degradation, during non- 
kinetic experiments.
The three methods of calculation were tested by degrading cirazoline 
hydrochloride (2 x 10”^ M) in equimolal phosphate buffer, (pH 6.85, 
70°C) using the method described in section 8.2.1a. CPAE is stable
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under these conditions (as confirmed by absence of HPLC peak at 1.4 
mins) and volume changes should be minimal as the experiment was 
rapid (about 40 minutes) and no titrant was used. All three methods 
should therefore be valid and give similar percent residual 
concentration values and rate constants. Results are shown in table
3.5 and figure 3.5. Total assay values (cirazoline plus CPAE 
concentration) were essentially constant during the degradation 
(Mean 1.903 x 10” ^ M, S.D. 0.019, CV 1.02%) confirming the stability 
of CPAE under these conditions. Assay concentration values are less 
than the input concentration as sampling was performed at 70°C; the 
density of water at 70°C (0.9778) is approximately 0.98 times that at 
20°C (0.9982). The slight degradation (1.5%) at time zero is due to 
the delay in taking the first sample in order to ensure complete 
mixing of the solutions (see section 8). All methods of calculation 
give similar results and derived rate constants, (t-tests for kobs 
give tcalc s 1/2 = 1.388, 1/3 * 0.682, 2/3 « 1.279; ttab - 2.120 
at P * 0.05) showing that under ideal conditions all methods are 
valid. The data calculated using cirazoline and CPAE concentration 
values (equation 3.8), however, had the smaller relative standard 
deviation and wherever possible percent residual concentration was 
calculated by this method.
An example of kinetic data where degradation of CPAE was significant 
(as indicated by mass balance inconsistencies and detection of an 
HPLC peak corresponding to the CPAE degradation product), is given 
by the hydrolysis of cirazoline hydrochloride in 0.1 M HC1 at 
70°C. These data are shown in table 3.6 and figure 3.6. Percent 
residual concentration in these cases was calculated by reference to 
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Coefficient 0.9986 0.9996 0.9998
Slope x 102 -1.415 -1.374 -1.396
(S.D. x 102 ) (0.026) (0.014) (0.010)
(RSD Slope) (1.84%) (1.02%) (0.72%)
Intercept 4.604 4.588 4.589
(S.D.) (0.006) (0.003) (0.002)
(Calculated % initial) (99.88) (98.30) (98.40)
k0bs x 10)4 6-1 2.36 2.29 2.33
Table 3.5 - Degradation of 2 x 10"3 M cirazoline [CIR] hydrochloride 
in phospate buffer pH 6.85 at 70°C. Residual 
concentrations and first order rate constants calculated 
according to equations 3.6 - 3.8.







Figure 3.5 - First order plot for the degradation of 2 x 10"^ M
cirazoline hydrochloride in phosphate buffer pH 6.85, 
70°C. Percent residual concentration (%RC) values 
calculated using (a) equation 3.6, (— □ — ), (b) equation 





CONCENTRATION (M x 103 )
1 1 
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Coefficient 0.9963 0.8361 0.9711
Slope x 103 -3.986 -0.853 -1.704
(S.D. x 103 ) (0.122) (0.198) (0.148)
(RSD Slope) (3.1%) (43.1%) (8.7%)
Intercept 4.569 4.515 4.535
(S.D.) (0.016) (0.025) (0.019)
(Calculated as % initial) (96.45%) (91.38%) (93.22%)
kobs x 10? s"1 11.1 2.37 4.73
Table 3.6 - Degradation of 1.6 x 10“3 M cirazoline [CIR] hydrochloride 
in 0.1 M HC1 at 70°C. Residual concentrations and first 
order rate constants calculated according to equations 
3.6 - 3.8.










Figure 3.6 - First order plot for the degradation of 1.6 x 10"3 M
cirazoline hydrochloride in 0.1 M HC1, 70°C. Percent 
residual concentration (%RC) values calculated using 
(a) equation 3.6, (— □  —  ), (b) equation 3.7, (— O — ), and 
(c) equation 3.8, (— A — ).
I I ^ 1 SB
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In surfactant studies where cirazoline dodecylsulphate was 
precipitated from solution and representative sampling of cirazoline 
could not be achieved, calculation of percent residual concentration 
was made by reference to CPAE concentration alone (method 2, equation 
3.7). An example of such data is given by the degradation of 
2 x 10~3 m cirazoline hydrochloride in 1 x 10“^ M SDDS at pH 7.0 and 
30°C, table 3.7 and figure 3.7.
3.1.7 Adaptation of HPLC Assay to Other Imidazolines
Antazoline, fenoxazoline and naphazollne samples were analysed using 
the HPLC conditions described for cirazoline with apovincamine as 
internal standard. HPL chromatograms of initial and partially 
degraded samples are shown In figures 3.8 to 3.10. Partial 
degradation in the Initial fenoxazoline sample is evident (see 
section 2.1.2.1). Tolazoline and xylometazoline could not be 
detected at 275 nm as their UV absorbance at this wavelength is too 
low. Assays were therefore, carried out at a wavelength of 240 nm in 
the absence of internal standard and calculation was by reference to 
external standard peak areas. HPL chromatograms of initial and 
partially degraded solutions are shown in figures 3.11 and 3.12. 
Tolazoline and xylometazoline degradation product peaks were not 
detected on the HPL chromatograms. Chromatographic parameters are 
presented In table 3.1; satisfactory resolution (Rs) and selectivity 
(a) were obtained for all peaks except the fenoxazoline/internal 
standard peaks (Rs = 1.0, a * 1.3), figure 3.9. This fenoxazoline 
assay method was used, however, as satisfactory peak area 
ratio/concentration linearity was obtained.
Calibration curves were constructed for each imidazoline up to a 
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Coefficient 0.0374 0.9957 0.9648
Slope x 104 +3.115 -36.97 -39.50
(S.D. x 10A ) (29.42) (1.221) (3.809)
(RSD Slope) (944%) (3.3%) (9.6%)
Intercept 4.231 4.597 4.583
(S.D.) (0.130) (0.006) (0.017)
(Calculated as % initial) (68.79%) (99.19%) (97.81%)
kobs x 106 5-1 - 1.03 1.10
Table 3.7 - Degradation of 2 x 10“3 M cirazoline [CIR] hydrochloride 
in 1 x 10"3 M SDDS at pH 7.0, 30°C. Residual 
concentrations and first order rate constants calculated 






Figure 3.7 - First order plot for the degradation of 2 x 1 0 m
cirazoline hydrochloride in 1 x 1 0 m SDDS, pH 7.0, 
30°C. Percent residual concentration (%RC) values 










5 Minutes 5 6 Minutes
HPL chromatogram of 3.2 x 10“^ M antazoline sulphate 
(II), (a) initial sample, (b) after storage in 
phosphate buffer pH 6.85, 70°C for 8.3 hours. I = 
degradation product, IS = 20 pg ml“l apovincamine. 







0 Minutes Q Minutes 5
HPL chromatogram of 3.2 x 10-/f M fenoxazoline 
hydrochloride (il), (a) Initial sample showing presence 
of degradation product (i), (b) after storage in 
phosphate buffer pH 6.85, 70°C for 38 minutes. IS =
20 pg ml-l apovincamine. (Chart speed = 5 mra min-1 , 









0 Minutes ^ 0 Minutes 5
Figure 3.10 - HPL chromatogram of 6.4 x 10”^ M naphazoline nitrate
(il), (a) initial sample, (b) after storage in 
phosphate buffer pH 6.85, 70°C for 77 hours. I = 
degradation product, IS = 10 jjg ml“l apovincamine. 






Figure 3.11 - HPL chromatogram of 3.2 x 10"* M tolazoline
hydrochloride (il), (a) initial sample, (b) after 
storage in phosphate buffer pH 6.85, 70°C for 
51 hours. (Chart speed = 5 mm min“ l, detection at 








0 Minutes 6 0 Minutes
- HPL chromatogram of 1.6 x 10”* M xylometazoline 
hydrochloride (il), (a) initial sample, (b) after 
storage in phosphate buffer pH 6.85, 70°C for 103 
hours. (Chart speed = 5 mm min- 1 , detection at 
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Figure 3.13 - HPLC calibration plots for antazoline
sulphate (— • — ) fenoxazoline 
hydrochloride (—  ▼— ) using 20 pg ml“l 
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Concentration (M x 10^)
HPLC calibration plot for naphazoline 
nitrate using 20 pg ml“ l apovincamine as 
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igure 3.15 HPLC calibration plots for tolazoline 
hydrochloride (—  • — ) and xylometazoline 

















Concentration (% x 10”3 )
Figure 3.16 - Beer Lambert plot for 2-methyl-2-imidazoline
in 4 x 10“3 M HC1 at 218 nm.
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Linear regression analysis data are summarised in table 3.8. 
Naphazoline and tolazoline calibration curves pass close to the 
origin (intercept < S.D.s. from the origin), but antazoline, 
fenoxazoline and xylometazoline curves have negative intercepts, > 2 
S.D.s. from the origin. The magnitude of the intercepts is small, 
however, and the error in first order rate constant determination 
resulting from the assumption that the calibration curves pass 
through the origin is considered to be minimal (<4%). All curves 
show the peak area (ratio) to be proportional to concentration.
Sample concentration was therefore calculated by reference to a 
single standard solution which was assayed alongside the samples,
(see equation 3.5).
2-methy1-2-imidazoline could not be analysed using the HPLC method as 
significant absorbance does not occur above the UV cut-off point of 
the mobile phase system; it was therefore assayed by UV 
spectrophotometry (section 3.2).
3.2 UV ASSAY OF 2-METHYL-2-IMIDAZOLINE
2-methy1-2-Imidazoline was assayed by UV analysis at 218 nm using a 
Perkin Elmer 550S UV-VIS spectrophotometer with 1 cm pathlength 
quartz cuvettes. Absorbance was measured in duplicate against 
double distilled water and spectra were recorded on a Perkin Elmer 
561 chart recorder.
A 0.05 M stock solution was prepared in 0.06 M HC1 solution. This 
HC1 concentration was chosen to ensure complete neutralisation of the 
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Table 3.8 - Linear regression analysis data for imidazoline HPLC 
calibration plots (peak area (ratio) against molar 
concentration). (ANT = antazoline, FEN *= fenoxazoline, 
NAP * naphazoline, TOL = tolazoline and XYL = 
xylometazoline)•
* Peak area ratio (internal standard = 20 pg/ml apovincamine)
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This stock solution was suitably diluted to provide eight 
concentrations in the range 0.672 - 3.024 x 10~®% (0.8 - 3.6 x 10”^ M 
nominal) in 4 x 10"® m HC1 from which a Beer-Lambert plo.t was 
constructed, (figure 3.16). Linear regression analysis on the data 
expressed in % w/v concentration terms gave the following data:
Correlation coefficient: 0.99997
Slope x 10"2 (S.D. x 10“2 ): 5.207 (0.016)
Intercept (S.D.): 0.017 (0.003)
Results show absorbance to be proportional to concentration with an 
value of 521 and an apparant molar extinction coefficient ( £ )  of
lcm
4.40 x 10® (literature value = 4.9 x 10® at 218 nm2®). The 
difference between the calculated and literature £  values (10%) is 
probably due to the presence of water within the sample (see section 
2.1.2.1). A positive intercept > ♦. 2 S.D.s. from the origin was 
obtained; the magnitude of the intercept was small, however, and the 
error resulting from the assumption that the calibration curve passes 
through the origin is considered to be minimal (<2%).
The assay was shown to be stability indicating by degrading a 
0.0168% w/v solution in 0.1 M NaOH at 70°C. 4 ml samples were
withdrawn at appropriate intervals, acidified with 5 mis of 0.1 M HC1 
and diluted to 25 mis, with distilled water. Absorbance was 
measured at 218 nm and the spectrum from 185 to 260 nm recorded. 
Samples showed a rapid fall in absorbance at 218 nm to a constant 
residual value 0.073. Spectra are shown In figure 3.17.
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The percentage residual concentration (% RC) for the degradation of 
2-methy1-2-imidazoline was calculated from equation 3.9:
A t - 0.073
% RC = ------------ x 100 (3.9)
Ax - 0.073
Where Aj and A t are the initial absorbance and absorbance after time 
t, respectively.
-156-






Figure 3.17 - UV spectra of 2-methyl-2-imidazoline (2.69 % w/v)
after storage as a 1.68 x 10"^ % w/v solution in 0.1 M 
NaOH, (a) initial, (b) after 6 minutes and (c) after 
104 minutes.
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4. pKo OF CIRAZOLINE AND CPAE
A . 1 INTRODUCTION
pKa values are of particular importance as a knowledge of the amount 
of ionised species is crucial when investigating ionic interactions. 
For the dissociation of cirazoline, the intrinsic or thermodynamic 
ionisation constant, Ka , is given by equation A.I.
. K a 
CIRH4 - . CIR + H4
aH4 . aCIR
Ka = --------  = - antilog pKa (A.l)
aCIRH4
Where a represents the activities of the various species. If the 
activities of the conjugate acid-base species are replaced by 
stoichiometric concentrations, [CIRH4 ] and [CIR], an apparant 
ionisation constant, K a', is obtained, (equation A.2):
aH+ [CIR]
Ka» = ---------- = - antilog pKa ' (A.2)
[CIRH4 ]
The thermodynamic and apparant pKa values are related by equation A.3: 
pKa' = pKa - logiQ •'^CIRH4 (A.3)
Where ^CIRH4 *s t i^e activity coefficient for the cirazoline cation, 
CIRH4 and can be calculated from the Debye-Huckel equation (equation 
l.lt). Equations A.l and A.2 may be written in the form of the 
Henderson-Hasselbalch equations, (equations A.A and A.5 respectively):
pKa = pH ♦ logio / aCIRH4 \ (A.A)
I aCIR J
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pKa * = pH 4 log10 fCIRH*1 (4.5)
[CIR]
As ionic strengths approach zero, concentrations approximate closely to 
activities and pKa * — > pKa.
The pKa values of weak bases such as cirazoline are particularly 
sensitive to temperature. Over temperature ranges where the standard 
enthalpy change ( A H 0) and standard entropy change ( AS°) for 
ionisation are constant, the pKa temperature dependency can be 
calculated from a form of the Van't Hoff equation (4.6):
PK a = AH° . 1 - A S 0 (4.6)
2.303R T 2.303R
Where R is the gas constant and T is in degrees Kelvin. Plots of pKa 
against T” 1 should therefore be linear. Over extended temperature 
ranges where A H° and A S° may show variations, pKa temperature 
profiles may show minima and temperature dependence can follow a vlrial 
equation:
pKa = 4 Q 4 R T   (4.7)
T
Where P and Q are constants. For temperature ranges where equation 4.6
holds, Perrin has proposed an expression for the calculation of a
temperature coefficient -d(pKQ) for the pKa of monoacidic bases
dT
(equation 4.8)200;
- d ( p K a )  =  p K „  - 0.9 (4.8)
dT T
Techniques for determining the pKa values of weak acids and bases 
include potentiometric titration, solubility, nuclear magnetic 
resonance spectoscopy, spectrophotometry and conductimetry. The method
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employ ed for the determination of cirazoline pKa was the potentiometric 
method described by Albert and Serjeant^Ol. This method involves 
titrating a solution of the weak base or acid for which the pKa is to 
be determined with a solution of strong acid or base. This method was 
chosen for its speed, an important factor as the stability of aqueous 
of cirazoline at high pH is poor. In view of this stability problem, 
special attention was given to minimising exposure of solutions to 
high pH; solutions were assayed after titration completion and the 
extent of degradation determined by reference to cirazoline and CPAE 
concentration. Titration of dilute solutions, (approximately 
1 x 10“3 M), was used due to the poor solubility of the free base. 
Potassium hydroxide was used as titrant rather than sodium hydroxide as
the potassium ion gives rise to less electrode error.
The presence of carbonate in the titrant solution produces 
inaccuracies in pKa determination as exact concentrations of salt and 
free base must be known. Formation of potassium hydrogen carbonate 
will reduce the amount of titrant able to react with cirazoline.
This will not be detected by standardization with a strong acid, as
unlike weak acids such as cirazoline hydrochloride, strong acids will
react with potassium hyrogen carbonate. Possible sources of 
carbonate contamination are:-
(a) Carbonate present on the surface of potassium hydroxide 
pellets.
(b) Carbonate present in water formed from equilibrium with 
carbon dioxide in the air.
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To overcome these problems, carbonate free potassium hydroxide 
solution was prepared, freshly boiled and cooled double distilled water 
used throughout and all solutions were maintained below nitrogen.
4.2 EXPERIMENTAL
4.2.1 Preparation of Carbonate-Free Potassium Hydroxide
A small amount of glass wool was placed in the bottom of a qulckfit 
dropping funnel and about 20 g of potassium hydroxide pellets added. 
Sufficient freshly boiled and cooled double distilled water was 
added to just cover the pellets. A soda-lime guard tube was fitted 
and the aqueous solution immediately drained to waste. After a 
repeat washing procedure, the dropping funnel was filled with more 
water, stoppered, and shaken until all the potassium hydroxide had 
dissolved. The soda-lime guard tube was replaced and the first 5 - 1 0  
mis of solution ran to waste. The remaining solution was collected 
in a qulckfit conical flask and stored under nitrogen. The 
concentration of solution thus produced was determined by diluting a 
sample and titrating against 0.1 M HC1 using methyl orange as 
indicator. The concentration of the stock solution of carbonate- 
free potassium hydroxide was found to be 0.3171 M.
4.2.2 Titration Procedure
The apparatus used for the determination of pKa values is shown in 
figure 4.1.
Potentiometric titrations of cirazoline hydrochloride were carried out 
at 25°, 30°, 35° and 40°C in the presence of 0.1 M potassium chloride 
since the electrode response time was slow at very low ionic strengths. 

















Figure 4.1 - Apparatus used for the determination of pKa 
values by potentiometric titration.
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Potassium chloride (1.49 g) and freshly boiled and cooled double 
distilled water (200 g) were weighed and transferred to the jacketed 
cell. About 50 mg of cirazoline hydrochloride or CPAE (approximately 
1 x 103 M) were accurately weighed into the cell and the bung inserted. 
The tip of the nitrogen feed line was positioned about 1 cm above the 
solution and the flow rate adjusted to produce a slight impression on 
the surface. The thermometer and pH probe were immersed in the liquid 
and all other holes in the cork bung stoppered. The magnetic stirrer 
was switched on and the solution allowed to equilibrate to 
temperature.
The Agla micrometer syringe, fitted with a straight glass needle, was 
carefully filled with carbonate-free potassium hydroxide solution, 
minimising exposure to air. The syringe was inserted into the cell and 
positioned so as the tip of the needle was just above the surface of 
the liquid. The titration commenced by lowering the syringe into the 
stirring solution and adding the required volume of potassium 
hydroxide. After a few seconds the syringe was withdrawn from the 
solution and the pH of the still solution recorded. The titration 
continued until at least four pH readings were produced. The volume of 
titrant added was always <0.2% of the initial volume. Immediately the 
titration was complete, the solution was acidified with 0.1 M HC1 and a 
sample taken for assay. The percent residual concentration was 
calculated by reference to cirazoline and CPAE concentration (method 3, 
equation 3.8, section 3.1.6).
4.2.3 Treatment of Experimental Data
Individual apparant pKa values were calculated after each addition of 
titrant using the Henderson-Hasselbalch equation (equation 4.5).
For very dilute concentrations of weak acid or base or at high pH,
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allowance must be made for the hydroxyl Ion concentration, [OH"], of 
the solution when calculating [CIRH*] and [CIR] which are derived 
from the ion balance equation (equation 4.9) and the mass balance 
equation (equation 4.10).
[CIRH4 ] 4 [K4 ] 4 [H4 ] - [Cl"] 4 [OH"] (4.9)
[CIRHC1]t - [CIRH4 ] 4 [CIR] = [Cl"] (4.10)
Where [K4 ] is the concentration of potassium ions and is equal to the 
concentration of titrant [KOH] added, [Cl"] is the concentration of 
chloride ions and is equal to the total concentration of cirazoline 
hydrochloride added, [CIRHCl]^. The experimental data in tables 4.1 - 
4.5 show that after the addition of the first increment of titrant, 
[H4] becomes negligible compared to values of [CIR]. Equation 4.9 may 
therefore be reduced to equation 4.11s
[CIRH4 ] - [CIRHC1]t 4 [OH"] - [KOH] (4.11)
Combining equations 4.10 and 4.11 gives:
[CIR] - [KOH] - [0H~] (4.12)
[OH- ] for this work was calculated from the hydroxyl ion activity,
aQH~» which was obtained from equation 4.13. pKw ' values were 
calculated from equation 4.14 using standard literature values for pKw 
at each experimental temperature^^.
“ logio 30H" = P V  " PH “ -logio[OH"]-l°gio jfoH" (A.13)
pKw ' - -log10Kw ' - pKw 4 2 log10 (4.14)
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Where Kw ' and Kw are the apparent and Intrinsic Ionisation constants 
for water a n d I s  the mean ion activity coefficient, and
were calculated as 0.75 using equation 1.18.
The cirazoline concentration terms used to calculate pKa ' values from 
equation 4.5 were therefore calculated from equations 4.11 and 4.12. 
Intrinsic pKa values were then estimated from equations 4.3 and 1.19. 
Values of A and B were taken from Robinson and Stokes-^, the product 
Ba^ was estimated as unity and the ionic strength, I, was taken as 
0.1 M.
4.3 RESULTS
Tables 4.1-4.5 show the titration data, derived species concentrations 
and apparant pKa ' values obtained in 0.1 m KC1 over the temperature 
range 24.9-39.5°. Mean values and the range were assessed using the 
protocol of Albert and Serjeant^*; the mean is derived by converting 
pKa ' to K a', calculating the mean K a ' and hence the mean pKa '. The 
range is the largest deviation of this value from those found 
experimentally. Results are set out in table 4.6; observed range 
values conform well within the proposed criterion of acceptance which 
is a scatter of 0.06.
Figure 4.2 shows a plot of pKa' against T for cirazoline in 0.1 m KC1. 
Linear regression analysis gave the following results: correlation
coefficient = 0.99997, slope (S.D.) = -2.677 (0.015) x 10"^, intercept 
(S.D.) = 17.58 (0.04). The temperature coefficient (-dpKa '/ -^p) is 
given by the slope and was found to be 0.027 pH units K“l. This is in 
good agreement with the calculated value of 0.029 pH units K“l 
(equation 4.8). Figure 4.3 shows the pKa -temperature data plotted 
according to the Van't Hoff equation (equation 4.6). Linear regression
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analysis data and thermodynamic parameters for the protonation of 
cirazoline at 25°C are shown in table 4.7.
A H 0 for cirazoline was calculated from the slope of the Van*t Hoff 
plot (figure 4.2), AG° was obtained from equation 4.15 and A S °  was 
calculated from equation 4.16.
A G° - 2.303 RT pKa (4.15)
AG° * AH°-T A S 0 (4.16)
The thermodynamic parameters in table 4.7 indicate that protonation of 
cirazoline to form CIRH+ is driven by a large negative free energy 
change (-54 kJ mol“l) which is derived from a large exothermic enthalpy 
change (-48.2 kJ mol“l) and a small positive entropy change 








OH” | CIRH4 
1
(M x 106 ) | 


























9.169 35.2 | 747.1 
1
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Table 4.1 - Data from the potentiometric titration of 0.3171 M KOH
against cirazoline hydrochloride in 0.1 m KC1 at 24.9°C. 
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Table 4.2 - Data from the potentiometric titration of 0.3171 M KOH
against cirazoline hydrochloride in 0.1 m KC1 at 29.0°C. 
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| 0.20 8.887 38.1 | 759.9 
1
1 I 





























Table 4.3 - Data from the potentiometric titration of 0.3171 m KOH
against cirazoline hydrochloride in 0.1 m KC1 at 34.9°C. 








OH- | CIRH4 
1
(M x 106 ) | 















8.674 32.7 | 693.3
1 1 








8.839 47.7 | 629.1
I 1 







8.965 63.8 | 566.0
1 1 














Table 4.4 - Data from the potentiometric titration of 0.3171 m KOH 
against cirazoline hydrochloride in 0.1 m KC1 at 39.5°C. 
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| 0.20 8.848 16.8
1 1 
















| 0.30 9.176 35.7
1 1 






















571.1 | 9.156 | 
1
Table 4.5 - Data from the potentiometric titration of 0.3171 m KOH 
against CPAE hydrochloride in 0.1 m KC1 at 25.0°C. 
Apparent pKa (pKa ') values calculated using ^ OH” = 0.75 
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Table 4.6 - Apparant and thermodynamic pKa values for cirazoline and 








| Slope (S.D.) 
1
2.495 x 103 (0.016 x 103 ) |
1
| Intercept (S.D.) 1.112 (0.051) |
1 a g °25 -54.1 kJ mol"1 |
1 AH°25 -48.2 kJ mol"1 |
1 AS°25 
1
420 J mol"1 K"1 |
1
Table 4.7 - Linear regression analysis results for the pKa data 
plotted according to equation 4.6 and derived 












Figure 4.2 - Effect of temperature on the
cirazoline hydrochloride apparant 
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Figure 4.3 - Cirazoline hydrochloride intrinsic 








5. 2 —IMIDAZOLINE EXOCYCLIC 
METHYLENE ACIDITY
The acidity of the imidazoline exocyclic methylene group was 
investigated using nuclear magnetic resonance (NMR) spectroscopy under 
controlled 'pH* and temperature conditions in order to evaluate the 
mechanism of imidazoline hydrolysis.
5.1 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
NMR spectroscopy is a standard technique used for determining the 
structure of organic molecules by providing information about the 
chemical environment of atoms, the number of atoms in each environment, 
and the structure of groups adjacent to each atom. Proton magnetic 
resonance (PMR) and l^C NMR are the commonest forms of NMR which is 
based on observing resonance of these magnetic atoms induced by an 
applied electromagnetic field. NMR theory is the subject of many text 
books202-204 an(j outside the scope of this thesis. Interpretation 
of structure is based on the provision of NMR spectra from which 
chemical shifts (S), peak area, spin-spin splitting and 
proton/deuterium (H/D) exchange can be determined.
The chemical shift, measured in parts per million (ppm) is a function 
of the electron density surrounding the nucleus and is determined 
relative to a standard peak e.g. tetramethylsilane, TMS, (0 ppm), HDO 
(4.6 ppm). In general the greater the chemical shift the lower the 
electron density surrounding the nucleus i.e. the nucleus is 
deshielded. The area under the resonance peak is proportional to the
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number of nuclei responsible for the absorption. Integration of peak 
area therefore allows quantification of nuclei and aids elucidation of 
structure. Spin-spin coupling causes production of a fine structure in 
a spectrum and is due to the presence of neighbouring magnetic nuclei. 
The extent of peak splitting is a function of the number and type of 
nuclei causing the splitting. For splitting induced by vicinal 
protons, the number of peaks in the fine structure is given by the 
number of protons causing the splitting plus one. Proton/deuterium 
(H/D) exchange is the process whereby deuterium, which has no 
absorbance in the proton spectral region, exchanges with labile protons 
from the solute. This is performed by using, D2O as solvent or 
preferably by deuteration, i.e. adding D2O to a sample dissolved in an 
inert solvent such as CDCI3. Typical labile protons are those 
associated with acidic or basic functional groups; these protons 
exchange very rapidly and a total loss of peak occurs immediately upon 
addition of D2O; such peaks are therefore not observed when the sample 
is prepared in D2O. This effect is a useful tool in the identification 
of acidic or basic groups. More stable acidic or basic groups, such as 
methylene groups close to an electron withdrawing groups, exchange at a 
much slower rate. In these cases the relevant proton peak(s) may be 
observed to diminish in magnitude by repeatedly scanning the sample at 
appropriate time intervals. The rate of exchange (given from the rate 
of decrease in peak area) is therefore a measure of the acidity or 
basicity of the group.
5.2 METHOD
The exocyclic methylene acidity of cirazoline hydrochloride, antazoline 
sulphate, fenoxazoline hydrochloride, naphazoline nitrate, tolazoline
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hydrochloride, xylometazoline hydrochloride and 2-methyl-2-imidazoline 
was investigated at 20°C in phosphate buffer 'pH' 6.9 using PMR.
Spectra were generated using a Jeol JNM GX270 FT NMR spectrometer in 
the range ^  = 0 to 10 ppm.
Solutions were prepared by dissolving 150 mg of sample in 5 mis of 0.025 m 
equimolal phosphate buffer 'pH' 6.9. The buffer was prepared according to 
Bates^5 except D2O was used as solvent. The 'pH' of the final buffered 
samples was determined as 'pH' 6.9 _+ 0.1 at 20°C. Unlike the other 
imidazoline samples, 2-methyl-2-imidazoline was only available as the free 
base; the hydrochloride salt was therefore prepared in situ by the 
addition of equimolar HC1 and dilution to volume with phosphate buffer.
The 'pH' of the final system was adjusted to 'pH' 6.9 using aqueous 
1 M HC1.
A scan was performed immediately after sample preparation and repeated at 
appropriate intervals during the study. The HD0 peak resulting from 
exchange of protons from the phosphate buffer salts with D2O was used as 
the internal reference ( £ =  A.60 ppm).
5.3 CALCULATION OF EXCHANGE RATE CONSTANTS
The number of protons associated with each absorption peak was calculated 
by peak area integration. For each sample, the number of protons (H) in 
each moiety of the molecule was calculated by reference to an inert 
'standard' moiety within the molecule;
Number of Protons = Number of Protons x Peak Area of Moiety (5.1)
in Moiety in Standard Moiety Peak Area of Standard Moiety
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The moieties within the imidazoline structure were defined as:
A * Endocyclic methylene groups 
B = Exocyclic methylene group 
C *= Substituent aromatic ring(s)
D-F = Substituent aliphatic group(s)
The aromatic ring (C) was used as the standard moiety for cirazoline, 
fenoxazoline, antazoline and tolazoline; the trimethyl groups (D) were 
used for xylometazoline and the endocyclic methylene group (A) was used 
for 2-methy1-2-imidazoline.
The rate of proton/deuterium exchange is given by:
dt
Where - dH represents the loss of protons with time, t; k]?x is the 
dt
exchange rate constant; H is the number of protons in the moiety and 
n is the order of reaction. For a first order exchange (i.e. n ■ 1):
Where H0 and H t are the number of protons in the moiety at time zero 
and after time t, and %RH is the percent residual proton number. 
First order exchange rate constants were determined for each 
imidazoline by fitting data to the first order rate equation 
(equation 5.3) using least squares regression analysis.




Initial and final NMR spectra of each imidazoline are shown in 
figures 5.1 to 5.7. The number of protons in each of the moieties 
(A-F) was calculated as described in section 5.3 and results are 
presented in tables 5.1 to 5.7. First order H/D exchange plots for 
naphazoline, antazoline, xylometazoline and tolazoline are shown in 
figure 5.8.
The initial NMR spectrum of fenoxazoline hydrochloride (figure 5.2a) 
shows the sample to be Impure and integration data (table 5.2) suggest 
an initial impurity level of about 20%. Chemical degradation (ring 
cleavage) was evident during the exchange for cirazoline and 
fenoxazoline. (the remaining compounds showed no such degradation).
NMR spectra for cirazoline and fenoxazoline show a decrease in the 
number of protons associated with the exo-(B) and endocyclic (A) 
methylene groups with time (tables 5.1 and 5.2) and the appearance of 
three peaks of equivalent area at chemical shifts of S * 3.0. 3.4 and
4.4 ppm. These peaks are consistant with the structure of the 
cirazoline and fenoxazoline hydrolysis degradation products (see figure 
1.2). The first order rate constant (k0^s) for the cirazoline and 
fenoxazoline hydrolysis reaction in phosphate buffer * pH' 6.9 in D2O, 
20°C was calculated from the endocyclic methylene proton (A) data using 
equation 5.4.
k0bs (S.D.) values were calculated using least squares regression 
analysis as 2.08 x 10"^ (0.08 x 10“^) s“ l and 1.79 x 10“  ^ (0.14 x 10“^)
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Figure 5.1 - Proton NMR spectra for cirazoline hydrochloride in
phosphate buffer, 'pH' 6.9, in D20, 20°C; (a) initial, 
(b) after 336 hours. I = impurity/degradation product.
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Table 5.1 - Stability of cirazoline protons in phosphate buffer, 'pH' 
6.9 in D2O, 20°C. HA * endocyclic methylene protons,
Hg ■ exocyclic methylene protons, H q c aromatic protons, 
Hj) * substituent methine protons, HE *= substituent 
methylene protons, Hg" = corrected exocyclic methylene 




Proton NMR spectra for fenoxazoline hydrochloride in 
phosphate buffer, 'pH' 6.9, in D2O, 20°C; (a) initial, 
(b) after 336 hours. I = impurity/degradation product.
TIME PROTON NUMBER
(HRS) «a 1 
1
Hfi HC hd 1 h e | 
1 1




















22 3 .211 1.91 4.0 0.98
1 1 






174 2 .87 | 1.48 4.0 0.99
1 1 












































% RESIDUAL PROTON NUMBER
Table 5.2 - Stability of fenoxazoline protons in phosphate buffer, 
'pH1 6.9 in D2O, 20°C. HA = endocyclic methylene 
protons,Hg = exocyclic methylene protons, Hq = aromatic 
protons, Hp = substituent methine protons, Hg = 
substituent methylene protons, Hg' = corrected exocyclic 
methylene protons (see text for further explanation of 
this function).
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j-^£ure— 5.3 - Proton NMR spectra for antazoline sulphate in phosphate 
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1 
1
2 1 1 
1 1 
1 1
Table 5.3 - Stability of antazoline protons in phosphate buffer, 'pH' 
6.9 in D2O, 20°C. HA = endocyclic methylene protons,
Hg = exocyclic methylene protons, Hq = aromatic protons, 
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Figure 5.4 - Proton NMR spectra for naphazoline nitrate in phosphate
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Table 5.4 - Stability of naphazoline protons in phosphate buffer, 
'pH' 6.9 in D2O, 20°C. HA = endocyclic methylene 
protons, Hg = exocyclic methylene protons, Hq = aromatic 
protons.
- 1 8 4 -
C HDO A-HB
TT T




10 8 6 4 02
Chemical Shift (ppm)
Figure j.5 - Proton NMR spectra for tolazoline hydrochloride in
phosphate buffer, 'pH' 6.9 in D20, 20°C, (a) initial, 
(b) after 678 hours.
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1 1
| TIME | PROTON NUMBER
1
% RESIDUAL PROTON NUMBER |
I
| (HRS) | 
1 _ 1
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1
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lable 5.5 - Stability of tolazoline protons in phosphate buffer, 'pH' 
6.9 in D2O, 20°C. HA = endocyclic methylene protons,
Hg = exocyclic methylene protons, H q = aromatic protons.
Figure 5.6
Chemical Shift (ppm)
Proton NMR spectra for xylometazoline hydrochloride 
in phosphate buffer, 'pH' 6.9, in D2O, 20°C;




























1.95 | 5.99 9.0 100
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1.94 | 5.98 9.0 101
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1 1 
1 1
Table 5.6 - Stability of xylometazoline protons in phosphate buffer, 
'pH* 6.9 in D2O, 20°C. HA = endocyclic methylene 
protons, HB = exocyclic methylene protons, Hq = aromatic 
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Figure 5.7 - Proton NMR spectra for 2-methyl-2-imidazoline
hydrochloride in phosphate buffer, 'pH' 6,9, in D2O,
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1 100 I 
1 1
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J Proton Number | 
1 1
4 3 1 1 
1 1
Table 5.7 - Stability of 2-methy1-2-imidazoline protons in phosphate 
buffer 'pH' 6.9 in D2O, 20°C. = endocyclic methylene






































Figure 5.8 - First order plots for imidazoline exocyclic methylene
proton (Hg)/deuterium exchange. Antazoline (— ■ — ), 
naphazoline (— • — ), tolazoline (— A — )t and xylometazoline 
(— ▼ — ), in phosphate buffer 'pH' 6.9 in D2O, 20°C.
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In order to determine the extent of exocyclic methylene H/D exchange 
for undegraded cirazoline and fenoxazoline, the percent residual 
exocyclic methylene proton number was recalculated as a function of the 
endocyclic methylene proton number (H^)f using equation 5.5:
Where % RHg' is the corrected percent residual exocyclic methylene 
proton number and and Hg are the number of endo and exocyclic 
methylene protons respectively. % RHg* is therefore a measure of the 
extent of exchange for undegraded cirazoline and fenoxazoline. All 
other spectra showed the absence of peaks associated with Imidazoline 
hydrolytic degradation products. The xylometazoline, naphazoline and 
antazoline endocyclic methylene proton number (H^) remained constant 
and close to the theoretical value during the study; mean (S.D.) 
values were calculated as 3.85 (0.10), 4.02 (0.09) and 3.87 (0.07) 
respectively.
The tolazoline endo (A) and exocyclic (B) methylene protons had 
absorption peaks very close together and Hg could not be calculated 
directly. Hg was therefore calculated by subraction of from the 
total methylene (H^ + Hg) protons (equation 5.6);
was assumed to be constant during the study and its value was 
determined from the spectrum at time zero (equation 5.7);
Hfi 4
% RHg1 * --  x —  x 100
h a  2
(5.5)
HB - <HA ♦ Hb ) - HA (5.6)
Ha = (HA ♦ Hb ) x 4 . at time zero
6
(5.7)
This calculation method is thought to be valid as the degradation (ring 
cleavage) rate of tolazoline is similar to naphazoline and antazoline
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(section 8.3.5) and these samples did not degrade during the exchange 
study. The derived exocyclic methylene H/D exchange rate constant for 
each imidazoline are shown in table 5.8. Results indicate that 
2-methy1-2-imidazoline, cirazoline and fenoxazoline have negligible 
exchange rates under the experimental conditions employed. Mean (S.D.) 
percent residual exocyclic methylene proton numbers were calculated 
as s 2-methy1-2-imidazoline % RHg = 103 (2), cirazoline %RHg' = 99.3 
(6.7) and fenoxazoline % RHg* ■ 107 (10).
Exocyclic methylene H/D exchange occurred in the antazoline, 
naphazoline, tolazoline and xylometazoline samples and the rate of 
exchange followed first order kinetics. The rates of exchange found in 
this study are much slower than observed by Kountourellis^O, where 
complete exchange occurred in 24-100 hours with these imidazolines when 
prepared In deuterated dimethylsulphoxide, DMS0. Under the conditions 
employed in this study (phosphate buffer in D£0 'pH' 6.9, 20°C) half- 
lives determined from the first order rate equation (equation 5.3) are 
In the range 109-1080 hours (4.5-45 days). The rank order for the rate 
of exchange also differs; Kounterellis found reactivity in the order;
tolazoline>naphazoline = antazoline>xylometazoline 
whereas these results indicate reactivity to be in the order;
naphazoline> tolazoline>antazoline>xylometazoline.
These discrepancies may be associated with the difference in 
experimental conditions employed.
The importance of the imidazoline ring In the mechanism of methylene 
H/D exchange is highlighted by the difference in stability of the 
antazoline exocyclic methylene protons (Hg) and substituent methylene 
protons (Hg). The exocyclic methylene group (B) is adjacent to the 
protonated imidazoline ring whereas the substituent methylene group
-193-









































• Table 5.8 - Exocyclic methylene proton (Hg) exchange first order rate 
constants (kEX(Hg) f°r imidazolines in phosphate buffer 
'pH 6.9' in D20, 20°C. (* = corrected first order rate
constants (kEX^g')*
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(D) is adjacent to a phenyl ring. Both are bonded to the antazoline 
tertiary amine group. No Hp exchange was detected during the 678 
hours (28 days) of the study (Hp mean = 1.94, S.D. = 0.14) whereas Hg 
exchanged with deuterium at a rate of 4.44 x 10"^ s“l, giving a half- 
life of 433 hours (18 days).
-195-




The interaction between cirazoline hydrochloride and SDDS in aqueous 
solution may be described in terms of ion-pair formation, complexation 
and micellization and solubilization. The relative amounts of 
cirazoline and SDDS in the aqueous (free ion), ion-pair, complex and 
micellar forms is dependent upon the concentrations of cirazoline 
hydrochloride and SDDS, temperature and presence of additives e.g. 
electrolyte. At SDDS concentrations well below the CMC of the system 
aggregation is absent and the system may be described in terms of the 
ion-pair association constant, K^p , and the solubility product, K s. 
These parameters were determined using an automated conductimetric 
titration procedure similar to the method described by Mukhayer and 
D a v i e s ^1# jn addition the physico-chemical nature of the formed 
cirazoline dodecylsulphate complex (CIRH-DDS(c)) was investigated by 
visual observation, microscopy, NMR and DSC. Solubility products and 
complex formation were also investigated in cirazoline hydrochloride- 
sodium alkylsulphate (Cq - C14) systems and antazoline sulphate-, 




6.2.1 Automated Conductlmetrie Titrations
6.2.1.1 DESCRIPTION
The apparatus used for conductimetric titrations is shown 
diagramatically in figure 6.1. The sample solution (normally a 
solution of the imidazoline) was equilibrated to the desired 
temperature in a thermostatted beaker; temperature was maintained 
constant by water pumped from a water bath and cooler unit. The 
titration mixture was agitated continously by a magnetic stirrer. The 
conductance of the system was measured using a glass-platinum Mullard 
dip cell, (nominal cell constant 1.44) in conjunction with a Wayne Kerr 
conductivity bridge and recorded in the form of a continuous trace on a 
chart recorder. The surfactant solution was automatically pumped from 
a Hamilton precision syringe into the titration vessel at a known rate 
using a Braun motorized syringe pump. The delivery tubing was 
constructed from HPLC microbore tubing to prevent premature delivery of 
titrant.
6.2.1.2 DETERMINATION OF CELL CONSTANT
The cell constant was determined by measuring the conductivity of 
standard solutions of potassium chloride at 25°C. A range of potassium 
chloride solutions (1 x 10“^ - 2 x 10“^ M) was prepared using dried 
potassium chloride (analar) and double distilled water. The 
conductivity bridge was trimmed and calibrated as decribed in the 
instrument manual. Each solution in turn was equilibrated to 25°C in 















Figure 6.1 - Conductimetric titration apparatus.
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The results, together with literature values and derived cell constants 
are shown in table 6.1. The mean cell constant was found to be 1.45; 
this value was used throughout.
6.2.1.3 SYRINGE CALIBRATION
The motorized syringe-pump unit was calibrated at each of the six flow 
rate settings used in the study. Different quantities of double 
distilled water at 20°C were titrated into a clean, dry, tared 
volumetric flask over a measured period of time (quartz stop watch).
The weight delivered was determined and the volume flow rate calculated 
using the density of water at 20°C (0.9982). Results are shown in 
table 6.2.
6.2.1.4 CALIBRATION OF CONDUCTIVITY BRIDGE AND SERV0G0R 120 CHART 
RECORDER
The conductivity cell was disconnected and the desired bridge range 
selected. The chart recorder deflection was calibrated using the 
bridge conductivity meter output as follows; the chart recorder range 
switch was set to a full-scale deflection of '100'; 1 calibrate 
/variable* switch *to variable'; and 'zero/mV/V' switch to mV. The 
bridge meter sensitivity switch was switched to position '3' and the 
conductivity meter reading set to zero using the conductivity trim 
control. The chart recorder deflection was adjusted to zero using the 
'zero' control. The bridge conductivity meter was then set to 
full-scale deflection and the chart deflection adjusted to full-scale 
using the variable control. The conductivity bridge was then trimmed 

































































































2767.0 | 1.445 j
1
Mean 1.454 | 
1
S.D. 0.012 | 
1
CV 0.8% I 
1
Table 6.1 - Conductivity readings, literature specific conductivity
values (calculated from equivalent conductivity values in 
Robinson and Stokes*!), and calculated cell constants for a 









Mean Flow Rate (S.D.)| 

















| 9 (hr) 
1
1
| 20.38, 20.25, 20.40, 20.42, 20.44 
1
1
20.38 (0.08) | 
11
| 1 (min) 
1
1













j 5 (min) 
1
1
j247.5, 253.1, 253.3 
1
1
251.3 (3.3) | 
1
Table 6.2 - Flow rate calibration data for automated syringe pump 
assembly at each flow rate setting shown, 20°C.
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6.2.1.5 GENERAL PROCEDURE FOR CONDUCTIMETRIC TITRATIONS
The conductivity bridge and chart recorder were calibrated at the 
desired range settings as described in Section 6.2.1.4.
The Hamilton precision syringe was carefully filled with titrant and 
any bubbles of air removed. The syringe was loaded on to the motorized 
syringe pump and the microbore delivery tube unit fitted. An elastic 
band held the syringe plunger tight against the pump ram. The 
titrant was run to waste at a fast flow rate until all air bubbles from 
the delivery tube were removed from the system. The titration flow 
rate was selected and a few drops of titrant again run to waste 
to ensure correct gear location.
50 mis of sample solution were pipetted into the jacketed beaker, the 
thermometer inserted and the magnetic stirrer switched on. The beaker 
was covered with a layer of aluminium foil and the solution allowed to 
equilibrate with respect to temperature and dissolved gases. At 
temperatures above ambient it was necessary to remove gas bubbles from 
the beaker walls with the thermometer before proceeding. After 
equilibration, the magnetic stirrer was switched off and the aluminium 
cover removed. The conductivity cell was carefully inserted into the 
solution, ensuring complete removal of air from the measuring 
compartment. The cell was positioned just above the magnetic flea and 
close to the edge of the beaker to avoid the vortex. The tip of the 
syringe microbore delivery tube was positioned in a similar manner but 
on the opposite side of the beaker from the conductivity cell. A 
specially cut sheet of aluminium foil was placed on top of the beaker 
to minimise evaporation and contamination during the tiration. After a 
few minutes re-equilibration time the chart speed was selected and the 
titration started by simultaneously switching on the motorized syringe
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pump unit and chart recorder. The conductivity meter reading was noted 
at the beginning and end of the titration to ensure the chart 
calibration was correct on each run.
6.2.1.6 CALCULATION OF CONCENTRATION
The concentration of added titrant at any point in the titration may 
be calculated using equations 6.1 and 6.2:
Concentration (M) = Titrant concentration (M) x V (6.1)
(504V)
V = F. _1__ (6.2)
v
Where V is the volume of added titrant in mis, F is the flow rate in 
mis min” l, 1 is the chart run length in mm, and v is the chart speed in 
mm min”l; (preliminary checks showed the chart speed settings were 
correct).
The concentration of solute being titrated at any point in the 
titration is given by equation 6.3:
Concentration (M) = Initial Concentration (M) x 50 (6.3)
(504V)
6.2.1.7 VALIDATION OF TITRATION METHOD
The titration technique was validated by comparing the conductivity of 
potassium chloride solutions during titration (dynamic method) with the 
conductivity of stock solutions of known concentration (static method). 
Determinations were performed at 30°C and at the two principal flow 
rates used in the study (20.38 and 50.48 pi min"^). The conductivity 




Solutions of 1 - 6 x 10"^ m potassium chloride were prepared from a 
0.1 M stock solution. Each solution, in turn, was equilibrated to 
30°C in the jacketed cell and the conductivity of the unstirred 
solution measured. Conductivity values were read off the bridge meter 
and also recorded on the chart recorder as a 'base line'. The 'static' 
specific conductivity values were calculated from both meter and chart 
readings.
(b) Dynamic Method ’
0.1 M potassium chloride was titrated into 50 mis of double distilled 
water at 30°C using the general method previously described (section 
6.2.1.5). Flow rates of 20.38 and 50.48 pi min-  ^were used at 
chart speeds of 12 cm hr"* and 60 cm hr"* respectively; chart range 
0 - 1 x 10”3 S; conductivity bridge range '6'. Conductivity was 
recorded as a curve on the chart recorder from which a plot of 
specific conductivity against potassium chloride concentration was 
constructed. The 'dynamic' specific conductivity corresponding to 1.0, 
2.0, 3.0, 4.0, 5.0 and 6.0 x 10"^ M potassium chloride solution was 
read from the graph using equations 6.1 and 6.2.
Results of 'static* and 'dynamic' experiments are shown in table 6.3. 
The results show a good agreement between 'static' and 'dynamic' 
specific conductivity values. The observed average difference between 
meter and static chart values (40.9%) and meter and dynamic chart 
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Table 6.3 - 'Static' and 'dynamic' specific conductivity of potassium 
chloride solution at 30°C.
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6.2.2 Differential Scanning Calorimetry
The physicochemical nature of the cirazoline alkylsulphate complex was 
investigated using differential scanning calorimetry (DSC). This is a 
thermal analysis technique in which the energy of a transition of a 
substance is measured as a function of temperature. The sample and 
reference material are subjected to a closely controlled increasing 
temperature programme and, in the event that a transition occurs in the 
sample, the thermal energy added to the sample or reference containers 
is varied in order to maintain both sample and reference at the same 
temperature. Because this energy input is precisely equivalent in 
magnitude to the energy absorbed or evolved in the particular 
transition, a recording of this balance energy between sample and 
reference yields a direct calorimetric measurement of the transition 
energy. Hence DSC not only yields the temperature of a particular 
transition but, also enables calculation of the enthalpy change of the 
transition.
In these studies the weight of the sample was not measured due to 
difficulty in sample preparation and the technique was therefore 
limited to the determination of transition temperatures and a 
qualitative indication of the nature of the transition (i.e. exothermic 
versus endothermic transition).
DSC curves were generated using a DuPont 910 differential scanning 
calorimeter with DuPont 9900 computer/thermal analyser. Aluminium, 
crimped pans (non-hermetic seal) were used. Sample and reference (air) 
pans were equilibrated automatically to the initial temperature.
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6.3 RESULTS
6.3.1 Physicochemical Nature of Formed Complexes
The formation and physicochemical nature of cirazoline-alkylsulphate 
and imldazoline-dodecylsulphate complexes were investigated.
6.3.1.1 CIRAZOLINE-ALKYLSULPHATE SYSTEMS
Complexes of cirazoline octylsulphate (CIRH-OS, 0.05 M), cirazoline 
decylsulphate (CIRH-DS, 0.033 M), cirazoline dodecylsulphate CIRH-DDS, 
0.01 M) and cirazoline tetradecylsulphate (CIRH-TDS, 0.005 M) were 
formed by mixing aqueous solutions of cirazoline hydrochloride and the 
appropriate sodium alkylsulphate in equimolar amounts at ambient 
temperature.
The CIRH-OS system immediately formed a white liquid-in-liquid 
dispersion which separated after about ten minutes to form a lower oily 
layer. Storage at 4°C for 24 hours resulted in the formation of a 
viscous supernatent and partial crystallization of the lower layer. 
After further storage at 4°C the viscosity reduced and the system 
consisted of a lower crystalline layer and a clear supernatent. CIRH- 
DS formed a liquid complex and the system appeared as a white milky 
dispersion. Slow crystallisation occurred upon storage at 4°C.
CIRH-DDS and CIRH-TDS systems immediately formed a slightly viscous, 
grey dispersion which precipitated with time to form a white 
crystalline solid and clear supernatent. CIRH-DDS precipitated after 
12-24 hours storage at ambient temperature whereas CIRH-TDS 
crystallised a few minutes after preparation.
The CIRH-DDS system was further investigated by preparing mixtures of 
different concentrations and mole ratio. Systems containing 2 x 10”  ^ m
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cirazoline hydrochloride and 2 - 10 x 10"3 m SDDS were prepared at 
ambient temperature. The 10 x 10“^ M SDDS mixture was well above the 
CMC of that system (see table 7.4, section 7.1.2.2) and formed a 
stable isotropic solution with no apparant increase in viscosity. 
Systems containing other SDDS concentrations formed clear or slightly 
hazy viscous solutions which precipitated overnight at ambient 
temperature. Birefringence was not detected in these systems when 
viewed under polarized light indicating the absence of liquid 
crystalline phase. Figure 6.2 shows the equimolar (2 x 10~3 m) systems 
at 30°C, (a) immediately after preparation and (b) after 24 hours 
storage.
Samples of all crystalline cirazoline alkylsulphate complexes were 
isolated at 4°C using Whatman No. 1 filter paper and dried to constant 
weight at ambient temperature in a desiccator containing 6ilica gel. 
Great care was needed in handling the hydrated CIRH-OS crystalline 
complex as rapid melting occurred with slight increase in temperature. 
The NMR spectra on the anhydrous complexes in CDCI3 (Appendix 1), show 
all complexes to be of lsl stoichiometry, (CIRH-OS = 1:0.979, CIRH-DS = 
1:0.946, CIRH-DDS = 1:0.996, and CIRH-TDS = 1:0.976). Figures 6.3 -
6.6 show photomicrographs of anhydrous and hydrated complexes at x 80 
magnification.
Determination of Transition Temperature
The effect of temperature on the physical nature of the hydrated 
complexes was investigated by determining the temperature of transition 
from stable hydrated solid complex to stable hydrated liquid complex 
using DSC. The CIRH-DDS complex transition temperature was also 
determined by visual observation.
- 2 0 7 -
jUgure 6.2 - Equimolar (2 x 10”^ M) cirazoline hydrochloride - SDDS 
system at 30°C, (a) immediately after preparation and
(b) after 24 hours storage.
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Figure 6.3 - Photomicrographs of cirazoline-octylsulphate complex 
at x 80 magnification, ambient temperature,
(a) anhydrous, (b) hydrated in distilled water.
- 2 0 9 -
C
Figure 6.4 - Photomicrographs of cirazoline-decylsulphate complex 
at x 80 magnification, (a) anhydrous, ambient 
temperature, (b) hydrated in distilled water at 
ambient temperature and (c) hydrated in distilled 
water -with warming.
- 2 1 0 -
Figure 6.5 - Photomicrographs of cirazoline-dodecylsulphate complex
at x 80 magnification, (a) anhydrous, ambient 
temperature, (b) hydrated in distilled water at ambient 
temperature and (c) hydrated in distilled water with 
warming.
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Figure 6.6 - Photomicrographs of cirazoline-tetradecylsulphate
complex at x 80 magnification, ambient temperature, 
(a) anhydrous and (b) hydrated in distilled water.
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Equimolar mixtures of cirazoline hydrochloride and SDDS were prepared 
at 1 x 10”^ , 2 x 10"3, 3.3 x 10"^, 1 x 10"^ and 5 x 10“^ M 
concentration levels and equilibrated at 25°C in a water bath. The 
temperature was increased in increments of about 1°C and the physical 
appearance of the system noted at each temperature. An equilibration 
time of at least one hour was allowed between temperature increase and 
assessment. The transition temperature was given by the formation of a 
grey liquid in liquid dispersion and the concomitant reduction in the 
amount of crystalline complex. Transition in each system occurred over 
a narrow temperature range (approximately 2°C) and all systems changed 
from a crystalline suspension to a grey dispersion in the temperature 
range 39 - 42°C.
The transition temperature of hydrated complexes was determined by DSC 
as follows: a small amount of anhydrous crystalline complex was placed
in a sample pan and two drops of chilled distilled water were added 
using a pasteur pipette. The pan was crimped (non-hermetic seal) and 
the exterior dried carefully with a tissue. Samples were equilibrated 
to temperature in the DSC furnace and scanned at a ramp rate of 1°C 
min"l. Large peaks with negative heat flow occurred which indicate 
endothermic solid -> liquid transitions. Figures 6.7 - 6.10 show the 
DSC spectrum for each system and indicate a transition temperature of 
17.8°, 34.1°, 44.9° and 52.7°C for CIRH-OS, CIRH-DS, CIRH-DDS and CIRH- 
TDS systems respectively. The CIRH-DDS complex transition temperature 
was also determined at a ramp rate of 0.2°C min” * and using crystalline 
complex formed in situ from aqueous solutions of cirazoline 
hydrochloride and SDDS; a transition temperature of 44.4°C was obtained 
for both these systems.










Figure 6.7 - DSC spectrum for cirazoline-octylsulphate complex in
distilled water showing solid — > M q u i d  complex transition 









Figure 6.8 - DSC spectrum for cirazoline-decylsulphate complex in
distilled water showing solid — > liquid complex transition 
endotherm, (ramp rate = 1°C min”-*).




- 0 . 6 -




Figure 6.9 - DSC spectrum for cirazoline-dodecylsulphate complex in
distilled water showing solid — > liquid complex transition









Figure 6.10 - DSC spectrum for cirazoline-tetradecylsulphate complex in
distilled water showing solid --> liquid complex transition 
endotherm, (ramp rate = 1°C min” ^).
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6.3.1.2 IMIDAZOLINE DODECYLSULPHATE SYSTEMS
1 x 10"3 M complexes of antazoline dodecylsulphate (ANTH-DDS), 
xylometazoline dodecylsulphate (XYLH-DDS), naphazoline dodecylsulphate 
(NAPH-DDS) and tolazoline dodecylsulphate (TOLH-DDS) were produced 
by mixing in equimolar quantities aqueous solutions of SDDS and the 
appropriate imidazoline salt at ambient temperature. The ANTH-DDS 
complex Immediately produced large, white solid floccules which 
separated to the surface. The XYLH-DDS and NAPH-DDS systems formed 
grey, viscous liquid-in-liquid dispersions. The former precipitated 
slowly at 4°C to form long, needle-like crystals whereas the NAPH-DDS 
system remained unchanged as a liquid-in-liquid dispersion at 4°C 
during the period of the study (about four months). The TOLH-DDS 
system was a clear isotropic viscous liquid at ambient and 4°C which 
was stable over the period of the study.
6.3.2 Determination of Solubility Products
6.3.2.1 CIRAZOLINE DODECYLSULPHATE EQUILIBRIUM SOLUBILITY PRODUCT
The apparant equilibrium solubility product for the cirazoline 
hydrochloride-SDDS system was determined at 30°C by conductivity and 
turbidity measurements. Systems containing 2 x 10"^ M cirazoline 
hydrochloride and a range of SDDS concentrations were prepared and 
equilibrated to 30°C over a 24 hour period. The presence of insoluble 
phase was detected by measuring the apparant absorbance of each system 
in a 10 mm cuvette at 500 nm using a Perkin Elmer 550S UV-VIS 
spectrophotometer. Conductivity was measured using the jacketed 
beaker, Mullard conductivity dip-cell and Wayne-Kerr conductivity 
bridge in static mode (see section 6.2.1.7a).
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The solubility product was calculated from a knowledge of the 
cirazoline hydrochloride concentration and the SDDS concentration 
associated with the appearance of insoluble phase (equation 1.67); a 
1:1 stoichiometry was assumed for this calculation. This point is 
signified by an increase in the turbidity of the system 
and an inflexion in the conductivity-SDDS concentration profile. 
Turbidity and conductivity measurements are shown in table 6.4 and 
figure 6.11.
The turbidity data show a marked increase in apparant absorbance at an 
SDDS concentration of 6 x 10"^ M. Systems containing concentrations of 
SDDS at or above this value produced a highly flocculated, solid 
complex indicating the cirazoline-dodecylsulphate solubility product 
had been exceeded. The conductivity-SDDS concentration profile shows a 
deviation from linearity at the same SDDS concentration associated with 
complex formation. The system containing 5.75 x 10"^ M SDDS was a 
clear isotropic solution and the apparent solubility product at 30°C 
was therefore estimated at between 1.15 x 10"^ and 1.20 x 10“^
moles^litre”2.
6.3.2.2 DETERMINATION OF SOLUBILITY PRODUCTS BY C0NDUCTIMETRIC 
TITRATION
Solubility products were determined from the end-point of 
conductimetric titrations using equations 6.1 - 6.3 and 1.67,
(a) Description
Figure 6.12 shows the conductivity curve for the titration of 0.01 M 
SDDS into 1.5 x 10"^ M cirazoline hydrochloride at 50°C, flow rate
50.48 pi min"l, chart speed 12 cm hr“l, chart conductivity range 











































































Table 6.A - Turbidity (apparant absorbance) and conductivity data for 
2 x 10"4 M cirazoline hydrochloride-SDDS systems at 30°C.
(a) approximately 18 hours after preparation and
(b) approximately 24 hours after preparation.
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SDDS Concentration (M x 10^)
Figure 6.11 - Specific conductivity, K, , apparant absorbance and physical
appearance of 2 x 10”^ M cirazoline hydrochloride-SDDS systems, 
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Volume of SDDS Solution Added (mis)
Figure 6 .12 - Conductimetric titration trace for SDDS (0.01 M) against cirazoline hydrochloride 
(1.5 x 10”3 m) at 50°C. Flow rate = 50.48 pi min"*, chart speed = 12 cm hr- 1 , 







The CIRH-DDS complex is liquid at this temperature (see section 6.3.1) 
and the conductivity curve resembles literature examples 
(figure 1.10a). The end-point of the titration is given by the point 
of initial deviation from linearity in the conductivity curve 
concomitant with phase separation (figure 6.12). The incremental 
increase in conductivity with added titrant decreases after this point 
due to formation of insoluble non-conducting complex. At 
concentrations below and well above the end-point the conductivity 
curve is linear (accounting for dilution effects) but of different 
slope.
At 30°C the equilibrium CIRH-DDS complex is solid and conductivity 
curves show an abnormal decrease in conductivity associated with 
formation of a white flocculated dispersion. Figure 6.13 shows the 
conductivity curve for the titration of 0.01 M SDDS into 1 x 10"^ M 
cirazoline hydrochloride at 30°C; flow rate 20.4 pi min"l, chart speed 
12 cm hr“l, chart conductivity range 70 - 90 x 10"^ S; (the chart 
recorder trace is shown in Appendix 2). The titration end-point for 
the solid complex solubility product is found to be given by 
extrapolation of the second linear curve to the first (figure 6.13). 
Verification for this is that the solubility product value of 1.16 x 
10”^ m o l e s ^ l i t r e " ^  calculated by this method is in good agreement with 
the equilibrium K s' value of 1.15 x 10"^ - 1.20 x 10”^ moles^litre”  ^
(section 6.3.1). The peak in the conductivity curve is thought to 
represent supersaturation due to the formation of a metastable system 
(see section 6.3.1.1).
(b) Effect of Titration Flow Rate
The effect of flow rate was investigated by titrating 0.01 M SDDS 












Volume of SDDS Solution Added (mis)
Figure 6.13 - Conductimetric titration trace for SDDS (0.01 M) against cirazoline hydrochloride (i x iq-3 m) at 3o°C.







30°C. Flow rates of 6.29, 12.39, 20.38, 50.48 and 173 pi min’1 
were used. The latter flow rate was selected as this Is similar to the 
molar rate of addition used by Mukhayer et al^O. The conductivity 
bridge and chart recorder were set to give a chart conductivity range 
of 70 -90 x 10”6 S. A chart speed of 3, 12 or 60 cm hr"^ was used as 
appropriate.
At flow rates of 6.29 - 50.48 pi min”l characteristic conductivity 
curves associated with formation of solid complex were produced. The
complex formed in this manner was similar in morphology to that
observed in equilibrium studies (sections 6.3.1 and 6.3.2.1). At a 
flow rate of 173 pi min”l, however, the characteristic decrease in 
conductivity associated with precipitation of solid complex was absent. 
The inflexion in the conductivity curve was a simple change in 
gradient, similar to that observed for the titration at 50°C (figure 
6.12). The system changed in appearance at this point from a clear 
solution to a turbid, grey dispersion and the complex was liquid in 
nature. A change in specific conductivity-SDDS volume, plot 
constructed using data from titration curves at flow rates of 20.38 and
173 pi min“l is shown in figure 6.14. Titration end-points are also 
shown for the calculation of the 'solid1 and 'liquid' solubility 
products. Both profiles are linear with similar slope until phase 
separation occurs. The profiles differ thereafter with the formation 
of the liquid and solid complexes.
Calculated solubility product values at each flow rate is shown in 
table 6.5. Titration at flow rates of 6.29, 12.39, 20.38 and
50.48 pi min“l was found to produce similar values and show good 
agreement with the equilibrium solubility product value (1.15 x 10"^ - 
1.20 x 10~7 moles^litre"^).
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End Point (b) 
'Solid Complex'
0.5 1.0 1.50 2.0
Volume of SDDS added (mis)
Figure 6.14 - Change in specific conductivity, a K , - SDDS volume plot 
for the titration of SDDS (0.01 M) against cirazoline 
hydrochloride (1 x 10"^ M) at 30°C and flow rates of 
(a) 173 pi min” l (— V — ), and (b) 20.38 pi rain"! (— □ — ).
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Table 6.5 - The effect of titrant flow rate on calculated cirazoline-
dodecylsulphate solubility product at 30°C. (* Equilibrium
solubility product value).
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The liquid complex system formed by titrating at a fast flow rate was 
found to precipitate with time, forming a white flocculated dispersion, 
similar in nature to the equilibrium complex. The liquid complex 
system is therefore thought to be metastable under these conditions.
(c) Reproducibility
The cirazoline dodecylsulphate solid complex solubility product at 30°C 
was determined seven times over a twelve month period by titrating 
0.01M SDDS against 1 x 10"^ m cirazoline hydrochloride at a flow rate 
of 20.38 pi min"l. The mean solubility product was found to be 1.17 x 
10”7 (s.D. * 0.03 x 10"^) m o l e s ^ l i t r e ” ^ . Four further titrations were 
performed at flow rates of 12.38 or 50.48 pi min”l and the mean for all 
eleven solubility product values was calculated as 1.17 x 10”  ^ (S.D. ° 
0.03 x 10“7) moles^litre"^.
The CIRH-DDS liquid complex solubility product was determined twice at 
50°C and twice at 37.5°C by titrating 0.01 M SDDS against 1 x 10”^ m 
cirazoline hydrochloride. At 50°C, flow rates of 20.38 and 50.48 pi 
min”l were used and solubility product values were calculated as 4.27 x 
10“^ ancj 4.10 x 10”^ moles^litre"^ respectively. At 37.5°C, flow rates 
of 20.38 and 172.7 pi min"^ were used and gave solubility product 
values of 2.62 x 10" ^ and 2.56 x 10"^ moles^litre"^ respectively.
The reproducibility of the titration end-point measuring technique was 
evaluated by analysing a solid complex titration curve (0.01 M SDDS v 
1 x 10"3 M cirazoline hydrochloride at 30°C), and a liquid complex 
titration curve (0.01 M SDDS v 1.5 x 10"^ M cirazoline hydrochloride at 
50°C). Each conductivity curve was reproduced six times using a 
photocopier and the end-point and resulting solubility product value of
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each curve determined. The mean solid and liquid complex solubility 
product was calculated as 1.16 x 10”^ (S.D. 0.01 x 10"^) mole^litre"^ 
and 2.78 x 10”^ (S.D. 0.04 x 10”^) moles^litre"^f respectively. These 
data therefore show the solid complex and liquid complex measuring 
techniques to be reproducible.
6.3.2.3 STOICHIOMETRY OF THE CIRAZOLINE HYDROCHLORIDE-SDDS INTERACTION
The interaction between cirazoline, (CIRH*), and dodecylsulphate, 
(DDS“), ions in aqueous solution may be represented by equation 6.4.
Ks* - [CIRH4(aq)]".[DDS-(aq)]P (6.4)
Where K s' is the apparant stoichiometric solubility product, [] are 
concentrations and n and p are the stoichiometric amounts of cirazoline 
and dodecylsulphate ions respectively. Rearrangement of equation
6.4 yields equation 6.5.
log10 [DDS-(aq)] - _1_ log10 Kg' - _JL l°gl0 [CIRH4(aq)] (6.5)
P P
The stoichiometry of the interaction (n:p) can thus be obtained from 
the slope of a plot of log^g [DDS”(aq)] against log^Q [CIRH*(aq)] at 
the complexation end-point.
The stoichiometry of the solid and liquid complexes was determined by 
titrating 0.01 M SDDS into solutions of cirazoline hydrochloride at 
30°C and 50°C respectively. All titrations were performed using a flow 
rate of 20.38 or 50.48 pi min“l and chart speed of 12 cm hr“l. Table
6.6 shows the concentrations of cirazoline, [CIRH*(aq)]e p ,  and 
dodecylsulphate, [DDS-(aq)]ep , ions at the complexation end-point for 
each initial cirazoline hydrochloride concentration, [CIRHCl]j, and 
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Table 6.6 - Conductimetric titration data for the interaction between 
cirazoline hydrochloride and S D D S  at 30°C and 50°C. 
([CIRHCl]j e initial cirazoline hydrochloride 
concentration, [CIRH+ (aq)]ep and [ D D S " ( a q ) ] e p  ■ cirazoline 
hydrochloride and S D D S  concentrations at titration 
end-point respectively, K s' = apparant solubility product 
calculated using a stoichiometry of 1 ; 1).
-228-
figure 6.15. The slope of each curve was determined by linear 
regression analysis and the stoichiometry of the CIRH -DDS solid 
(30°C) and liquid (50°C) complexes was calculated as 1 s 1.004 (S.D.
1 s 0.007) and 1 s 0.978 (S.D. 1 s 0.020) respectively. The apparant
solubility product, K s*, calculated using a stoichiometry of 1 : 1 is
given for each titration in table 6.6.
Equation 6.4 indicates that a plot of [ D D S “ ( a q ) ] e p  against 
[CIRH*(aq)]ep”  ^ is linear with a slope of K s' for interactions with a 
1 : 1  stoichiometry. Such plots were constructed for solid (30°C) and 
liquid (50°C) data and are shown in figure 6.16. Linear dependence was 
observed for both sets of data and linear regression analysis data gave 
K s* “ 1.17 x lO"^ ( S . D .  0.01 x 10"^) moles^ litre-^ for the solid 
complex at 30°C and K s' ■ 4.08 x 10”  ^ ( S . D .  0.10 x 10”^) moles^ litre”^ 
for the liquid complex at 50°C.
Intrinsic solubility product values, (Ks), were calculated using 
equation 1.70 and the Debye-Huckel equation, (equation 1.16). Values 
of the Debye-Huckel constant, (A), at 30°C and 50°C were obtained from 
standard literature tables^!, the product a^B was taken as unity and 
ionic strength was calculated from the concentrations of cirazoline 
hydrochloride and SDDS at the titration end-point. The intrinsic 
solubility product for the solid complex at 30°C and liquid complex at 
50°C were thus calculated as 1.09 x 10”  ^ and 3.88 x 10"^ moles^ l i t r e " ^
I
j respectively. ^ __
6.3.2.4 EFFECT OF TEMPERATURE
The effect of temperature on the cirazoline dodecylsulphate solubility 
product was studied by titrating 0.01 M SDDS Into 1 x 10"^ M cirazoline 








[CIRH+ (aq)]ep (M x 103 )
Figure 6.15 - Stoichiometry of the cirazoline-dodecylsulphate interaction
(a) solid complex, 30°C, (— □ — ), (b) liquid complex,
50°C, (— V — ). Concentration of dodecylsulphate, [DDS“ (aq) ] ep, 
and cirazoline, [CIRH*(aq)]ep, ions at titration end point 
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[CIRH*(aq)]ep-l (M-l x 10-3) [CIRH4 (aq)]ep- 1 (M' 1 x 10'3)
Figure 6.16 - Plot of dodecylsulphate concentration at titration end point, [DDS"(aq)]ep, against reciprocal
cirazoline concentration at titration end point, [CIRH*(aq)]ep~^» f°r solid complex, 30°C and







173 |il min“ l were used and conductivity traces were recorded at 
chart speeds of 12 cm hr"l and 60 cm hr“ ^ respectively. Intrinsic 
solubility products were calculated from apparant solubility product 
values as described in section 6 .3.2 .3. Y
Apparent and intrinsic solubility products at each temperature are 
given in table 6.7. The nature of the formed complex at each 
temperature and titrant flow rate are also shown. At temperatures of 
37.5°C and below, the nature of the formed complex and conductivity 
curve are dependent upon titration flow rate. Crystalline complex was 
formed at the slow flow rate (20.38 pi min"l) and titration curves show 
the characteristic inflexions associated with sudden precipitation of 
solid complex. Titrations at the fast flow rate (173 pi min“ l) 
produced liquid complex and the Inflexion in conductivity curves 
associated with phase separation was a simple change in gradient.
These liquid complex systems were metastable and precipitated with time 
to form crystalline complex. Above 37.5°C, however, the solid complex 
did not form and only liquid complex was produced. The apparent 
solubility product, K s ', is plotted as a function of temperature in 
figure 6.17; both solid and liquid apparant solubility products 
increase with temperature in a curvilinear fashion.
Van't Hoff plots for the intrinsic solubility product - temperature 
data were linear (figure 6.18) for both solid and liquid complex 
systems; linear regression analysis data and thermodynamic parameters 
calculated using equations 1.76 to 1.78 are shown in table 6 .8 . These 
data indicate that solid complex formation is driven by a large 
negative enthalpy change, AH°f, but hindered by a negative entropy 
change, A S ° f , reflecting the increased order in the solid phase. The
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Table 6.7 - Effect of temperature on the cirazoline dodecylsulphate
solubility product determined at a flow rate of (a) 20.38 
pi min~l and (b) 173 pi min"l. (initial cirazoline 
hydrochloride concentration = 1 x 10"8 M, titrant =
1 x 10-2 M SDDS).











Figure 6.17 - Effect of temperature on the cirazoline-dodecylsulphate 
apparant solubility product, K s ', for (a) solid complex 
formation, (— ■ —0 , and (b) liquid complex formation, (— ▼ — ).
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Temperature"! (K"1 x 10^)
3.5
Figure 6.18 - Van't Hoff plots (intrinsic solubility product, K s , on a 
loglO scale against reciprocal absolute temperature) for 
cirazoline-dodecylsulphate (a) solid complex formation (— ■ — ) 
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| A H ° f , 30 0(2 ( kJ mo 1” 1) | -62.9 | -29.2 | 
j
| AS°f,30OQ(Jmol“lk”1) | -40.6 | 65.6 | 
1
Table 6.8 - Linear regression analysis data for solid and liquid
CIRH-DDS intrinsic solubility products plotted according to 
equation 1.76 and energetics of solid and metastable liquid 
complex formation at 30°C.
-236-
liquid phase separation process is driven by a combination of a 
negative enthalpy change and a positive entropy change.
Extrapolation of the solid complex curve to the liquid complex curve 
gives an intersection point at 42.5°C, K s * 2.93 x 10"^ m o l e s ^ l i t r e ” ^ #
6 .3.2.5 EFFECT OF IONIC STRENGTH
The effect of ionic strength on the cirazoline-dodecylsulphate * solid' 
solubility product was investigated at 30°C. 0.01 M SDDS was titrated
at a flow rate of 20.38 pi min“ l into 1 x 10”  ^ M cirazoline 
hydrochloride solution in the presence of 1 x 10”^ - 1 x 10“^ M sodium 
chloride. Higher ionic strengths could not be studied successfully as 
the change in conductivity during the titration was too small relative 
to the high background conductivity. The 'solid' solubility product in 
the presence of 1 x 10“^ , 5 x 10"^ and 1 x 10"^ M sodium chloride was 
determined as 1.16 x 10”  ^ , 1.16 x 10”^ and 1.13 x 10”^ moles^litre"^. 
These results are similar to the solubility product in the absence of 
added sodium chloride (Ks* = 1.17 x 10"? m o l e s ^ l i t r e " ^ ) and show that 
low concentrations of electrolyte have minimal effect on the cirazoline 
dodecylsulphate solubility product.
6.3.2.6 EFFECT OF ALKYLSULPHATE CHAIN LENGTH
The effect of alkylsulphate chain length on the solubility product of 
cirazoline alkylsulphates was investigated at temperatures of 10°, 20°, 
30° and 50°. Alkyl chain lengths of Cg (cirazoline octylsulphate, 
CIRH-0S), C^q (cirazoline decylsulphate, CIRH-DS), (cirazoline




0.1 M sodium octylsulphate (SOS) was titrated at a flow rate of 20.38 
or 50.48 pi min"l into 0.01 M cirazoline hydrochloride (10° - 30°C) and 
0.025 M cirazoline hydrochloride (30° and 50°C). The higher cirazoline 
hydrochloride concentration was necessary because of the large 
solubility products observed at higher temperatures. Liquid complex 
was formed at all temperatures.
(b) CIRH-DS
0.05 M sodium decylsulphate was titrated at a flow rate of 12.39, 20.38 
or 50.48 pi min”l into 2.5 x 10”^ M cirazoline hydrochloride.
The (stable) complex form was liquid at 30°C and 50°C and solid at 10°C 
and 20°C. Metastable liquid complexes could also be formed at the 
lower temperatures. The stoichiometry of the liquid complex at 30°C 
was determined using 0.05 M SDS as titrant and initial cirazoline 
hydrochloride concentrations of 2.5 x 10"^, 3.75 x 10"^ and 5 x 10"^ M.
Data plotted according to equations 6.4 and 6.5 gave a stoichiometry of
1 s 1.02 (S.D. 1 : 0.18) and a mean K s* value of 2.05 x 10“^ (S.D. 0.41
x 10”6) moles^ litre”^.
(c) CIRH-DDS
Data were taken from table 6.7.
(d) CIRH-TDS
Initial cirazoline hydrochloride concentrations of 5 x 10”-* - 
5 x 10”^ M were used. STDS concentrations of 5 x 10"^ - 5 x 10"^ M 
were employed at flow rates of 12.39 or 20.38 pi min"l.
(Stable) liquid complex was formed at 50°C and solid complex was 
produced at all lower temperatures. Metastable liquid complex could be
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form ed by fast titration (e.g. 50.48 pi min“l) at the lower 
temperatures, however. A reliable estimate of the solid solubility 
product at 10°C could not be obtained; solid phase separation occurred 
but extrapolation of conductivity curves to determine the solubility 
product was difficult. This is probably due to the very low solubility 
product at this temperature and the slow rate of initial crystal 
nucleation. The stoichiometry of the solid CIRH-TDS complex was 
studied at 30°C using 5 x 10“3 M STDS and initial cirazoline 
hydrochloride concentrations 2.0, 3.0, 4.0 and 5.0 x 10"^ M. Data 
plotted according to equations 6.4 and 6.5 gave a stoichiometry of 1 : 
0.93 (S.D. 1 : 0.03) and mean K s' of 3.65 x 1CT9 (S.D. 0.09 x 10"9 ) 
moles^ litre“2.
Intrinsic and apparant solubility products for CIRH-0S, CIRH-DS and 
CIRH-TDS systems at each temperature studied are shown in table 6.9. 
Titration conditions employed and nature of formed complex are also 
shown. Van*t Hoff plots (log^Q ^s versus K”^) were constructed from 
these data and are shown in figure 6.19. In contrast to the behaviour 
of CIRH-DDS, the liquid K s versus plots were non-linear. The 
temperature of transition from solid/metastable liquid systems to 
stable liquid complex systems is shifted to lower temperatures with a 
decrease in alkylchain length. Solid complex is observed at 30°C and 
below in the CIRH-TDS system, at 10°C and 20°C in the CIRH-DS system, 
and no CIRH-0S solid complex was observed In the temperature range 
studied. (Solid CIRH-DDS complex was formed at temperatures of 37.5°C 
and below, see section 6.3.2.4). The CIRH-DS solid complex is 
anomolous as it appears to be more stable than the liquid complex 
species; however, this is unlikely to be so and these results may be 
due to the close proximity of the solid and liquid end-points.








| FLOW RATE 














| 50.48 3.87xlO-5 3.14x10-3
1
Liquid |
20.10 | 0.01 0.1 | 50.48 4.42x10-3 3.57x10-3 Liquid |
30.00 | 0.01 0.1 | 20.38 5.00x10-3 4.03x10-3 Liquid |
| 0.025 0.1 | 20.38 6 .28x10”3 4.54x10-3 Liquid |
50.00 | 0.025 0.1 | 20.38 
1
10.2x10-3 7.28x10-3 Liquid | 
1



















30.10* |2 .5 -5 x 10-3 0.05 | 20.38 2.05xl0’6 1.83x10-6 Liquid |
50.00 |2.5x10*3 0.05 | 50.48 
1
3.73x10-6 3.32x10-6 Liquid | 
1
| CIRH-TDS| 10.00 |5xlO-5 5xlO-4
1
| 50.48 4.92x10-9 4.84x10-9
1
Liquid J
20.00 |2xl0-4 lxl0“3 | 12.39 1.08xl0-9 1.05x10-9 Solid |
30.00* |2-5xl0“4 5x10-3 | 20.38 3.65x10-9 3.45x10-9 Solid |
|5xl0-4 5x10-3 | 20.38 1.03xl0-8 9.78x10-9 Liquid |
50.00 |5xl0-4
1
5x10-3 | 20.38 
1
2.81xl0-8 2 .66xlO-8 Liquid |
i
Table 6.9 - The effect of temperature on cirazoline octylsulphate (CIRH-OS), cirazoline
decylsulphate (CIRH-DS) and cirazoline tetradecylsulphate (CIRH-TDS) complex 
formation and apparant (Ks*) and intrinsic (Ks) solubility products determined 
by conductimetric titration using initial cirazoline hydrochloride concentrations, 
[CIRHC1]];, sodium alkylsulphate titrant concentrations, [titrant], and flow rates 
indicated. (* = data from stoichiometry determination).














i - 6 - (b) CIRH-DSx






Temperature"1 (K."^  x 10^)
Figure 6.19 - Van't Hoff plots (intrinsic solubility product, K s , on a 
loglO scale against reciprocal absolute temperature) for
(a) cirazoline-octylsulphate, CIRH-OS, (— v— ),
(b) cirazoline-decylsulphate, CIRH-DS, (-*□— ),
(c) cirazoline-dodecylsulphate, CIRH-DDS, (— O — ),
(d) cirazoline-tetradecylsulphate, CIRH-TDS, (— a — ). Solid 
symbols = solid complex, open symbols = liquid complex.
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Alkyl chain length has a profound effect on aqueous solubility due to 
the hydrophobic nature of the methylene group. The standard free 
energy change upon complex formation, AG°f, is given by equation 1.78. 
Hence the contribution of each methylene group to the overall free 
energy change, d( ^ G°f)/(jn may be obtained from a plot of log^Q ^s 
against the number of methylene groups, n (equation 6.6).
d( A G ° f) = RT d log1n K G (6.6)
dn dn
Where R is the gas constant and T is absolute temperature. Figures 
6.20 and 6.21 show the effect of number of methylene groups in the 
alkylchain on the cirazoline alkylsulphate solid and liquid intrinsic 
solubility product at each temperature studied. The liquid complex 
data and the limited solid complex data Indicate a linear relationship 
between log^Q ^s anc* n as predicted from equation 1.79. Linear 
regression analysis results for these data are shown in table 6.10.
The free energy contribution per methylene group to the complexation 
process, d(AG°f)/(jn» was calculated from the slopes of these plots and 
equation 6.6 and is shown for each temperature and complex type in 
table 6.11. d(AG°f)/(jn f°r the liquid complex formation was 
independent of temperature and calculated as -3.46 (S.D. 0.04) kJ 
mol” -*-. d(^G°f)/(in f°r solid complex formation was greater than for 
liquid complex formation and was dependent upon temperature; at 10°, 
20°, and 30°C d(AG°f)/cjn was calculated as -5.17, -4.57 (S.D. - 0.06) 
and -4.44 kJ mol respectively.
6.3.2.7 EFFECT OF IMIDAZOLINE STRUCTURE
The effect of imidazoline structure on complex formation and 
solubility product in imidazoline-DDS systems was investigated at 



























Figure 6.20 - Effect of number of methylene groups in the alkylchain, n, on the cirazoline-alkylsulphate 
intrinsic solubility product, K s; (a) 10°C (-A-), (b) 20°C (-□-)! open symbols - liquid 
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Figure 6.21 - Effect of number of methylene groups in the alkylchain, n, on the cirazoline-alkylsulphate 
intrinsic solubility product, K sj (a) 30°C (— V — ), (b) 50°C (— O — ); open symbols = liquid 
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Table 6.10 - Linear regression analysis data for liquid and solid 
cirazoline alkylsulphate complex intrinsic solubility 







| d ( A G ° f)/dn 
| SOLID 
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Table 6.11 - Methylene group contribution to the free energy of
cirazoline alkylsulphate complexation, d(AG°f)/(jn» f°r 
solid and liquid complexes at each temperature.
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dodecylsulphate (XYLH-DDS), naphazoline dodecylsulphate (NAPH-DDS) and 
tolazoline dodecylsulphate (TOLH-DDS) were studied by titrating SDDS 
into imidazoline solutions at a flow rate of 12.39 or 20.38 pi min~l. 
The stoichiometry and mean K s' values of imidazoline DDS complexes were 
determined for all systems (except TOLH-DDS) using the method described 
for CIRH-DDS complex (section 6.3.2.3). Apparant and intrinsic 
solubility product, stoichiometry of interaction and nature of complex 
for each system are shown in table 6.12.
(a) ANTH-DDS
Solid complex was produced by all titrations and conductivity curves 
displayed the characteristic inflexions associated with sudden 
crystallization (see section 6.3.2.2). Accurate determination of ANTH- 
DDS solubility products could not be made, however as the degree of 
supersaturation was large (see section 6.3.2.2) and the formed complex 
was highly flocculated and adsorbed onto the titrant delivery tube, 
blocking the orifice.
(b) NAPH-DDS
Stable liquid complexes were formed and the Inflexion in the 
conductivity curves was a simple change of gradient (see figure 6.12).
(c) XYLH-DDS
Both metastable liquid, and stable solid XYLH-DDS complexes were formed 
by titrating 0.01 M SDDS at a flow rate of 12.4 pi min"l into 
xylometazoline hydrochloride solutions. An initial liquid phase 
separation occurred followed by precipiation of crystalline complex. 
Solid and liquid solubility products were similar under these 








































































































Table 6.12 - Mean apparant solubility product (Ks'), stoichiometry and nature of formed complex for antazoline 
dodecylsulphate (ANTH-DDS), naphazoline dodecylsulphate (NAPH-DDS), xylometazoline 
dodecylsulphate (XYLH-DDS) and tolazollne dodecylsulphate (TOLH-DDS) systems determined by 
conductimetric titration using initial imidazoline concentration, [Imidazoline]j, SDDS 
titrant concentration, [titrant], and flow rates indicated,30°C.
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sufficiently fast to prevent accurate measurement of the solid 
solubility product.
(d) TOLH-DDS
A single determination of the TOLH-DDS solubility product was made and 
resulted in the formation of stable liquid complex.
6.3.2.8 CPAE DODECYLSULPHATE SOLUBILITY PRODUCT
The apparant CPAE dodecylsulphate solubility product, K s*, at 30°C was 
determined in order to Investigate the effect of CPAE formation on the 
structure of cirazoline hydrochloride-SDDS systems (see section 8.3.6). 
0.01 M SDDS was titrated into 1 x 10"^ M CPAE solution at a flow rate 
of 20.38 pi min“ l. A stable liquid complex was formed and the 
solubility product was calculated as 2.43 x 10"^ moles^ litre-^. This 
Is slightly greater than the liquid cirazoline dodecylsulphate 
solubility product, (Ks' “ 2.01 x 10“  ^ moles^ litre”2 at 30°C), 
reflecting the more polar CPAE structure (figure 1.2).
6.3.3 Determination of Cirazoline dodecylsulphate and CPAE 
dodecylsulphate Ion-palr Association Constants
The cirazoline-dodecylsulphate and CPAE dodecylsulphate ion-palr 
association constants, K^p, were determined at 30°C by the method 
described by Mukhayer and Davis^l (see section 1.4.2.1). The latter 
was determined in order to investigate the effect of CPAE formation on 
the structure of cirazoline hydrochloride-SDDS systems (see section 
8.3.6).
0.01 M SDDS was titrated at a flow rate of 20.38 pi min"l into
(a) double distilled water, (b) 1 x 10"^ M cirazoline hydrochloride and
(c) 1 x 10"3 m  CPAE hydrochloride. The chart conductivity range was
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set at (a) 0 - 10 x 10”6 S, (b) 70 - 80 x 10”6 S and (c) 80 - 90 x 10~6 
S. A chart speed of 60 cm hr"l was used for all titrations.
The conductivity of eleven different concentrations of SDDS was 
measured from the blank titration curve (titration a). Specific K$DDS» 
and equivalent-^-sDDS» conductivities of these solutions were 
calculated using equation 1.43 and 1.44 respectively. Specific 
conductivities of the cirazoline hydrochloride-SDDS (titration b) and 
CPAE hydrochloride-SDDS (titration c) mixtures, K' mix , at similar SDDS 
concentrations were then calculated using equation 1.43. The difference 
in specific conductivity due to interactions within the mixtures, A K m iX , 
the concentration of formed ion-pair, [CIRH-DDS(aq)], and the ion-pair 
association constant, Kip, were then calculated for each SDDS 
concentration using equations 1.63, 1.61 and 1.56. The equivalent 
conductivities of cirazoline hydrochloride,*^ciR, an(* CPAE hydrochloride, 
jtcPAE* at 30°C were calculated from the conductivity of the initial 
solutions. These values were assumed to be constant during the 
titrations since the increase in volume due to titrant addition was very 
small. The limiting ionic conductivities of sodium, X ° N a * » anc* 
chloride,X°C1"» ions were taken as 55.80 and 84.30 S eq"^ cm^ 
respectivelyll.
Table 6.13 shows the calculated cirazoline dodecylsulphate and CPAE 
dodecylsulphate ion-pair association constant at each SDDS 
concentration. ^SDDS »“^ SDDS • ^mix anc* A ^ m i x  values are also shown. 
Results indicate a mean ion-pair association constant of 232 (S.D. 20) 
for cirazoline dodecylsulphate and 248 (S.D. 9) for CPAE dodecylsulphate.
1
| [SDDS] 













































































































































Table 6.13 - Cirazoline dodecylsulphate, CIRH-DDS, and CPAE dodecylsulphate, CPAEH-DDS,
ion-pair association constants, Kfpt at 30°C. SDDS specific conducitivity,KsDDS» 
SDDS equivalent conductivity,^-SDDS» specific conductivity of each mixture, K mix»
and difference in specific conductivity due to interaction of each mixture mlXf
are also shown.
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7, AGGREGATION IN 
CIRAZOLINE—DODECYLSULPHATE 
SYSTEMS
7.1 MICELLIZATION AND SOLUBILIZATION
7.1.1 Introduction
Formation of micelles above the CMC of cirazoline hydrochloride-SDDS 
systems allows Interaction between cirazoline and micellar SDDS. The 
system may be characterised by the following parameters:
(i) its apparent CMC (CMC1); this is expressed in terms of the
total SDDS concentration present in the system at its point of 
determination,
(ii) the true C M C  (= [ D D S ” (a q ) ]); this is the concentration of free 
S D D S  monomers present in the aqueous phase at the point of 
determination,
(iii) the solubilizing concentration of surfactant (SOL-p); this is 
the total SDDS concentration necessary to effect total 
solubilization of formed complex in a given system,
(iv) the association constant (K^) for the interaction between 
cirazoline and SDDS micelles.
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The Interaction between cirazoline and SDDS micelles may be viewed 
in terms of:
(a) solubilization of the sparingly soluble neutral cirazoline 
dodecylsulphate ion-pair, (CIRH-DDS), due to partition into the 
micellar pseudophase which is characterised by the partition 
constant, Kp (equation 7.1);
K p




Where the subscripts (aq) and (jf) refer to aqueous and micellar forms 
respectively.
(b) Mass action type binding of the cirazoline ion, CIRH+(aq) to the 
negatively charged dodecylsulphate micelles, DDS"(jf), to form the 
electrically neutral cirazoline dodecylsulphate micellar species, 
CIRH-DDS(h ); characterised by the association constant, K^, (equation 
7.2):
KaCIRH+ (aq) * DDS*(h)?=SCIRH-DDS(M )
[CIRH-DDS(M )]
Ka  =   (7.2)
[CIRH*(aq)][DDS-(„)]
The data treatment adopted in this thesis is based on the mass action 
binding model described by Sepulveda and Co-Workers^O» 139-141# ^he 
association constant, K^, may be obtained from a knowledge of [CIRH- 
DDS^)], [CIRH'f(aq)] and [DDS“(jj)], (equation 7.2). For a saturated 
system, these parameters may be calculated from the CMC1, SOL'j and 
the solubility product for the complex, Kg 1, (see section 6). The 
total concentration of cirazoline hydrochloride, [CIRHCl]^, and SDDS,
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[SDDS]^, in the system are given by equations 7.3 and 7.4 
respectively:
[CIRHCl]T=[CIRH4(aq)]4[CIRH-DDS(M )]4[CIRH-DDS(c)] (7.3)
[ SDDS ]T= [DDS”(aq) ]* [ CIRH-DDS (j^ ) ] + [DDS"(j1) ]♦ [ CIRH-DDS (c) ] (7.4)
Where [DDS~(m )] is the concentration of dodecylsulphate in the 
micellar form which is not bound to cirazoline, and [CIRH-DDS(c)] is 
the concentration of precipitated complex.
At or below the CMC' of the system, [CIRH-DDS(m )] = [DDS“(m )] = 0 and 
equations 7.3 and 7.4 reduce to equations 7.5 and 7.6 respectively:
[CIRHC1]t « [CIRH4(aq)] ♦ [CIRH-DDS(c)] (7.5)
[SDDS]t = [DDS” (aq)] 4 [CIRH-DDS(c)] (7.6)
At the CMC* of the system, equation 7.6 may be written as:
CMC' = CMC 4 [CIRH-DDS(c)] (7.7)
The true CMC of the system and [CIRH4 (aq)] at the CMC1 may then be 
calculated from a knowledge of K s', (equations 7.8 and 7.9):
Ks* = [CIRH+(aq)]. CMC (7.8)
or, Kg' - ([CIRHCl]T-[CIRH-DDS(c)])(CMC,-[CIRH-DDS(c)]) (7.9)
At the total solubilization point, SOL<p, [CIRH-DDS(c)] * 0 and 
equations 7.3 and 7.4 respectively reduce to equations 7.10 and 7.11 
or 7.12:
[CIRH-DDS(m )] = [CIRHC1]t - [CIRH4(aq)] (7.10)
[DDS~(M )] = [SDDS]t - [DDS“(aq)] - [CIRH-DDS(M )] (7.11)
or, [DDS"(M )] = S0Lt - CMC - [CIRH-DDS(M )] (7.12)
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Since the interaction being considered is between CIRH*(aq) and 
DDS"(aq) to form CIRH-DDS(m), CIRH-DDS(c) and CIRH-DDS(aq) do not 
interact directly with DDS“ micelles,but provide a reservoir for 
CIRH*(aq) as it reacts with micelles then CIRH'f(aq)t CIRH-DDS(aq) and 
CMC remain constant as [SDDS]^ goes from CMC' to SOL-p and CIRH- 
DDS (M ) results only from CIRH-DDS(c). Consequently if the volumes of 
the system at the CMC* and SOL-p are identical then:
[CIRH-DDS(c)] at the CMC' = [CIRH-DDS(m )] at the SOL^, and equation 
7.12 can be directly substituted in equation 7.7 to give equation 
7.13:
[DDS“ (M )] = SOLt - CMC' (7.13)
Substitution of equations 7.8, 7.10 and 7.13 into equation 7.2 yields 
equation 7.14 from which KA may be calculated.
([CIRHC1]1 - (Kg'/CMC)). 1
Ka  = ------------------------------------    (7.14)
(S0Lt - CMC') (Kg'/CMC)
When the volume of the system is not constant, e.g. during a 
conductimetric titration, then equation 7.13 is not strictly valid 
and the volume change of the system between the CMC* and SOL'j- must be 
considered.
7.1.2 Experimental
The SDDS concentration at the CMC', total solubilization 
concentration, S0L-j>, and the cirazoline micelle-water association 




The solubility of cirazoline hydrochloride at different ionic 
strengths in the presence of SDDS was determined by the following 
method.
Systems containing the required concentrations of cirazoline 
hydrochloride, SDDS and sodium chloride was prepared by mixing 
concentrated stock solutions and diluting to 25 mis. One ml of 
0.01 M HC1 (final concentration 4 x 10”4 M) was included in the 
formulation to inhibit cirazoline hydrolysis. A typical formulation 
for cirazoline hydrochloride (2 x 10“3 M)in the presence of SDDS 
(2.5 x 10"3 m ) and sodium chloride (0.1 M) is given below.
Stock Solution Volume Final
(Concentration) (mis) Concentration (M)
Cirazoline HC1 (0.01 M) 5.0 2 x 10“3
SDDS (0.01 M) 5.0 )
) 2.5 x 10“3
SDDS (6.25 x 10’3M) 2.0 )
Sodium Chloride (0.5 M) 5.0 0.1
HC1 (0.01 M) 1.0 4 x 10‘4
Double distilled water to 25.0
After making up to volume, the system was immediately shaken and 
transferred to a 3 dram glass vial. Polytetrafluoroethylene (PTFE) 
tape was wrapped around the screw thread of the vial and the top and 
screw thread covered with a layer of aluminium foil. The plastic top 
was screwed tightly on to the vial and sealed with a wrapping of 
autoclave tape. Vials were transferred to a constant temperature 
shaking water bath and shaken at a rate of 50 oscillations min"^.
The PTFE/aluminium foil acted as the primary barrier to moisture
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ingression and the autoclave tape prevented the top from working 
loose as well as acting as a preliminary barrier to penetration.
After equilibration the vials were sampled by filtering the system 
through Whatman 25 mm membrane filters (0.45 pm pore size) in Swinnex 
units. The first 5 mis of filtrate were run to waste and the second 
5 mis collected in a 10 ml volumetric flask. 4 mis of this solution 
were immediately mixed with 1 ml of 0.1 M HC1 and suitably diluted 
for assay. All filtration and sampling apparatus except the membrane 
filter were aged (as described for glassware, section 2) and warmed 
to approximately the experiment temperature prior to sampling.
(a) Effect of Filtering on Assay
Adsorption of cirazoline on to surfaces of the filtering apparatus 
may occur. To investigate the significance of any interaction, 
vials containing 5 x 10"^ m cirazoline hydrochloride, 1.2 x 10“^ M 
SDDS and 4 x 10“^ M HC1 were equilibrated at 30°C for 24 hours.
Under these conditions, cirazoline is totally solubilised and no 
6olld phase is present. The vials were sampled directly and by the 
filtration technique. Assay results are shown in table 7.1 and 
indicate no significant difference between the filtered and 
unfiltered samples (tCalc = 1*72, tta^ * 2.23, p = 0.05).
(b) Determination of Equilibration Time
Six vials containing 5 x 10"^ M cirazoline hydrochloride, 9 x 10”^ M 
SDDS and 4 x 10"^ M HC1 were held at 30°C in the shaking water bath. 
Under these conditions, cirazoline is partially solubilized and the 
system contains solid, aqueous and micellar phases. Samples were 
withdrawn at 24 hour intervals and assayed; results are shown in 












CONCENTRATION (M X 103 ) |
1

















































































1 1-5% | 
1 1
Table 7.1 - The effect of filtration on cirazoline assay. Vials 
contain 5 x 10"3 M cirazoline hydrochloride,
1.2 x 10“2 M SDDS and 5 x 10“4 M HC1.
| VIAL
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rable 7.2 - Solubility equilbration time for 5 x 10"3 M
cirazoline hydrochloride in the presence of 9 x 10”3 M 
SDDS and 4x 10~4 M HC1 at 30°C and at a shaking rate of 
50 oscillations per minute.
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(vials 2 - 6 ,  mean concentration * 1.99 x 10"^ M (CV = 3.3%)). In 
practice, samples were left to equilibrate for between 5 and 10 days. 
D e p r ^ f l a r f n n  n f  cirazoline was not detected over this period.
(c) Calculation of CMC, SOL-p and
The SDDS concentration at the CMC' and SOL-p can be obtained from 
inflexions in profiles of cirazoline solubility against SDDS 
concentration. Figures 7.13 and 7.14 (section 7.1.3.3) shows such 
profiles for 2 x 10"^ M and 5 x 10“^ M cirazoline hydrochloride - 
SDDS systems at 30°C. Equimolar concentration, CMC* and SOL-p points 
are indicated for each system. Below the CMC* of the system, the 
theoretical amount of cirazoline in solution may be predicted from 
K s* values using the quadratic form of equations 7.5 and 7.9. 
Theoretical aqueous cirazoline solubility-SDDS concentration curves 
for each system were constructed using equation 1.70 and K s values 
from table 6.7 and are shown as dashed lines in figures 7.13 and 
7.14.
At SDDS concentrations below the equimolar concentration, i.e. when 
cirazoline is in excess, an increase in SDDS concentration causes a 
rapid decrease in the solubility of cirazoline due to hydrophobic 
complex formation, (figures 1.13 and 1.14). Above the equimolar 
concentration point the free SDDS concentration increases 
dramatically and micellization occurs at the CMC*. Cirazoline 
solubility increase in this region due to solubilization of the 
complex and the CMC* is given from the intersection of the linear 
solubilization curve with the theoretical solubility curve due to 
complex formation (figures 7.13 and 7.14).
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At the SOL>p» all cirazoline is solubilized and further increase in 
SDDS concentration above this point has therefore no effect on the 
solubility of cirazoline and SOL-j1 is thus given by extrapolation of 
the linear solubilization curve to [CIRHC1]T , (figures 7.13 and 
7.14). values were calculated using equation 7.14 and [CIRH+ (aq)] 
was calculated using equations 7.5 and 7.9. K s' values were 
calculated from K s values in table 6.7 and equation 1.70 (ionic 
strength = CMC' * added [NaCl]). CMC values were calculated from 
CMC* values using equations 7.7 and 7.9.
7.1.2.2 CONDUCTIMETRIC TITRATIONS
(a) Description
Aggregation and solubilization in cirazoline hydrochloride - SDDS 
systems was studied using the automated conductimetric titration 
technique described in section 6. SDDS solution (0.1 M or 0.2 M) was 
normally titrated into cirazoline hydrochloride solution at a flow 
rate of 20.38 or 50.48 pi min-*, chart speed 12 cm hr“^.
Conductivity range was selected to give optimum deflection and was 
dependent upon cirazoline hydrochloride concentration, temperature 
and presence of electrolyte.
The initial phase of these titrations involves the formation of 
hydrophobic complex. The presence of a separate phase in the system 
was found to affect conductivity values through an obstruction 
effect. Robinson and Stokes^- have described this effect and derived 
expressions for the specific conductivity and equivalent conductance 
of the electrolytes in relation to the volume fraction of the 
disperse phase. This treatment regards the disperse phase as 
insulating monodisperse spheres of low volume fraction in an aqueous
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mixture of electrolytes. Mukhayer and Davis^l have applied this 
treatment to account for differences in theoretical and experimental 
conductivity data in liquid complex systems. The correction gave 
reasonable agreement between theoretical and experimental 
conductivity data although differences were noted at higher 
concentrations. This approach, however, is not valid for 
crystalline complex systems as the assumption that the insoluble 
phase resembles monodisperse spheres clearly does not apply. In 
addition the highly flocculated nature of the solid cirazoline 
dodecylsulphate complex and its affinity for electrode and glass 
surfaces was found to cause an accumulation of complex in the 
measuring volume of the conductivity cell. This caused fluctuations 
in conductivity readings and increased the error in CMC* and SOL-p 
measurements.
The obstruction effect of the crystalline complex was overcome by 
continuously filtering the mixture using a specially designed 
jacketted cell, (figure 7.1). Crystals formed during the titration 
are held by the glass wool suspended in the jacketted cell. The 
glass wool is isolated from the conductivity dip-cell and magnetic 
flea by a specially designed glass insert. This consisted of an open 
vertical semi-circular shield attached to a lower cylindrical support 
which sat at the bottom of the jacketted cell. A coarse glass mesh 
covered the top of the support and divided the cell into upper and 
lower compartments. The magnetic flea was placed in the lower 
compartment, the dip-cell inserted into the shelld (which acted as an 
extension of the lower compartment) and the glass wool spread loosely 
throughout the upper compartment. The syringe was inserted through 
the glass wool and positioned so that the tip just protruded into the
Figure 7.1 - Thermostated jacketted cell assembly for conductimetric
titrations. 2 x 1 0 m cirazoline hydrochloride solution 
upon addition of 0.2 M SDDS, (a) showing stirring 
suspension of cirazoline dodecylsulphate in the absence 
of the glass insert and (b) showing glass insert and 
glass wool in position.
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lower compartment. This arrangement allowed mixing of the filtrate 
and prevented glass wool and entrapped complex from interfering with 
conductivity measurements, (figure 7.1). One disadvantage of this 
assembly was that the glass wool increased the background 
conductivity in the system to approximately 15-50 x 10"^S. This 
remained approximately constant during the titration.
The obstruction effect due to liquid complex formation was not such a 
serious problem and these titrations were performed in the absence of 
the insert.
The changes in specific conductivity - SDDS concentration profiles 
for the titration of 0.2 M SDDS against (a) double distilled water,
(b) 2 x 10“^ m and (c) 5 x 10"3 M cirazoline hydrochloride at 30°C are 
shown in figure 7.2. Chart recorder traces for these titrations are 
shown in Appendix 3. Curve (a) shows a clear inflexion in 
conductivity at the CMC. A total of seven titrations were performed 
against double distilled water, five of which were in the absence 
and two in the presence of the specially designed glass insert; the 
mean (S.D.) CMC values were determined as 8.21 x 10“3 M (0.09 x 
10“3 M) and 8.25 x 10"3 M respectively. These data are in agreement 
with reported CMC values for SDDS at 30°C (CMC = 8.2 - 8.5 x 
10“3 M)3 ^ and indicate the specially designed glass insert does not 
affect the CMC.
Curve (b) is divided into six characteristic regions, distinguished 
by five inflexions, A - E. Each inflexion is associated with a 
change in the physico-chemical nature and appearance of the system. 
Prior to point A, the system was a clear solution which consisted 
primarily of cirazoline monomers and cirazoline dodecylsulphate ion- 
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Figure 7.2 - Change in specific conductivity, AK, against SDDS 
concentration for the titration of 0.2 M SDDS into
(a) double distilled water, (b) 2 x 1 0 M cirazoline 
hydrochloride and (c) 5 x 10“^ M cirazoline hydrochloride 
at 30°C. A = liquid complex phase separation, B = liquid 
--> solid complex transition, C = equimolar concentration, 
D = CMC' and E = SOL-p points.
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to the inflexion used in the determination of the liquid complex 
solubility product (section 6). The system becomes turbid at this 
point and region A - B represents formation of metastable liquid 
complex. The region A - C is a non-linear curve, punctuated by a 
decrease in conductivity at point B. This inflexion is associated 
with a change in appearance from a grey liquid dispersion to a white 
flocculated suspension and precipitation of crystalline complex 
occurred at this point. Point C represents the cirazoline 
hydrochloride - SDDS equimolar point and further increase in SDDS 
concentration results in a linear curve, C - D. Inflexion D is 
followed by a second linear region, D - E, but of smaller slope. The 
concentration of crystalline complex reduces during this phase of the 
titration until, at point E, the system becomes a clear solution. 
Points D and E therefore represent the SDDS concentration at the 
CMC* and SOL-p of the system respectively. Further addition of SDDS 
results In an increase in conductivity and a non-linear curve.
The titration against 5 x 10“3 m  cirazoline hydrochloride, curve (c), 
is similar to curve (b) except the Inflexion points C - E are shifted 
to higher SDDS concentration. Points A (phase separation) and B 
(phase transition) are absent as crystalline complex was formed 
almost immediately upon addition of SDDS. The curve in the complex 
formation region (i.e. prior to point C) is initially linear but 
curves upwards as the SDDS concentration approaches the equimolar 
concentration point, C.
The form of the derived Onsager plots (equivalent conductivity of the 
mixture,-A.m ix , against square root of total concentration ([CIRHCl]^ 
4 [SDDS]T)l/2, for the titrations against (a) 2 x 10"^ M and
(b) 5 x 10“3 m  cirazoline hydrochloride are shown in figure 7.3,
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(Total Concentration)^ (M^ x 10^)
Figure 7.3 - Equivalent conductance of titration mixture, _A. mix, against 
square root of total concentration of mixture (cirazoline 
hydrochloride 4 SDDS) for the titration of 0.2 M SDDS into 
(a) 2 x 10“  ^ M cirazoline hydrochloride and (b) 5 x 1 0 M 
cirazoline hydrochloride at 30°C. A = liquid complex phase 
separation, B = liquid --> solid complex transition, C = 
equimolar concentration, D = CMC' and E = SOL-p points.
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. these were obtained by taking at least 25 values from the recorder 
traces; (data points are not shown for the sake of clarity). For 
curve (a), addition of SDDS causes a rapid fall in -A.mix indicating 
that cirazoline hydrochloride and SDDS are not behaving as 
independent strong electrolytes. Onset of complexation (point A) 
results in a rapid decrease in A  miX as ions are removed from 
solution. The phase transition point (B) is clearly shown as a 
discontinuity. A mix continues to fall with increase in SDDS 
concentration until the equimolar concentration point (C) is 
exceeded. A region which is independent of concentration is then 
observed indicating the added SDDS is behaving as a strong 
electrolyte. The CMC* (point D) is associated with a decrease in 
A  mix* A decrease in the rate of fall of - A mpx with concentration is 
observed at the SOL-p (point E). The nature of the inflexions at 
points C - E in curve (b) are similar to those observed in curve (a).
The conductivity curves in figure 7.2 relate to formation and 
solubilization of crystalline complex. Conductivity curves produced 
with liquid complex systems had different characteristics, however, 
Figure 7.4 shows the change in the specific conductivity - SDDS 
concentration profile for the titration of 0.1 M SDDS into 2 x 10"^ M 
cirazoline hydrochloride at 40°C, (the chart recorder trace is shown 
in Appendix 3). Point A in figure 7.4 marks the phase separation
boundary and the system was turbid in the region A - E. No phase
transition inflexion (B) occurred as the liquid complex is stable at 
this temperature (see section 6). The plot between onset of 
complexation and aggregation (region A - D) is a gentle upward curve 
with no inflexion at the equimolar concentration point (C). An
upward discontinuity in the curve is observed at point D and the











SDDS Concentration (M x 10^)
Figure 7.4 - Change in specific conductivity,AK, against SDDS 
concentration for the titration of 0.1 M SDDS into 
2 x 10”3 M cirazoline hydrochloride at 40°C. A = liquid 
complex phase separation, C = equimolar concentration,
D = CMC' , and E = SOL-p points.
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system is totally clear and a decrease in the rise in conductivity 
with SDDS concentration is observed. The curve beyond point E is 
linear over the SDDS concentration range studied. Visual observation 
indicates that region D - E is the solubilization region and, 
therefore, points, D and E are the CMC and SOL^ of the system 
respectively. However, these inflexions in the conductivity curve 
are the inverse of those observed with the solid complex system; i.e. 
an increase in the change in conductivity with concentration is 
observed at the CMC* and a decrease at the SOL-p. The Onsager plot 
(-Amix against ([CIRHCl]1 ♦ [SDDS]1 )1/2 , figure 7.5) is similar to 
the solid complex plots (figure 7.3) in that a dramatic fall i n « A miX 
is observed due to ion-pairing and complexation. - A  m^x continues to 
fall beyond the equimolar concentration point (C) but unlike the 
solid complex plot, a shallow minimum in the curve is observed. An 
Increase i n - A mix with increase in concentration at the CMC*
(point D) followed by a slight decrease i n - A m^x at the SOLy 
(point E) then takes place.
(b) Calculation of CMC1, SOLf and KA
CMC1 and SOLt points were determined by extrapolation of the 
appropriate regions of the conductivity curves (e.g. in figures 7.2 
and 7.4). Inflexion points were normally taken directly from chart 
traces and the SDDS concentration calculated using equation 6.1. 
Conductivity curves for the solubilization of liquid complex were 
more difficult to analyse due to the non-linear nature of the 
profiles. Data points from these profiles are therefore, thought to 
be subject to appreciable error.
values were determined using equation 7.14 as described in 
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Figure 7.5 - Equivalent conductance of titration mixture, - A - raix, 
against square root of total concentration of mixture 
(cirazoline hydrochloride 4 SDDS) for the titration of 
0.1 M SDDS into 2 x 10“3 M cirazoline hydrochloride at 
40°C. A = liquid complex separation, C = equimolar 
concentration, D = CMC and E = SOL-p points.
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progressively more dilute with respect to cirazoline and equations 
7.13 and 7.14 are not strictly valid. However, the volume change of 
the system between the CMC1 and SOLp was always small and the maximum 
error in using equation 7.14 for the calculation of values in this 
thesis was calculated as 2.5%.
(c) Effect of Flow Rate
The effect of titrant flow rate on the calculated CMC*, SOLp and 
values was determined. SDDS (0.2 M) was titrated into 2 x 10** ^ M 
cirazoline hydrochloride at 30°C and at flow rates of 12.39, 20.38,
50.48 and 251.3 pi min**l. Chart speeds of 3 - 60 cm hr” -^ were used
as appropriate and a chart conductivity range of 0 - 500 x 10“^ S was 
employed. Calculated CMC', SOLp and values are shown for each 
titration flow rate in table 7.3. At all but the fastest flow rate 
(251.3 pi min“l) metastable liquid complex was formed initially but 
precipitated during the titration to form crystallation complex. 
Micellization and solubilization data at these flow rates therefore 
relate to the equilibrium solid complex species. At a flow rate of
251.3 pi min"l, however, the crystalline complex did not form and the 
conductivity curve was similar in character to the titration curve at 
40°C (figure 7.4). Accurate values could not be obtained for this 
system due to the fast titration speed.
The values in table 7.3 indicate that flow rate in not critical
providing the titration is performed sufficiently slowly to enable 
the equilibrium system to form. Conductimetric titrations for the 
study of aggregation behaviour were therefore normally carried out at 
a flow rate of either 20.38 or 50.48 pi min“l.
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| FLOW RATE 
j (jil min"*) 
1
| CMC' 
j (H x 103 ) 
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Table 7.3 - The effect of flow rate on the determination of CMC',
SOL-p and KA values by conductimetric titration. Data for 




The reproducibility of the conductimetric titration technique for the 
determination of CMC1, SOLp and KA values at 30°C was determined by 
titrating SDDS into 2 x 10“^ M cirazoline hydrochloride ten times 
over a seven month period. Table 7.4 shows SDDS concentration, flow 
rate and calculated CMC', SOLp and KA values for each titration. 
Statistical analysis shows the technique to give satisfactory 
reproducible values of CMC* (CV - 2%), SOLp (CV = 3%) and 
Ka  (CV =7%).
7.1.3 Results
7.1.3.1 EFFECT OF CIRAZOLINE CONCENTRATION
The effect of initial cirazoline hydrochloride concentration on 
micellization and solubilization in cirazoline hydrochloride-SDDS 
systems was determined at 30°C by conductimetric titration. SDDS 
(0.1 or 0.2 M) was titrated at a flow rate of 20.38 or 50.48 pi min"! 
using a chart speed of 12 cm hr“l and chart recorder range 0 - 500 x 
10“6 S or 0 - 1000 x lO"^ s. Table 7.5 is a summary of the 
micellization and solubilization data for each initial cirazoline 
hydrochloride concentration. CMC values were calculated from the 
apparant CMC (CMC1) using equations 7.9 and 7.7 and [CIRH-DDS(h)], 
[DDS” (h)] and KA values were calculated using equations 7.10, 7.13 
and 7.14 respectively.
Figure 7.6 shows the effect of cirazoline concentration (corrected 
for titrant dilution) on (a) S0L<p, (b) total SDDS concentration in 
the system at the CMC (CMC'), and (c) true SDDS CMC. The presence 
of low concentrations of cirazoline in SDDS systems initially lowers
-272-
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Table 7.4 - Reproducibility of the conductimetric titration technique 
for the determination of CMC', SOL*p and values. Data 
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0.5 0.031 0.44 4.54 4.06
1
I 5.06 0.52 | 2.8
1.0b 0.032 0.91 4.76
(4.74-
4.78)




















2.5 0.038 2.27 5.61 3.25
1
j 7.55 1.94 | 3.1
3.0 0.044 2.84 5.74 2.83 | 7.96 
1
2.22 | 2.9
3.2 0.043 3.02 5.99 2.89
1
j 8.41 2.42 | 2.9
4.0d 0.048 3.76 6.46
(6.43-
6.49)
















a - approximate value
b - mean (range) of two determinations
c - mean (range) of ten determinations
d - mean (range) of three determinations
Table 7.5 - Effect of cirazoline hydrochloride concentration on 
micellization and solubilization in cirazoline 
hydrochloride-SDDS systems at 30°C.
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(M x 103 )
Figure 7.6 - Effect of cirazoline hydrochloride concentration
(corrected for dilution) on (a) SOL-y, (b) CMC' and
(c) CMC, for SDDS at 30°C.
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the CMC*, reaching a minimum at 2 x 10“^M, further increase in 
cirazoline concentration then increases CMC'. This is due to the 
increased formation of CIRH-DDS complex and the consequent removal of 
dodecylsulphate ions from solution. The effect of cirazoline 
concentration on the micellization of SDDS is shown by the true SDDS 
CMC curve (c). This decreases with increase in cirazoline (and 
therefore complex) concentration. The SDDS concentration required to 
completely solubilize cirazoline (SOL'p) increases with increase in 
solubilizate (complex) concentration.
The molar ratio of cirazoline to dodecylsulphate moieties within the 
aggregates may be estimated from the slope of a plot of [CIRH-DDS(m )] 
against ([SDDS(m )1 + [CIRH-DDS(jj)] ) , (figure 7.7). Linear regression 
analysis gave : regression coefficient = 0.9987, slope (S.D.) = 0.604 
(0.012), and intercept (S.D.) = -2.34 x 10”^ (0.56 x 10”^). The 
molar ratio of cirazoline to dodecylsulphate moieties within the 
aggregates is thus 0.6 : 1.
values were Independent of cirazoline concentration and gave a 
mean value of 2.9 x 10^ (S.D. * 0.2 x 10^ M"*).
7.1.3.2 EFFECT OF TEMPERATURE
The effect of temperature (10° - 50°C) on aggregation and 
solubilization within cirazoline hydrochloride - SDDS systems was 
investigated by conductimetric titration. Titrations were performed 
by titrating 0.1 or 0.2 M SDDS into 2 x 10“^ M cirazoline 
hydrochloride at a flow rate of 12.39, 20.38 or 50.48 |il min“^. A
chart speed of 3 or 12 cm/hr was used in conjunction with chart
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Figure 7.7 - Cirazoline : dodecylsulphate moiety ratio in aggregates.
Plot of concentration of cirazoline in aggregates,
([CIRH-DDS(m )], against total concentration of 
dodecylsulphate in aggregates, ([ C I R H - D D S ] + 
[DDS~(m )]). Concentrations expressed with respect to 
total volume of the system.
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Solid CIRH-DDS complex was formed at temperatures of 35°C and below 
whereas liquid complex was produced at higher temperatures. Table 
7.6 shows micellization and solubilization data at each temperature 
studied. The mole fraction of SDDS at the CMC, X q m o  is also shown.
values were calculated using equation 7.14 and the solubility 
product values given in table 6.7. Figure 7.8 shows plots of CMC' 
and SOL-p against temperature are biphasic. Approximately linear 
decrease in both CMC1 and SOL«p with temperature is observed for both 
crystalline and liquid CIRH-DDS systems with the break occurring at 
the transition temperature. For the solid complex system, the 
relative magnitudes of SOL-p and CMC* slopes indicate that 
solubilization is more sensitive to temperature change than the 
micellization process. The effect of temperature on the liquid 
complex values for CMC' and SOL-j* is less pronounced and these 
solubilization and micellization processes appear to be equally 
affected by temperature.
The Van't Hoff plot for the derived true CMC (mole fraction) is 
biphasic with a non-linear plot for the crystalline complex systems 
with the inflexion corresponding to the transition point, (figure 
7.9). The standard free energy change for the micellization 
process, AG° jj, was calculated at each temperature using equation 
1.29. The degree of dissociation, a, was taken as zero for these 
calculations (since cirazoline is strongly bound to the micelles).
The standard enthalpy change for micellization, AH° m , at each 
temperature was determined from the slope of the curves and use of 
equation 1.30. The standard entropy change for micellization, A S 0^, 
was calculated using equation 1.31. Table 7.7 is a summary of 
thermodynamic parameters for the micellization process at each 




(MxlO3 ) (MxlO3 )
CMC
(MxlO3 ) (385) SOLp(MxlO3 ) AGGREGATERATIO k a |(M^xlO”4 ) 1
| Solid Complex 
| 10 0.004 8.06
(7.96-8.15)
6.15 11.1 15 0.21 7.2 |
1 15 0.006 7.41
(7.38-7.44)
5.49 9.89 12.60 0.27 5.7 |
| 20 0.012 6.73
(6.72-6.74)
4.81 8.67 10.60 0.33 4.0 |
1 25 0.020 6.07
(6.01-6.12)
4.15 7.48 8.87 0.40 3.4 |
































1 45 0.157 4.21 2.45 4.44 4.58 0.82 3.0 |
1 50 0.196 4.00 2.28 4.11 4.40 0.81 2.2 I
a ■ Mean (range) of ten determinations, b = Mean (range) of four determinations
Table 7.6 - Effect of temperature on micellization and solubilization in 2 x 10”3 M cirazoline
hydrochloride - SDDS systems. Unless otherwise indicated figures in parentheses represent
range of two determinations. (Xq m c * mole fraction of SDDS at the CMC).



















Figure 7.8 - Effect of temperature on the SDDS concentration
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Figure 7.9 - Van't Hoff plot for micellization in
2 x 10-3 M cirazoline hydrochloride - SDDS
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SOLUBILIZATION 
A G ° a AH° a A S° a ,
(kJmol-1) (kJmol” !) (Jmol“^K"^)
Table 7.7 - Thermodynamics of micellization and solubilization
processes in 2 x 10”^ M cirazoline hydrochloride-SDDS 
systems.
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all temperatures studied. Micellization is therefore driven by a 
large positive entropy change and hindered by an endothermic enthalpy 
change. Micellization in liquid complex systems is driven by similar 
forces although a H°m  and A S 0^ are somewhat less than for the solid 
complex system.
The effect of temperature on the ratio of cirazoline to 
dodecylsulphate moieties within the aggregates is shown in figure 
7.10. The ratio increases with increase in temperature until the 
phase transition point is reached, e.g. at 10°C the ratio is 0.21 
which rises to 0.65 at 35°C, thereafter remaining approximately 
constant at about 0.8.
For the solid complex system, values decrease with increase in 
temperature and indicate the affinity of cirazoline ions for SDDS 
micelles diminishes as the temperature Increases, (figure 7.11). A 
rapid increase in occurs at the phase transition point; for the 
association in the presence of liquid complex then falls rapidly with 
Increasing temperature.
The Van't Hoff plot for the association of cirazoline ions to SDDS 
micelles is biphasic with a break corresponding to the transition 
temperature, (figure 7.12). The standard free energy change for the 
association process, AG°^, was calculated at each temperature using 
equation 1.84; the standard enthalpy change, AH°^, was determined 
from the slope of the curves and use of equation 1.85; and the 
standard entropy change,AS°^, was calculated using equation 1.86. 
These thermodynamic parameters are shown alongside micellization data 
in table 7.7. AG°^ is negative and independent of temperature for 
each system. At low temperature the association process is driven by 
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Figure 7.11 - The effect of temperature on the association 
constant (K^) for the interaction between 
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Figure 7.12 - Van't Hoff plot for the association of 
cirazoline to SDDS micelles. Data plo 







These values decrease with increase in temperature until the phase 
transition temperature is reached. The association in the presence 
of liquid complex is characterised by similar forces.
The validity and error in determining these values are discussed in 
section 9.
7.1.3.3 EFFECT OF IONIC STRENGTH
The effect of ionic strength (I) on aggregation and solubilization in 
2 x lO"^ M and 5 x 10"^ M cirazoline hydrochloride - SDDS systems was 
studied at 30°C using both conductimetric titration (I = 2 x 10"^ - 
1 x 10“2 M) and solubility (I = 2 x 10“^ - 1 x 10“1 M) methods.
Ionic strength was adjusted by the inclusion of sodium chloride 
solution in the systems. Solid CIRH-DDS complex was formed in all 
systems. Conductimetric titrations were performed by titrating 0.1 M 
or 0.2 M SDDS into 2 x 10"^ M or 5 x 10“^ M cirazoline hydrochloride 
at a flow rate of 20.38 or 50.48 pi min”l. Titrations were limited 
to sodium chloride concentrations of 0.01 M and below due to the high 
background conductivity of concentrated electrolyte solutions.
The effect of SDDS and sodium chloride concentration on the 
solubility of cirazoline is shown in tables 7.8 and 7.9. The 
physical nature of each system is also shown. Cirazoline solubility 
- SDDS concentration profiles in the absence and presence of sodium 
chloride and shown in figures 7.13 and 7.14. Theoretical aqueous 
solubility profiles (calculated using K s values from table 6.7 and 
equations 1.70, 7.9 and 7.5), equimolar concentration, CMC* and SOL-p 
points are also shown. Below the CMC' of 2 x 10"^ M cirazoline 
hydrochloride-SDDS systems, cirazoline solubility falls with increase 
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Table 7.8 - The solubility of cirazoline in 2 x 10”3 M cirazoline
hydrochloride-SDDS sytems in the absence and presence of 
0.01, 0.05 and 0.1 M sodium chloride, 30°C. Symbols in 
parentheses represent physical nature of the system,













0 . 1 i
| NIL 4.76 (S) 4.96 (S) 4.94 (S) 4.74 (S) |
| 5 .0 0.184 (C) 0.218 (C) 0.378 (C) 1.05 (C) |
j 5.5 - 0.126 (C) 0.420 (C) 0.88 (C,T?) |
| 6 .0 0.086 (C) 0.130 (C) 0.887 (C) 1.61 (C,T) |
| 6.5 - 0.268 (C) 1.80 (C,T) 2.18 (C,T) |
| 7.0 0.168 (c) 0.811 (C) 2.51 (C,T) 2.98 (C,T) |
1 7.5 - 1.37 (C) 3.28 (C,T) 4.36 (C,T) |
| 8.0 0.641 (C) 1.90 (C) 4.14 (T) 4.33 (T) |
| 8.5 1.09 (C) 2.74 (C) 4.00 (T) 4.50 (T) |
| 9.0 1.66 (c) 3.32 (C) 4.09 (T) 4.61 (T) |
1 9.5 2.21 (c) - - -
| 10.0 2.87 (c) 4.88 (C) 3.98 (T) 4.40 (T) |
| 10.5 3.34 (c) - - -
| 11.0 3.89 (c) - - -
| 12.0 4.66 (s) 4.93 (S) 4.78 (S) 4.80 (S) |
Table 7.9 - The solubility of cirazoline in 5 x 10"^ M cirazoline
hydrochloride-SDDS sytems in the absence and presence of 
0.01, 0.05 and 0.1 M sodium chloride, 30°C. Symbols in 
parentheses represent physical nature of the system,








































Due To Complex Formation
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Figure 7.13 - The effect of added sodium chloride concentration on the solubility of cirazoline 









































Theoretical Solubility Curve Due to Complex Formation
11.05.0 6.0 8 10.0 12.0.0 9.07.0
SDDS Concentration (M x 10^)
Figure 7.14 - The effect of added sodium chloride concentration on the solubility of cirazoline 







slightly increases the solubility of the cirazoline dodecylsulphate 
complex at a given SDDS concentration. The CMC' of the system is 
also lowered with increasing sodium chloride concentration and the 
solubility curves are shifted to lower SDDS concentration. The 
physical nature of the system is also affected by the presence of 
electrolyte. In the absence of sodium chloride partially solubilized 
systems appear as a suspension of crystalline complex, the quantity 
of which decreases as cirazoline is solubilized. After filtration 
the filtrate is a clear, non-viscous solution. In the presence of 
0.05 and 0.1 M sodium chloride crystalline complex is again formed 
but the systems become viscous and turbid with a blue haze,
(usually indicative of a colloidal suspension), as cirazoline is 
solubilized. The turbidity and high viscosity remain after 
filtration. Birefringence was not detected in these systems when 
viewed through polarised light indicating the absence of liquid 
crystalline phase.
Similar results were obtained with the 5 x 10~^ M cirazoline 
hydrochloride-SDDS systems (table 7.9, figure 7.14). In the absence 
of and presence of 0.01 M sodium chloride, partially solubilized 
systems are crystalline suspensions and the filtrate is a clear non- 
viscous solution. In the presence of 0.05 and 0.1 M sodium chloride, 
however, systems become increasingly viscous and turbid during the 
solubilization process. At SDDS concentrations 8 - 10 x 10”3 m 
cirazoline is fully solubilized (i.e. crystalline complex is absent) 
but the analytical data shows cirazoline solubility is less than the 
input concentration. Results are erratic and indicate that the 
sampling technique is not valid in this SDDS concentration region. 
Clear solutions are formed at very high SDDS concentrations 
(12 x IQ'3 M) well In excess of S0LT , SOLt points wer6j therefore(
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determined by extrapolation of the linear regions of the 
solubilization curves to [CIRHC1]T (figure 7.14).
Micellization and solubilization data for 2 x 10"^ M and 5 x 10“^ H 
cirazoline hydrochloride systems are summarised in tables 7.10 and 
7.11 respectively.
CMC* values determined by conductimetric titration and solubility 
show reasonable agreement for both 2 x 10“^ M and 5 x 10“3 M 
cirazoline hydrochloride-SDDS systems.
The effect of ionic strength on the CMC and S0L*p is shown in figure 
7.15. The 2 x 10"^ and 5 x 10"^ M cirazoline hydrochloride - SDDS 
CMC-ionic strength profiles are similar but SOL-p curves are shifted 
to higher SDDS concentration with increase in initial cirazoline 
concentration due to the greater amount of formed complex.
Increasing sodium chloride concentration decreases the CMC and SOL-p 
of both systems. The trend in the SOLp curves closely follows that 
of the CMC curve, indicating that sodium chloride primarily affects 
micellization and not solubilization. Figure 7.16 shows the CMC data 
plotted according to equation 1.35 (logpQ CMC v logpo*)* The plot 
is linear with a slope (S.D.) of -0.632 (0.017) which is similar to 
the reported values of -0.503^3 and -0.675^3 f0r pure SDDS systems 
and indicates that ionic strength affects the CMC of cirazoline 
hydrochloride -SDDS systems in a similar manner to that of the pure 
surfactant.
values show a decrease in cirazoline association with SDDS 
micelles as ionic strength is increased, (tables 7.10 and 7.11), 
e.g. in the absence and presence of 0.1 M sodium chloride was 
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| 3.43 | 7.04 | 
(6.79-7.31)j
0.52 3.1




5.25 | 3.29 | 6.55 | 0.60 4.0




5.45 1 3.53 | 7.05 | 0.54 3.4




5.27 1 3.35 | 6.94 | 0.53 3.1







| 3.38 | 6.87 | 
(6.79-6.96) j
0.55 3.3




4.37 1 2.47 | 6.13 | 0.52 2.0







| 2.03 | 5.56 | 
(5.44-5.67) j
0.53 1.8




2.62 1 0.82 | 3.46 | 0.68 1.1




2.19 1 0.54 | 3.32 | 0.59 0.42
Mean and range of a = two, b * three and c = ten determinations
Table 7,10 - The effect of ionic strength (i) on micellization and solubilization in 2 x 10"3 m 
cirazoline hydrochloride - SDDS systems at 30°C. Data determined by conductimetric 
titration and solubility (+) studies.
Aggregate Ratio = ------(M)]- - - - - - - - - - - - - -








j at CMC' 
| (MxlO3 ) 
1
[ C I R H + ( , g )  
(M x 103 J
1





(MxlO3 ) | 





(M^xlO4 ) 1 
1
I
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1 5.10 j 
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a = Mean and range of two determinations
Table 7.11 - The effect of ionic strength (i) on micellization and solubilization in 5 x 10~3 m
cirazoline hydrochloride-SDDS systems at 30°C. Data determined from conductimetric
titration and solubility (+) studies.
Aggregate Ratio = ______L?JMr.PP-S.CnjL]-------



































Figure 7.15 - The effect of ionic strength on the CMC and SOL-p of
2 x 10“3 M and 5 x 10“3 M cirazoline hydrochloride. - SDDS 
systems at 30°C as determined by conductimetric titration 
(CT) and solubility (S) methods.
2 x 10“3 M 
CT S
5 x 10"3 M 
CT S
S0LT - n -  
CMC -  a -
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4.0-







0.005 0.01 0.05 0.10.02
Ionic Strength (M)
Figure 7.16 - The effect of ionic strength on the CMC of 2 x 10“3 M
(•— A — ) , and 5 x 10“3 M (— Y — ) , cirazoline hydrochloride 
- SDDS systems at 30°C. Data plotted according to 
equation 1.35. Solid symbols = from solubility studies, 
open symbols=from conductimetric titration studies.
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this trend is due to an increase in aqueous cirazoline solubility and 
the ratio of cirazoline to dodecylsulphate moieties within the 
aggregates remains approximately constant and independent of ionic 
strength at about 0.6 s 1.
7.2 PARTICLE SIZE ANALYSIS
7.2.1 Introduction
Particle size of 2 x 10"^ M cirazoline hydrochloride-SDDS systems was 
determined using the Coulter N4MD sub-micron particle size analyser. 
This is a is a photon correlation spectrometer (PCS) and estimates 





Where KB is the Boltzmann constant, T is the temperature, is the 
viscosity of the diluent and r is the equivalent spherical 
hydrodynamic diameter. The PCS technique involves illuminating the 
particles with a laser and measuring the scattered light with 
photomultipliers. Brownian movement of the particles cause a 
constantly varying light intensity at the detector. Large, 
relatively slow moving particles change position slowly and cause 
slow intensity fluctuations; conversely, small quickly moving 
particles cause rapid intensity fluctuations. PCS sizes particles by 
characterising the time scale of these random intensity fluctuations. 
Detailed PCS theory is set out in standard texts^05#
The Coulter N4MD unimodal analysis provides an estimate of the mean 
equivalent spherical hydrodynamic diameter and standard deviation of
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the distribution assuming a log-normal distribution. A knowledge of 
the sample temperature and the viscosity and refractive index of the 
diluent is required to achieve an estimate of particle size.
7.2.2 Experimental
Systems were designed to investigate the size of aggregates both 
saturated and unsaturated with respect to cirazoline.
Systems for particle size analysis were prepared by the method 
described for solubility studies (section 7.1.2.1). Samples were 
filtered (Whatman 25 mm membrane filter, 0.45 pm pore size) and 
re-equilibrated to temperature for 15 minutes within the Coulter N4MD 
sample compartment before commencement of particle size analysis.
Six x three minute unimodal analyses were performed on each sample.
7.2.3 Results
The effect of SDDS and sodium chloride concentration on the particle 
size of cirazoline hydrochloride-SDDS systems was investigated at 
30°C. Mixtures were prepared containing 2 x 10“^ M cirazoline 
hydrochloride in the absence and presence of 0.05 M and 0.1 M sodium 
chloride. SDDS concentrations at the CMC1 and encompassing the SOL-p 
of the system were used.
Table 7.12 shows the mean number of counts, mean diffusion 
coefficient and mean particle diameter for each SDDS concentration in 
0.05 M and 0.1 M sodium chloride. Standard deviation of mean 
diffusion coefficient and mean particle diameter are also shown. The 
particle size distribution of all samples was extremely broad.
Figure 7.17 shows the mean particle diameter - SDDS concentration 
profile for systems containing 0.05 M and 0.1 M sodium chloride.
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1 1 
1 [SDDS] | 








(cm2 s- l x l08)
1
MEAN UNIMODAL | 
PARTICLE j 
DIAMETER j 













46.9 4.20 (0.05) 133 (1) 1
1 1 




175.0 2.77 (0.06) 200 (4) |
I 1 














| 2.50 | 
1 |
66.4 2.61 (0.16) 214 (12) |
1 1 1 2.75 |
1 I
119.0 2.66 (0.05) 209 (4) |
1 1 
j 3.00 j 
1 |
167.0 2.17 (0.25) 259 (28) |
1 1 
1 3.25 | 1 | 190.0 2.56 (0.11) 217 (9) |
1 1 
| 3.50 | 
1 |
168.0 2.73 (0.05) 204 (4) | 1
1 1 
1 3.75 | 
1 |
23.1 3.05 (0.02) 182 (1) 1
1 1 
| 5.00 j 
1 |





3.66 22.1 (5.0) 26. 3 (5.7) | 
1 
1
Table 7.12 - Unimodal particle size analysis data for 2 x 10”^ M 
cirazoline hydrochloride-SDDS systems at each SDDS 
concentration ([SDDS]) and sodium chloride 
concentration, 30°C. Data represent mean and standard 











i o o -
-  10.0CMC5 0 -
82.0 .02.5 3.0 3.5 .5 5.04.0
SDDS concentration (M x 103)
Figure 7.17 - Effect of SDDS conce-ntration on the mean diffusion coefficient, D, and mean particle
diameter, r, of aggregates in 2 x 10“3 M cirazoline hydrochloride-SDDS systems in the
presence of (a) 0.05 M and (b) 0.10 M NaCl, 30°C.
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CMC' and SOL-p of each system are shown (data obtained from table
7.10), Systems containing no added electrolyte were prepared using 
A.5 x 10“3 - 5 x 10“2 m  SDDS. Particle size analysis indicated a 
small particle size but the scattering intensity of these samples was 
insufficient for valid particle size analysis.
The particle size of SDDS aggregates in the presence of 2 x 10~3 M 
cirazoline hydrochloride and 0.05 M and 0.1 M sodium chloride is 
extremely large with a broad particle size distribution. In both 
systems the lowest SDDS concentration studies approximates to the 
CMC' of the system (2.19 x 10“3 M in 0.1 M NaCl, 2.62 x 10‘3 M in 
0.05 M NaCl, table 7.10). Increasing SDDS concentration above the 
CMC results in an initial Increase in particle size up to a maximum 
associated with the total solubilization concentration, SOL-p,
(3.32 x 10-3 M in 0.1 M NaCl, 3.46 x 10~3 M in 0.05 M NaCl, table
7.10). Further Increases in SDDS concentration after total 
solubilization of cirazoline result in a decrease in particle size. 
For example, in 0.1 M NaCl the mean particle diameter rose from 
180 nm close to the CMC to 259 nm at SDDS concentration near the 
SOL-p, then decreased to 26.3 nm at 8 x 10“3 M SDDS. Similar effects 
are observed with the 0.05 M NaCl system (figure 7.17). This 
suggests that particle size Increases as the concentration of SDDS 
aggregates saturated with cirazoline increases, then decreases as the 
degree of unsaturation Increases.
Electrolyte concentration has two effects on aggregation. Increasing 
electrolyte concentration decreases the CMC of the system and thereby 
Increases the concentration of micellar surfactant at a given SDDS 
concentration. This effect is shown by the shift in peak particle 
size from 3.5 x 10“3 M SDDS in 0.05 M NaCl to 3.0 x 10"3 M SDDS in
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0.1 M NaCl. Electrolyte concentration also affects the nature of the 
aggregates. In the absence of sodium chloride a small particle size 
was indicated (although scattering intensities were too low for valid 
analysis). In systems containing added electrolyte, for a given 
concentration of micellized SDDS, an increase in NaCl concentration 
caused an increase in the size of the aggregates. This effect is 
shown as a shift in the mean particle diameter - SDDS curve to higher 
particle diameter with increasing NaCl concentration (figure 7.17). 
The peak particle size diameter in the 0.1 M NaCl system is 259 nm 
and occurs at a micellar SDDS concentration of 0.75 x 10“^ M. In 
0.05 M NaCl, however, peak particle diameter is smaller - 200 nm - 
and is associated with a slightly greater micellar SDDS 
concentration - 0.88 x 10“^ M.
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8 . KINETICS OF IMIDAZOLINE 
HYDROLYSIS
8.1 INTRODUCTION
First order rate constants for the hydrolysis of cirazoline and other 
imidazolines were determined at constant pH and temperature. Samples 
were withdrawn at known intervals during the hydrolysis, analysed and 
the percent residual concentration calculated by one of the 
methods described in section 3.1.6. Samples were normally taken at 
ten time intervals during each experiment. All data were fitted to 
the first order rate equation (equation 1.4) using linear regression 
analysis to obtain the observed first order rate constant.
Reactions in the absence of SDDS were usually followed down to a 
percent residual concentration below 60%. Due to the relatively slow 
rate in SDDS solutions, reactions in the presence of surfactant were 
normally only followed down to a percent residual concentration of 
about 80%. This limitation was also a result of the desire to 
avoid large amounts of degradation product which may disrupt the 
structure of the cirazoline-SDDS system.
pH control during degradation was effected either by pH-statting or 
the use of buffers.
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(a) Buffered Solutions
The choice of a buffering system was dictated by the following:
(i) pH required,
(ii) chemical nature of buffer materials,
(iii) buffer capacity required,
(iv) dilution value,
(v) neutral salt effects,
(vi) temperature coefficient,
( vii) stability.
Kinetic studies in buffered systems were performed in equimolal 
(0.025 m) phosphate buffer, pH 6.87 at 25°. This system was chosen 
as this is an NBC primary standard, has good buffer capacity at pH 7 
and a low temperature coefficient.
(b) pH Statting Technique
The pH-stat technique maintains pH by the addition of titrant to the 
reaction flask. The automated pH-stat assembly used in this study 
consisted of a two-necked, round bottomed reaction flask, magnetic 
stirrer, combined glass - silver/silver chloride pH electrode, PHM 61 
pH meter, TTT60 titrator and ABU12 autoburette with micro-delivery 
tube. A diagramatic representation of the apparatus is shown in 
figure 8.1. The pH of the stirring reaction mixture is maintained by 
addition of titrant from the autoburette. Flow of titrant is 
controlled by the titrator, which is connected directly to the pH 
meter and autoburette. The required pH is set on the titrator 
through the end-point control. As the pH of the solution changes 
during the hydrolysis process, the titrator activates the autoburette 


























required value, the titrator deactivates the autoburette and the flow 
of titrant is stopped. The rate of addition and concentration of 
titrant must be carefully selected to avoid pH drift, (insufficient 
titrant addition) or pH overshoot, (excess titrant addition) during 
the experiment.
In studies where the rate of hydrolysis- and hence rate of change of 
pH - is low (defined as kinetic reactions with half-life > 2 days), 
satisfactory pH control may be obtained by adding titrant manually. 
This technique was necessary for studies involving SDDS where the pH 
electrode cannot be left in the reaction mixture for long periods 
(section 2.2.5.3) .
8.2 EXPERIMENTAL
8.2.1 General Procedures For Kinetic Studies
(a) Using Buffered Solution
95 ml of equimolal phosphate buffer solution were placed in a 
stoppered 200 ml volumetric flask and equilibrated in a constant 
temperature water bath. 5.0 ml of appropriate stock solution of 
drug was added and the flask shaken. A 4.0 ml sample was 
withdrawn after about 2 minutes equilibration time (■ time zero), 
added to 1 ml of 0.1 M HC1 to stop the reaction and suitably diluted 
for assay. Repeat 4 ml samples were withdrawn at appropriate 
intervals and similarly prepared for assay. The pH of the reaction 
mixture was measured at the start and end of the experiment and in 
all cases was found to be within 40.05 pH units of the stated pH of 
equimolal phosphate buffer at the reaction temperature.
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(b) Using Automated pH-stat Apparatus
The pH required was set on the titrator of the pH-stat assembly and 
the burette filled with the appropriate concentrations of sodium 
hydroxide titrant (0.02 - 0.2 M). 95 mis of double distilled water
were placed in the reaction flask and equilibrated in a constant 
temperature water bath. The magnetic stirrer was switched on and 
5 ml of cirazoline hydrochloride stock solution were added to the 
reaction vessel. The pH-stat assembly was switched on and titrant 
delivered until the pH reached the required value. Further 
quantities of titrant were added automatically to counteract the fall 
in pH during hydrolysis. A A ml sample was withdrawn immediately 
after reaching the desired pH (=time zero), added to 1 ml of 0.1 M 
HC1 to stop the reaction and suitably diluted for assay. A ml 
samples were withdrawn at appropriate intervals and similarly 
prepared for assay.
In studies involving high pH (> pH 9) or low pH (< pH 5), 95 ml of 
sodium hydroxide or hydrochloric acid solution of appropriate 
concentration were equilibrated to temperature and 5 ml of 
cirazoline hydrochloride stock solution added. This reduced the time 
and volume of titrant required to bring the cirazoline reaction 
solution to the desired pH.
In all automated pH-stat experiments the volume of titrant added was 
small (< 1 ml). The dilution effect is therefore minimal and was 
ignored in kinetic calculations.
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(c) Using Manual pH-stat
The reaction mixture was prepared at room temperature by mixing the 
required amounts of stock solutions in a 100 ml volumetric flask and 
making up to volume (100 ml) with double distilled water. The 
mixture was immediately shaken, transferred to a stoppered 100 ml 
conical flask and equilibrated in a constant temperature water bath. 
The pH was then raised to pH 7.0 by the dropwise addition of sodium 
hydroxide solution (0.001-0.1 M). A 4 ml sample was withdrawn,
(° time zero), and added to 1 ml of 0.1 M HC1 to stop the reaction 
and suitably diluted for assay. 4 ml samples were withdrawn at 
appropriate intervals and similarly prepared for assay. pH was 
monitored throughout the experiment and adjusted as necessary by 
the dropwise addition of sodium hydroxide or hydrochloric acid 
solution (0.001 -0.01 M). Volume of titrant added and pH readings 
were recorded for each experiment. In all manual pH-stat experiments 
the volume of titrant added was small (< 2 ml). The dilution effect 
is therefore minimal and was ignored in kinetic calculations.
In studies involving SDDS, reaction mixtures were equilibrated for 
longer periods before commencing the kinetic study to allow for 
possible phase transitions. At 30°C, systems were left stirring for 
24 hours, whereas at 50°C 1 hour was found to be sufficient. Assay 
results show the amount of degradation during equilibration to be 
negligible. Systems containing insoluble complex were continually 
stirred using a magnetic stirrer and flea to ensure intimate mixing 
of phases and to prevent deposition. During pH measurement the 
magnetic stirrer was switched off and readings were taken as rapidly 
as possible to minimise adsorption on to the electrode 
(see section 2.2.5.3).
-307-
pH measurements during kinetic experiments were normally within ♦_ 
0.05 pH units of the desired pH. Any trend in measured pH values 
was compensated for by adjusting the pH to a value slightly beyond 
the nominal pH (> 0.1 pH unit). As pH adjustment was usually carried 
out numerous times between samples, the mean pH is thought to be 
within ♦_ 0.05 pH units of the desired pH.
8.2.2 Reproducibility of pH-statting Techniques
The degradation of cirazoline hydrochloride at 30°C was monitored 
twelve times using the manual pH-stat method (pH 7.0) on two 
different dates spaced five months apart, and three times using the 
automated pH-stat method (pH 7.1) on two different dates spaced nine 
months apart. Percent residual concentration was calculated 
by method 3 (section 3.1.6) and derived first order rate constants 
are shown in table 8.1.
The manual pH-stat data show satisfactory reproducibility (S.D. = 
0.18, CV = 9%) and a t-test on the data obtained on 22.1.86 and 
23.6.86 show the data to be indistinguishable at the P = 0.05 level 
(tcalc “ 1.032, ttafc = 2.23). The automated pH-stat technique is 
also reproducible (S.D. ■ 0.16, CV = 6%). The mean k0fos value 
obtained by this technique is 32% greater than that obtained by the 
manual method. This is consistant with a pH difference of ♦ 0.12 pH 
units (measured pH difference = * 0.10 pH units) assuming cirazoline 
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I j 2.05 (0.40)
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Table 8.1 - Reproducibility of automated and manual pH-statting
techniques. First order rate constants (k0^s) for the 
degradation of cirazoline hydrochloride at pH 7.1 




8.3.1 Order of Reaction
The order of reaction with respect to cirazoline hydrochloride 
concentration was determined using time and concentration based 
methods. All percent residual concentration values were calculated 
by reference to both cirazoline and CPAE concentrations (method 3, 
section 3.1.6).
8.3.1.1 TIME BASED METHODS
The order of reaction was calculated by three different methods:
(i) fractional lifetime method, (ii) integration method and 
(iii) the Guggenheim method. The latter method is normally used for 
the determination of first order rate constants but a linear 
Guggenheim plot is indicative of first order kinetics.
Data were generated by degrading 2 x 10"^ M cirazoline hydrochloride 
at pH 7.1 and 60°C using the automated pH-statting technique. The 
hydrolysis was followed to a percent residual concentration of 12.5%
- equivalent to three half-life periods. Results and calculated data 
are shown in table 8.2.
(i) Fractional Lifetime Method
The integrated form of equation 1.2 may be expressed by equation 8.1:
loSlO tl/y = (1 ~ n) log10 [S0 ] (8.1)
Where t^/y is the time taken for the initial concentration of 
substrate, [S0], to fall by a fraction 1/y and n is the order of 
reaction. The order of reaction can therefore be determined from the 



































































Table 8.2 - Sample times, percent residual concentration values
and Guggenheim calculated data? A[S]^for the hydrolysis 
of cirazoline hydrochloride at pH 7.1, 60°C.
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Table 8.3 - Time taken for the percent residual concentration to
decrease by successive fractions of 3/4 ^ 3/4) for the 
hydrolysis of cirazoline hydrochloride at pH 7.1, 60°C.
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The time taken for the percent residual concentration to decrease by 
successive fractions of 3/4 ^ 3/4) was determined by plotting percent 
residual concentration against time (figure 8.2). Results are shown 
in table 8.3. A plot of log^Q against logjo [S0] was
constructed and the slope, determined by linear regression analysis, 
was found to be -1.796 x 10”^ M"^(S.D. = 3.09 x 10"^ M~^) and the 
order of reaction with respect to time was calculated as 1.018.
(ii) Integration Method
The order of reaction can be determined by plotting experimental data 
according to each of the integrated rate equations (equations 1.3 to 
1.5). A linear plot is obtained when the integrated form of the 
correct rate law is used. For a first order reaction, a plot of 
percent residual concentration on a log^Q scale versus time is linear 
with a slope equal to - k/2.303 (equation 1.4). Such a plot was 
constructed using data for the hydrolysis at pH 7.0, 60°C (figure 
8.3). Linear regression analysis data gave a slope of -1.157 x 
10”2 min "I (S.D. = 0.009 x 10”^ min-*) and correlation coefficient 
of 0.9998. The small error of slope (CV = 0.8%) and good correlation 
coefficient value indicate a linear plot which is consistant with a 
first order reaction.
(iii) Guggenheim Method
The Guggenheim method involves calculating the change in
concentration, A [ S ] , of a reactant over a fixed time interval,At.
Equation 1.6 predicts a plot ofA[S] on a log^Q scale against time is
linear for a first order reaction with a slope equal to - k
2.303
A time interval of 60 minutes (approximately equivalent to the half- 









Figure 8.2 - Percent residual concentration (% RC) against
time for the hydrolysis of cirazoline 








1^ 0) 120 
Time (Minutes)
Figure 8.3 - Percent residual concentration (% RC) on
a logjQ scale against time for the 
hydrolysis of cirazoline hydrochloride 
at pH 7.1, 60°C. (First order plot).
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hydrolysis data in table 8.2 and the Guggenheim plot is shown in 
figure 8.4. Linear regression analysis on the Guggenheim data gave a 
slope of -1.217 x 10“2 min“ l (S.D. ■ 0.014 x 10"^ min"l) and a 
correlation coefficient of 0.9998. The small error of slope (CV = 
1.2%) and good correlation coefficient indicate a linear plot and a 
first order reaction.
8.3.1.2 CONCENTRATION BASED METHODS
The order with respect to concentration may be determined by the 
Van't Hoff method of initial rates. Equation 1.2 may be written in 
the form:
loglO M s ] \  - log10 k0bs ♦ » l°glo [S0] (8.2)V dt)°
Where the subscript 0 denotes initial values. A plot of log^Q 
initial rate against log^g initial substrate concentration thus 
yields the order of reaction with respect to concentration from the 
slope.
Hydrolysis reactions were conducted at pH 7.0 and 30°C using the 
manual pH-statting technique. Initial cirazoline hydrochloride 
concentrations of 2 x 10“^ - 5 x 10“^ M were used and reactions were 
followed down to a percent residual concentration of about 50%. 
Results are shown in table 8.4.
The initial rate of each reaction was determined by plotting percent 
residual concentration against time and drawing a tangent to the 
curve at time zero, as shown for 5 x 10“^ M initial concentration in 
figure 8.5. The initial rate was calculated from the product of 
initial concentration, [S0], and the slope of the tangent. Results 










Figure 8.4 - Guggenheim plot for the hydrolysis of cirazoline
, hydrochloride at pH 7.1, 60°C. Data plotted according to
equation 1.6, A S  = change in percent residual concentration 
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Table 8.4 - Sample times and percent residual concentration values
for the hydrolysis of cirazoline hydrochloride at pH 7.0, 
30°C at each initial concentration shown.
1 1 
| CIRAZOLINE CONCENTRATION |
1 <M> I 
1 1 _
1
INITIAL RATE | 








































Table 8.5 - Initial rate of hydrolysis of cirazoline hydrochloride at 
pH 7.0, 30°C at each initial concentration.
100 , Cirazoline
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Initial Cirazoline Hydrochloride 
Concentration (M x  1 0 ^ )
Time (hours)
Percent residual concentration (% RC) against Figure 8.6 
time for the hydrolysis of cirazoline 
hydrochloride at pH 7.0, 30°C.
Double log2Q plQt °f initial rate of cirazoline 
hydrochloride hydrolysis C-dS/dt) against initial 
cirazoline hydrochloride concentration for the 







[SG] was constructed and the slope determined by linear regression 
analysis (figure 8.6). The order of reaction with respect to
concentration was found to be 0.988 (S.D. = 0.014).
8.3.2 Effect of pH
The effect of pH on the hydrolysis of 2 x 10”^ M cirazoline
hydrochloride was studied using the automated pH-statting technique. 
The large range in rate constants necessitated two experiment 
temperatures - reactions at pH *7.1 were performed at 70°C and those 
at pH y 7.1 at 25°C. Percent residual concentration was calculated 
by reference to both cirazoline and CPAE concentration (method 3, 
equation 3.8, section 3.1.6) except for the reaction at pH 1.1, 70°C 
where hydrolysis of CPAE was significant; percent residual 
concentration was therefore calculated by method 1 (equation 3.6, 
section 3.1.6). The reaction at pH 13.1 was undertaken at an initial 
cirazoline concentration of 4 x 10“^ M due to the poor solubility of 
the cirazoline free base.
The observed rate constant, k0bs, at each pH for reactions at 70°C 
and 25°C are shown in tables 8.6 and 8.7 respectively. Theoretical 
rate constants calculated as shown in section 8.3.2.1 are also given. 
Observed and theoretical pH profiles at 70°C and 25°C are shown in 
figures 8.7 and 8.8 respectively. The observed pH profile at 70°C 
shows the hydrolysis of cirazoline to be almost independent of pH in 
moderately strong acidic solutions (pH <3). Above about pH 4 the 
rate constant increases dramatically with pH indicating cirazoline 
hydrochloride is susceptable to specific base catalysis. The 
observed first order rate constant is extremely sensitive to pH 
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Table 8.6 - The effect of pH on the hydrolysis of 2 x 10"8 M
cirazoline hydrochloride at 70°C. k0t>s = observed first
order rate constant, fgn* = fraction of protonated
cirazoline species calculated using pKa' = 8.40, k2 ■ 
specific base catalysed rate constant calculated using 
equation 8.4, k-p = theoretical rate constant calculated 
using equation 8.6, k0 * uncatalysaed reaction rate 
constant, a ^ "  ■ hydroxyl ion activity calculated using 








Figure 8.7 - Observed, (— ■ — ), and theoretical, (— □ — ), stability-pH
profiles, (first order rate constant on logjg scale 
against pH), for the hydrolysis of cirazoline 
hydrochloride at 70°C. Theoretical rate constants 




















































































Table 8.7 - The effect of pH on the hydrolysis of 2 x 10“3 M
cirazoline hydrochloride at 25°C. k0bs “ observed first 
order rate constant, fsH4 “ fraction of protonated 
cirazoline species calculated using pKa ' * 9.50, k£ = 
specific base catalysed rate constant calculated using 
equation 8.8 , k-j* * theoretical rate constant calculated 
using equation 8 .10, aQjj- * hydroxyl ion activity 
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pH
Figure 8.8 - Observed, (— H — ), and theoretical, (— stability-pH 
profiles, (first order rate constant on log]Q scale 
against pH), for the hydrolysis of cirazoline 
hydrochloride at 25°C. Theoretical rate constants 
calculated using equation 8.10.
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8.3.2.1 TREATMENT OF DATA AND CALCULATION OF THEORETICAL RATE 
CONSTANTS
(a) Calculation of k0 and k£ values at 70°C
At pH 1-3 the hydrolysis is almost independent of pH which is 
characteristic of an uncatalysed reaction involving attack of neutral 
water. It may therefore be assumed that in this pH range the base 
(and acid) catalysed reaction(s) are negligible and providing also 
that the hydrolysis of the free base species is negligible (pKa “ 8.4 
at 70°C, section 4.2.4), equation 1.10 reduces to equation 8.3;
kobs e ko (8.3)
as k£ [OH"] “ kj [H3O4 ] “ 0 and fgH4 ^ 1 at pH 1-3.
The mean kQ values (pH 1.1-3.1) was thus calculated as 1.18 x 10"8 
(S.D. 0.15 x 10"8 ) s"1. Ionic strength effects at low pH (<3) are 
discussed in section 8.3.2.1 c).
At pH >3.1 the base catalysed reaction becomes significant and 
providing the contribution from the free base hydrolysis to the 
overall reaction is minimal, the reaction may be described by 
equations 8.4 and 8.5.
kobs “ (ko ♦ k2 [0H-]).fSH« (8.4)
and at low Ionic strengths when aQjj-[OH"],
(
kobs\" ko
  I “ lo8l0 k2 " PKw 4 PH <8 *5 )
f sH y
Figure 8.9 shows the pH 4.1 - 7.1 data plotted according to equation 
8.5. Linear regression analysis gave; correlation coefficient “ 
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Figure 3.9 - The effect of pH on the hydrolysis of
cirazoline hydrochloride at 70°C. Data plotted 
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Figure 3.10 - The effect of pH on the hydrolysis of
cirazoline hydrochloride at 25°C. Data plotted 
according to equation 8.9
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The linear plot with slope close to unity confirms that equations 8.4 
and 8.5 adequately describe the overall reaction in the pH 4.1 - 7.1 
region. k2 was determined at each pH (4.1 - 7.1) using equation 8.4 
(table 8.6) and gave mean k2 = 261 (S.D. 31) M” * s"l at 70°C.
A theoretical rate constant kp was calculated at each experimental 
pH between 1.1 and 7.1, 70°C using equation 8.6:
kT = (kQ ♦ k2 [OH-]).fSH+ = (1.18 x 10"6 * 261 [OH-]).fSH4 s"1 (8.6)
kp values at each pH are shown in table 8.6 and the theoretical pH 
profile is shown in figure 8.7. The theoretical pH profile shows 
good agreement with the observed pH profile in the region pH 1.1 -
7.1 and demonstrates the validity of equations 8.4 and 8.6.
(b) Calculation of k2 at 25°C.
At 25°C and pH >7 the uncatalysed and (any) specific acid catalysed 
reaction rates will be negligible and equation 1.10 reduces to 
equation 8.7:
kobs “ <k2 [0H-]).fSH+ + (k5 [0H-]).fs (8.7)
In the absence of free base hydrolysis equation 8.7 further reduces
to equation 8.8:
k0bs = (k2 [0H“ ]).fSH+ (8.8)
[0H“] will increase tenfold for every unit increase in pH but the 
fraction of protonated species, fsH+ » will decrease with increase in 
pH due to formation of free base species(S). The pKa of cirazoline 
at 25°C was determined as 9.48 (section 4.3) giving a pKa ' of 9.50 in 
2 x 10“3 M solution (equation 4.3). Use of the simple Henderson- 
Hasselbalch equation (equation 4.5) indicates that cirazoline is
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present as >99% SH+ at a pH below 7.5 and >99% S at a pH above 11.5. 
Above pH 11.5, fsH4 decreases approximately tenfold for every unit 
increase in pH and the reaction rate for the protonated species 
should therefore be constant above pH 11.5, which isi the case 
observed experimentally (figure 8.8).
At low ionic strengths agjj- =[0H“ ] and equation 8.8 may be written in 
the form of equation 8.9:
Observed rate constant data plotted according to equation 8.9 are 
shown in figure 8.10. At high pH (>11), ag^" 1 [0H“ ] and equation 8.9 
is not strictly valid. These ionic strength effects are discussed in 
section 8.3.2.1 (c). Linear regression analysis gave : correlation 
coefficient =* 0.9997, slope = 0.9731 (S.D. 0.0085), and intercept 53 
-12.88 (S.D. 0.08). The linear plot with slope close to unity 
confirms that equation 8.8 and 8.9 adequately describe the overall 
reaction in the pH region 7.1 - 13.1, 25°C. k2 was determined at 
each pH (7.1 - 13.1) using equation 8.8 (table 8.7) and gave mean 
k£ = 7.37 (S.D. 1.32) M-1 s-1 at 25°C.
A theoretical rate constant, kx , at 25°C was calculated at each 
experimental pH using equation 8.10:
The theoretical pH profile is shown in figure 8.8 and shows good 
agreement with the observed profile indicating equation 8.10 is 
satisfactory in describing the cirazoline hydrolysis in the pH 
region 7.1 - 13.1, 25°C.
(8.9)
kx = k2 .[0H- ].fSH+*7.37.[0H- ].fSH+ s-1 (8.10)
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(c) Correction for Ionic Strength Effects
The ionic strength, I, of the reaction mixtures varies with the pH of 
the solution. At intermediate pH*s (pH 4 - 10) I is essentially 
constant at 2 x 10”^ M due to the concentration of cirazoline 
hydrochloride. At low pH (<3) and high pH (>11) ionic strength will 
increase significantly above this level due to the high 
concentrations of hydrochloric acid and sodium hdroxide, 
respectively.
At low pH (1-3), the increase in ionic strength with decreasing pH 
has three possible effects on the rate of reaction (section 1.12(c));
(i) a decrease in the base catalysed reaction (section 8.3.4),
(ii) an increase in any acid catalysed reaction,
(iii) a slight modification in the neutral water (uncatalysed) 
reaction.
The observed slight downward trend in k0^s values with decreasing pH 
- and hence increasing ionic strength - is typical of electrolyte 
effects an ion-dipole reactions and further suggests that the 
dominant reaction in this pH region is between the cirazoline ion and 
neutral water.
At high pH, the specific base catalysis of the protonated cirazoline 
species may be described by equation 8.11;
kT ' = k2 1•[OH” ].fSH* (8.11)
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Where kp' is the calculated apparant reaction rate constant and k2 ' 
is the apparant specific base catalysed reaction rate constant. For 
a given pH and temperature, an increase in ionic strength will tend 
to:
(i) decrease the rate of reaction due to increased shielding of 
the reacting ions, i.e. decrease k2 *, (equation 1.13 and 
section 8.3.4), and
(ii) increase the rate of reaction due to an increase in pKa * 
(equation 4.3) and fraction of protonated species, fsH+ > 
(equation 4.5).
These two factors will have opposing effects which tend to cancel 
out; e.g. at pH 12.1, [OH"] - 0.014 M (X* - 0.88), I - 0.016 M, 
pKa' * 9.54, fgH* = 2.747 x 10"^ M and k2 ' ° 6.41 which gives kp1 * 
247 x 10"^ s"1 (equation 8.11). This value is similar to the kp 
value at pH 12.1 of 233 x 10"** s"l (table 8.7) which is calculated 
ignoring activity effects. Similarly at pH 13.1, [OH"] * 0.170 M 
(XV = 0.74), I = 0.174 M, pKa » - 9.63, fSH+ - 3.387 x 10"4 and k2 ' * 
4.18 giving kp1 ■ 241 x 10"** s"l (equation 8.11) which is similar to 
the kp value of 233 x 10"** s"^ at pH 13.1 (table 8.7).
8.3.3 Effect of Temperature
The effect of temperature on the specific base catalysed hydrolysis 
(pH 7.1) and the uncatalysed (neutral water) hydrolysis (pH 1.1) of 
cirazoline hydrochloride was examined. Experiments at pH 7.1 were 
performed at 25 - 70°C using the automated pH-statting technique. An 
initial cirazoline hydrochloride concentration of 2 x 10" ^ M was used 
and percent residual concentration was calculated by reference to 
both cirazoline and CPAE concentration (equation 3.8, section 3.1.6).
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Experiments at pH 1.1 were carried out at temperatures of 50 - 80°C 
in 0.1 M HC1; no pH-statting was required as the buffer capacity of 
the HC1 was sufficient to maintain pH. An initial cirazoline 
hydrochloride concentration of 1.6 x 10”^ M was used and percent 
residual concentration was calculated by reference to cirazoline 
concentration alone (equation 3.6, section 3.1.6) as CPAE degradation 
was significant under these conditions.
The observed rate constant at each temperature and pH is shown in 
table 8.8. k£ and kQ values were calculated for each temperature 
using equations 8.8 and 8.3 respectively and are also shown in table
8.8. k£ and kQ data were plotted according to the Arrhenius 
relationship (log^o k versus T“^, equation 1.23, figure 8.11), and 
Transition State relationship (log^o k/-p versus T"l, equation 1.24). 
Linear regression analysis data and derived frequency factor, A, and 
activation energy, Ea , and standard enthalpy change,AH*, and 
standard entropy change, AS*, values for transition state formation 
are shown in table 8.8.
8.3.4 Effect of Ionic Strength
The effect of ionic strength on the hydrolysis of 2 x 10"^ M 
cirazoline hydrochloride was determined at pH 7.0 and 30°C. Control 
of pH was by the manual pH-stat technique and percent residual 
concentration was calculated by method 3 (section 3.1.6). Ionic 
strength was varied by the inclusion of different concentrations of 
sodium chloride (1 x 10“^ - 1 x 10“ ^ M) in the formulation. The 
concentration of cirazoline hydrochloride (2 x 10”^ M) was included 
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Correlation coefficient 0.9921 0.9992 0.9927 0.9992
















Ea (KJ mol-1) - - 62.5 95.9
A H *  (kJ mol’1) -59.9 -93.0 - —
A s* (J mol’1 k-1) -25.7 -89.3 _ _
Table 8.8 - The effect of temperature on the hydrolysis of 2 x
10"3 m cirazoline hydrochloride at pH 7.1, and 1.6 x 
10"3 m cirazoline hydrochloride in 0.1 M HC1 (pH 1.1) 
Linear regression analysis results for the k£ and kQ 
data plotted according to equation 1.23 (log10k versus 
T"1) and equation 8.24 (log^Q k/«p versus T’1). Derived 
frequency factor, A, activation energy, Ea , standard 
enthalpy change, AH*, and standard entropy change,AS*, 





Standard Deviation. Within Symbols
2.80 3.002.90 3.10
-3-
Standard Deviation Within Symbols
-4_
2.9 3.23.0 3.1 3.3
Temperature"1 (K"1 x 103) Temperature"1 (k"1 x 103)
Figure 8.11 - Arrhenius plots for the hydrolysis of cirazoline hydrochloride (a) at pH 7.1 and
(b) in 0.1 M HC1 (pH 1.1).
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The rate constant at each ionic strength (I), k', is shown in table
8.9. Substitution of equation 1.18 into equation 1.13 yields 
equation 8.12:
loglOk1 = logiok + 2AZ^Zg Ij (8.12)
1 + li
A plot of k* on a log^o scale versus I^/2/l+il/2 was constructed 
according to equation 8.12 and is shown in figure 8.12.
The data (omitting the mean aqueous rate constant value) were 
subjected to linear regression analysis and results are shown in 
table 8.9. The negative slope is good evidence for the interaction 
of the cirazoline cation with hydroxide ion. The Debye-Huckel 
constant, A, was determined from the slope and was calculated as 
0.503 which is in good agreement with the literature value of 0.516 
at 30°C. The rate constant at infinite dilution and at an ionic 
strength of 2 x 10“-* M (equivalent to zero added sodium chloride 
concentration) were calculated from these data as 2.72 and 2.47 x 
lO”^ s”1 respectively. The latter value is 23% higher than the 
observed mean aqueous rate constant (2.00 x 10"^ s” l, CV ■ 9%); such 
an error could be produced by a change of *0.09 pH units or +1.3°C. 
Due to the good linear relationship obtained, it is considered that 
the data are satisfactory in demonstrating that the effect of ionic 
strength on the rate of specific base catalysed hydrolysis is 
governed by equation 8.12.
8.3.5 Kinetics of the Hydrolysis of Imidazolines
The stability of 2 x 10“^ M concentrations of cirazoline 
hydrochloride, fenoxazoline hydrochloride, naphazoline nitrate, 
tolazoline hydrochloride, xylometazoline hydrochloride, antazoline 












| OBSERVED RATE j 
j CONSTANT (S.D.) j 
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| 2.40 (0.06) | 
1 1















| 2.14 (0.06) j
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| 1.81 (0.04) |
1 I





j 1.54 (0.03) j
1 1 1 1
Correlation Coefficient : 0.9962
Slope (S.D.) : -1.005 (0.052)
Intercept (S.D.) : -5.564 (0.007)
Table 8.9 - The effect of ionic strength on the hydrolysis of 
cirazoline hydrochloride at pH 7.0,30°C. Linear 
regression analysis results for the 1 x 10"3 M - 1 x 
10”! M data plotted accorded to equation 8.12 
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Figure 8 .12 - The effect of ionic strength on the hydrolysis of
cirazoline hydrochloride at 30°C. Data plotted according 
♦ to equation 8 .12.
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phosphate buffer pH 6.85. Under these conditions all imidazolines 
are present as >95% protonated species (sections 1.2 and 4 ). 
Imidazolines were assayed using the methods described in sections
3.1.1 and 3.1.7. Percent residual cirazoline concentration was 
calculated using method 3 (equation 3.8, section 3.1.6). Table 8.10 
shows the observed first order rate constant and half-life 
(calculated using equation 1.4) for each imidazoline. The results 
show that stability decreases in the orders xylometazoline > 2- 
methy1-2-imidazoline > naphazoline > tolazoline > antazoline > 
cirazoline > fenoxazoline.
Cirazoline and fenoxazoline are structurally closely related 
(figure 1.1) and contain an ether linkage between the imidazoline 
ring and the aromatic moiety. These compounds are by far the least 
stable being about 35 times more prone to hydrolysis than 
tolazoline.
8.3.6 Effect of SDDS on Kinetics of Cirazoline Hydrolysis
The effect of lon-palr formation, complex formation and micellar 
solubilization on the specific base catalysed hydrolysis of 
cirazoline was investigated using SDDS. The effect of added 
electrolyte on the hydrolysis of solubilized cirazoline was also 
studied.
8.3.6.1 EFFECT OF SDDS CONCENTRATION
The amount of ion-paired, complexed and solubilized cirazoline 
depends upon the total concentration of cirazoline and SDDS present 
in the system. In this work the effect of these interactions was 
investigated by constructing cirazoline stability - SDDS 








| OBSERVED RATE | 
| CONSTANT (S.D.) j 























































Table 8.10 - The effect of imidazoline structure on the hydrolysis
reaction rate constant and half-life in phosphate buffer 
pH 6.85, 70°C.
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concentrations. Stabilization was measured by a stability factor - 
defined as the ratio of the aqueous first order rate constant in the 
absence of SDDS, k(aq), to that obtained in the presence of SDDS, 
ksDDS ~ hence the greater the stability factor the greater the 
stabilizing effect of SDDS.
Kinetic studies were undertaken at pH 7.0 using the manual pH-stat 
technique. Percent residual concentration was calculated using 
method 3 (equation 3.8, section 3.1.6) except in the presence of 
CIRH-DDS complex when method 2 (equations 3.7) was used.
Temperatures of 30° and 50°C were employed to investigate the solid 
and liquid complex systems respectively. Experiments at 30°C were 
limited to 28 days duration due to microbial contamination.
Table 8.11 shows the first order rate constant for the hydrolysis of 
2 x 10“^ M cirazoline hydrochloride at 30°C in the presence of 1 x 
10“^ - 2 x 10”2 m SDDS. Standard deviation of rate constant, 
stability factor and the physical appearance of each system are also 
shown. The stability factor was plotted as a function of SDDS 
concentration on a log^g scale and is shown in figure 8.13. The 
solubility product of the CIRH-DDS complex under these conditions was 
determined as 1.17 x 10“^ moles^ l i t r e " ^ (section 6.3.2.2(c)), and 
the SDDS concentration at the CMC* of the system was estimated at
4.4 x 10“3 M (table 7.5) by conductimetric titration. Hence 
concentrations of SDDS in the range 5.9 x 10"^ M - 4.4 x 10"^ M will 
result in phase separation due to complex formation. The SDDS 
concentrations associated with phase separation and micellar 
solubilization and the physical nature of the systems are shown on 
the profile. At concentrations below the solubility product the 
systems are clear and the stability factor is close to unity,
-337-
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Table 8.11 - The effect of SDDS concentration, [SDDS],on the
hydrolysis of 2 x 10"^ M cirazoline hydrochloride at pH 
7.0, 30°C. * Mean and standard deviation of 12
determinations.
- 3 3 8 -














Figure 8.13 - 2 x 10“^ M cirazoline hydrochloride stability-SDDS
concentration profile, 30°C. Plot of stability factor 
(kaq/kspDs) against SDDS concentration (log|Q scale) 
for the hydrolysis at pH 7,0, 30°C,
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indicating that the formation of ion-pairs did not affect the rate of 
cirazoline hydrolysis. At concentrations of SDDS above the 
solubility product, but below the CMC' of the system a floculated 
suspension is formed confirming that phase separation occurred. The 
stability factor increases dramatically with increasing SDDS 
concentration around the CMC' of the system indicating that 
solubilization by SDDS is a potent method of stabilization. A 66
fold increase in stability was observed with 8 x 10”^ M SDDS and
negligible degradation occurred over a 27 day period at SDDS 
concentrations of 1 x 10” ^ and 2 x 10“^ M.
The extent of complexation in the 2 x 10“^ M cirazoline
hydrochloride-SDDS systems was too small to allow assessment of any 
stabilizing effect. A profile was therefore constructed using a 
tenfold greater concentration of cirazoline hydrochloride. Table 
8.12 gives the first order rate constant for the hydrolysis of 2 x 
10"3 m  cirazoline hydrochloride at 30°C in the presence of 3 x 10"^
- 3 x 10“2 m SDDS. Standard deviation of rate constant, stability 
factor and the appearance of each system are also shown. Under these 
conditions, the concentration of SDDS required to produce an 
insoluble complex is 5.85 x 10“-* M and all systems in this profile 
are therefore above the solubility product. The SDDS concentration 
at the CMC' of the system was determined as 5.36 x 10"^ M (S.D. =
0.12 x 10~3 M) by conductimetric titration and as 5.25 x 10”^ M from 
solubility studies (tables 7.4 and 7.10). The total solubilization 
concentration, SOL^, was calculated as 7.04 x 10“^ M SDDS (S.D. *
0.19 x 10”3 M) by conductimetric titration and 6.51 x 10“^ M SDDS 
from solubility studies. The resultant stability profile is given in 
figure 8.14, which also shows CMC' and SOL-j- points and the physical 
nature of the system. The stability factor increases from
-340-
1 1 
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Table 8.12 - The effect of SDDS concentration, [SDDS], on the
hydrolysis of 2 x 10“8 M cirazoline hydrochloride at 
pH 7.0, 30°C. * Mean and relative standard deviation
of 12 determinations. * = Approximate value.















Figure 8.14 - 2 x 10”^ m cirazoline hydrochloride stability-SDDS
concentration profile, 30°C. Plot of stability 
factor (kaq/kSDDS^ against SDDS concentration (log^o 
scale) for the hydrolysis at pH 7.0, 30°C.
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1.24 at 3 x 10“4 M SDDS to 65.1 at 5 x 1CT3 M SDDS as cirazoline is 
removed from solution to form the solid CIRH-DDS complex. In the 
CMC' region, however, the stability factor decreases to 38.1 as the 
complex is solubilized. Further increases in SDDS concentration 
beyond the total solubilization point result in formation of a clear 
solution and a marked increase in stability. Only slight cirazoline 
degradation was observed at 2 x 10"^ M and 3 x 10”^ M SDDS and the 
stability factors were approximately 190 and 220, respectively.
The profiles at 30°C involve the formation of the solid CIRH-DDS 
complex. The effect of liquid complex formation on cirazoline 
stability was investigated at 50°C; the rate of aqueous cirazoline 
hydrolysis is approximately 16 times greater at this temperature 
than at 30°C and this therefore allowed the effect of high SDDS 
concentrations to be evaluated. Table 8.13 shows the first order 
rate constant for the hydrolysis of 2 x 10“3 M cirazoline 
hydrochloride at 50°C in the presence of 2 x 10~3 - 1 x 10“ ^ M SDDS. 
Standard deviation of rate constant, stability factor and the 
appearance of each system are also presented. The solubility product 
for the liquid complex at 50°C was determined as 4.19 x 10“^ moles^ 
litre“2 (section 6.3.2.2(c)) and all systems are therefore above the 
solubility product. The SDDS concentration at the CMC' and SOL-p 
under these conditions was determined by conductimetric titration as
4.00 x 10"3 M and 4.40 x 10“3 M, respectively (table 7.6). These 
CMC* and SOLp points and the nature of the system are shown on the 
stability profile (figure 8.15). The stability factor increases as 
the complex separates to form a liquid dispersion. Solubilization 
into micelles further increases the degree of stabilization but no 
inflexion around the initial micellization and solubilization region 
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Table 8.13 - The effect of SDDS concentration, [SDDS], on the


































2 x 10“3 4 x 10”3 1 x 10
SDDS Concentration (M)
Figure 8.15 - 2 x 10”3 M cirazoline hydrochloride stability-SDDS
concentration profile, 50°C, Plot of stability 
factor (kaq/kgDj)s) against SDDS concentration (log^o 
scale) for the hydrolysis at pH 7.0, 50°C.
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profile peaks at a stability factor of 126 at 0.06 M SDDS; further 
increase in SDDS concentration to 0.1 M results in a slight decrease 
in stability.
8.3.6.2 EFFECT OF IONIC STRENGTH
The effect of added electrolyte on the hydrolysis of solubilized 
cirazoline hydrochloride was investigated at pH 7.0, 30°C using the 
manual pH-stat technique. Systems were prepared containing 
2 x 10”3 m cirazoline hydrochloride, 7 x 10”^ M SDDS and 1 x 10"^ -
1 x 10"! M concentrations of sodium chloride.
Addition of electrolyte will have opposing effects on the aqueous and 
micellar reaction rate constants. The aqueous rate constant 
decreases as the electrolyte concentration increases according to 
equation 8.12, (table 8.9), whilst the micellar rate constant will 
Increase due to reduced repulsion of hydroxide ions from the micellar 
surface. An increase in electrolyte concentration will also reduce 
the CMC of the system, increasing the volume of micelles.
Table 8.14 shows the first order rate constants and their standard
deviations for the hydrolysis of 2 x 10“^ M cirazoline hydrochloride 
at pH 7.0, 30°C in the presence of 7 x 10”^ M SDDS and 1 x 10”3 m - 
1 x 10” ^  M concentration of sodium chloride, k's^Dg. Stability 
factors are given with respect to:
(1) the aqueous rate constant, k(aq);
(2) the rate constant in the appropriate aqueous concentration of 
sodium chloride, k'(aq); and
(3) the change in concentration of micellar SDDS, 
([S]T-CMC')(aq)/(lS]T-CMC') NaC1,
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1.02X10”1 7.04 (0.18) | 28.4 | 21.9 
1
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1 7.5 j 
1 1
Table 8.14 - The effect of added sodium chloride concentration, 
[NaCl], on the hydrolysis of solubilized cirazoline 
hydrochloride, pH 7.0, 30°C. Systems contain 2 x 10”3 M 







k ’(aq) . ([S]T-CMC')(aq) 
k ’SDDS ([S]T-CMC')NaCl
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subscripts (aq) and NaCl refer to systems in the absence and 
presence of sodium chloride .
Therefore (1) is an expression of the overall stabilizing effect due 
to the presence of SDDS and sodium chloride, (2) compensates for the 
increased aqueous stability in the presence of sodium chloride (3) 
compensates for the increased aqueous stability and change in 
concentration of micellar SDDS due to sodium chloride. k'(aq) and 
CMC' values were taken from tables 8.9 and 7.10 respectively.
All three methods of expressing stability show a decrease in 
protection afforded by SDDS with an increase in electrolyte 
concentration. Compensation for change in aqueous stablity and 
micelle concentration reveals a dramatic decrease in potency of 




9.1 THE AQUEOUS HYDROLYSIS OF CIRAZOLINE
Cirazoline is a monoacidic base and can, therefore, exist in two forms,
i.e. protonated and unprotonated. The relative amount (mole ratio) of 
each species under given conditions is governed by the pKa' of 
cirazoline and the pH of the system, (equation 4.5). Hence a knowledge 
of the cirazoline pKa ' is essential for Investigating the mechanism and 
kinetics of aqueous hydrolysis, (equation 1.10).
Cirazoline pKa ' determination was hampered by problems with aqueous 
solubility and stability under the experimental conditions employed. 
These problems were minimised by restricting potentiometric titrations 
to the half-neutralisation point (4-5 determination per titration).
The extent of degradation was dependent upon temperature, being 
greatest at 40°C where a maximum of 7.2% CPAE formed during the 
titration (table 4.6). Results showed good reproducibility within a 
given titration (+0.03 pH units maximum).
The pKa of cirazoline was determined as 9.48 *_ 0.02 at 25°C which is in 
good agreement with the reported value of 9.44^1 (see table 1.1). The 
cirazoline pKa-temperature dependence is typical of monoacidic bases 
and falls with increasing temperature. Using the data in table 4.7 and 
equation 4.6, the pKa at 30°, 50° and 70° was calculated as 9.34, 8.83 
and 8.38 respectively.
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Alt hough hydrolysis reactions are bimolecular they often follow first 
order kinetics at constant pH. Kinetic studies performed under pH- 
statted conditions in the absence of buffer salts 6howed the hydrolysis 
of cirazoline hydrochloride to follow first order kinetics (section 
8.3.1). The degradation of 2 x 10"^ m cirazoline at pH 7.1, 60°C was 
followed over three half-lives and the data analysed by three different 
time-based methods (section 3.1.6). The fractional life-time method 
(equation 8.1) gave an order of reaction of 1.018 (SD 0.039) and linear 
plots were obtained when the data were plotted according to the 
integrated first order equation (equation 1.4) and the Guggenheim 
equation (equation 1.6), thus indicating a first order reaction.
The order of reaction was also found to be first order by a 
concentration based method. Degradation studies were carried out over 
the concentration range 0.2-5 x 10"^ M at pH 7.0, 30°C. Results 
analysed by the Van*t Hoff method of initial rates gave an order of 
reaction of 0.988 (S.D. 0.014).
Two mechanisms of hydrolysis of cirazoline hydrochloride were 
identified (section 8.3.2), namely a neutral water reaction (attack of 
molecular water on protonated cirazoline) and a base catalysed reaction 
(attack of hydroxide ion on protonated cirazoline). No acid catalysed 
reaction or free base hydrolysis were observed. The overall reaction 
rate may be described by equation 8.4 which reduces to equation 8.8 at 
high pH when the uncatalysed (neutral water) reaction is negligible and 
may be ignored. Equation 8.4 is a form of equation 1.26 and indicates 
that the observed rate constant is a function of the uncatalysed (Ic q ) 
and specific base catalysed (k£) reaction rate constants, hydroxide ion 
concentration ([OH"]) and fraction of protonated cirazoline species 
(fgtj*). Hence the stability of cirazoline may be predicted from a
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knowledge of pH, pKw , kg, k2 and pKa . Figure 9.1 shows theoretical 
stability-pH profiles for the hydrolysis of 2 x 10”^ M cirazoline 
hydrochloride in the absence of added electrolyte and buffer salts at 
30, 50 and 70°C. Data were calculated using equations 8 .6 , 1.23, 4.2, 
4.3, 1.16 and 4.6, data from tables 4.7 and 8.8 and literature values 
for The rate constant at pH 4.6, 70°C (k-p = 2.6 x 10"^ s”l)
predicted from these data is similar to that reported by Davies et al 
for the hydrolysis of cirazoline under similar conditions but using 
Mcllvaines citrate-phosphate buffer at ionic strength 0.5 M to maintain 
pH, (k0bs * 3.72 x 10“6 b-1)15. The difference in rate constants may 
be due to the high ionic strength and in particular presence of 
general acid/base catalysis in the buffered system^.
pH has a profound effect on the rate of hydrolysis of cirazoline 
through its effect on both the concentration of hydroxide and 
cirazoline ions. Below pH 3, [OH**] is extremely low and the reaction 
rate is governed by the uncatalysed reaction and is, therefore, 
independent of pH. Above pH 3 the rate of reaction increases 
dramatically due to an increase in the rate of the base catalysed 
reaction. In the pH range 5 to 8 the stability-pH profile is linear 
but above pH 8 the relative increase in hydrolysis rate with pH 
decreases due to formation of the stable free base species. Above pH 
10-11 the reaction rate is independent of pH. This effect is due to 
two opposing factors being in balance i.e. the increase in the 
concentration of OH” and the decrease in the concentration of 
protonated species with increasing pH.
Like most reactions, the rate of hydrolysis of cirazoline increases 
with an increase in temperature (section 8.3.3). The data in table 8.8 
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Figure 9.1 - Theoretical stability - pH profiles for the hydrolysis
of 2 x lCT^M cirazoline hydrochloride in the absence of 
added electrolyte and buffer salts at each temperature 
shown. Theoretical rate constants, kT , calculated using 
equation 8.6 and data from tables 4.7 and 8.8 and 
literature values for Kw2°l.
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of activation (62.5 kJ mol"l) and enthalpy of transition state 
formation (59.9 kJ mol“l) than the uncatalysed reaction (95.9 and 93.0 
kJ mol~l respectively) which is a typical feature of catalytic 
behaviour. The frequency factor is approximately 2000 times greater for 
the catalysed reaction which may be explained by charge attraction 
effects. The entropy of transition state formation is negative for both 
reactions although numerically the entropy associated with the neutral 
water reaction is far greater, (-89.3 J mol K~l), than for the 
catalysed reaction, (-25.7 J mol K"l).
This difference in entropy change may be explained by the difference in 
the degree of solvation and hence water structure around the charged 
and uncharged species. In the neutral water reaction, both the 
cirazoline reactant and transition state species are charged and 
solvated whereas the base catalysed reaction involves the loss of two 
highly solvated ions to form an uncharged transition state species. 
Also, the neutral water reaction transition state species will be more 
bulky and sterically unfavoured relative to the transition state 
species in the base catalysed reaction.
For temperatures in the range 30°-70°C the reaction at pH 7 represents 
the optimum condition for studying the reaction of hydroxide ion with 
cirazoline ion. At this pH, the slopes of the observed stability 
profiles (figures 8.7 and 8.8) are approximately unity (indicating the 
expected absence of general acid-base catalysis), that the rate of the 
uncatalysed reaction is negligible and that the fraction of protonated 
cirazoline species is close to unity; use of equation 4.5 Indicates 
that the fraction of protonated species at pH 7.0 is 0.996 and 0.962 at 
30° and 70°C respectively. Specific base catalysed hydrolysis at pH 7 
is also supported by the effect of ionic strength on k0^s at 30°C
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(table 8.9). kQ^s decreased with increasing ionic strength, I,
according to equation 1.18, the calculated slope of 0.503 from figure 
8.12 being close to the literature value of 0.516 at 30°C^-^. These 
results are consistant with a reaction between two oppositely charged 
ions such as hydroxide and cirazoline ions. However, k0bs in the 
absence of added electrolyte (I = 2 x 10"^ M) was calculated from the 
slope of figure 8.12 to be 23% higher than the mean k0bs value (CV = 
9%). this observation is thought to be due to an error in the 
experimental conditions empolyed, i.e. a slightly higher pH and/or 
temperature. Such a reaction rate could be produced by a pH of 7.09 or
a temperature of 31.3°C.
The stability of cirazoline relative to a series of other imidazolines
with different 2-substituents was determined at pH 6.85, 70°C (section 
8.3.5). Degradation studies were performed on 2 x 10"^ M 
concentrations of cirazoline hydrochloride, fenoxazoline hydrochloride, 
anatazoline sulphate, tolazoline hydrochloride, naphazoline nitrate, 
xylometazoline hydrochloride and 2-methy1-2-imidazoline using 0.025 
equimolal phosphate buffer to maintain pH. This was considered 
acceptable despite possible general acid-base catalysis as only 
comparative stability of the imidazolines was required. The observed 
rate constants for xylometazoline and tolazoline (table 8.10) agree 
reasonably well with the data reported by Grabowska for the reactions 
in phosphate buffer at pH 7.1, 70°C^^»^^. Assuming specific base 
catalysed hydrolysis and fgH* * 1 In this pH region, rate constants for 
the reaction at pH 7.1, 70°C may be calculated from the data in table 
8.10 using equation 8.8. Rate constants for xylometazoline and 
tolazoline under these conditions were calculated as, (literature 
value^3»34 in parentheses); 1.0 x 10“^ (1.2 x 10"^) s"l and 1.2 x 10"-* 
(1.7 x 10"^) s-1 respectively.
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J Cirazoline 9.44 0.028 4.85 No Exchange |
| Fenoxazoline - 0.029 4.75 No Exchange |
| Antazoline 10.23 0.65 4.30 0.38 |
1 Naphazoline 10.48 2.12 4.00 1.51 |
| Tolazoline 10.59 1.00 3.70 1.00 |
| Xylometazoline 10.85 12.2 3.75 0.152 |
| 2-methy1-2-imidazoline 11.09 2.44 2.00 No Exchange |
Table 9.1 - pKa , stability and NMR exocyclic methylene (Hg) data for 
imidazolines, ktol/kimid * substituent stability factor 
for hydrolysis (from table 8.10) and Hg exchange (from 
table 5.8). Hg chemical shifts ( S )  from tables 5.1 to 
5.7.
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Using the data from table 8.10, a substituent stability factor was 
calculated for each imidazoline which are shown alongside pKa data 
(from table 1.1) and NMR data in table 9.1. This factor is defined as 
the ratio of the tolazoline rate constant to the rate constant of the 
other imidazoline . Tolazoline was selected as the
reference imidazoline as its stability is in the centre of the 
stability range.
A feature of some 2-substituted imidazolines in solution is exocyclic 
methylene exchange^. As part of the study into the mechanism of 
hydrolysis of cirazoline, the acidity of the imidazoline exocyclic 
methylene protons was investigated using NMR (section 5). This 
technique allowed the number of protons in each moiety to be monitored 
over a period of time. Reactions were performed under as similar 
conditions as possible to the degradation studies ('pH' = 6.85 in 0.025 
equimolal phosphate buffer), with the exception of temperature. The 
temperature of the exchange studies was selected as 20°C as rapid 
exchange was predicted from literature data^O.
Common protons to all the medicinal imidazolines studied are the 
endocyclic protons (H^) and the exocyclic protons (Hg), (section 5.3).
for all compounds studied had chemical shifts in the range s  * 3.55 
- 3.80 indicating similar endocyclic electrical characteristics for all 
imidazolines. Any hydrolysis of imidazolines was detected by a 
decrease in the intensity of the peak and a concomitant appearance 
and increase in intensity of peaks corresponding to degradation 
products (figure 1.2). All imidazolines except cirazoline and 
fenoxazoline were stable under the conditions of the experiment; these 
imidazolines slowly degraded, the observed reaction rate for cirazoline
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(2.08 (S.D. 0.08) x lO-^ s“l) being similar to that calculated for 
pH 6.85, 20°C using equations 8.6 and 1.23, (3.5 x 10"^ s"l).
Hg chemical shifts were dependent upon the nature of the 2-substituent 
and are summarized in table 9.1.
First order Hg exchange occurred with antazoline, naphazoline, 
tolazoline and xylometazoline but no exchange was detected for 
cirazoline, fenoxazoline and 2-methy1-2-imidazoline. A substituent 
exchange factor defined as the ratio of the tolazoline exchange rate 
constant to the exchange rate constant of the imidazoline (ktol/kimid) 
was calculated and is also shown in table 9.1.
The data in table 9.1 show a reasonable trend between the stability of 
the imidazoline and its basicity (defined by pKa). This trend follows 
the electron withdrawing ability of the 2-substituent as demonstrated 
by the chemical shifts of the exocyclic methylene protons (Hg). For 
example, cirazoline (pKa = 9.44, Hg &  - 4.85) degrades 87 times faster 
than 2-methy1-2-imidazoline (pKa * 11.09, Hg 2.00) at pH 6.85, 
70°C. As the electron withdrawing strength of the substituent 
increases, the ability of the imidazoline group to donate electrons 
decreases causing a reduction in basicity and pKa. This inductive 
effect also increases the positive charge on the quaternary carbon and 
increases the reaction rate with hydroxide ion.
The major exception to the correlation between basicity and stability 
is given by the data for xylometazoline. The electron withdrawing 
ability of the xylometazoline substituent is predicted to be 
approximately similar to that for tolazoline and naphazoline. This is 
reflected in the Hg chemical shift and pKa data. However, 
xylometazoline is found to be considerably more stable than the other
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imidazolines studied. Xylometazoline has two methyl groups in the 2 
and 6 position of the aromatic ring (see figure 1.1) which would 
present considerable obstruction to attack by hydroxyl ions at the 2- 
position of the imidazoline ring. Thus the main stabilizing property 
in xylometazoline is not an inductive effect but steric hinderance.
Also naphazoline is slightly more stable, and cirazoline and 
fenoxazoline are appreciably more unstable than predicted from 
inductive effects (see pKa and Hg chemical shifts, table 9.1). These 
findings may be explained using the exocyclic methylene exchange data 
in table 9.1. For cirazoline, fenoxazoline, antazoline, naphazoline 
and tolazoline, a clear relationship exists between Hg acidity and 
stability; i.e.
naphazoline > tolazoline > antazoline > cirazoline = fenoxazoline
No exchange was detected in the samples of cirazoline or fenoxazoline 
over a 14 day period indicating a low level of acidity. These 
imidazolines are extremely unstable relative to the other medicinal 
imidazolines studied. A possible explanation for these observations is 
outlined in figure 9.2, which shows the proposed mechanism of base 
catalysed hydrolysis and exocyclic methylene exchange. Charge effected 
attack of hydroxide ion at the 2-position of the imidazoline ring leads 
to formation of the unstable quaternary intermediate. The reaction may 
then follow one of two pathways leading to either hydrolysis (A) or 
exchange of Hg (B). For a given imidazoline, both processes may occur, 
the favoured pathway being dependent upon the nature of the 2- 
substituent (represented by R in figure 9.2). This imbalance between 
the velocity of the two reactions confers either stability (exchange 
pathway favoured) or instability (hydrolysis pathway favoured). The 
substituent determines the relative velocity of the pathways by its
R - C H 2-


















EXOCYCLIC METHYLENE EXCHANGE 
PATHWAY B
Figure 9.2 - Proposed mechanism for the base catalysed hydrolysis
(ring cleavage) and exocyclic methylene proton exchange 
reactions for the 2-(Rl-CH2)-2-imidazolinium ion.
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ability to stabilize the intermediate, e.g. by charge delocalization 
or resonance. Figure 9.3 shows the extensive resonance structures 
possible for the intermediate in the tolazoline reaction.
This resonance is inhibited by atoms which prevent conjugation with the 
aromatic ring; for example substituents with an oxygen atom spaced 
between the aromatic ring and the exocyclic methylene group (e.g. in 
cirazoline and fenoxazoline, figure 1.1) will strongly inhibit 
conjugation, whereas the presence of a nitrogen atom (e.g. in 
antazoline) will allow limited conjugation. Substituents with a larger 
aromatic moiety than tolazoline (e.g. in naphazoline) will allow 
greater conjugation and increased acidity and stability.
2-methy1-2-imidazoline does not possess an aromatic substituent and 
consequently does not have acidic protons. Stability is, therefore, 
only due to the presence of the electron donating methyl group. 
Xylometazoline has a very low rate of exchange which is probably due to 
the low rate of initial hydroxyl ion attack caused by steric 
hinderance.
Additional evidence for the proposed mechanism arises from the 
numerical similarity between the observed rates of cirazoline 
hydrolysis (pathway A) and naphazoline, tolazoline and antazoline 
exchange (pathway B). The first order rate constant for the hydrolysis 
of cirazoline under the conditions of the NMR experiments was 
calculated as 2 x 10~7 s’1 which is similar to the first order rate 
constants for antazoline, tolazoline and naphazoline exchange 
(4 - 20 x 10’7 s’1).
Direct comparison of the imidazoline hydrolysis and exchange data is 






Figure 9.3 - Possible resonance structures for the intermediate formed 
during the exchange of tolazoline exocyclic methylene 
protons.
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Bolute concentration and in particular temperature. More direct 
evidence comes from the behaviour of the antazoline substituent 
methylene protons (Hp in figure 5.3 table 5.3). No exchange occurred 
with Hp protons whereas Hg exchanged with deuterium at a rate of 
4.4 x 10"^ s’ 1, giving a half life of 18 days. These data suggest that 
the protonated imidazoline ring is fundamental to the exchange process.
The proposed mechanism also predicts an increase in exocyclic methylene 
exchange with an increase in pH, similar to the stability-pH profile 
(e.g. figure 9.1). This would, therefore, account for the observation 
by Kounterellis that the free base species of the imidazolines 
exchanges more rapidly than the protonated species^O (c.f. early 
stability reports, section 1.2.3).
The mechanism of imidazoline hydrolysis whereby ring cleavage is due to 
specific base catalysis of the unprotonated species as proposed by 
Harnsberger and R i e b s o m e r ^ >26 ancj Fernandez and Lamden^? is 
inconsistant with the data in this thesis which support the findings of 
Martin and Parcell^®, Savignac et al^9 and Ross et al1®. They indicate 
that the imidazolinium ion is the labile species and hydrolysis is
mediated through attack of neutral water (at low pH) and hydroxide ion
(at medium and high pH).
9.2 PHYSICOCHEMICAL NATURE OF CIRAZOLINE HYDROCHLORIDE-SDDS SYSTEMS
The interaction between cirazoline hydrochloride and SDDS in aqueous
solution was studied in terms of ion-pair formation, complexation,
mlcellization and solubilization. Aqueous, solid and liquid complex 
and micellar (pseudo)phases were identified, the relative amounts of 
each being dependent upon the concentrations of cirazoline 
hydrochloride and SDDS, temperature and electrolyte. The equilibria
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formed between these species were described by the ion-pair association 
constant, K^p, apparant, (Ks'), and intrinsic, (Ks), solubility 
products, apparant, (CMC1), and true, (CMC), critical micelle 
concentrations, the SDDS concentration required to completely 
solubilize cirazoline, (SOL-p)* and the cirazoline micellar association 
constant, (K^* These parameters and the physicochemical nature of the 
formed (pseudo)phases were investigated by automated conductimetric 
titration, solubility, microscopy, NMR, DSC and PCS techniques.
9.2.1 Ion Pair Formation
Formation of cirazoline dodecylsulphate ion-palrs was demonstrated 
using an automated conductimetric titration technique (section 6.2) 
based on the method described by Mukhayer and D a v i s ^ l .  At 30°C, K^p 
was determined as 232 (S.D. = 20) which is in good agreement with 
reported values for similar sized ions^^. CPAE dodecylsulphate was 
found to have a similar K^p value of 248 (S.D. “ 9) at 30°C, again 
consistant with the similarity in the size of the cirazoline and CPAE 
ions.
9.2.2 Complex Formation
At concentrations of cirazoline hydrochloride and SDDS above the 
solubility product but below the SOL-j* of the system, phase separation 
occurred to form cirazoline dodecylsulphate complex. Both solid and 
liquid complex forms were produced dependent upon temperature. Solid 
complex systems formed at ambient temperature and below resulting in a 
highly flocculated suspension. Microscopic examination of the 
suspension and isolated complex revealed long needle-like crystals, 
(figure 6.5a and b). Liquid complex formed at higher temp'eratures and 
produced a grey dispersion or 1coacervate' consisting of discrete
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'oily' globules in water, (figure 6.5c). However, formation of solid 
complex was time dependent and metastable liquid complex and/or 
metastable viscous solutions were readily produced by mixing aqueous 
solutions of cirazoline hydrochloride and SDDS at ambient temperature. 
These systems crystallised with time to form solid complex.
Surfactants are known to inhibit crystallization and formation of these 
metastable systems is indicative of supersaturation^l.
The solubility of the solid and liquid complexes was determined by 
measuring the solubility product using the automated conductimetric 
titration technique (section 6.3.2). (This method also enabled the 
stoichiometry of the interaction to be rapidly and accurately 
determined). Conductivity curves for titrations involving the 
formation of liquid complex resembled literature examples in that the 
phase separation point is given by a deviation from linearity, (figures 
1.10a and 6.12). Titrations involving the formation of solid complex, 
however, were characterised by a sudden fall in conductivity and rapid 
phase separation leading to the production of a crystalline suspension. 
Continued addition of titrant resulted in a further increase in 
conductivity and a linear titration curve of smaller slope than the 
initial precomplex region (figure 6.13). This behaviour was similar to 
that reported by Tomlinson and Davis^® for the titration of indigo 
carmine against qulndecylbenzyldimethylammonium chloride at 25°C, (see 
section 1.4.2.2 and figure 1.10b). The inflexions in the curves were 
attributed by these authors to coacervate flocculation phenomena due to 
the presence of ionic salts and titration end-points were taken as the 
initial deviation from linearity. However, for the cirazoline 
hydrochloride-SDDS system in this study it was found that the titration 
end-point for the solid complex solubility product was given by 
extrapolation of the second linear region to the first, (figure 6.13).
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A solubility product value of 1.17 x 10“ ^ moles^ litre^ was calculated 
by this method which is in good agreement with the equilibrium K s* 
value of 1.15 - 1.20 x 10"^ moles^ litre”^ determined by turbidimetry 
and static conductimetry (section 6.3.2.1). The peak in the 
conductivity curve shown in figure 6.13 is thought to represent 
supersaturation due to formation of a metastable system; the 
extrapolated curve in figure 6.13 therefore represents a theoretical 
conductivity curve in the absence of supersaturation.
The automated conductimetric method for the determination of solid 
complex solubility products was found to be reproducible, (CV = 2.6% 
for eleven determinations). K s* values for the liquid complex system 
were determined in duplicate at 37.5°C and 50°C and gave values within 
2% of the means.
For a given complex species, titrant flow rate was not critical for K s' 
determination (e.g. at 30°C solid complex K s* ■ 1.16 - 1.23 x 10“  ^
moles^ litre"2 at flow rates of 6.29 - 50.48 pi min“l, (table 6.5); 
liquid complex K s* = 2.56 (37.6°C) and 2.62 (37.5°C) x 10“ ^ moles^ 
litre“2 at flow rates of 20.38 and 173 pi min"l, (table 6.7). However, 
metastable liquid complex could be formed by fast titration, e.g.
173 pi min”l, table 6.5. This effect is similar to that observed 
during the bulk mixing of cirazoline hydrochloride and SDDS aqueous 
solutions, (section 6.3.1), and is caused by the liquid complex K s* 
being exceeded before onset of crystallization. Metastable liquid 
complex K s* values were obtained from inflexions in conductivity curves 
in a similar manner to that described for the stable liquid complex 
species. For some temperature conditions, optimization of flow rates 
enabled calculation of both metastable liquid and solid K s' values from 
a single titration.
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The stoichiometry of the CIRH-DDS complexes was found to be 1 : 1, 
(solid 1 : 1.004, liquid 1 : 0.978), by the initial phase separation 
method, (equations 1.67 and 6.5). NMR analysis of isolated crystalline 
complex dissolved in CDCI3 confirmed the 1 ; 1 stoichiometry of the 
solid complex (1 : 0.996) (section 6 .3.1.1, Appendix I).
Attempts to measure the effect of ionic strength on the solubility of 
solid complex by conductimetric titration (section 6.3.2.5) were 
limited by the high background conductance of electrolyte solutions. 
Results on systems containing low levels of added sodium chloride 
(0.1 - 1 x 10”3 M; I “ 2 . 1 -  3 x 10"^ M) showed no effect on K s*. 
Solubility studies on both 2 x 10”^ m and 5 x 10“^ M cirazoline 
hydrochloride-SDDS mixtures at 30°C showed an increase in complex 
solubility as ionic strength increased over the ranges I * 0.002 -0.102 
M and 0.005 -0.105 M (tables 7.8 and 7.9). However, these data were 
not sufficiently accurate to determine the quantitative relationship 
between solubility and ionic strength. Mukhayer and Davis have shown 
that the solubility of complexes increases with ionic strength 
according to equations 1.70 and 1.82^^. Intrinsic solubility products 
and apparant solubility products at a given ionic strength were 
therefore calculated from the data in table 6.7 using equations 1.70 
and 1.16.
The effect of temperature on the CIRH-DDS K s' was determined over the 
range 10 - 50°C. At temperatures at or below 37.5°C, both stable solid 
complex and metastable liquid complex could be formed, dependent upon 
titrant flow rate. Above this temperature solid complex could not be 
formed even at slow flow rates. The solubility of both complex forms 
increased with increasing temperature, (figure 6.17). Van't Hoff 
plots, (figure 6.18), show a linear relationship between log^Q K s and
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T”1 for both solid and liquid complexes but of different slope; the 
solubility of the solid complex having a greater temperature 
dependence. The linear plots in figure 6.18 are unusual in that 
previous reports for a variety of interacting systems over a similar 
temperature range indicate the presence of a temperature of maximum 
solubility (minimum K s')^^. Like most of the reported systems at 
higher temperatures (table 1.2), the CIRH-DDS liquid complex 
(coacervate) phase separation process is driven by a large negative 
free energy change (-49.1 kJ mol”* at 30°C) which is due to a 
combination of a negative enthalpy change, ( AH°f = -29.2 kJ mol“ ^) and 
a positive entropy change, ( AS°f * +65.6 J mol”l K”* at 30°C), 
indicating favourable contributions from both coulombic and hydrophobic 
interactions. This gain in entropy upon complexation or coacervate 
formation is probably due to loss of water structure.
The data in table 6.8 indicate that solid complex formation, although 
driven by a free energy change ( AG°f ° -50.6 kJ mol”l at 30°C) similar 
to that for the liquid complex, is controlled by different factors. 
Crystallization of complex results in a larger negative enthalphy 
change, (AH°f = -62.9 kJ mol"l), but a marked decrease in entropy,
( AS°f = -40.6 J mol K“1 at 30°C). Thus solid complex formation is 
driven by coulombic forces but is inhibited by entropic factors. The 
latter is probably due to the high internal order within the crystals 
masking water structuring or hydrophobic effects.
The solid and liquid complex Van't Hoff plots intersect at a point 
equivalent to a transition temperature of 42.5°C and K s of 2.93 x 10"^ 
moles^ litre“2, (figure 6.18). Below this temperature the negative 
free energy of solid complex formation is numerically greater than for 
liquid complex formation, (e.g. at 30°C, A G ° f >soi^(j = -50.6 kJ mol”!,
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AG°f,H q Uid = “49.1 kJ mol"1) and the solid complex is the stable form. 
At 42.5°C, AG°f>soii(j = AG°ffiiqUid = “50.0 kJ mol"1 and both 
complexes are stable and in equilibrium. Above this temperature, 
A G ° f (SOn <j is numerically less than A G ° f > liquid anc* the liquid complex 
system is the stable species.
The temperature of transition from solid to stable liquid complex was 
also determined by DSC and visual observation, (section 6.3.1.1). 
Macroscopic visual determination was performed by observing the change 
from an aqueous flocculated suspension of solid complex to a grey 
dispersion of liquid complex as the temperature was increased in small 
increments (l°C). DSC on a sample of solid CIRH-DDS complex suspended 
in water showed a large endothermic peak due to melting of the hydrated 
complex from which the temperature of transition was obtained. The 
endothermic nature of the transition from solid to liquid complex is 
consistant with that predicted from the AH°f values in table 6.8 ,
( AH°ff solid c -62.9 kJ mol”1, AH°f>liquid ■ -29.2 kJ mol”1, 
i.e. A H ° soii(j _> liquid “ *33.7 kJ mol”1). Unfortunately due to 
sample preparation problems the enthalpy change of transition could not 
be determined by DSC.
Transition temperatures for hydrated CIRH-DDS complex determined by 
each method show reasonable agreement and are summarised below:
Visual macroscopic appearance (section 6 .3.1.1) 39° - 42°C
DSC (section 6.3.1.1) 44.6°C (43.0-46.2°C)
Temperature dependence of K s' (section 6 .3.2.4) 42.5°C
Subsequent work has indicated a transition temperature of 42.9°C by 
DSC.
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The hydrophobic effect in complex formation was demonstrated by the 
formation of cirazoline octylsulphate, decylsulphate, and 
tetradecylsulphate complexes (sections 6 .3.1.1 and 6.3.2.6). 
Complexation was similar to the CIRH-DDS systems in that both 
crystalline and liquid (coacervate) species were formed depending upon 
temperature (section 6.3.1.1). Metastable liquid complex and/or 
metastable viscous solutions could also be obtained by preparing 
systems above the solid complex solubility product. Isolation of the 
solid complexes was more difficult for the lower alkylchain homologues 
due to their high solubility, the low temperature required for 
crystallization and the slow rate of crystal formation. The 
stoichiometry of the complexes was found to be 1 s 1 by NMR (see 
section 6.3.2.6 and Appendix 1).
Determination of K s* values was hampered by both high (CIRH-OS) and low 
(CIRH-TDS) solubilities of the complexes. The latter was particularly 
troublesome for the solid CIRH-TDS system at low temperature due to the 
high degree of supersaturation and the consequent greater degree of 
extrapolation required to obtain titration end-points. Unlike CIRH-DDS 
systems, Van*t Hoff plots showed a non-linear relationship between 
log^o Kg' and T“^, (figure 6.19), indicating temperature dependence of 
A H ° f .
The temperature of transition from solid complex to liquid complex 
Increased with increasing chain length; DSC gave hydrated complex 
melting points of 17.8, 34.1, 44.6 and 52.7°C for CIRH-OS, -DS, -DDS 
and -TDS complexes respectively. This shift in transition temperature 
was also observed in the limited K s' temperature dependence data 
determined by conductimetric titration, (figures 6.20 and 6.21).
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The solubilities of the cirazoline alkylsulphate complexes was 
consistant with interactive reports for other complex systems in that 
K s is related to the number of methylene groups in the alkylchain 
according to equation 1.79125,128,129,136,137  ^ -phe free energy change 
due to the transfer of a methylene group from the aqueous phase to the 
liquid complex phase was independent of temperature (10 - 50°C) and was 
calculated as d( AG°f )/dn s -3.46 (S.D. ■ 0.04) kJ mol"! (table 6.11). 
This is similar to previously reported values in the range -3.2 to -3.5 
kJ mol’1 for various liquid coacervate s y s t e m s 1 ^ » 128,129 ,136 ,137 and 
suggests partial structuring within the liquid complex phase1^ .  
d( AG°f)/(jn data for solid complexes were limited but suggest a greater 
methylene group contribution to the free energy change upon crystalline 
complex formation compared to liquid (coacervate) formation (e.g. at 
20°C d ( A G ° f)/dn = -4.57 (S.D. = 0.06) and -3.42 (S.D. = 0.17) kJ mol’1 
respectively). The data in table 6.11 also indicate temperature 
dependence for the free energy associated with transfer of a methylene 
group to solid complex, d ( AG)/dn increasing with decreasing 
temperature.
These physicochemical phenomena were not specific to cirazoline 
alkylsulphate systems. Formation of crystalline complexes and/or 
stable and metastable viscous solutions and liquid complexes was also 
observed in a total of four other imidazoline-SDDS systems studied 
(sections 6.3.1.2 and 6 .3.2.7). The nature and solubility of formed 
complex was dependent upon the imidazoline 2- substituent (table 6.12). 
Tolazoline and naphazoline have unsubstituted aromatic moieties 
(figure 1.1) and formed viscous liquid complex systems with SDDS. No 
solid complex species was formed in these systems even at low 
temperature (4°C). NAPH-DDS was more soluble than the (metastable) 
CIRH-DDS liquid complex at 30°C (Kg. * 3#01 and 2 .01 x 10-7 moles2
-370-
litre” 2 respectively) but was much less soluble than TOLH-DDS complex 
(Ks* = 2.53 x 10"® moles^ litre"^ at 30°C) which reflects the more 
hydrophobic nature of the naphazoline 2-substituent (figure 1.1). 
Xylometazoline, like cirazoline, readily formed both solid and liquid 
complexes with SDDS. K s* values for the liquid and solid XYLH-DDS 
species are also similar and indicate a transition temperature close to 
30°C. Slow crystallization from liquid complex occurred at 4°C. 
Antazoline is a much larger molecule than the other imidazolines 
studied (figure 1.1) and at 30°C only formed a poorly soluble solid 
complex (Kg' = 1.24 x 10“® moles^ litre"^). Solid complex precipitated 
immediately when antazoline sulphate and SDDS solutions were mixed at 
room temperature and no metastable viscous solution or liquid complex 
species were produced. However, extensive supersaturation did occur 
during conductimetric titrations making accurate determination of K s* 
difficult.
CPAE and SDDS also interacted to form a liquid complex or coacervate 
system at 30°C, (Kg' “ 2.43 x 10" ^ moles^ litre"^).
9.2.3 Aggregation and Solubilization
A mathematical approach to aggregation in cirazoline hydrochloride-SDDS 
systems has been discussed in section 7.1.1 involving the partition 
constant (Kp) for the solubilization of the neutral ion-pair by SDDS 
micelles (equation 7.1) and the equilibrium constant (K^) for the 
binding of the protonated cirazoline ion to the negative SDDS micelles. 
Sepulveda and Perez-Cotopoz^O derived equation 1.87 for the calculation 
of but this requires an assay capable of distinguishing between 
'free* and 1 bound* (micellar) solute. Consequently the simple 
treatment described in section 7.1.1 leading to equation 7.14 for the 
calculation of ^as been adopted in this thesis. This approach, like
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that of Sepuveda and Perez-Cotopoz relies on the following assumptions 
(terminology is fully defined in section 7.1.1);
(i) the concentration of ion-pair in aqueous solution is small and 
constant,
(ii) equation 7.8 is valid at the CMC of the system,
(iii) the aqueous concentration of cirazoline and dodecylsulphate 
remain constant in the presence of micelles.
A knowledge of the total cirazoline concentration, the aqueous 
cirazoline concentration and the concentration of SDDS at the CMC' and 
SOL-p is required for the determination of (equation 7.14). These 
parameters were determined using the solubility and automated 
conductimetric titration techniques described in sections 6.2 and 
7.1.2.
The solubility method was used to detemine CMC' and SOL-p values at 30°C 
from the effect of SDDS concentration on the solubility of cirazoline. 
Crystalline complex was formed above the solubility product and below 
the SOl/p; the amount of cirazoline was determined by filtration and 
subsequent HPLC assay (chapter 3). However, this solubility technique 
was slow and laborious as it involved preparation, equilibration and 
assay of numerous systems. In addition, CMC' and SOL<p values were 
often difficult to determine from theoretical and observed solubility 
curves.
A far quicker and precise method for the study of aggregation was the 
automated conductimetric titration technique described in sections
6.2.1 and 7.1.2.2 which enabled the determination of CMC', SOLp, 
aggregate ratio and values within a matter of hours. For the
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2 x 10"3 H cirazoline hydrochloride solid complex system at 30°Cf the 
method was shown to be reproducible, (CV for CMC' = 2%, S0L<p ® 3%, KA = 
7%, table 7.4), and independent of titrant flow rate at 12.4 - 
50.5 pi min, (CMC' = 5.20 - 5.27 x 10"3 M, S0LT - 6.79 - 7.04 x 10**3 M, 
KA = 2.7 - 3.4 x 10^ table 7.3). However, fast titration (251.3
pi min"l) resulted in the CMC' being exceeded before crystallization of 
solid complex and measured parameters, therefore, relate to aggregation 
in metastable liquid complex system.
A reasonable correlation between parameters determined from 
conductimetric titrations and solubility studies was obtained; CMC' = 
5.36 and 5.25 x 10“3 M, S0LT = 7.04 and 6.55 x 10"3 M and KA = 3.1 and 
4.0 x 10^ for the 2 x 10~3 M cirazoline hydrochloride system (table 
7.10) and CMC' « 7.48 and 7.50 x 10"3 M, S0LT = 10.73 and 11.65 x 
10~3 M and KA = 3.1 and 2.4 x 10^ M"1 for the 5 x 10” 3 M cirazoline 
hydrochloride system (table 7.11). The observed differences in values 
determined by the two techniques may be due to the limited solubility 
data available.
A problem associated with the measurement of conductivity in disperse 
systems is the obstruction effect caused by the presence of non­
conducting particles. This was a potentially serious problem with 
crystalline complex systems but was overcome by continuously filtering 
the mixture using a specially designed glass cell (figure 7.1). This 
assembly was shown to have no effect on aggregation (SDDS CMC at 30°C = 
8.25 x 10“3 M in the absence and 8.21 (S.D. - 0.09) x 10“3 M in the 
presence of the assembly). However, the presence of the glass wool in 
the assembly increased the background conductivity to approximately 
15 - 50 x 10"6 S and an alternative to glass wool would, therefore, be 
preferable.
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The conductimetric titration method involved titrating SDDS into a 
solution of cirazoline hydrochloride and calculating CMC1 and SOL-p 
points from inflexions in the conductivity chart traces. The nature of 
these inflexions was dependent upon the type of complex formed; for the 
solid complex systems (e.g. 2 x 10“^ m cirazoline hydrochloride, 30°C, 
figure 7.2) inflexions were noted at the liquid complex phase 
separation, complex transition, equimolar concentration, CMC* and SOLp 
points.
At the phase separation and phase transition points, conductivity 
curves resembled those for complexation, (section 6.3.2.2). Further 
addition of SDDS to the system beyond the phase transition point 
produced a linear response until the equimolar concentration point was 
approached, (e.g. curve c, figure 7.2). In this region the 
concentration of CIRH+(aq) decreases rapidly and after the equimolar 
concentration point little complex is formed and the majority of 
dodecylsulphate remains as the free ion species, (DDS“(aq)). This 
results in a linear conductivity curve, (figure 7.2) and the Onsager 
plots, (figure 7.3, region C-D) indicate that the added SDDS is 
behaving as a strong electrolyte with little or no interaction between 
added SDDS and formed complex. The equimolar concentration point is 
further evidence of a 1 : 1 stoichiometry in the solid complex.
The sharp inflexion in conductivity curves at the CMC1 (curves b and c 
in figures 7.2 and 7.3) is indicative of formation of aggregates with a 
large aggregation number, micelle equilibration constant and counterion 
binding (see section 1.3.1). The S0L-j> point Is characterised by an 
increase in conductance and a decrease in equivalent conductance.
These conductance changes are consistant with the formation of a more 
highly conducting species, e.g. the formation of smaller and/or more
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hlghly charged aggregates due to dilution of saturated aggregates with 
free dodecylsulphate ions, (DDS“ (h )).
For the liquid complex system (e.g. 2 x 10“^ m cirazoline 
hydrochloride-SDDS system, 40°C, figure 7.4) Inflexions at the phase 
separation point, CMC* and SOL-p were evident. Unlike the solid complex 
system (c.f. figures 7.2 and 7.4) the conductivity curve between the 
phase separation and aggregation points, (region A-D), is non-linear 
with no obvious inflexions at the equimolar concentration point 
(point C). The increase in conductivity at the CMC1 indicates the 
formation of more highly conducting species due to aggregation. This 
is abnormal and may be explained by the liquid nature of the complex 
being solubilized. Partitioning into or more likely, adsorption of 
dodecylsulphate monomers on to the complex phase is likely to occur due 
to the surface active properties of SDDS. The composition of the 
formed complex phase will not, therefore, be of 1 : 1 stoichiometry in 
the presence of excess SDDS but will be rich in dodecylsulphate. When 
the concentration of aqueous dodecylsulphate (DDS~(aq)) reaches the CMC 
aggregation and solubilization of complex occurs. This 'liberates' the 
dodecylsulphate associated with the liquid complex phase resulting in 
increased micellar dodecylsulphate (DDS” (h)) and an increase in 
conductivity. At the SOLf all complex phase has been solubilized and 
the relative increase in conductivity with SDDS concentration, 
therefore, decreases. Adsorption and/or partioning of DDS~(aq) into 
the complex phase is also conslstant with Inflexions in the Onsager 
plot (figure 7.5). This explanation predicts that equation 7.8 for the 
determination of [CIRH+(aq)] (CMC) at the apparent CMC (CMC'), and 
equations 7.10-7.14 for the determination of values are not valid 
for liquid complex systems.
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The effect of cirazoline hydrochloride concentration (0.2 - 5 x 10“^ m) 
on the interaction with SDDS was studied at 30°C by conductimetric 
titration (section 7.1.3.1). Results indicate a potent CMC' decreasing 
effect at low cirazoline concentrations followed by an increase in CMC' 
and SOLt at higher concentrations due to increased formation of 
crystalline complex, (table 7.5, figure 7.6). The true CMC, however, 
continues to decrease with increase in cirazoline hydrochloride 
concentration which is probably due to the increase in inorganic 
electrolyte concentration (Na+ and Cl") with increasing complex 
formation. Addition of electrolyte was shown to have a similar effect 
on reducing the CMC in CIRH-DDS aggregation systems as on the pure SDDS 
system (figure 7.16). The true CMC-ionic strength plots for 2 x 10"^ 
and 5 x 10"^ M cirazoline hydrochloride-SDDS systems are similar and 
indicate that the amount of formed complex per se does not affect the 
CMC of the system, (figure 7.15).
An indication of the structure of formed cirazoline dodecylsulphate 
aggregates was obtained by determining the molar ratio of cirazoline to 
dodecylsulphate moieties within the aggregates. For the system at 
30°C, a plot of micellar cirazoline concentration against micellar 
dodecylsulphate concentration was linear from which the cirazline : 
dodecylsulphate moiety ratio was calculated as 0.60 j 1. This is an 
extremely high ratio of solubilizate to surfactant and indicates a 
strong interaction between cirazoline and SDDS micelles which is 
reflected in the high KA value of 2.9 x 104 (S.D. = 0.2 x 104 ). These 
parameters are similar in value to those reported for CTAB - sodium p- 
toluenesulphate, toluate, benzenesulphonate and phenylphosphate systems 
by Sepulveda et 31^9,90^ (CTAB; organic ion molar ratio = 1 : 0.4 - 1 
: 0.77 and KA « 1.3 - 2.2 x 104 M’1).
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The effect of added electrolyte ( 1 x 10”^ - 1 x 10" ^ M NaCl) on 
aggregation and solubilization was studied by conductimetric titration 
and solubility studies at 30°C, (section 7.1.3.3). The CMC* and SOL-p 
for 2 x 10"3 and 5 x 10"^ M cirazoline hydrochloride-SDDS systems 
decreased with increasing electrolyte concentration (tables 7.10 and 
7.11, and figure 7.15). However, electrolyte primarily affects the 
degree of aggregation and has minimal effect on the association of 
cirazoline to SDDS micelles; the cirazoline s dodecylsulphate moiety 
ratio within the aggregates for both 2 x 10"^ and 5 x 10"^ M cirazoline 
systems was approximately constant at 0.57 (S.D. = 0.05) s 1. This is 
consistant with literature reports of ion exchange between large 
organic ions (such as CIRH4) and small inorganic ions (such as Na+) at 
the surface of micelles, (see section 1.3.1 and 1.5.3.3). Although the 
composition of the aggregates remains approximately independent of 
ionic strength, the solubility of cirazoline in the aqueous phase 
increases with increasing electrolyte concentration resulting in a 
reduction in values, (tables 7.10 and 7.11).
Particle size analysis using photon correlation spectroscopy (section 
7.2) showed that electrolyte had a profound effect on the size of 
cirazoline dodecylsulphate aggregates (table 7.12 and figure 7.17). No 
valid analysis was obtained in the absence of added sodium chloride 
indicating a small aggregate size. Extremely large aggregates were 
detected in the presence of added 0.05 and 0.1 M NaCl, however, (e.g. 
mean diameter = 259 nm for 2 x 10"^ M cirazoline hydrochloride - 
3 x 10“3 M SDDS - 0.1 M NaCl system at 30°C). Maximum aggregate size 
was greater in 0.1 M NaCl than in 0.05 M NaCl systems but in both cases 
corresponded to the S0L<p of the system indicating that size is a 
function of;
-377-
(i) the amount of cirazoline solubilized,
(ii) the degree of cirazoline saturation within the aggregates,
(iii) the concentration of electrolyte.
The increase in particle size of saturated aggregates with increase in 
the amount of solubilized cirazoline suggests that systems containing 
higher initial concentrations of cirazoline hydrochloride will result 
in larger aggregates upon solubilization. This is supported by the 
solubility data for 5 x 10“^ M cirazoline hydrochloride-SDDS systems in 
the presence of 0.05 and 0.1 M NaCl (table 7.9 and figure 7.14).
These samples were filtered through a 0.45 pm filter to remove excess 
complex before assay. As the SDDS concentration approached the SOL-p 
for the system, the cirazoline assay values became erratic and were 
lower than predicted. These data are consistant with the formation of 
extremely large aggregates (>450 nm) which were filtered from solution 
during sample preparation.
Larger aggregate size in cirazoline-SDDS-NaCl system is also 
indicated by the highly viscous nature of solubilized systems. Visual 
observation indicated that in the presence of 0.05 and 0.1 M NaCl, 
systems became increasingly viscous and turbid during the 
solubilization process. This turbidity and viscosity was reduced in 
systems well above the SOLp of the system, (e.g. 5 x 10"^ M cirazoline 
systems, table 7.9).
Temperature was found to have a profound effect upon aggregation. 
Micellization and solubilization was studied over the range 10 - 50°C 
by conductimetric titration at an initial cirazoline hydrochloride 
concentration of 2 x 10"^ M. for the solid complex system (< 35°C) 
both the true and apparent CMC (CMC') decreased with increase in 
temperature. The sensitivity of the CMC to temperature change is
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ref lected in the unusually high enthalpy values for micellization, 
A H ° m » (11-42 kJ mol“l, table 7.7). For pure SDDS, A H ° m has been 
reported as -1.3 to *2.2 kJ mol’*^- at 25°C^^ and the change in CMC with 
temperature is slight in the range 20 - 30°C but increases at higher 
and lower temperatures^-, (figure 1.9). The continuous fall in CMC 
values with rise in temperature for the systems studied here is 
probably due to the increase in cirazoline dodecylsulphate aqueous 
solubility with temperature (figure 6.17). The presence of small 
quantities of cirazoline in the aqueous phase has a potent CMC 
decreasing effect, (figure 7.6), and increase in temperature will, 
therefore, reduce the CMC of the system. The effect of temperature on 
A S ° m is also unusual; pure surfactant systems usually exhibit a 
decrease in AS°^ with increase in temperature due to the reduction in 
water structuring.
The effect of temperature on the ability of aggregates to solubilize 
pre-formed cirazoline dodecylsulphate crystalline complex is shown by 
the rapid fall in S O L - j -  as temperature is increased from 1 0 °  to 3 5 ° C  
(figure 7 . 8 ) .  This increase in solubility is brought about by an 
increase in both aqueous cirazoline solubility (tables 6 . 7  and 7 . 6 )  and 
the interaction between C I R H + ( a q )  and D D S ” ( j j ) (table 7 . 6 ) ;  the molar 
ratio of cirazoline to dodecylsulphate moieties within the aggregates 
increases from 0 . 2 1  ; 1  at 1 0 ° C  to 0 . 6 6  j 1  at 3 5 ° C .  The result of 
these two factors is a decrease in the affinity of C I R H ' f ( a q )  to D D S " ’ ( ^ )  
as shown by the fall in values from 7 . 2  x 1 0 ^  M"1 at 1 0 ° C  to 2 . 7  x
10^ M“1 at 35°C, (table 7.6 and figure 7.11). At low temperatures the
1
association process is characterised by large positive entropy and 
enthalpy changes. Unlike the micellization process the magnitude of 
these parameters decreases with temperature increase, (table 7.7).
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A sharp inflexion in CMC* and SOL-p-temperature curves is observed 
corresponding to the phase transition temperature of the systems, 
(figure 7.8). The temperature of transition is slightly lower in these 
systems compared to the transition temperature of pure complex systems 
(36°C versus 39 - 44.6°C); it is not clear whether this is due to a 
real effect of excess SDDS in the system or to the formation of 
metastable systems. The effect of temperature on the CMC* and SOL<p in 
liquid complex systems is less pronounced than with the solid complex 
system and micellization and solubilization appear to be equally 
affected by temperature. This inflexion in the CMC'-temperature curve 
is probably due to the change in complex solubility characteristics, 
(figure 6.17).
Clear inflexions in the plots of CMC (Van't Hoff plot, figure 7.9), KA 
(figure 7,11 and Van't Hoff plot, figure 7.12), and aggregate ratio, 
(figure 7.10), against temperature are also apparant. However, the 
values of these parameters for aggregation and solubilization rely on 
the validity of equations 7.8 - 7.14. These equations are not thought 
to be valid for the liquid complex systems due to partitioning and/or 
adsorbtion of dodecylsulphate into the complex phase. Such effects 
would lead to erroneously high CMC, aggregate ratio and values when 
using the treatment described in section 7.1.1.
9.2.4 Structure of Cirazoline Dodecylsulphate Systems
The interactions and formed structures possible within cirazoline 
hydrochloride-SDDS systems are outlined in figure 9.4. At very low 
concentrations of cirazoline and dodecylsulphate ion-association occurs 
to form electrically neutral ion pairs, CIRH-DDS(aq) but complex and 
micellar (pseudo)phases are absent. The equilibrium between the free 
ions and the ion-pair is quantified by the ion-pair association
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Figure 9.4 - Possible interactions and structures in cirazoline 
dodecylsulphate systems.
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constants, (Kass or K^p equations 1.53 and 1.54), and the corresponding 
dissociation constant (K<Jiss» equation 1.64). At concentrations of SDDS 
below the CMC' of the system an increase in either cirazoline or SDDS 
concentration leads to increased ion-pair formation, (equation 1.54), 
until the apparant solubility product (Ks* equation 1.70) is reached.
At this point phase separation occurs and cirazoline dodecylsulphate 
complex is formed. Complex may be crystalline or liquid (coacervate) 
in nature dependent upon temperature. However, if the CMC' of the 
system is less than the SDDS concentration necessary to exceed the 
solubility product then phase separation will not occur.
Interaction between complex and free cirazoline and/or dodecylsulphate 
ions is possible due to adsorption and/or partitioning into the complex 
phase. This is thought to be more important for the liquid complex 
systems in the presence of excess SDDS and adsorption onto complex 
crystals is thought to be minimal. Addition of excess SDDS to the 
system (i.e. [SDDS] > [CIRHC1]) leads to an increase in free 
dodecylsulphate ion (DDS” (aq)) concentration and aggregation occurs at 
the CMC of the system (Kjj, equation 1.33). Formation of the SDDS 
micellar pseudophase allows its interaction with CIRH-DDS(aq), (Kp, 
equation 1.36) and CIRH+(aq), (K^» equation 1.83). Interaction of 
cirazoline with the dodecylsulphate aggregates by either mechanism 
leads to dissolution of complex in order to maintain the CIRH-DDS(aq) 
and CIRH+(aq) concentration. At the SOLp point sufficient micellar 
pseudophase is present to completely dissolve the complex and the 
system clears to form a micellar solution.
Between the CMC1 and SOLp points both aqueous and micellar (pseudo) 
phases are saturated with respect to cirazoline. Large aggregates are 
thought to be formed in this region probably due to cooperative
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interaction between cirazoline aromatic moieties within the aggregates, 
(figure 9.4), Further addition of SDDS above the SObp leads to 
formation of unsaturated aggregates and a reduction in the 
concentration of CIRH-DDS(aq) and CIRH+(aq). Aggregate size decreases 
due to reduced interaction between the cirazoline aromatic moieties 
until, in dilute cirazoline micellar solutions, approximately spherical 
micelles are formed as evidenced by observed viscosity changes.
The interactions and system of events just described refer to 
equilibrated systems. However, above the solubility product metastable 
systems may occur due to slow nucleation and/or slow rate of complex 
crystal formation. Metastable systems may take the form of liquid 
complex (coacervate) or large aggregates leading to viscous micellar 
solutions (sections 1.4.3.2 and 6.3.1). These phenomena are 
particularly important when solutions of cirazoline hydrochloride and 
SDDS are bulked (section 6.3.1) and during conductimetric titrations 
(sections 6.3.2 and 7.1.2.2).
Figure 9.5 shows predicted phase diagrams for the cirazoline 
hydrochloride-SDDS system at 10 - 50°C together with that in the 
presence of 0.1 M NaCl at 30°C. The aqueous solution - 
suspension/coacervate boundary was calculated using equation 1.70 and 
the Kg' values in table 6.7, (Ks* at 30°C for the systems in 0.1 M NaCl 
was calculated as 1.86 x 10“^ moles^ litre^ using equations 1.70 and 
1.16). The aqueous micellar solution boundary represents the CMC* of 
the systems and the suspension/coacervate - micellar solution boundary 
represents the SOL-p of the system. These values for the system at 30°C 
with no added electrolyte were taken from table 7.5. Values for other 































Cirazoline Hydrochloride Concentration (M)
Figure 9.5 - Predicted phase diagram for cirazoline hydrochloride-
SDDS systems at (a) 10°C, (b) 30°C, (c) 50°C and (d) 30°C 
in the presence of 0.1 M NaCl. Solid lines represent the 
suspension/coacervate - aqueous/micellar solution 
boundary; dashed lines represent the aqueous solution - 
micellar solution boundary.
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An increase in temperature increases the solubility of cirazoline in 
SDDS systems due to an increase in aqueous solubility (Ks'), a decrease 
in the CMC* of the system and an increase in the capacity of aggregates 
to interact with or 'solubilize* cirazoline. Addition of electrolyte 
also increases the solubility of cirazoline in SDDS systems although 
addition of sodium chloride does not affect the capacity of aggregates 
to solubilize cirazoline.
At moderately high electrolyte concentrations (0.05 and 0.1 M) 
extremely large saturated aggregates formed which resulted in a viscous
system (section 7.1.3.3). These structures may result from
flocculation of cylindrical aggregates due to a reduction in charge 
repulsion. Similar effects have been noted for a variety of large 
organic ion-ionic surfactant systems, (section 1.4.3.2). A highly 
interactive meshwork of aggregates may then result due to interaction 
of aromatic moieties from different aggregates or regions of aggregates 
resulting in an increased viscosity of the system. Birefringence was
not detected in these systems indicating the absence of liquid
crystalline phase (section 7.1.3.3).
The ability of the organic ion to associate with aggregates and produce 
viscous solutions may be due to the structure of the ion and its 
ability to interact at the surface of the aggregates. Hence simple 
aromatic moieties (e.g. in tolazoline, tosylate and benzenesulphonate 
ions) may interact strongly to form rod-like micelles and viscous 
solutions even in the absence of added electrolyte. Bulky organic ions 
may have limited self-interaction or cooperativity resulting in 
decreased association.
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9.3 THE EFFECT OF SDDS ON THE HYDROLYSIS OF CIRAZOLINE
The effect of SDDS concentration on the hydrolysis of cirazoline at 
pH 7.0 was studied at two initial cirazoline hydrochloride 
concentrations (0.2 and 2 x 10“^ M) and at two temperatures involving 
formation of crystalline complex (30°C) and liquid complex (50°C). The
n
effect of added electrolyte (1 x 10“^ M - 0.1 M Nacl) on the hydrolysis 
of cirazoline in the 2 x 10“^ M cirazoline hydrochloride - 7 x 10"^ M 
SDDS system was also investigated. Kinetic studies were performed 
using the manual pH stat technique in the absence of added buffer 
salts. Aqueous hydrolysis of cirazoline under these conditions was 
shown to be due to specific base catalysed hydrolysis of the protonated 
species (section 8.3.2 and 9.1). The cirazoline degradation product, 
CPAE, was shown to have similar properties to cirazoline with respect 
to its interaction with SDDS (see K^p, K s' values, section 6) and will, 
therefore, cause minimal disruption to the structure of the system. 
However, kinetic studies were generally not followed beyond 80% 
residual cirazoline concentration to avoid large amounts of CPAE 
formation.
In the absence of added electrolyte, moderately low concentrations of 
SDDS had a potent stabilizing effect; e.g. for the 2 x 10“^ M 
cirazoline hydrochloride system at 30°C, 0.008 M SDDS resulted in a 66 
fold increase in stability (table 8.11); addition of 0.03 M SDDS to 
2 x 10”3 m  cirazoline hydrochloride increased its stability at 30°C by 
220 times (table 8.12), and addition of 0.06 M SDDS to 2 x 10“^ M 
cirazoline hydrochloride resulted in a 126 fold increase in stability 
at 50°C (table 8.13).
A knowledge of K^p, K s', CMC* and SOL-j- and careful selection of 
concentrations enabled the contribution of each cirazoline containing
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species to be evaluated, i.e. free aqueous ion, C I R H 4 ( a q) ;  ion pair, 
C I R H - D D S (aq); complex, C I R H - D D S (c); and solubilized cirazoline 
CIRH-DDS(m) species, (figure 9.4). Degradation may proceed at 
different rates for each species leading to equation 9.1 which defines 
the overall first order rate constant for protonated cirazoline in the 
presence of S D D S ,  ksDDS!
kSDDS * k (aq)»f(aq) + k(ip)«f(ip) 4 k (c)*f(c) 4 k(M)*f(M) (9.1)
Where k ( a q )» k(ip)» k ( c ) and k(jj) are the relevent first order rate 
constants and f(aq), f(ip)» f(c) anc* f(M) are tke fractions of 
CIRH4(aq), CIRH-DDS(aq), CIRH-DDS(c) and CIRH-DDS(M ) in the overall 
system respectively.
The effect of ion-pair formation was studied using the 2 x 10“^ M 
cirazoline hydrochloride S D D S  system. S D D S  concentrations up to 5.9 x 
10“^ M resulted in formation of an homogeneous aqueous solution as 
concentrations of cirazoline and dodecylsulphate are below the 
solubility product and C M C *  of the system (figure 9.5). The observed 
stability factor is close to unity for these systems indicating that 
formation of ion-pairs does not significantly influence the rate of 
cirazoline hydrolysis, (table 8.11 and figure 8.13), and that 
k (ip)«f(ip) “ k (aq)*f(aq)* U^se equations 1.55 and 1.70 predicts 
that [C I R H - D D S (aq)J = 2.7 x 10”^ M  (f(ip) = 0.14) at the phase 
separation point and the vast majority of cirazoline is, therefore, 
present as C I R H 4 ( a q ).
Equation 9.1 may be simplified using the assumptions that formed 
complex is inert (i.e. k ( a q) >> k(c) “> 0) end R(ip).f(ip) = 
k (aq)*f(aq)» equation 9.2:
kSDDS = k(aq)«f(aq) 4 k(M)*f(M) (9.2)
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Equation 9.2 may be written in terms of a stability factor (see section 
8.3.6):
k(aq) k(aq)
Stability Factor = ----- = - ■ ■ —  (9.3)
kSDDS k(aq)«f(aq) * k(M)*f(M)
and below the CMC' of the system when f(n) * 0, equation 9.3 further 
reduces to equation 9 .A:
k(aq) 1
Stability Factor = 1 ■ ** ■■ (9.4)
kSDDS f(aq)
The stabilizing effect due to complex formation was investigated by 
studying systems between the complex separation point and the CMC' of 
the system. In this region f(n) * 0 and the amount of formed complex - 
and hence concentration of remaining free aqueous cirazoline ion - was 
calculated using equation 1.71. Theoretical stability factors for each 
system were calculated using equation 9.4 and are shown alongside 
observed stability factors (from tables 8.11 - 8.13) and calculated 
f(c) and f(aq) values in tables 9.2 —  9.4.
Calculation of the contribution of the solubilized cirazoline species 
to the overall reaction requires a knowledge of k(fl) and f(n). These 
parameters were calculated using the Menger and Portnoy kinetic model 
(section 1.5.3.1) and the Lineweaver-Burke equation (equation 1.91). 
Table 9.5 shows the transformed experimental data obtained in this 
study and derived and k(jj) values for each of the experimental 
systems. Only data above the SOLf were used and data for the higher 
SDDS concentrations at 50°C were excluded because of high ionic 
strength effects. Figure 9.6 shows the Lineweaver-Burke plots for each 
system. f(M) values for each system were determined using the 
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Table 9.2 - The distribution of cirazoline and observed and theoretical 
stability factors for the 2 x 10”4 M cirazoline 
hydrochloride-SDDS system at 30°C. f(c)» f(M) anc* ^(aq) =
fractions of cirazoline distributed in the complex, 
micellar and aqueous (pseudo)phases respectively. 
Theoretical stability factors were calculated using 
equation 9,3 and k(aq) = 2,00 x 10~8 s“l, k(fl) s 1.82 x 
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Table 9.3 - The distribution of cirazoline and observed and theoretical 
stability factors for the 2 x 10"3 M cirazoline 
hydrochloride-SDDS system at 30°C. f(c)» f(M) anc* ^(aq) =
fractions of cirazoline distributed in the complex, 
micellar and aqueous (pseudo)phases respectively. 
Theoretical stability factors were calculated using 
equation 9.3 and k(aq) = 2.00 x 10"^ s“ l, k(fl) = 6.82 x 
10-9 s"1, Ka  - 3.28 x 104 M"1, CMC' = 5.36 x 10"3 M and 
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Table 9.4 - The distribution of cirazoline and observed and theoretical 
stability factors for the 2 x 10“3 M cirazoline 
hydrochloride-SDDS system at 50°C. f(c)» f(M) anc* ^(aq) =
fractions of cirazoline distributed in the complex, 
micellar and aqueous (pseudo)phases respectively. 
Theoretical stability factors were calculated using 
equation 9.3 and k(aq) = 3.10 x 10”3 s~l, k(M) * 1.63 x 
10“7 s"1, Ka = 9.380 x 103 M"1, CMC' = 4.00 x 10“7 H and 
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Table 9.5 - Calculated KA and k(^) values for (a) 2 x 10“4 M cirazoline 
hydrochloride-SDDS systems at 30°C, (b) 2 x 10”3 m 
cirazoline hydrochloride-SDDS systems at 30°C and 
(c) 2 x 10"3 m cirazoline hydrochloride-SDDS systems at 
50 °C.
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together with the stability factors calculated using equation 9.3.
The fraction of cirazoline present as complex, micellar and aqueous 
species over the solubilization range for the 2 x lO”^ M cirazoline 
hydrochloride-SDDS system (30°C) was calculated assuming?
(i) [CIRH+ (aq)] = constant;
(ii) [CIRH-DDS(M )] a [DDS’ (M )];
(iii) [CIRH-DDS(c)] at CMC' - [CIRH-DDS(M )] at S0LT .
Observed and theoretical stability profiles for each system generally 
show good agreement (figures 9.7 to 9.9) and indicate equations 9.2 and
9.3 are satisfactory in describing the hydrolysis of cirazoline in the 
presence of SDDS. The predicted stabilizing effect due to complexation 
in the systems at 30°C is slightly less than that observed 
experimentally indicating that the K s' value of 1.17 x 10”^ moles^ 
litre^ may be slightly too high or that 1pre-micellar* aggregation 
occurs below the CMC1 of the system. For the 2 x 10"^ M cirazoline 
hydrochloride system at 30°C the decrease in stability due to initial 
aggregation is slightly more than predicted using equation 9.3. This 
may be due to experimental error or, alternatively, it may indicate a 
reduced stabilizing effect of aggregates saturated with cirazoline 
compared to unsaturated aggregates formed at higher SDDS 
concentrations.
The predicted stabilizing effect due to liquid complex formation at 
50°C is greater than that observed experimentally and the expected 
decrease in stability in the initial solubilization region is not 
apparent. These discrepancies may be explained by
adsorption/partitioning of dodecylsulphate into the complex phase (see 
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Figure 9 .6 - The effect of micellar SDDS on the hydrolysis of
cirazoline at each initial cirazoline hydrochloride 
concentration and temperature shown. Data plotted 























3 x K T 4 1 x 10"*3 3 x 10~3 1 x 10
SDDS Concentration (M)
Figure 9.7 - Observed (—  ® — ) and theoretical (— O — ) 2 x 10"^ M
cirazoline hydrochloride stability-SDDS concentration 
profiles. Plot of stability factor (k(aq)/ksDDs) against 
SDDS concentration for the hydrolysis at pH 7.0, 30°C. 





















1 x 10~3 3 x K T 3 1 x 10"2 3 x 10-2 1 x 10
SDDS Concentration (M)
Figure 9.8 - Observed (— A — ) and theoretical (— A — ) 2 x 10"3 M
cirazoline hydrochloride stability-SDDS concentration 
profiles. Plot of stability factor (k(aq)/kSDDs) against 
SDDS concentration for the hydrolysis at pH 7.0, 30°C. 























Figure 9.9 - Observed ( —  ■ — ) and theoretical (-□--) 2 x 10”3 H
cirazoline hydrochloride stability-SDDS concentration 
profiles. Plot of stability factor (k(aq)/kSpDs) against 
SDDS concentration for the hydrolysis at pH 7.0, 50°C. 
Theoretical profiles calculated using equation 9.3.
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predicted by the Menger and Portnoy treatment and may be due to the 
high ionic strength of concentrated SDDS solutions ( 0,1 M),
values for the system at 30°C determined using the 0.2 and 
2 x 10" ^ m cirazoline hydrochloride-SDDS kinetic data (2.6 and 3.3 x 
104 M"1, table 9.5) are in good agreement with values determined by 
conductimetric titration (mean 2.9 (S.D. 0.2) x 104 M"l, table 7.5) and
solubility studies (mean 3.2 x 104 M~l, table 7.10 and 7.11). The
value for the system at 50°C (0.94 x 104 M"l) is lower than the value
determined by conductimetric titration (2.2 x 104 M"l, table 7.6)
which is further evidence for the inaccuracy of values determined by 
conductimetric titration for liquid complex systems.
Micellar stabilization of cirazoline may be associated with several 
mechanisms e.g.:
(a) proximity effects, i.e. a reduction in the pH at the surface of
micelles due to repulsion of hydroxyl ions and attraction of
hydronium ions, (sections 1.1.2, 1.5.1.2 and 8.3.2);
(b) medium effects, (sections 1.1.2 and 1.5.1.1) e.g.:
(i) changes in the dielectric constant and/or ionic strength at 
the surface of micelles (section 8.3.4);
(ii) formation of stable neutral cirazoline species (sections 4 
and 8.3.2);
(iii) a change in hydrolysis mechanism, e.g. enhanced exocyclic 
methylene exchange (sections 5 and 9.1).
Mechanisms (b)(i) and (b)(ii) are thought unlikely to provide the 
degree of stability observed experimentally. The imidazoline and 
aromatic moieties in cirazoline are fairly polar and are unlikely to be
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buried deeply in the micelle (sections 1.3.2.3 and 1.4.3.2). The 
presence of anionic micelles usually increases the pKa' of solubilized 
weak bases (section 1.5.1.1.) and no decrease in bulk pH was apparant 
which would accompany a transition from protonated to neutral 
cirazoline species (equation 4.1). Although no information is 
available as to the factors affecting the rate of exocyclic methylene 
exchange, (mechanism (b)(ii)), proximity effects are thought to be the 
prime mechanism for cirazoline stability in SDDS micelles 
(mechanism (a)). Support for this is provided by the effect of 
electrolyte on the reactivity of solubilized cirazoline and the 
calculated k(^) values at 30°C and 50°C (table 9.1). Although the
values for k(jj) at 30°C calculated from the 0.2 and 2 x 10"® M
cirazoline hydrochloride-SDDS data are not in very good agreement,
(1.82 and 0.68 x 10"® s"l respectively), the mean value of 1.3 x 10"® 
s"1 is identical to the calculated value for the uncatalysed (neutral 
water) reaction at 30°C (kg, table 8.8 and equation 1.23). The k(^) 
value at 50°C is also similar to the predicted kg value (1.9 x 10" ^ s"l 
and 1.3 x 10"^ s"l respectively) and indicates that the neutral water 
reaction is dominant at the micelle surface (i.e. k(j^ ) * kg) which 
requires a reduction of >3 pH units at the micelle surface 
(figure 9.1).
Added electrolyte is known to reduce the degree of micellar effects on 
bimolecular reactions involving ionic reagents due to competition for 
micelle binding sites between the reactive ions and the added
unreactive ions (section 1.5.2.2). The results in table 8.14 show a
marked decline in the ability of 0.007 M SDDS to stabilize 2 x 10"® M 
cirazoline hydrochloride upon addition of sodium chloride. A stability 
factor of 7.5 was estimated when calculations were compensated for the 
increase in aqueous stability and micelle concentration in 0.1 M NaCl.
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The decreased stability in electrolyte solution is probably due to an 
increase in k(fl) resulting from an increase in the local pH at the 
surface of the aggregates.
Using the assumptions that k(j{) = kg it is possible to predict the 
effect of SDDS on cirazoline hydrolysis at other initial cirazoline 
hydrochloride concentrations, pHs and temperatures using the values 
for K^, k(aq), kg and K s* in tables 7.6, 8.6-8.8 and 6.7 to calculate 
cirazoline species fractions and thus solve equation 9.3.
Figures 9.10-9.12 show predicted stability profiles for 2 x 10”^ M 
cirazoline hydrochloride-SDDS systems at 10-30°C, pH 7.0; pH 5-7 at 
30°C; and for 0.2 - 5.0 x 10"^ M cirazoline hydrochloride-SDDS systems 
at pH 7.0, 30°C.
Temperature is thus predicted to have a profound effect on the degree 
of stabilization afforded by both complexation and solubilization 
mechanisms, (figure 9.10). The stabilizing potency associated with 
complexation decreases with increasing temperature due to an increase 
in Kg' (figure 6.17). Micellar stabilizing potency increases with 
increasing temperature, however, due to an increase in the difference 
between the uncatalysed (kg or k(fl)) and base catalysed (k£) rate 
constants (table 8.8). A decrease in the CMC1 of the system with 
increase in temperature also shifts solubilization effects to lower 
SDDS concentrations.
pH will not significantly affect the degree of stabilization due to 
complex formation as K s* is predicted to be independent of pH except at 
very low or high pHs when associated ionic strength effects will 
become significant. The stabilizing effect due to solubilization is 
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Figure 9.10 - Predicted effect of temperature on the cirazoline
hydrochloride stability - SDDS concentration profile. 
Plot of stability factor (k(aq)/ksDDs) against SDDS 
concentration for the hydrolysis of 2 x 10"  ^ M 
cirazoline hydrochloride at pH 7.0 and each temperature 
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9.11 - Predicted effect of pH on the cirazoline hydrochloride 
stability - SDDS concentration profile. Plot of 
stability factor (k(aq)/ksDDS) against SDDS concentration 
for the hydrolysis of 2 x 10"3 M cirazoline hydrochloride 












Figure 9.12 - Predicted effect of cirazoline concentration on the
stability - SDDS concentration profile. Plot of
stability factor (k(a(J)/kSDDS) against SDDS
concentration for the hydrolysis at pH 7.0, 30°C and each 
initial cirazoline hydrochloride concentration shown. 
Profiles calculated using equation 9.3
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system will be approximately independent of pH but as pH decreases 
from 7.0 to 5.0, k£ [0H“ ] -> kQ (= k(jj)) and the stabilizing effect due 
to incorporation within micelles is lost.
Initial cirazoline hydrochloride concentration is predicted to have 
little effect on stability at high SDDS concentrations as under these 
conditions the vast majority of cirazoline is incorporated into SDDS 
micelles (figure 9.12). Stabilization in the complexation and initial 
solubilization regions is dependent upon initial cirazoline 
hydrochloride concentration, however, due to changes in the equimolar 
concentration and CMC* of the system.
It must be noted that a decrease in temperature and/or pH increases the 
overall stabiliy of cirazoline (i.e. kgDDs decreases) and the degree of 
stabilization required is, therefore, not as great. However, the 
predictions shown in figures 9.10-9.12 indicate that care must be taken 
in extrapolating stability effects measured for one system to systems 
at different pH, temperature and/or initial cirazoline hydrochloride 
concentrations.
9.4 CONCLUSIONS
This study has shown that:
1. Cirazoline degrades in aqueous solution by uncatalysed and specific 
base catalysed hydrolysis of the protonated species. No 
significant acid catalysed hydrolysis or hydrolysis of the 
cirazoline free base species occurs. Equation 8.4 is satisfactory 
in characterising the stability pH profile. These results support 
the findings of Martin and Parcell^®, Savignac et al^9 and 
Ross et all® with respect to the mechanism of imidazoline 
hydrolysis.
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2. Steric effects, inductive effects and exocyclic methylene acidity 
have been identified as factors contributing towards the stability 
of medicinal 2-substituted imidazolines. The poor stability of 
cirazoline (and fenoxazoline) is due to the presence of an ether 
linkage in the 2- substituent.
3. The interaction between cirazoline and dodecylsulphate ions in 
aqueous solution may be described in terms of ion-pair formation, 
complexation and micellization and solubilization. Aqueous, 
crystalline complex, liquid complex (coacervate) and micellar 
(pseudo)phases may all exist, the relative amounts of each being 
dependent upon the concentration of cirazoline hydrochloride and 
SDDS, temperature and presence of electrolyte. Metastable liquid 
complex and/or viscous solutions of aggregates may be formed upon 
rapid addition or bulk mixing of cirazoline hydrochloride and SDDS. 
Similar physicochemical phenomena are observed in cirazoline 
alkylsulphate (Cg - C14) systems and in a range of imidazoline 
dodecylsulphate systems.
4. Cirazoline dodecylsulphate ion-pair association constant, 
crystalline and liquid complex (coacervate) solubility products,
CMC values, and the amount of SDDS required to solubilize 
cirazoline may be rapidly and reproducibly determined using an 
automated conductimetric titration technique. Cirazoline-micelle 
association constants and cirazoline:dodecylsulphate moiety ratios 
in aggregates may also be determined for systems in the presence of 
crystalline complex.
5. A temperature of transition from crystalline complex to stable 
liquid complex (coacervate) occurs for a range of cirazoline 
alkylsulphate systems. The transition temperature is a function
-405-
of alkylchain length and increases with increased hydrophobicity of 
the surfactant. The solubility of both complex forms increases 
with temperature and decreases with surfactant alkylchain length. 
Solubility and transition temperature are also a function of the 
Imidazoline structure.
6. Cirazoline interacts strongly with micellar SDDS to form aggregates 
rich in cirazoline under saturated conditions. Added electrolyte 
decreases the CMC of the system, increases aggregate size and the 
viscosity of the system but has little effect on the interaction 
stoichiometry of cirazoline with micellar SDDS. Increased 
temperature decreases the CMC of the system and increases the 
capacity of SDDS micelles to incorporate cirazoline.
7. Cirazoline dodecylsulphate ion-pair formation has little or no 
effect on cirazoline stability but complexation and incorporation 
into SDDS micelles are potent mechanisms for stabilization at pH 7, 
30°C in the absence of added electrolyte or buffer salts.
Equation 9.2 allows prediction of the effect of SDDS on the rate of 
hydrolysis of cirazoline. Addition of electrolyte, reduction in
pH (<7) and temperature are predicted to reduce micellar 
stabilizing effects. However, the latter two parameters are potent 
mechanisms for reducing the overall rate of hydrolysis.
8. Micellar stabilization is considered to be due to repulsion of 
hydroxide ion from the surface of micelles (proximity effects) and, 
at pH <7, the rate of hydrolysis within the micelles is governed by 
the rate of the uncatalysed hydrolysis reaction.
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9.5 SUGGESTIONS FOR FUTURE WORK
The use of NMR as a tool in the elucidation of imidazoline hydrolysis 
and proton exchange mechanisms has been demonstrated. Further work in 
this area aimed at refining the technique, further testing of the 
proposed mechanism and expanding the research into a wider range of 
2-imidazoline structures would be useful. Experiments at, e.g. pH 7.0, 
50°C might enable simultaneous monitoring of exchange and ring cleavage 
reactions.
Work reported in this thesis and by a variety of other workers indicate 
that crystalline complex formation is not restricted to cirazoline 
dodecylsulphate systems. Factors affecting crystalline complex 
formation, solubility, temperature of transition to liquid complex 
(coacervate) and formation of metastable systems for a range of organic 
ion-ionic surfactant systems should be investigated further using such 
techniques as automated conductimetric titration, viscosity, DSC and 
hot stage microscopy techniques. Further probing for liquid crystal 
phases should also be considered.
A better characterisation of the solubilization region in liquid 
complex systems would be a useful area of future research, e.g. use of 
solubility and turbidity techniques to confirm CMC and SOL-p points. 
Inflexions in conductivity curves might be better defined in systems 
containing higher initial cirazoline hydrochloride concentrations. 
Replacement of glass wool as a means of entraping formed solid complex 
during conductimetric titrations would be advantageous and might allow 
more detailed analysis of conductivity curves.
The concept of organic ion cooperativity at the surface of aggregates 
should be tested e.g. by determining values under unsaturated
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conditions and extending the study to a variety of organic ion 
structures with varying degrees of aromaticity and hydrophobicity.
Production of 'metastable' and 'equilibrium' cirazoline hydrochloride- 
SDDS phase diagrams at a range of temperature and electrolyte 
concentrations and further investigation into the high viscosity of 
aggregated systems would be useful.
Kinetic studies into the effect of SDDS on the hydrolysis kinetics and 
mechanism of micellar stabilization of cirazoline should be repeated in 
more detail and extended to higher SDDS concentrations. This may be 
possible for solid complex systems by using slightly higher pH and 
temperature conditions e.g. pH 7.5, 35°C. The validity of equation 9.2 
in predicting stability-SDDS concentration profiles should be further 
tested, e.g. at a variety of pH, temperature and initial cirazoline 
hydrochloride concentrations.
Finally, the effect of pharmaceutical excipients such as buffer salts, 
electrolyte and non-ionic additives (e.g. alcohols, glycerol) on the 
interaction and stabilizing effect of SDDS would be a useful area of 
further work.
APPENDIX 1
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Figure 1.1 - Proton NMR spectrum for (a) cirazoline-octylsulphate,





Chemical Shift ( ppm)
Figure 1.2 - Proton NMR spectrum for (a) cirazoline-dodecylsulphate, 
(CIRH-DDS) and (b) cirazoline-tetradecylsulphate, 
(CIRH-TDS) in CDCI3 .

















Figure II.1 - Conductimetric titration trace for SDDS (0.01 M)
against cirazoline hydrochloride (1.5 x 1 0 m) at 50°C, 
Flow rate = 50.48 (il min“ l, chart speed = 12 cm hr"-*-, 






Figure 11,2 - Conductimetric titration trace for SDDS (0.01 M) against cirazoline hydrochloride (1 x 1 0 m) 
at 30°C. Flow rate = 20.38 pi min“ l, chart speed = 12 cm hr“ ^, chart conductivity range =











Figure 111,1 - Conductimetric titration trace for SDDS (0.2 M) against 
double distilled water at 30°C. Flow rate =
50.48 ill min"l, chart speed = 12 cm hr” -*-, chart 
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Figure III.2 - Conductimetric titration trace for SDDS (0.2 M) against
line hydrochloride (2 x 10"^ M) at 30°C. Flow ratecirazo
chart speed = 12 cm hr'20.38 pi min' chart





Figure III.3 - Conductimetric titration trace for SDDS (0.2 M) against cirazoline hydrochloride (5 x 10“^ M) 
at 30°C. Flow rate = 20.38 pi min"l, chart speed = 12 cm hr“ l, chart conductivity range =
0 - 1000 x 10“6 s;
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Figure III .4 - Conductimetric titration trace for SDDS (0.1 M) against 
cirazoline hydrochloride ( 2 x 10”-* m) at 40°C. Flow
rate = 12.39 jj. 1 min“ l, chart speed = 3 cm hr- *, chart
conductivity range = 0 - 500 x 10“^ S.
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